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ABSTRACT 
Pharmaceutical managers and sales representatives (PSRs) rely greatly on relationship 
marketing activities in order to develop relationship quality (RQ) with physicians. The aim 
is to influence physicians' prescription behaviour to engender positive sales outcomes 
based on their RQ. There is little known about how PSR-physician RQ develops in the 
context of Pakistan, or how far RQ helps a PSR to achieve objective outcomes for a firm (i.e. 
positive sales), when it interacts or interplays with product price, particularly in specific 
economic conditions such as those of patients in Pakistan - who pay directly for their 
medicines. Drawing on available literature on RQ, this research firstly aims to discover 
what determinants are required and why they help to achieve RQ between a PSR and 
physician. Secondly, by integrating the literature on physician's prescription decision 
making, it seeks to identify how far product price affects RQ’s objective (or sales) outcomes 
under contingent patient economic conditions. 
Based on critical realism's guiding philosophical principles, this qualitative research 
adopted an embedded case study strategy; and using a semi-structured interview method 
22 participants (i.e. pharmaceutical sales managers and physicians) from urban and rural 
sales areas of Multan in Pakistan were purposively interviewed in two sequential phases. 
Findings revealed that along with determinants identified through RQ literature, i.e. firm's 
image product quality, PSR's visit frequency, product knowledge, ethical selling behaviour 
and relationship investments, some additional determinants such as PSR's appearance, 
communication, and flexible responses to varied situations were also required by a PSR to 
achieve RQ with physicians in the context of Pakistan. These determinants were essential 
in order to fulfil physicians' technical, as well as social needs. When a PSR fulfils these 
physician needs, both physician's self-interest and emotional sentiments for a PSR are 
engendered, which serve as mechanisms that further foster the physician's reciprocity 
mechanism for a PSR. The presence of a reciprocity mechanism for a PSR thus influences 
the physician's prescription decision making in terms of a PSR's product. However, 
findings also indicated that higher product price serves as a barrier, which mitigates the 
effect of reciprocity mechanism because of the presence of more prevalent mechanisms, 
i.e. patient's non-affordability due to overall poor economic conditions. This engenders 
further mechanisms such as physician's emotional sentiments for patients, physician's self-
interest in patient's wellbeing, their retention and physician's own practice viability. 
Therefore, the price of a product did not affect subjective or behavioural outcomes, such as 
physicians providing more time and priority to the PSR, when they had RQ. However, PSR-
physician RQ worked more effectively for PSR in terms of achieving his objective (sales) 
outcomes, when product price and quality was competitive.  
Thus, the findings of this research suggest that RQ determinants are contingent to the 
research context and the context of the research should be taken into account. 
Furthermore, RQ's objective outcomes cannot be seen in isolation or by just predicting that 
RQ between the partners will ultimately lead to objective outcomes. For its comprehensive 
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understanding and implementation, it is crucial to investigate other prevailing factors, 
such as: broader economic conditions and the presence of various relationships in the 
value chain that either support, or restrain, RQ between partners. Because, RQ works more 
effectively in terms of achieving its objective (or positive sales) outcomes in the context 
where overall economic conditions and product price related mechanisms support 
salespeople-customer's RQ related reciprocity mechanism. 
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1 INTRODUCTION  
1.1 MOTIVATION 
This research was initiated by my own professional experience and academic interest in 
relationship marketing scholarship and because of its wide application in the selling of 
pharmaceutical products. Particularly, in the context of the pharmaceutical industry, it 
is believed by a majority of managers that relationship marketing activities help to 
achieve long-term customer relationships, which in turn help a firm in achieving its core 
objectives of sales excellence and hence profitability. The theories of relationship 
marketing also put forward such claims and there is no doubt, if applied appropriately, 
relationship marketing activities help to achieve quality relationships with customers. 
However, how these quality relationships develop and transcend into actual sales 
outcomes in the presence of other factors, such as product price and patient's particular 
economic status, is not dealt with adequately in existing RQ literature-particularly in the 
context of pharmaceutical sales. This interest in finding out the 'reality' of PSR-
physician RQ and its outcomes in terms of physician's prescription decision making, i.e. 
for whom and in what conditions these quality relationships work more effectively in 
terms of achieving sales or objective outcomes, motivated me to undertake the DBA 
programme and this research. 
1.2 RESEARCH CONTEXT 
This research was carried out in the context of the Pakistani pharmaceutical industry's 
sales structure (mainly in its Multan sales division, please see section one in chapter 4). 
The primary entities of pharmaceutical sales structure includes physicians, patients, the 
pharmaceutical firms and their salespeople. Pharmaceutical firms include 
multinationals (or MNCs), national (or local) players - and the franchise operations of 
national firms. However, the two major categories of pharmaceutical firms (i.e. MNCs 
and national) comprise the vast majority of the Pakistani pharmaceutical industry. 
Almost all of the MNCs and national firms have divided their product portfolios into 
different groups; therefore, there is a huge sales-force within these firms that interacts 
with physicians to sell the firm's products. Thus, there is intense competition between 
firms, principally due to the presence of the generic or ‘me-too’ products. Therefore, all 
such firms depend on the quality of their products and an effective sales team who 
devote their efforts to developing quality relationships with physicians in order to 
maximize their firm's market share. The sales team is usually directed by a marketing 
and sales director, supported by national and regional sales managers, who are 
responsible for pharmaceutical sales managers (PSMs) and the pharmaceutical sales 
representatives (PSRs) who report to them (see figure 1.1 below). Although a sales team 
is responsible for the sales efforts in their area, PSRs are responsible for promoting 
products and developing relationships with the local physicians to generate higher 
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prescription share and to achieve their allocated sales quotas (Andaleeb & Tallman, 
1996; Scharitzer & Kollarits, 2000), visiting physicians regularly alongside PSMs. Thus, 
the role of the PSM is as much field based as it is to have oversight of a specific group of 
PSRs. 
Each PSR reports to his or her specific PSM, who with their PSRs visit physicians and 
monitor the individual PSR's sales calls performance and hence their training. 
Furthermore, an individual PSR also needs the approval of his or her PSM if a physician 
requests a particular service (such as medical equipment or academic scholarships, etc.) 
If appropriate, PSMs approve the request at their level, otherwise they refer it to the 
regional sales manager for approval. PSMs cover and visit a wider sales areas than 
allocated to PSRs (as there is usually more than one PSR for whom they are 
responsible). Therefore, PSMs are more exposed the needs of physicians practicing in 
different sales areas and support their PSRs to develop long-term quality relationships 
with physicians. Nevertheless, PSRs have a more decisive role in the development of 
relationship with physicians. This is because as the firm's primary contact persons, they 
visit physicians on a regular basis in their allocated sales areas (compared to PSMs, who 
cover wider sale areas) in order to provide the necessary information and trials (by 
providing free samples) of their medicines (Lang & Chahal, 2018) and offer other 
services (such as gifts, business dinners, continued medical education) during sales calls 
(Murshid & Mohaidin, 2017). Furthermore, they need to make the follow-up sales calls 
in order to remind physicians about their products' name, information and to request a 
share of prescription. This is because of the presence of a huge number of PSRs from 
different MNCs and national firms in Pakistan, resulting in many individual visits to 
physicians (sometimes lasting only a few minutes). Physicians can therefore 
Figure 1.1: Usual sales team structure in Pakistan 
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consequently find it hard to remember a particular PSR's product and hence prescribe it 
to patients.  
Physicians also need the products' and services' information offered by PSRs. This is 
because the pharmaceutical industry is a highly dynamic in terms of new product 
innovations and advancements in treating diseases (e.g. Lagace et al., 1991). Therefore, 
physicians perceive the PSRs' visits to be very important as they consider PSRs a 
primary source of information (e.g. Wright & Lundstrom, 2004). As physicians are busy 
in their clinical practices, to keep themselves updated, they seek out information from 
PSRs (Murshid & Mohaidin, 2017). These interactions with PSRs help physicians to 
acquire the necessary information for their patients' treatment and wellbeing. 
Therefore PSRs and physicians have a primary or direct relationship in this sales 
structure; although the patients are the end-users of their products or services - they do 
not have any direct relationship with PSRs, who therefore have a contingent (or 
indirect) relationship with patients (please see figure 2.5).     
Patients have their primary or direct relationship with physicians as they seek 
healthcare services by paying physicians and also pay directly for the prescribed 
medicines at pharmacies. As a developing country, the vast majority of patients in 
Pakistan live in rural areas (small towns or villages) and their income is primarily 
dependent on agriculture. On the other hand, the population in urban areas (or cities) 
generate more income; however, they have more household financial commitments. 
Physicians who practice in an area for many years, normally have a good awareness of 
the economic and medical conditions of their patients. Therefore, patients' particular 
economic and medical conditions and the price of products have a great impact in 
deciding the choice of a particular pharmaceutical product.  
Physicians therefore hold the more powerful role in this sales structure (Mehralian et 
al., 2017) because they act as agents on behalf of patients in deciding the 
pharmaceutical product(s) or medicines to treat a patient's particular medical condition 
(Murshid & Mohaidin, 2017). Therefore, physicians are the direct customers of 
pharmaceutical firms (Shamimulhaq et al., 2014). Moreover, given the intense 
competition between firms, relationship based selling has become important for firms' 
PSMs and PSRs, especially when physicians have available hundreds of brands under 
one product category from which to prescribe, with varying and/or similar prices.   
1.3 RESEARCH PROBLEM 
Relationship marketing (RM) has attracted the interest of commentators when 
reconsidering the inefficiencies of a traditional transaction-based marketing approach 
(Dwyer et al., 1987; Payne et al., 1998; Rose, 2018; Sheth & Parvatiyar, 1994). This is 
particularly the case when commentators have considered mature industries and those 
that are subject to intense competition (Vieira et al., 2008). In such contexts customers 
are more demanding and need more attention and collaboration from the sellers (Sheth 
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& Parvatiyar, 2000). Moreover, the goods or services offered by sellers provide little or 
no differentiation (Vieira et al., 2008). Many alternatives of similar products or services 
are available at varying prices (Ryu & Lee, 2017) and customers have become more 
price sensitive (Çalık & Balta, 2006) in particular perhaps as a response to a prevailing 
economic climate.  RM is often seen as capable of mitigating such issues (Jham & Khan, 
2008; Prasertchuwong, 2018). This is because RM provides a means of exerting 
differentiation by building long-term relationship bonds with customers to achieve 
their loyalty and retention (Wray et al., 1994). Alongside customer retention, RM also 
provides sustainable competitive advantage to organizations because  the intangible 
facets of relationships are not easy for competitors to duplicate (Roberts et al., 2003). 
Research on RM in recent decades has also confirmed that it has a helpful impact on 
business performance (Abdullah et al., 2014). This on-going RM research stream has 
identified the concept of relationship quality (RQ) as one of its pillars (Vieira et al., 
2008). In the realm of interpersonal selling, Crosby et al. (1990) identify that although 
relationship selling is very important and salespeople act as a relationship manager, 
future sales opportunities are determined by the RQ between salesperson and 
customer. It follows that RQ plays a crucial role in the development of customers' 
patronage intentions (Sciarelli et al., 2017). Therefore, in viewing the importance of RM, 
pharmaceutical marketers also focus on RM strategies (Wright & Lundstrom, 2004) that 
seek to develop RQ between pharmaceutical sales representative (PSR) and physician. 
The aim is to influence physicians' prescription behaviour to engender positive sales 
outcomes based on relationships (Clark et al., 2011). 
Pharmaceutical selling is different to many other contexts, as the primary decision 
makers (i.e. physicians) are not the end users of the products or services (Clark et al., 
2011). The end-users (patients) have a contingent association to the physician within 
the physician-medical representative’s dyadic relationship. Patients cannot affect the 
physician-medical representative relationship directly, but they can produce a set of 
circumstances that might cause a change in a physician's behaviour and thus affect 
prescription decision making as an outcome. For instance, pharmaceutical prices may 
influence the choice of the brand prescribed by physicians (Gönül et al., 2001), 
particularly in specific economic conditions, such as those of the patients in Pakistan - 
who pay directly for their medicines. Pakistan, like other developing countries, has no 
publicly funded health system and the majority of patients are not members of any 
health insurance provider and thus bear all or part of the cost of treatment and drugs. 
This context is likely to influence the prescription behaviour of physicians. 
There is considerable research on RQ in different settings and empirical investigation 
suggests that RQ acts as a mediator between relational input factors (i.e. RQ 
determinants) from sellers, which produce positive outcomes or consequences in 
customers (Palmatier et al., 2006). However, the majority of previous studies on RQ 
have been undertaken from a positivist philosophical approach, therefore, particular 
use has been made of quantitative methods (Osobajo & Moore, 2017a), including those 
in a pharmaceutical context (e.g. Clark et al., 2011; Lagace et al., 1991) and in other 
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settings in general (Caceres & Paparoidamis, 2007; Crosby et al., 1990; Hennig-Thurau 
et al., 2002 etc.; Osobajo & Moore, 2017b; Sciarelli et al., 2017). Here, RQ outcomes were 
seen as a constant conjunction of the observable events (between buyer and seller) 
within the stable conditions of closed systems. There is not a single study in general that 
has considered RQ outcomes when the relationship interacts with external, or 
contingent, factors (e.g. the impact of patients' economic conditions, particularly in a 
pharmaceutical setting) or has seen RQ as taking place in an open system, where 
different uncontrolled underlying mechanisms countervail or reinforce each other to 
shape human decision making (e.g. Carter & New, 2004; Danermark et al., 2002; Easton, 
2002 etc.).  
Furthermore, there is little known about the key determinants that contribute to RQ, as 
most of the studies on RQ deal with developed countries (e.g. Boles et al., 2000; Clark et 
al., 2011; Crosby et al., 1990; de Ruyter et al., 2001; Dorsch et al., 1998; Gounaris, 2005; 
Rauyruen & Miller, 2007 etc.) and there might be additional (or different) RQ 
determinants that are required with respect to the Pakistani context - as it is a 
developing country. 
1.4 RESEARCH AIMS AND OBJECTIVES 
Hence, the overall purpose of this research is to critically explore the determinants and 
mechanisms that contribute to RQ. Furthermore, the aim is to investigate how far 
product price (and related mechanisms) have an impact on the "outcomes" of PSR-
physician's RQ under specific patient economic situations - in the context of Pakistan. 
Hitherto, no research has been undertaken in this context to date. 
This research seeks to address the following research questions: 
1) What determinants are needed and why are they required to build up RQ between 
PSRs and physicians in a Pakistani pharmaceutical context? 
2A) How does PSR-Physician RQ (i.e. trust, satisfaction and commitment) interact with 
the product price in relation to patient's economic status?   
2B) What are the outcomes of this interaction in terms of physicians' prescription 
decision making and tendencies in their choice of pharmaceutical products? 
In order to operationalize the research questions, the following research objectives are 
developed: 
 To identify the key determinants and their underlying mechanisms needed by PSRs 
to build RQ with physicians in the Pakistani pharmaceutical selling context. 
 To explore how physician-medical representative dyadic RQ interacts with product 
pricing and related mechanisms under the influence of contingent patient economic 
conditions. 
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 To examine the interplay of the underlying mechanisms and the tendencies they 
exhibit in the physician's prescription decision making in terms of pharmaceutical 
brands. 
 To explore the efficacy of physician-PSR RQ, i.e. under what conditions, or contexts, 
it is more effective in terms of its outcomes. 
1.5 RESEARCH APPROACH 
The research approach of this study is based on the guiding principles of critical 
realism. Critical realism believes in an open system of inquiry and emphasises outcomes 
resulting from contingent conjunctions of mechanisms that exhibit tendencies rather 
than regularities (Ackroyd, 2009; Danermark et al., 2002). Such elements can be better 
explored and explained through qualitative methods (Sayer, 1992). Such explanations 
first require the identification of underlying mechanisms and then verification of how 
these mechanisms interact within different contexts to produce certain outcomes (Reed, 
2009; Sayer, 2000). 
Therefore, critical realism suggests of reality that our concepts are theory-laden (Sayer, 
1992) and considers prior theoretical concepts as real features of the world (Maxwell, 
2012). Thus, to conduct this research prior theories on the RQ phenomenon are used to 
identify the inter-relationship between different variables (i.e. RQ determinants, 
dimensions and outcomes) introduced by these theories to infer their related 
mechanisms. Further mechanisms are identified by reviewing the literature on 
physician's prescription decision making. These concepts and structural analysis of 
pharmaceutical sales are used and integrated to form the preliminary conceptual 
framework before entering the field for data generation (Sobh & Perry, 2006).  
Based on an embedded case study strategy and using a semi-structured interview 
method, 22 participants (i.e. pharmaceutical sales managers and physicians) were 
interviewed in two sequential phases to address the research questions and objectives. 
The data generated was then qualitatively analysed in order to identify and verify the 
mechanisms associated with determinants needed to develop PSR-physician's RQ. 
Moreover, how RQ (and mechanisms associated) interacts or interplays with 
mechanisms related to the product's price and patients' economic conditions present in 
an open system to produce physician's prescription decision making as an outcome was 
considered. Based on the findings and analysis, this research is concluded by presenting 
for whom, and under what conditions, PSR-physician's RQ outcomes are more effective 
in achieving RQ’s objective outcomes in terms of physician's prescription decision 
making. The following section provides the structure of the thesis, which further 
highlights the research process undertaken. 
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1.6 STRUCTURE OF THESIS 
Along with this introduction chapter, this thesis consists of five main chapters: 
Chapter two presents a review of RQ literature, which not only provides the current 
knowledge base on RQ but also helps in the development of an initial conceptual 
framework by reviewing and integrating the literature on physician's prescription 
decision making. After the introduction, it begins by examining prior conceptualization 
and modelling of RQ that has been achieved within closed system based enquiries. This 
is followed by the examination of different RQ definitions and dimensions, which leads 
to adoption of a definition, as well as dimensions, for this research. After the adoption of 
a RQ definition, each of its dimensions (trust, satisfaction and commitment) are 
examined to infer their mechanisms. RQ determinants are then discussed and some of 
them are chosen, by providing a rationale or justification on their appropriateness in 
the context of pharmaceutical setting, particularly in the context of Pakistan. This is 
followed by an examination of RQ outcomes, i.e. both subjective and objective outcomes 
through the effects of different mechanisms. Throughout the review, the gaps in current 
knowledge of RQ, which this research seeks to address, are identified. Finally, an initial 
or preliminary conceptual framework is presented, which helps later in data generation 
and analysis.  
Chapter three provides a discussion of the methodology and data generation methods 
used in this research. It begins by providing a statement of the aim and objectives of this 
study, which were developed through the initial conceptual framework drawn from the 
literature review. The next section discusses the philosophical perspective of critical 
realism, which underlies the research process. Next, the reasons for choosing an 
embedded case study design and qualitative research approach are discussed. Details of 
participant selection and recruitment are followed by details of the methods of data 
generation, preparation and analysis. Finally, ethical considerations are discussed.  
Based on the initial conceptual framework, chapter four examines the perspectives of 
pharmaceutical sales managers and physicians on RQ and its outcomes as physician's 
prescription decision making under contingent patients' economic conditions. Part A of 
chapter four begins with the context of the case study so that the findings can be 
followed. Next, the details of participants that were interviewed for the first phase of 
this embedded case study are described. Parts B and C, which comprise the main body, 
present the findings, analysis and discussion. This chapter finally presents a new 
revised conceptual framework, which also encapsulates the underlying mechanisms 
that affect the formation of RQ and its outcomes.  
Chapter five presents the findings, analysis and discussion of the second phase of this 
research, which was conducted in rural and urban sales areas as embedded subunits of 
the overall case. This phase extends the chapter four findings one step further and 
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gathers the physicians' perspectives on how the mechanisms identified in the first 
phase interact with product price in two economically different geographic areas. 
Chapter six presents the research conclusions and begins by summarizing the findings 
with respect of the research questions. The limitations of this research are considered, 
followed by discussion of contribution in relation to existing RQ knowledge. Next, the 
practice implications and recommendations are discussed. Finally, suggestions for 
future research and comments on the research approach are also considered.
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2 LITERATURE REVIEW  
2.1 INTRODUCTION 
Relationship quality (RQ) has been discussed in the literature as an overall strength of a 
relationship (Smith, 1998a) and is considered the main determinant of on-going future 
relationships between the partners (Crosby et al., 1990). There is wide agreement in 
literature that RQ between partners is a decisive factor in the durability and strength of 
this relationship and, therefore, the ultimate achievement of RM activities (Hennig-
Thurau, 2000). As such, there is evidence that customers' perceived relationship quality 
provides a firm with better results and greater competitive advantage than either 
product or service quality (Vieira et al., 2008). Considerable research in various 
contexts has reported that the quality of relationships between salesperson and 
customers provides a firm with superior subjective and objective outcomes, such as: 
customer retention (Hennig-Thurau & Klee, 1997) behavioural loyalty (De Wulf et al., 
2001; Prasertchuwong, 2018), sales effectiveness (Crosby et al., 1990; Palmatier et al., 
2006) and customers’ business share (Leuthesser, 1997). Therefore, RQ has emerged as 
a central construct and a key factor in the success of long-term business relationships 
(e.g. Hennig-Thurau, 2000; Leuthesser, 1997; Lin, 2013; Naudé & Buttle, 2000).  
The purpose of this chapter is to provide the insights on the current RQ knowledge base 
and highlights the issues in existing literature that this research seeks to address. 
Further maintaining critical realism's view that our concepts are theory-laden (Sayer, 
1992), prior theories on the RQ phenomenon are used to identify the inter-relationship 
between different variables (i.e. RQ determinants, dimensions and outcomes) 
introduced by these theories to infer their related mechanisms (please see section 
3.3.3.2 and 3.3.3.3). Additional mechanisms are also identified by reviewing the 
literature on PSR-physician relationships as well as physician's prescription decision 
making and integrating an analysis of the Pakistani pharmaceutical selling structure. 
The resulting literature review is used to form an initial conceptual framework. 
Therefore, the initial section of this chapter firstly describes the literature search 
strategy. Next it presents how scholars have previously conceptualized and modelled 
RQ in different contexts. After this consideration turns to the varied definitions and 
dimensions of RQ in different contexts, which leads to the adoption of a definition and 
dimensions of RQ for this research. Then the next section offers a critical evaluation and 
the identification of determinants that influence RQ between physician and PSR in the 
context of Pakistan. Finally, the chapter presents RQ outcomes in terms of physicians' 
prescription decision making, while taking into account the product price and patients' 
economic and medical conditions. To conclude, the review results into an initial 
conceptual framework to evaluate the PSR-physician RQ outcomes in terms of 
prescription decision making.  
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2.2  LITERATURE SEARCH STRATEGY  
This research uses descriptive narrative inquiry around the literature on RQ and other 
related concepts. Review of literature has revealed that RQ is a higher order construct, 
which is comprised of trust, satisfaction and commitment (e.g. Smith, 1998b). The 
literature was searched using different techniques. For instance firstly journal articles 
were searched using the keywords: 'relationship quality', 'relationship quality in 
business-to-business, business to consumer markets, and/ or relationship quality in 
interpersonal professional services', 'how salespeople build quality relationships', 'trust 
between salesperson and customers', 'customer's satisfaction and commitment' etc. 
Further literature on the PSR-physician relationships and physician prescription 
decision making was searched by using key words such as 'relationship quality in the 
pharmaceutical industry', 'relationships between medical representatives and 
physicians', 'physicians relationship with pharmaceutical industry', 'pharmaceutical 
marketing and other factors in prescribing decisions', 'patients' trust in physicians', 
'moral hazard in physician prescription behaviour', 'pricing of drugs and its impact on 
physicians’ choice behaviour', etc. Journal articles were also considered through cross 
referencing technique i.e. by following the different related articles' reference lists. The 
databases mainly used Google Scholar and University of Gloucestershire's library 
discovery services which has further access to different databases such as: business 
source complete, AbI/Inform, EBSCO, Proquest, Emerald, Science direct etc. Some 
related text books were also consulted.  
2.3  PRIOR CONCEPTUALIZATION AND MODELLING OF RELATIONSHIP 
QUALITY: 
The idea of RQ was first introduced by Evert Gümmesson in 1985 (Gümmesson, 1987). 
However, it attracted more attention after the seminal work offered by Lawrence A. 
Crosby and colleagues in 1990. Since then, scholars and researchers have extensively 
examined determinants, dimensions and outcomes of RQ in different business-to-
business and business-to-consumer marketing contexts (Osobajo & Moore, 2017b). For 
example in distribution or channel marketing (Dwyer et al., 1987; Kumar et al., 1995), 
industrial marketing (e.g. Holmlund, 2008; Huntley, 2006), supply-chain marketing (e.g. 
Asnai et al., 2009; Woo & Ennew, 2004), retail marketing (Hennig-Thurau, 2000; 
Shamdasani & Balakrishnan, 2000; Wong & Sohal, 2002), pharmaceutical marketing 
(Clark et al., 2011; Lagace et al., 1991), financial retail marketing (e.g. Bejou et al., 1996; 
Ou et al., 2012; Wray et al., 1994), life insurance (Crosby et al., 1990). Within the large 
body of RQ literature, irrespective of its focus on business-to-business (Boles et al., 
2000; Parsons, 2002; Smith, 1998b) or business-to-consumer relationships (Bejou et al., 
1996; Clark et al., 2011; Crosby et al., 1990; Lagace et al., 1991; Wray et al., 1994) 
attention is placed on people-based interpersonal relationships and their role in both 
goods and/or service sales situations.  
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Although RQ has been widely investigated as a vital construct in the RM literature (Lee, 
2016) in the different contexts discussed above, there are still ambiguities in its 
conceptualization due to a lack of consensus on what it constitutes (Hennig-Thurau et 
al., 2001; Holmlund, 2008; Sciarelli et al., 2017). There is however consensus among 
scholars that RQ is a high order (or meta-construct) that encompasses a variety of 
distinct, but interrelated, dimensions (Crosby et al., 1990; Dorsch et al., 1998; Giovanis 
et al., 2015; Hennig-Thurau et al., 2002; Roberts et al., 2003; Rose, 2018). Among these 
dimensions trust, satisfaction and/or commitment are accepted as the dimensions that 
conceptualize RQ in the majority of studies (Athanasopoulou, 2009; Rose, 2018; Sciarelli 
et al., 2017; Vieira et al., 2008). This consensus is based around the RQ 
conceptualization offered by Crosby et al., (1990). According to them, RQ is comprised 
of at least two dimensions i.e. 'trust' and 'satisfaction' - which are engendered by input 
variables (or determinants). RQ also gives rise to output variables, i.e. positive outcomes 
or consequences. This input (determinants)-process (dimensions)-outcome based 
approach to modelling RQ that has emerged in the literature is outlined below in figure 
2.1.  
                Relational input factors              Process                  Output 
 
Figure 2.1. Prior relationship quality modelling 
Considerable previous research has thus considered RQ as a mediator between 
relational input factors (i.e. RQ determinants) from sellers that produce positive 
outcomes or consequences in customers (Palmatier et al., 2006). Examples of positive 
outcomes are: customer loyalty, re-purchase intentions, words-of-mouth and 
recommendations; and there are presumptions that these subjective outcomes will 
ultimately lead to objective outcomes, which are increased financial or sales 
performance of a firm (Vieira et al., 2014). 
However, the majority of previous studies on RQ have been undertaken within a closed 
system; including those conducted in a pharmaceutical context (e.g. Clark et al., 2011; 
Lagace et al., 1991) and in other settings (e.g Bejou et al., 1998; Boles et al., 2000; 
Caceres & Paparoidamis, 2007; Crosby et al., 1990; Hennig-Thurau et al., 2002 etc.). In 
these studies, RQ outcomes were seen as a constant conjunction of the observable 
events (between buyer and seller). Studies in RQ literature that consider RQ outcomes 
when the relationship interacts with external, or contingent, factors (e.g. the impact of 
patients' economic conditions particularly in a pharmaceutical setting) or are seen as 
taking place in an open system, where different uncontrolled underlying mechanisms 
countervail, or reinforce each other to shape human actions in a particular social 
situation (e.g. Carter & New, 2004; Danermark et al., 2002; Easton, 2002 etc.) are rare. 
There are few studies that have considered the interaction effect of moderators and/or 
RQ 
Determinants
RQ Dimensions
(Trust, satisfaction 
and/or commitment)
RQ Outcomes
(Subjective & 
Objective)
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intervening variables with determinants when modelling RQ (as reflected below in 
figure 2.2).  For example, De Wulf et al. (2001) verify the impact of product category 
involvement and customer relationship proneness on RQ. Similarly, Lin (2013) 
validated the development of RQ under the presence of customers’ relationship 
proneness and customer perceived price as moderators. Conversely, previous studies 
did not consider the impact of moderators and/or intervening variables on the 
outcomes mediated through RQ and the presumption in prior work is of a closed 
system. Therefore, RQ outcomes particularly objective (or measureable-sales) outcomes 
have remained unexamined i.e. how RQ interacts with wider contingent contextual 
factors to produce actual outcomes.  
    Moderator or intervening variable  
         Relational input factors              Process                  Output 
 
Figure 2.2 Prior relationship quality modelling 
Despite limited empirical investigation, many RQ researchers draw attention to these 
contingent factors, which they suggest can influence the outcomes of an exchange 
relationship. For example, Leuthesser (1997) indicates that RQ impacts significantly on 
business share, but how the overall environment interacts with this is, as yet, unknown 
and there is a need for further investigation. Similarly, Hennig-Thurau and Klee (1997) 
pointed out that in addition to intra-psychological mechanisms of RQ, there might be 
other contextual mechanisms that can influence customers' repurchase decision and 
that these should be included in an RQ model. Additionally, in terms of the importance 
of contingent mechanisms, Holmlund (2001) discusses the influence of other 
relationships in the value chain on the outcomes of RQ as a challenging area for future 
research. It appears from the literature that much of the limitation in evaluating 
important contingent factors on the outcomes of RQ is due to the use of quantitative 
approaches and regression techniques (e.g. Wray et al., 1994). Similarly, Smith (1998a) 
discusses the analysis of the interaction of potential confounding variables and their 
threshold level to each other, which is not possible with the use of regression 
techniques. Osobajo and Moore (2017a) also recently confirmed that the majority of 
existing studies on RQ are confined to quantitative methods. An advanced 
understanding of RQ, and its effectiveness in buyer-seller relationships, requires the 
analyses of contextual factors that structure the exchange process (Fichman & 
Goodman, 1996). Furthermore, Palmatier et al. (2006) suggest that along with the 
identification of the factors that contribute to RQ, there is also a need to verify under 
what conditions RQ provides the expected positive outcomes. 
There is a clear recognition by the scholars of the need to include the contingent 
contextual factors in research on RQ phenomenon, however the choice of their research 
RQ 
Determinants
RQ Dimensions
(Trust, satisfaction 
and commitment)
RQ Outcomes
(Subjective & 
Objective
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approach largely precludes this. Limiting considerations on purely technical grounds 
does not serve to create a better understanding of RQ phenomenon. Therefore, this 
research considers the outcomes of RQ in an open system where different objects of the 
study are considered as entities (such as PSR, physician, patient and pharmaceutical 
product) that hold their own causal powers and mechanisms; and buying decisions (i.e. 
physicians' prescription decision making) are made through the interactions of different 
mechanisms (Danermark, 2002). This includes the characteristics of pharmaceutical 
products (i.e. quality and price) and physician-patient relationship (in particular the 
patient's economic conditions) that can interact with PSR-physician's RQ outcomes. The 
pharmaceutical sales context is characterized by the PSR's frequent interaction with 
physicians, which is necessary to develop RQ (Clark et al., 2011; Lagace et al., 1991). 
Therefore, this context provides an opportunity, firstly, to investigate the factors that 
can develop interpersonal RQ between PSRs and physicians. Secondly, it provides an 
opportunity to investigate the outcomes of RQ under the contingent economic 
conditions of the patient in terms of the price of a product a physician prescribes and 
patients’ ability to afford it. 
However, it is argued that to provide a better understanding of RQ, it is obligatory to 
evaluate both the definitions and the dimensions that form the RQ construct (Woo & 
Ennew, 2004). Therefore, to conceptualize RQ for this research it is necessary to define 
RQ in the first instance. Since, the identification of suitable determinants that influence 
the PSR-physician's RQ can only be possible after deciding what RQ is and what it 
comprises (i.e. its dimensions). Furthermore, for academic researchers it is crucial that 
a conceptual definition is explained as a precondition of valid and reliable measures 
used to propose and test the theory (Broom et al., 1997).  
2.4 DEFINITIONS AND DIMENSIONS OF RELATIONSHIP QUALITY: 
The review of RQ literature reveals that despite more than two decades of RQ research, 
there is still no agreement on a universal definition of RQ and the dimensions that make 
up the RQ construct (Athanasopoulou, 2009; Jelodar et al., 2016; Jiang et al., 2016; 
Osobajo & Moore, 2017b; Rose, 2018; Smith, 1998a; Vieira et al., 2008). Many authors 
have argued about the reasons for the lack of a singular formal RQ definition. For 
example, in an early study Hennig-Thurau (2000) discusses that conideration of the 
literature on RQ reveals: there is a lack of a sophisticated discussion on the complex 
issues of relationships between partners; everybody has their own point of view on the 
RQ construct, and scholars do not feel the need to closely define the RQ construct. This 
has been confirmed by Holmlund (2008), who feels that the RQ construct is still under-
explored and lacks a formal definition.  
The reason for this lack of universal RQ definition is perhaps that the relationships are 
of various forms, which can be observed across various business markets (e.g. business-
to-business, business-to-consumers) and at different levels, such as social, emotional, 
structural and economic (Woo & Ennew, 2004). Therefore, scholars have adopted or 
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defined RQ according to the suitability of the definition to their research context 
(Pantouvakis & Bouranta, 2017; Vieira et al., 2008).  
As, there are varied RQ definitions in the literature that have emerged from different 
research settings, it is therefore of equal importance to realize the research context (e.g. 
Asnai et al., 2009; Casidy & Nyadzayo, 2017; Izogo, 2016b; Roberts et al., 2003). From 
the RQ literature three notable contexts can be identified (or categorised) where 
scholars have predominantly studied, and thus defined RQ accordingly. That is: RQ 
development between firm-to-firm, firm-to-consumers and interpersonal RQ between 
salesperson and customer (albeit in a firm-to-firm or consumer context) (Osobajo & 
Moore, 2017b). Categorisation of these study contexts is difficult, as there is a 
considerable overlap between constructs (i.e. RQ determinants and dimensions) used 
within, and among, the identified contexts. However, in order to develop general 
understanding for this research, the RQ studies are categorised according to their focus. 
For example, the interpersonal selling context is considered, where attention is placed 
on salespeople’s personal or relational characteristics to develop RQ with customers. 
Similarly, the firm-to-consumer context is considered, where consideration is given to 
the firm's elements both the goods or services and the contact person's characteristics. 
Finally, the firm-to-firm context is examined, where the focus is placed on the business 
seller and firms buying either goods or services. The following sections evaluate the 
different definitions of RQ that appear from these different contexts. This leads to the 
adoption of a definition for this research, which rests on the interpersonal RQ between 
PSR and physicians. 
2.4.1 RQ DEFINITIONS AND DIMENSIONS IN INTERPERSONAL SELLING CONTEXTS: 
The RQ definitions in interpersonal selling contexts have emerged in the literature both 
from firm-to-firm and firm-to-consumer selling contexts and salespeople are seen as 
crucial to developing RQ with customers (Prasertchuwong, 2018). Keating et al. (2003) 
discusses that from services selling perspective in firm-to-consumer context, RQ is 
viewed as a "trade-off" between "value and risk". Where customer's percieved 
uncertainity is reduced, the value of his or her relationship with a salesperson and/or 
firm is improved (Keating et al., 2003). This is because it has been argued by many 
scholars that the intangible nature of many services creates uncertainity for customers 
in their buying decision; for example,  life insurance and financial services  (e.g. Bejou et 
al., 1998; Wray et al., 1994). In selling of these kind of services, the salesperson's role 
becomes more crucial to reducing the uncertainity of a customer by gaining the 
customer's trust and increasing their satisfaction (Crosby et al., 1990).  
Thus, Crosby et al. (1990) propose a highly cited definition of RQ: as a higher-order 
construct that encompasses at least two dimensions i.e. 'trust in' and 'satisfaction with' 
salesperson performance in the services selling context of life insurance. Table 2.1 
below confirms that most studies in the interpersonal selling context have adopted the 
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RQ definition provided by Crosby et al. (1990) with trust and satisfaction, as its 
dimensions.  
Table.2.1 Dimensions adopted in interpersonal selling contexts 
Author/Year Relationship Nature /Context Dimensions 
  Trust Satisfaction Commitment Other Dimension 
Crosby et al., (1990) Salespeople and individual customer: buyer 
perspective: life insurance services 
    
Lagace et al., (1991) Pharmaceutical salespeople and individual 
customer: buyer perspective: 
    
Wray et al., (1994) Salespeople of financial services 
intermediaries and consumers: buyer 
perspective 
    
Palmer and Bejou (1994) Salespeople of financial services 
intermediaries and consumers: buyer 
perspective 
    
Bejou et al. (1996) Salespeople and consumers: buyer 
perspective: financial services providers 
and consumers 
    
Bejou et al. (1998) Financial advisers or salespeople and 
consumers: buyer perspective: financial 
services providers and consumers 
   Customer-orientation, Sales-
orientation, Ethics, Expertise, 
Relationship Length 
Smith (1998a) Salespeople and purchasing executives: 
buyer perspective: B2B goods 
    
Smith (1998b) Salespeople and purchasing executives: 
buyer perspective: B2B goods 
    
Boles et al. (2000) Salesperson and business customers: 
buyer perspective: services 
telecommunication 
    
 
Parsons (2002) Industrial purchasers and suppliers 
relationship: buyer perspective: B2B goods: 
individual salesperson-to-customer  & firm-
to-customer 
    
Shamdasani and Balakrishnan 
(2000) 
Professional service providers and 
customers: buyer perspective: services: 
firm-to-customers 
    
Clark et al. (2011) Pharmaceutical salespeople and individual 
customer: buyer perspective 
    
Ou et al. (2012) Financial salespeople and the customers of 
financial institutions 
    
Lin (2013) Services providers of the banks and their 
customers 
    
Mullins et al. (2014) Salesperson and customers of industrial 
and consumer goods, dyadic perspective 
    
Al-Alak (2014) Services providers of the banks and their 
customers 
    
Itani and Inyang (2015) Salespersons of the banks and their retail 
customers 
    
Balaji et al. (2017) Services providers of the banks and their 
customers 
    
[Source: Author's compilation] 
From table 2.1 it appears that different scholars merely replicate the studies in different 
services selling contexts by including different suitable determing constructs and tested 
their significance to RQ (i.e mainly trust and satisfaction) (Abdullah et al., 2014; Bejou et 
al., 1996; Boles et al., 2000; Izogo, 2016a; Lagace et al., 1991; Palmer & Bejou, 1994; 
Wray et al., 1994). Thus, RQ is conceptualized and definied predominantly in 
interpersonal selling context by considering trust and satisfaction as its social 
dimensions.   
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Besides trust and satisfaction, commitment has also attained the attention of some 
scholars as a necessary first order RQ construct, after the advent of "Commitment and 
Trust theory of RM" by Morgan and Hunt (1994 as cited in Vieira et al., 2008). Many 
scholars either define RQ by adding commitment or adopting it as an important 
dimension, particularly in the interpersonal selling context and also in other contexts 
(see Tables 2.1, 2.2 and 2.3). For example, in business-to-business interpersonal selling 
context, Smith (1998b) considers commitment as a necessary RQ dimension with trust 
and satisfaction. She defines RQ as a higher order construct consisting of positive 
relationship outcomes, i.e. trust, satisfaction and commitment that reflect the strength 
of the relationship and that meet the expectations of partners (Smith, 1998b, p. 4). 
Similarly, in a recent study on RQ, Mullins et al. (2014, p. 39) distinguish the RQ 
perceived by the customers and salespeople. They define " ‘customer relationship 
quality’ as the combined strength of a customer’s trust in, satisfaction with, and 
commitment to a given salesperson, and ‘salesperson relationship quality’ as the 
combined strength of a salesperson’s perceptions of a given customer’s trust in, 
satisfaction with, and commitment to him/her".  
Although the majority of scholars have defined RQ by considering trust and satisfaction 
as its dimensions; a significant group of scholars have suggested that commitment is 
also a necessary RQ dimension in interpersonal selling contexts. Therefore, within 
studies examining such contexts the focus is placed on RQ's social dimensions to 
conceptualize and define it (please see section 2.4.4 below for more detail). 
2.4.2 RQ DEFINITIONS AND DIMENSIONS IN FIRM-TO-CONSUMER RELATIONSHIP 
 CONTEXTS: 
Several studies have been conducted under the firm-to-consumer context, and many 
adopt the dominant view of RQ, and it is defined by trust, satisfaction and/or 
commitment and the focus is rather placed on seeking to explore what RQ determining 
factors influence these constructs as outlined below in table 2.2. For example, De Wulf 
et al. (2001) concentrate on the firm's relationship investment towards consumers (in 
terms of preferential treatment, direct mail, tangible rewards and interpersonal 
communication) to engender RQ i.e. to influence trust, satisfaction and commitment as 
its necessary elements. Similarly, Wong and Sohal (2002) give attention to the role of 
firms’ key individuals' interaction with consumers, and investigate that consumers' RQ 
with a firm develops through the consumer's trust in and commitment to a particular 
contact person. In the same context, Wong and Zhou (2006) examine the significance of 
service quality and customers' overall satisfaction with a shopping experience, in a 
retail setting, on RQ. Likewise in the context of mobile network services firms, Raza and 
Rehman (2012) consider trust and satisfaction as RQ dimensions and investigate the 
influence of service quality, consumers price perception and brand image on RQ.         
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Table.2.2 Dimensions adopted in firm-to-consumers relationship contexts: 
[Source: Author's compilation] 
However, Hennig-Thurau and Klee (1997) argue that in a conceptualization of RQ with 
trust in and satisfaction with the salesperson, other related factor like social needs, 
interaction effeciency and cost reduction in transaction should also be taken in account. 
They view service quality and transactional factors such as product quality as important 
dimensions, along with trust and commitment, to develop a firm's RQ with consumers.  
Thus, Hennig-Thurau and Klee (1997, p. 751) define that "RQ can be seen as the degree 
of appropriateness of a relationship to fulfill the needs of the customer associated with 
that relationship". In a different context of the relationship between users of market 
information and firms providing marketing information, Moorman et al. (1992, p. 316) 
define RQ as "preceived quality of interactions is the degree to which users view user-
researcher interactions as productive". The definition provided by Moorman et al. 
Author/Year Relationship Nature /Context Dimensions 
  Trust Satisfaction Commitment Other Dimensions 
Moorman et al., (1992) Market research firms and various users:  buyer 
perspective: knowledge services 
   Perceived quality of 
interaction 
Hennig-Thurau and Klee 
(1997) 
Conceptual/ relationship between firms and 
consumers 
   Product/service quality  
Hennig-Thurau (2000) Manufacturers and consumers of electronics 
products: buyer perspective: firm-to-customers 
   Product/service quality 
Hennig-Thurau et al. 
(2001) 
Universities and their alumni students: buyer 
perspective: services: firm-to-customers 
   Service quality 
De Wulf et al. (2001) Retailer-consumer relationship: buyer perspective: 
services: firm-to-customers 
   - 
(Hennig-Thurau et al., 
2002) 
Consumers and service firms relationship: buyer 
perspective: services: firm-to-customers  
   - 
Wong and Sohal (2002) Relationship between departmental store and its 
shoppers: individual salesperson-to-customer  & 
firm-to-customer 
   - 
Roberts et al. (2003) Consumers and services firms buyer perspective: 
services: firm-to-customers 
   Affective conflict 
Keating et al. (2003) Online consumers and service providing firms 
relationship: buyer perspective: services: firm-to-
customers 
   Value,  effort,  
communication, power, 
understanding 
Wong and Zhou (2006) Relationship between departmental store and its 
shoppers: individual salesperson-to-customer  & 
firm-to-customer 
   - 
Sanchez-Franco and 
Rondan-Cataluna (2010) 
Relationship between online shoppers and service 
providers 
   Emotions 
Raza and Rehman (2012) Relationship between mobile network companies 
and their customers: firm-to-customer 
   - 
Giovanis et al. (2015) Relationship between auto repair maintenance 
firms and their customers: firm-to-customer 
   Calculative and affective 
commitment 
Izogo (2016a) Relationship between banks and their customers: 
firm-to-customer 
    
Izogo (2016b) Relationship between banks and their customers: 
firm-to-customer 
    
Wahid and Ismail (2017) Relationship between banks and their customers: 
firm-to-customer 
    
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(1992) reflects a similar view of Hennig-Thurau and Klee (1997) in which both stressed 
that the interaction between partners should be productive and can fulfil the needs of 
exchange partners. Conversly, Roberts et al. (2003) view service provider interaction 
quality with consumers as a determining factor, rather than dimension that leads to 
greater trust, satisfaction, and commitment. Table 2.2 above shows the dimensions 
employed by a range of studies that have sought to define RQ, which shows that sholars 
not only considered social but also product and/or service quality as necessary 
dimensions of RQ in firm-to-consumer contexts (please see section 2.4.4 below for more 
detail) . 
2.4.3 RQ DEFINITIONS & DIMENSIONS IN FIRM-TO-FIRM RELATIONSHIP CONTEXTS: 
A large number of studies have been done in business-to-business firm level exchange 
relationships in different research settings, as shown in Table 2.3. Many of the studies 
adopted the dominant dimensions of RQ, i.e. trust, satisfaction and/or commitment in 
their research (e.g. Čater & Čater, 2010; Ivens, 2004; Ivens & Pardo, 2007; Leuthesser, 
1997; Walter et al., 2003). However, along with trust, satisfaction and/or commitment, 
many scholars have also considered other dimensions important to influencing RQ 
according to their research settings. For example, in the channels or distribution 
context, Kumar et al. (1995) define RQ as a high order construct comprising conflict, 
willingness to invest in the relationship, expactation of continity, trust and commitment. 
Similarly, in the context of a relationship between vendors and their customer firms, 
Dorsch et al. (1998, p. 130) consder RQ as high-order construct comprising trust, 
satisfaction, commitment, minimal opportunism, ethical profile, and customer 
orientation as its dimensions. Thus, both the definitions above consider the formation of 
RQ not only at social level of firm's representatives but also at their rationally driven 
behaviours such as minimal opportunism and more customer orientation, ethics, and 
willingness to invest in the relationship. The reason might be that opportunistic 
behaviour by one partner leads to a trust deficit, which is prerequisite for the 
development of RQ. Conversely, customer orientation leads to the greater level of trust 
development between partner firms and hence RQ between them. Therefore, trust is 
considered necessary to develop RQ. 
  
However, Huntley (2006) argues that in the majority of RQ studies, it is defined on the 
basis of relational or social dimensions. For a comprehensive definition in business-to-
business firm level relationships, it is important to consider the product related and 
economic dimensions with the relational. Thus, in the context of industrial buyer-seller 
relationships, Huntley (2006, p. 706) defines RQ as "the degree to which buyers are 
satisfied over time with the overall relationships as manifested in product quality, 
service quality and price paid for the value received and the degree to which 
relationships function as a partnership". Similarly, Holmlund (2008;2001) argues that 
the studies on RQ focus more on intangible aspects of relationships, e.g. service quality 
and communication etc. However, little attention has been paid to its tangible aspects, 
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such as product related quality, pricing and resources exchange, which should all be 
considered in a business-to-business relationship. For RQ's broader definition along 
with social dimension, the economic and technical dimensions should also be 
considered. Accordingly, in a dyadic business-to-business context, Holmlund (2008, p. 
35) defines RQ as "perceived RQ is the joint cognitive evaluation of business 
interactions by significant individuals in both firms in the dyad. The evaluation 
encompasses a comparison of experienced with desired, potential, usual or previous 
interactions which constitute comparison standards". 
Table.2.3 Dimensions adopted in firm-to-firm relationship contexts: 
Author/Year Relationship Nature /Context Dimensions 
  Trust Satisfaction Commitment Other Dimension 
Dwyer et al. (1987) Automobile manufacturers and dealers: buyer 
perspective : B2B goods: firm level 
   Minimal opportunism 
Kumar et al. (1995) Large and small automobile dealers: buyer 
perspective: B2B goods: firm level   
   Continuity expectation, 
relationship investment, conflict 
Dorsch et al. (1998) Purchasing executives of buying firms and their 
vendors: buyer perspective: B2B goods: firm level 
  
Minimal opportunism, customer-
orientation and ethical profile 
Leuthesser (1997) Industrial purchasing executives of firms and 
many suppliers: buyer perspective: B2B goods: 
firm level  
   - 
Naudé and Buttle (2000) Executives and suppliers from various industries: 
buyer perspective: B2B goods firm level 
   Power, profit and coordination 
Holmlund (2001) Conceptual process & outcome: dyad 
perspective: B2B goods/services: firm level 
   Technical, social and economic 
Hewett et al. (2002) Industrial purchasing executives and sellers: dyad 
perspective: B2B goods: firm level 
   - 
Walter et al. (2003) Manufacturing supplier and purchasing 
professionals buyer perspective: B2B goods firm 
level 

 
  - 
Ivens (2004) Purchasing managers and suppliers: buyer 
perspective: B2B goods firm level 
   - 
Woo and Ennew (2004) Engineers professional services: buyer 
perspective: B2B services firm level 
   
Adaption, cooperation, 
atmosphere 
Huntley (2006) Firm and customer representative of IT products 
and after sales service: buyer perspective: B2B 
goods/services firm level 
   
Technical, social, economic, time, 
partnership 
Ivens and Pardo (2007) Professional purchases managers in goods 
packaging company: buyer perspective: B2B 
goods/services firm level 
   - 
Rauyruen and Miller 
(2007) 
Customers of courier services:  buyer 
perspective: B2B services Firm Level 
   Service quality 
Caceres and 
Paparoidamis (2007) 
Survey of 234 advertising agencies' clients/        
B2B relationship between firms and their clients 
   - 
Holmlund (2008) Personal interviews from firms managing 
directors/ process & outcome in B2B settings 
   Technical, social and economic 
Asnai et al. (2009) Sample of questionnaires survey collected from 
middle and senior executives of four different 
countries UK:40, Iranian:55, Russian:41 and 
Chinese 50/B2B relationship 
   Profit, power 
Čater and Čater (2010) B2B relationships between manufacturer and 
customers   
Information sharing, coercive and 
non-coercive power, dependency 
and conflict  
Rasila (2010)  B2B relationships between landlord and tenant     Opportunism, power 
Hoppner et al. (2015) B2B relationships between US and Japanese 
firms  
   Conflict 
Muylle and Standaert 
(2016) 
B2B relationship between auction and 
procurement firms 
    
Odongo et al. (2016) 150 agricultural businesses survey: B2B supply 
chain relationships between supplier, focal firm 
and customers    
    
Rose (2018) B2B relationship between customer-supplier 
relationships in family business setting 
    
[Source: Author's compilation] 
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Table 2.3 above highlights that along with trust, satisfaction and/or commitment, some 
scholars have considered other dimensions important for RQ according to their 
research settings. Minimal opportunism is considered an important RQ dimension by 
many scholars (e.g. Dorsch et al., 1998; Dwyer et al., 1987; Rasila, 2010). Therefore, 
opportunistic behaviour is inversly related to trust and should be at a minimum level 
for greater trust development between the partners (Morgan & Hunt, 1994). Similarly, 
Kumar et al. (1995) in a distribution or channels relationship context viewed conflict as 
an important RQ dimension. They found that relationships with greater 
interdependence between the firms result in greater trust, more commitment and lower 
conflict, thus leading to quality working relationships. 
Some scholars have paid attention to the power balance among the partners as a 
necessary RQ dimension (e.g. Asnai et al., 2009; Naudé & Buttle, 2000; Rasila, 2010). 
Due to power abuse, conflict arises: therefore, for the enduring quality of a working 
relationship, power should be equally shared between the two parties (Asnai et al., 
2009; Rasila, 2010). In the same way, as can be seen in table 2.3, some scholars include 
profit as a necessary condition for RQ development between two firms (e.g. Asnai et al., 
2009; Naudé & Buttle, 2000). The same view of profit is also reflected in Holmlund 
(2008) and Huntley (2006) economic dimensions, whereby they consider important 
tangible aspects such as economic (profit and/or pricing) and technical (product 
quality) as well. Woo and Ennew (2004) adopt a different perspective and define RQ as 
a high-order construct of cooporation, adoption and overall atmosphere in which a 
relationship develops. Moreover, they view cooporation as a behavioural manifestation 
of trust and commitment. Adoption is considered as relationship specific investment 
that either a firm, or both firms, invest in, alligning the exchange process in areas such 
as products, production process and finance management. Finally, atmosphere is 
regarded as one of the cooporative intentions that is necessary for RQ development 
between two firms. Thus, seeing relationship formation at various levels i.e. social, 
technical, ethical, rational and economic scholars have considered these varied 
dimensions necessary in order to develop RQ suitable to their research setting in 
different firm-to-firm relationship contexts. This aspect is further evaluated in 
subsequent section. 
2.4.4 EVALUATION OF THE DEFINITIONS & DIMENSIONS ADOPTED IN DIFFERENT 
 CONTEXTS: 
The above sections present the varied first order constructs or dimensions of RQ that 
scholars have considered, depending on their suitability to the research context. 
However, 'trust', 'satisfaction' and/or 'commitment' are the most accepted dimensions 
to conceptualize RQ in a majority of the studies. It appears also from the above sections 
that the RQ construct is evaluated and defined on the basis of the requirements of the 
particular context (e.g. Vieira et al., 2008).  
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For instance, the scope of the firm-to-firm level studies is wider in terms of formation of 
relationships at different levels such as social, rational, ethical and economic 
(Athanasopoulou, 2009), therefore research have considered the elements or attributes 
important to developing RQ between firms (Rasila, 2010). The reason perhaps is that 
the business-to-business firm level relationships are characterized as being composed 
of more rationally driven behaviours and are based on contractual mechanisms (Dwyer 
et al., 1987). Therefore, products and services are exchanged with a greater degree of 
customization and on negotiated formal contracts (Assael, 1987). Hence, the definitions 
included social, technical and economic dimensions (e.g. Holmlund, 2001; Huntley, 
2006), as well as profit and power (e.g. Asnai et al., 2009; Naudé & Buttle, 2000).  
Similarly, for relationships between firm-to-consumer, along with trust and 
commitment with service provider or contact person (i.e. social dimensions to fulfil 
social needs), product/or service quality is also considered an important dimension. 
Such product/or service quality accordingly fulfils the technical needs of the consumers 
(e.g. Hennig-Thurau, 2000; Hennig-Thurau & Klee, 1997; Hennig-Thurau et al., 2001) 
and hence is considered as important in developing firm's RQ with consumers. 
Therefore, the existance of the product/or service in exchange relationships is a 
necessary condition for the instigation of broader relationship around it (Čater & Čater, 
2010). Customers do not show their motivation for continuing the relationship wholly 
because of the relationship itself unless they receive a quality product/service that 
matches the customers' expectations by adding value in one way or another (Human & 
Naudé, 2014). Therefore, product/or service quality is considered a vital dimension for 
the development of RQ between customer and a firm.  
However, as seen above in Tables 2.1, 2.2 and 2.3 there is considerable overlap in terms 
of social or relational dimensions (i.e. trust, satisfaction and/or commitment) in 
different studies. For example, at firm-to-firm level relationships, RQ is not only viewed 
in terms of its technical (product and service quality) and economic (price and profit) 
but also on social dimensions (e.g. Asnai et al., 2009; Holmlund, 2001, 2008; Huntley, 
2006; Naudé & Buttle, 2000). Similarly, social dimensions have been considered vital in 
the firm-to-consumer context, along with product/or service quality (e.g. Hennig-
Thurau, 2000; Hennig-Thurau & Klee, 1997). Therefore, products/or services delivery, 
economic gains from relationships, and the interaction between the key individuals in 
the exchange process are all interrelated and basic business functions.  
The stress on social dimensions implies that, business relationships cannot be 
developed merely on the basis of a customer's satisfaction with product or service 
quality, since it is only an entry condition (Crosby et al., 1990). There also exist some 
personal and social forces between buyers and sellers (Oliver, 1999) that are realized 
through successful satisfactory interaction episodes between the key individuals, which 
make the real difference in shaping the relationships (Čater & Čater, 2010). Therfore, 
the quality of interaction between the key individuals of firms is a common factor in 
each definition of RQ ( Vieira et al., 2008).  
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This aspect is examined more precisely in interpersonal selling context, whereby 
different people-based relational or personal characteristics are investigated, to 
improve interaction quality and hence to influence RQ (or trust, satisfaction and/or 
commitment as its necessary elements). The development of an interpersonal 
relationship with the customers can be done through the interaction of any firm's 
marketing or operational staff; however, particular attention is paid in RQ literature to 
the salesperson's role (e.g. Prasertchuwong, 2018; Wray et al., 1994). The role of 
salespeople as a relationship manager is considered vital, because in many industries 
they are the firm's primary contact with customers (Crosby et al., 1990). Therefore, in 
seeing the importance of salespersons’ social interactions with customers, the main 
focus in the literature is placed on the salesperson's personal and relational attributes 
to influence social dimensions (i.e. trust, satisfaction and/or commitment).  
The relationship between customer and salesperson is more interpersonal in nature 
than the firm-to-firm and firm-to-consumer level relationships (Mullins et al., 2014). 
The majority of studies and definitions in interpersonal selling have emerged from the 
services selling context. Because of this it has been argued by many scholars that the 
intangible nature of many services creates uncertainity for customers in their buying 
decision-making (e.g. Bejou et al., 1998; Wray et al., 1994). In the selling of services, the 
salesperson's role becomes critical in reducing the uncertainity level of a customer by 
gaining customer trust and satisfaction (Crosby et al., 1990). Therefore, extensive 
attention is paid in RQ research to the salesperson’s characteristics, which can help in 
the development of quality relationships with customers (Palmer & Bejou, 1994). A 
salesperson's customer-orientation, relational behaviour, frequent interaction with 
customers and service knowledge, for example, engender RQ that encompasses 
customer's trust in, and satisfaction, with a salesperson. Accordingly, this leads more 
strongly to outcomes such as customer purchase decision-making (Palmatier et al., 
2006). Therefore, the adoption of dimensions and definitions are highly context 
dependent. The following section examines the nature of RQ between a physician and 
PSR in pharmaceutical selling context, which leads to the adoption of a definition and 
dimensions for this research.    
2.5 RELATIONSHIP QUALITY IN PHARMACEUTICAL SELLING CONTEXT &  
 RATIONALE FOR ADOPTION OF A DEFINITION & ITS DIMENSIONS: 
In the pharmaceutical selling context, the role of PSR is very important as they provide 
physicians, the information services about the use of their product(s) to treat a patient's 
specific disease(s) or ailment(s) (Lagace et al., 1991). Uncertainity may be inherently 
present in this context in terms of the physician's perception of trustwortiness of the 
information provided by a PSR. This is because a physician uses the information in 
making the decision to prescribe a particular product and is concerned about the 
wellbeing of his or her patient (Clark et al., 2011). A patient's response to the product 
develops the physician's trust in the PSR and satisfaction with the information 
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exchanged with the PSR, and this leads to the physician's commitment with a given PSR 
to on-going future prescriptions (Lagace et al., 1991).  
However, in highly competitive markets such as  the pharmaceutical, uncertainity is also 
present among firms, because there is always a risk of the customers (or physicians) 
switching to the competitor's products or services (Parsons, 2002). As, more often, once 
the patent of a branded pharmaceutical product expires, many  generic alternatives 
become available to physicians at varying prices under one theurepatic category (Clark 
et al., 2011). Therefore, the PSR's role becomes more critical and firms require the PSR's 
frequent interaction with the physicians to develop relationships and sell their products 
based on the bond created.  
It was suggested earlier that successful satisfactory interaction episodes led to longer-
term quality relationships with customers (Crosby et al., 1990). These quality 
relationships (i.e. based on trust, satisfaction and commitment as its necessary 
elements) create bonds of an intra-psychological kind (Hennig-Thurau & Klee, 1997). 
This includes the feelings and emotional states of the customer for a given salesperson 
developed through the salesperson's efforts in maintaining a relationship with a 
customer (Al-Alak, 2014). Further the social bonds that develop through social 
interactions between salesperson and customer also serve as a mechanism (Vieira et al., 
2008) that provides customer retention, loyalty and sustainable competitive advantage 
for the firm. This is because different intangible aspects of the relationship (e.g. 
interaction quality) cannot easily be duplicated by competitors (Roberts et al., 2003); 
such loyal customers are less price-sensitive and are less likely to respond to alternative 
promotional initiatives by defecting to competitors (Stank et al., 2003). Moreover, it is 
also argued that the higher price levels might be compensated by more congenial social 
contacts, e.g. interaction frequency (e.g. Holmlund, 2001). Thus, the PSRs' RQ with 
physicians provides an environment whereby pharmaceutical firms can sell their 
products based on more secure PSR-physician relationship bonds. The PSR with his/her 
abilities can develop RQ with physicians and thus can reduce the uncertainty level 
attached to the pharmaceutical firm by means of enhancing physicians’ prescriptions to 
the patients (Clark et al., 2011).  
However, as discussed above, the pharmaceutical selling context is different to others 
(Clark et al., 2011), because physicians act as intermediaries in the prescription decision 
making process, between the pharmaceutical firm's PSR and the patient as the ultimate 
consumer (Gönül et al., 2001). Therefore, physicians are the  customers in this context 
but not the consumer (Gönül et al., 2001; Miao-Sheng & Yu-Ti, 2008). Many scholars 
examplify this context as similar to organisational buying or a purchasing context such 
as a gift, where the buyer is not the user (e.g. Kotler, 2003) and where buying 
behaviours are mostly influenced by the price (Krapfel Jr, 1985). Therefore, this 
research considers Holmlund's (2008) and Huntley's (2006) economic view as a 
confounding and/or mediating factor rather than an RQ dimension; as a part of an open 
system that can interact with PSR-physician RQ outcomes.  
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This is because previous studies have identified that the price of a product or service 
has no significant effect on the development of buyer-seller RQ. For instance, the 
findings of the study carried out by Lin (2013) identified that customer's perceived 
price does not necessarily produce any barrier to the development of RQ with 
customers. Particularly in a pharmaceutical context, a customer perceives high price as 
a signal of quality (Gönül et al., 2001). However, Lin (2013) also identified that when 
customers pay a higher price they seek more relational behaviour (e.g. interaction 
frequency, customer orientation) from salesperson, which leads to trust in and 
satisfaction with that salesperson and hence RQ. Moreover, Dorsch et al. (1998) found 
in their study that  many qualified vendors (i.e. those with quality products and with 
reasonable prices) were excluded from the customer list of vendors on the basis of 
weak relationship quality. Therefore, economic dimension (i.e. price and/or profit) is 
more appropriate in firm-to-firm level RQ.  
Although the dominant approach to define RQ in interpersonal selling context is based 
on trust and satisfaction as its dimensions, in recent investigations, commitment also 
appears to be a vital RQ first order construct (e.g. Morgan & Hunt, 1994). Moreover, Van 
Tonder et al. (2017) in their study found that all these construct (trust, satisfaction and 
commitment) should be present to achieve optimum benefits of RQ in terms of receiving 
customer's favourable behaviour for a service provider (such as loyalty); and in this 
respect customer's commitment plays a significant role. Particularly, in a 
pharmaceutical selling context, physician's commitment with a PSR is a necessary 
condition for his or her products ongoing prescription to future patients. Thus, based on 
the above discussion, this research  adopts the RQ definition of Smith (1998b, p. 4); that 
RQ is a higher order construct consisting of positive relationship outcomes, i.e. trust, 
satisfaction and commitment that reflect the strength of the relationship and that meet 
the expectations of partners.  
This definition is consistent with the prior conceptualization of RQ in interpersonal 
selling context in general and also in the pharmaceutical context (e.g. Clark et al., 2011). 
Moreover, it has also been argued by Woo and Ennew (2004) that to advance RQ 
conceptualization, researchers should consider the broader meaning of the term RQ, 
which is an overall assessment of buyer-seller relationships. Accordingly, attention 
should be placed on the elements that create RQ as characterized by a degree market or 
industrial context specificity. 
Therefore, having adopted a RQ definition and dimensions for this research; the next 
task is to critically evaluate the nature of trust, satisfaction and commitment, and to 
infer the mechanisms they entail. Furthermore, this will help to identify suitable 
determinants that can influence these RQ dimensions. 
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2.5.1 TRUST 
Trust is the basis of almost all endeavours to assess relationships (Roberts et al., 2003) 
and may be the single cornerstone element for the development and maintenance of 
enduring relationships (Simpson, 2007). Trust is considered as a central dimension of 
RQ (Moorman et al. 1992) within almost all business contexts, since it is essential to all 
relational exchanges (Morgan & Hunt, 1994). Morgan and Hunt (1994, p. 23) define 
trust as "one party's confidence in the exchange partner's reliability and integrity". 
Similarly, Moorman et al. (1992, p. 315) define trust as "a willingness to rely on an 
exchange partner in whom one has confidence." Likewise, in the interpersonal selling 
context Crosby et al. (1990, p. 70) offer an almost identical definition of trust as the 
customer's confident belief in a salesperson, that he or she can be relied upon to behave 
in a manner that serves the customer's long-term benefits. It appears from the RQ 
literature that in order to evaluate trust, studies in different contexts follow the 
conventions laid by the definitions above, where trust has been viewed in two ways in 
these definitions (Moorman et al., 1992).    
First, trust is viewed as the individual's behavioural intentions, which is the reliance on 
the benevolence of the partner (Crosby et al., 1990; Kumar et al., 1995; Moorman et al., 
1992; Rasila, 2010). This view implies that trust allows individuals to take a risk 
(McAllister, 1995) on the part of the partner's uncertain anticipation of future actions 
(Zaheer et al., 1998). The literature on trust in selling contexts suggests that trust is 
developed in the interaction exchange episodes (Bejou et al., 1998; Boles et al., 2000; 
Crosby et al., 1990; Osobajo & Moore, 2017b); and is required in the decision making for 
complex products and/or services, as the customer suffers uncertainty in such 
situations (Crosby et al., 1990). Therefore, according to this view a salesperson's 
benevolence for the customer is an important condition to develop the customer's trust 
in a salesperson (e.g. Hewett et al., 2002; Roberts et al., 2003; Walter et al., 2003). It is 
referred to as the likelihood that the salesperson would value the customer's interests 
and welfare as compared to their own (Sanchez-Franco & Rondan-Cataluna, 2010). Such 
perceived customer confidence in a salesperson's benevolent intentions, for instance 
customer orientation (Bejou et al., 1996; Wray et al., 1994), is critical to reduce 
customers' uncertainty level, which enhances a customer's RQ with the salesperson 
(Shamdasani & Balakrishnan, 2000).  
Second, trust is seen as beliefs, sentiments or expectations of the individual in relation 
to the honesty and the trustworthiness of his/her partner (Crosby et al., 1990; 
Moorman et al., 1992; Morgan & Hunt, 1994; Rasila, 2010). This requires trust in a 
partner's (or salesperson's) credibility and responsible behaviour (McAllister, 1995; 
Moorman et al., 1992). For customers, the credibility at individual's or salesperson's 
level is the extent to which that individual is reliable, likeable, expert or competent and 
dependable in a relationship (Holmlund, 2001; Swan et al., 1985). Finally, the product 
and/or service quality experience of the customer enhances the customer’s trust in the 
credibility of an individual or salesperson and the firm he/she represents (de Ruyter et 
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al., 2001; Sanchez-Franco & Rondan-Cataluna, 2010). This is because a customer's trust 
in a salesperson is developed on the basis of the customer's evaluation of promised 
versus delivered performances (Wray et al., 1994) with respect to product and/or 
services. Sciarelli et al. (2017) in their study found that the service provider is likely to 
be more trusted by the customers, once they feel satisfaction with the service provider's 
conscious efforts in service delivery. Likewise, the salespeople who are experts on their 
products/or services are likely to be more trusted by the customers (Crosby et al., 1990; 
Ou et al., 2012) and their product or services are considered to be more reliable, with 
improved quality assessment (Huntley, 2006). In addition, trust enables customers to 
exchange their concerns and needs openly, which helps salespeople in better meeting 
customer needs and consequently enhancing RQ (Boles et al., 2000). 
In addition, scholars have also attempted to distinguish interpersonal trust in two 
distinct but interrelated types, which are cognitive and affective trust (e.g. Arnott et al., 
2007; Johnson & Grayson, 2005; McAllister, 1995). Cognitive trust is based more on 
reasonable knowledge about the partner's reliability and reputation or credibility, 
which enables predictions about a partner to be made with confidence (Johnson & 
Grayson, 2005). For example, in selling situations the customer's initial trust is more 
likely to develop based on his/her knowledge about a firm's or brand's reputation (Ou 
et al., 2012). Furthermore, it can also be built up on the series of previous interaction 
episodes, whereby a salesperson behaved in reliable, competent and dependable 
manners (Arnott et al., 2007). Therefore, it can be argued that cognitive trust is linked 
with the beliefs or the sentiments of customers, emerging from a customer's knowledge 
about a salesperson's trustworthiness, his/her firm and product or service 
performances. This positive reinforcement from the cognitive trust of a customer 
engenders self-interest mechanisms (Smith, 2011), as the customer feels confident with 
the products or services provided, resources used and the reliable conduct of 
salesperson, which will fulfil his or her future needs and long term interests 
(Shamdasani & Balakrishnan, 2000). This consequently enhances the RQ between 
salesperson and customer because the customer 'believes' the relationship with the 
salesperson is valued enough to continue it.  
Affective trust on the other hand is based on emotions that arises from a customer's 
supposed personal experience with the salesperson's care and obligations (Johnson & 
Grayson, 2005; McAllister, 1995). Affective trust provides the customer with a sense of 
security and strength in the relationship (Johnson & Grayson, 2005) due to emotional 
bonds developed through the benevolent conduct of the salesperson during interactions 
with the customer (Arnott et al., 2007). Therefore, it can be proposed that the 
customer's affective trust in a salesperson can generate affective or emotional 
mechanisms. Since a customer is exposed to the salesperson's genuine care and concern 
for their welfare during ongoing service delivery (Johnson & Grayson, 2005), these 
emotional mechanisms in turn bind the customer to maintaining the relationship with 
the salesperson or elicit the customer's commitment to that relationship.  
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Smith (2011, p. 79) discusses that "the self-interest and/or emotional mechanisms to 
trust are not mutually exclusive. For any trust relationship, any combination of these 
elements may be simultaneously coactive. Indeed, the simultaneous cooperation of 
these mechanisms is often necessary and different types of trusting relationships may 
be based upon different mechanisms to varying degrees".  
Therefore, it can be expected that at an interpersonal level, trust between customer and 
salesperson both cognitive or self-interest and affective or emotional mechanisms can 
exist, which emerge from salesperson's trustworthiness and benevolent conduct 
perceived by the customer.  
Thus, based on the above evaluations this research follows Crosby et al. (1990, p. 70) 
definition of trust -, which is the customer's confident belief that a salesperson, can be 
relied upon to behave in a manner that serves the customer's long-term benefits. 
Furthermore, this research also relies upon the above discussed assumptions that a 
PSR's trustworthiness, competency and expertise, benevolent intentions and sincerity 
with the physician can engender both cognitive and affective trust. That is to say, the 
PSR's trustworthiness, competency and expertise in product or service delivery and 
error-free interactions with physician can lead to his/her cognitive trust in the PSR. 
Affective trust, however, is based on emotions that arises from a customer's (or 
physician's) personal experience with the salesperson's (or PSR's) care and obligations 
(Johnson & Grayson, 2005; McAllister, 1995). Both these kinds of trust develop over 
time and entail the self-interest and emotional mechanisms that engender a physician's 
trust in the PSR, which in turn bind the physician to maintaining a relationship with the 
PSR and make him/her more likely to take a risk based on the information the PSR’s 
supplies. Therefore, physician's trust in a PSR is considered an essential dimension of 
PSR-physician's RQ, which can influence the physician's prescription decision making.        
2.5.2 SATISFACTION 
Satisfaction is a multi-dimensional construct that is considered a necessary condition 
for relationship quality (Bejou et al., 1998; Crosby et al., 1990). Crosby and Stephens 
(1987) discuss that customer satisfaction can emerge from three different levels:  
satisfaction with interpersonal interaction; satisfaction with an intangible aspect such 
as service; and satisfaction with the firm. They found that although all three aspects 
contribute to overall relationship satisfaction, it was satisfaction with the key service 
that had the largest effect on overall customer satisfaction with the salesperson and the 
firm. However, many scholars also suggest that satisfaction can also be influenced by 
tangible aspects such as product quality (e.g. Elsäßer & Wirtz, 2017; Johnson & Grayson, 
2005; Parsons, 2002). Therefore, this research, along with other factors suggests that 
product quality is also considered vital element to achieve customer satisfaction.  
Westbrook and Oliver (1991) define satisfaction as an emotional state generated 
cognitively by a comparison of two processes: firstly, the customer expectation of 
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service performance. Secondly, an emotional evaluation of the performance actually 
achieved during consumption. In the selling context, a customer develops emotional 
feelings towards salesperson when he/she evaluates the error-free efforts of the 
salesperson in maintaining the relationship and gets positive feedback from his or her 
appraisal of the salesperson's efforts. The interpersonal quality of the interaction 
between customer and service provider influences customer satisfaction; however,  
customer satisfaction will be achieved only if the quality of product or service 
performance meets the customer’s prior expectations (Shamdasani & Balakrishnan, 
2000).  
This is because a customer’s cognitive and affective assessment is the result of their 
experiences throughout all the interactions in a relationship (Storbacka et al., 1994), the 
sense of satisfaction engendered at each stage develops a perception of equity, which in 
turn builds confidence that the partner will deliver on future obligations (Ganesan, 
1994). However, as Roberts et al. (2003) found, unsatisfied customers are less likely to 
develop a relationship with services providers, because a customer's satisfaction with 
the service provider develops trust, which leads to his/or her commitment to the 
service provider (Sciarelli et al., 2017).  Therefore, satisfaction is an essential construct 
and necessary condition in order to develop RQ with the customer (Bejou et al., 1998). 
Customer relationship satisfaction has an impact on customer retention and loyalty 
through its impact on trust and commitment (Caceres & Paparoidamis, 2007; Hennig-
Thurau et al., 2001). In that sense customer's satisfaction with a salesperson is a 
fundamental condition for the existence of his or her trust and commitment with the 
salesperson. Therefore, because customers evaluate salespeople across many 
dimensions, it is likely that cognitive and affective trust are the outcomes of perceptions 
of satisfaction (Johnson & Grayson, 2005). Hence, it can be expected that satisfaction 
also entails both cognitive and affective or emotional mechanisms.  
Thus, based on the discussions above, this research considers satisfaction to be an 
emotional state of a customer that develops through his or her overall cognitive and 
affective assessments about a salesperson in a relationship. It can be anticipated that a 
physician's overall evaluations and satisfaction with the PSR's interactions, product/ 
service he or she offers and the firm he or she represents can engender both cognitive 
and affective trust, which entails both the self-interest and emotional mechanisms that 
engender the physician's trust in and commitment to the PSR. Therefore, customer's 
satisfaction with a salesperson develops alongside trust, which leads to his or her 
commitment to the salesperson. Thus, a physician's satisfaction with the PSR is 
considered to be an essential dimension of PSR-physician RQ. 
2.5.3 COMMITMENT 
Commitment is another important construct in relation to RQ (Ivens & Pardo, 2007) and 
critical for successful relational exchanges between firms and their partners (Gundlach 
et al., 1995; Morgan & Hunt, 1994). Commitment is an essential factor for maintaining 
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RQ (Parsons, 2002) since it expresses a value judgment and maintains the relationship, 
as the partners involved are willing to make certain efforts in order to preserve the 
relationship (Ivens & Pardo, 2007). Thus, it is the wish of the partners for relationship 
continuity demonstrated by their willingness to invest resources (e.g., assets, time, 
efforts) into a relationship (Gounaris, 2005).  
Moorman et al. (1992, p. 316) define relationship commitment as "an enduring desire to 
maintain a valued relationship". However, Hennig-Thurau and Klee (1997, p. 752) view 
commitment as a combination of both emotional and rational benefits, encompassing 
evaluation of the relationship by the customer and defined as a "customer's long-term 
orientation towards a relationship grounded on both an emotional bond to the 
relationship (affective aspect) and on the conviction that remaining in the relationship 
will yield higher net benefits than terminating it (cognitive or calculative aspect)". 
Therefore, it represents strong relational (Dwyer et al., 1987), as well as emotional 
bonds (Hennig-Thurau & Klee, 1997) between partners. Likewise, parallel to affective 
and cognitive trust,  Kumar et al. (1994) viewed commitment in two forms, which are 
affective and calculative commitment.  
Calculative commitment is based on exchange partners motivation to stay in the 
relationship because of the resources they possess from each other that cannot be 
replaced easily in case of a termination of the relationship (de Ruyter et al., 2001). It is a 
rationally based commitment because it considers cost-or-benefit calculations (Hennig-
Thurau, 2000). Affective commitment conversely is based on the positive sentiments of 
the customer toward the seller (de Ruyter et al., 2001). The customer develops these 
emotions through the quality of interaction with the seller and also with the excellent 
product/service quality (Hennig-Thurau, 2000). These continuous episodes of 
interpersonal interaction fulfil the customer's social needs and efforts made by the 
seller create emotional bonds and thus lead to affective commitment (Hennig-Thurau & 
Klee, 1997).  For instance, in building and maintaining strong relationship quality, a 
salesperson’s (i.e. a PSR) commitment to the relationship in terms of relationship 
investment (i.e. time, efforts and resources etc.) is an important factor (Wong & Sohal, 
2002). The salesperson, by delivering excellent product or service quality and by 
effective relationship management helps customers in developing trust in, and 
satisfaction with, the salesperson, thus leading to the customer's affective and cognitive 
commitment to a salesperson (Gounaris, 2005).  
Commitment cannot exist without trust between the partners (Naudé & Buttle, 2000). 
Furthermore, affective commitment is also mostly influenced by the presence of trust 
between partners (de Ruyter et al., 2001; Gounaris, 2005). Prior research reveals that 
only affective commitment influences the customer's intention for relationship 
maintenance with a firm (Roberts et al., 2003) due to its impact on the customer’s 
attitudinal and behavioural loyalty (Čater & Čater, 2010). Therefore, trust is a major 
antecedent (or determinant) of relationship commitment (Morgan & Hunt, 1994; Ou et 
al., 2012). Additionally, Van Tonder et al. (2017) found in their study that a customer's 
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commitment not only depends on trust but also the extent to which the customer is 
satisfied with the service provider. Further, because cognitive and affective trust are 
potentially the outcomes of perceptions of relationship satisfaction (Johnson & Grayson, 
2005), it is likely that  both trust and satisfaction with a salesperson engender the 
customer's cognitive and affective commitment. This process is outlined below in figure 
2.3. 
 
 
 
  
 
 
 
Thus, based on the aforementioned discussion, this research follows Hennig-Thurau 
and Klee (1997, p. 752) definition of commitment as-""customer's long-term orientation 
towards a relationship grounded on both an emotional bond to the relationship and on 
the conviction that remaining in the relationship will yield higher net benefits than 
terminating it"". Calculative commitment can be based on physician's cognitive 
evaluations regarding the rational benefits that the physician achieves (such as quality 
of information and product) by maintaining the relationship with a PSR. Affective 
commitment can be developed through the physician's emotional feelings that are 
engendered through the PSR's personal care, obligations, benevolent intentions and 
sincerity with the physician. Together calculative and affective commitment entail self-
interest and emotional mechanisms, which in turn bind the physician to maintaining the 
relationship with the PSR in terms of physician's prescriptions for the PSR's product. 
Therefore, a physician's commitment to a PSR is considered an essential dimension of 
PSR-physician RQ that can influence the physician's prescription decision making. 
Moreover, previous studies provide the evidence that when customers are satisfied with 
the services received, they are able to trust in the service provider and show 
commitment to remain in the relationship by demonstrating the favourable behaviour 
to the service provider (Van Tonder et al., 2017).      
 
In summary, from the above discussion it should be understood: that although these 
constructs i.e. trust, satisfaction, and commitment are distinct in nature, they are 
interrelated and comprise RQ (Giovanis et al., 2015). Therefore, it can be anticipated 
that RQ entails both cognitive and affective mechanisms. The three components of RQ 
Figure 2.3. The interrelationship between trust, satisfaction and commitment 
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(trust, satisfaction, and commitment) and the mechanisms (cognitive and affective) they 
can entail are summarized below in table 2.4. 
Table 2.4. RQ dimensions and its mechanisms 
RQ Dimensions Mechanisms 
Trust Customer's trust in salesperson can entail both cognitive or self-interest and 
affective mechanisms, emerging from salesperson's trustworthiness and 
benevolent conduct. 
Satisfaction Customer's satisfaction with salesperson emerges from customer's overall 
cognitive and emotional evaluation of error-free product and service 
encounter, thus entails cognitive and affective mechanisms.                                                                                                                                                                                                      
Commitment Both customer's trust in and satisfaction with salesperson engenders 
customer's calculative and affective commitment. Thus, fostering cognitive 
or self-interest and affective mechanisms.  
Having identified the mechanisms that RQ dimensions can entail, the following section 
evaluates and identifies the determinants that are required to influence these 
constructs to develop RQ between PSR and physician in the context of Pakistan. 
2.6 THE DETERMINANTS OF RELATIONSHIP QUALITY EMPLOYED IN 
INTERPERSONAL SELLING CONTEXT 
The last section discussed the nature of trust, satisfaction and commitment as RQ 
dimensions and also the mechanisms they entailed that lead to certain performance 
objectives, which is pivotal for buyer-seller exchange relationships. However, RQ is not 
engendered by itself, the determinants of RQ influence RQ and its dimensions (Ou et al., 
2012). It has already been discussed that there may be many factors that contribute to 
the development of strong quality buyer-seller relationships; however, it may depend 
on the nature of the organization, the individuals who represent the organization and 
the situational factors around it (Parsons, 2002). In essence the determining factors of 
RQ are contingent on wider contextual factors (Hewett et al., 2002; Naudé & Buttle, 
2000). For that reason it appears from RQ literature that scholars have investigated the 
significance of a diverse range of determinants influencing RQ suitable to the context of 
their studies and therefore there is no general agreement on RQ determinants (Izogo, 
2016a). Thus, the task of this section is the identification of the determinants that are 
important to developing PSR-physician interpersonal RQ, which are also relevant in the 
context of Pakistan.  
In the interpersonal selling context (albeit in a firm-to-firm or consumer context), 
scholars have identified salespeople’s varied relational and personal characteristics as 
important determinants to developing RQ with customers. For example, in services 
context Crosby et al. (1990) identify that a salesperson's relational selling behaviour 
(i.e. interaction frequency, cooporation and mutual disclosure) and  personal 
characteristics (such as similarity and expertise) are important to influencing a 
customer's trust in and satisfaction with the salesperson. Similarly, Palmer and Bejou 
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(1994) investigate customer orientation, selling orientation, expertise, and ethics as 
influences on trust and satisfaction. Likewise, Wray et al. (1994) and Bejou et al. (1996) 
examine the impact of  customer orientation, selling orientation, expertise, ethics and 
relationship duration on trust and satisfaction. Boles et al. (2000) just replicate the 
study by Lawrence A. Crosby and colleagues in 1990 by adding equity found trust and 
satisfaction as important dimensions of RQ. 
Likewise, Smith (1998a) considers relationship investment and open communication to 
be aspects of relationship management, and life-stage, gender, cultural background, 
work attitude and personality as aspects of similar importance to influencing trust, 
satisfaction and commitment. In another study Smith (1998b) added relationship bonds 
(i.e. structural, social and functional) to her previous study as an RQ determinant and 
found that social bonds have a significant impact on trust, satisfaction and commitment. 
Similarly, Mullins et al. (2014) examined self-efficacy, similarity and customer 
orientation as important RQ determinants that have significant impact on trust, 
satisfaction and commitment.  
Although there is a limited consensus on the determinants of RQ (Izogo, 2016a), a few 
salesperson's relational and personal characteristics are more frequently used by 
different scholars as the important RQ determinants, as shown in table 2.5.  
 
Table. 2.5: RQ determinants used in interpersonal selling context 
Determinants of RQ Study 
 Interaction Frequency 
 
Cooperation 
Mutual Disclosure 
 
(Boles et al., 2000; Crosby et al., 1990; Lagace et al., 1991; Lin, 2013; Rose, 
2018) 
(Boles et al., 2000; Crosby et al., 1990; Rose, 2018; Smith, 1998b) 
(Boles et al., 2000; Crosby et al., 1990; Lin, 2013) 
Similarity (between salesperson & 
customer e.g. shared values, 
culture, sex, life stage) 
(Boles et al., 2000; Crosby et al., 1990; Mullins et al., 2014; Smith, 1998b) 
Expertise (Bejou et al., 1996; Boles et al., 2000; Clark et al., 2011; Crosby et al., 1990; 
Izogo, 2016b; Lagace et al., 1991; Ou et al., 2012; Smith, 1998a, 1998b) 
Ethics or Ethical behaviour (Bejou et al., 1996; Lagace et al., 1991; Ou et al., 2012) 
Relationship Duration (Bejou et al., 1996; Lagace et al., 1991; Smith, 1998b) 
Customer Orientation (Bejou et al., 1996; Izogo, 2016a, 2016b; Mullins et al., 2014) 
Selling Orientation (Bejou et al., 1996) 
Social Bonds (Smith, 1998a) 
Relationship Investment (Clark et al., 2011; Smith, 1998a, 1998b) 
Communication (Smith, 1998a, 1998b) 
Equity (Boles et al., 2000) 
Corporate Reputation (Ou et al., 2012) 
Relationship Benefits (Clark et al., 2011) 
Relationship Dependence (Clark et al., 2011) 
Product/Service Quality 
 
Empathy and Listening Behaviour  
Language Divergence 
(Caceres & Paparoidamis, 2007; Čater & Čater, 2010; Giovanis et al., 2015; 
Roberts et al., 2003; Wong & Zhou, 2006) 
(Itani & Inyang, 2015) 
(Balaji et al., 2017) 
[Source: Author's compilation] 
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For example, salesperson's personal attribute such as salesperson's expertise of the 
product/or services (e.g. Bejou et al., 1996; Boles et al., 2000; Clark et al., 2011; Crosby 
et al., 1990; Lagace et al., 1991; Ou et al., 2012; Smith, 1998a, 1998b), ethics or ethical 
behaviour (e.g. Bejou et al., 1996; Lagace et al., 1991; Ou et al., 2012), salesperson-
customer similarity (e.g. Boles et al., 2000; Crosby et al., 1990; Mullins et al., 2014; 
Smith, 1998b). Similarly, relational characteristics such as contact or interaction 
frequency (e.g. Boles et al., 2000; Crosby et al., 1990; Lagace et al., 1991; Lin, 2013), 
cooperation (e.g. Boles et al., 2000; Crosby et al., 1990; Smith, 1998b) and mutual 
disclosure (e.g. Boles et al., 2000; Crosby et al., 1990; Lin, 2013) are considered as 
important determinants to developing RQ with customers. Therefore, based on the 
above discussed RQ determinants that have been employed by scholars in different 
interpersonal selling contexts, the aim of subsequent section is the identification of RQ 
determinants suitable to Pakistan's pharmaceutical interpersonal selling context. 
    
2.7 THE RQ DETERMINANTS IDENTIFICATION FOR PAKISTAN’S 
PHARMACEUTICAL INTERPERSONAL SELLING CONTEXT  
In the pharmaceutical interpersonal selling context, Lagace et al. (1991) identified a few 
of the identical determinants as discussed above in other selling contexts and outlined 
in table 2.5. They found that the PSR's expertise, ethical behaviour and contact 
frequency had significant impact on RQ. Clark et al. (2011) identified relationship 
benefits (i.e. companionship and information services provided by a PSR to physician), 
relationship investment (investment of time, effort and spending), relational 
dependence and PSR's expertise as the most important determinants that influence RQ 
with physicians.  
 
However, whilst the PSR's personal and relational characteristics are very important to 
cultivate the quality relationships with physicians, product quality and firm's image or 
reputation are also crucial in the pharmaceutical context (Scharitzer & Kollarits, 2000). 
However, it has also been argued that product and/or-service quality is merely an entry 
condition (e.g. Crosby et al., 1990). Nevertheless, in some contexts, such as in 
pharmaceutical selling, product quality is a vital aspect because for the physician, the 
ultimate goal is the early recovery of his/her patient (Lagace et al., 1991). Therefore, if a 
product fails to improve the patient's condition, it might deteriorate the physician's 
trust in the PSR and satisfaction with the information exchanged. Product quality has 
not been taken into account in previous studies in the pharmaceutical selling context.  
 
Moreover, previous studies on RQ have mainly been conducted in US, UK and other 
western developed countries (Asnai et al., 2009; Osobajo & Moore, 2017b) including 
those conducted in a pharmaceutical setting (e.g. Clark et al., 2011; Lagace et al., 1991). 
In these contexts, issues related to product quality are ensured by the monitoring of 
different institutional mechanisms as compared to the developing countries, such as 
Pakistan, where the govermental and institutional mechanisms for health regulations 
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are weak and inefficient (Ehsan & Ashill, 2014). Furthermore, in Pakistan there are 
more than 400 licensed pharmaceutical companies (including national and 
multinationals) operating and the total number of registered pharmaceutical products 
was more than 40000 in 2012 (Chandio, 2012). This can create uncertinity in the 
prescription decisions related to the quality of a particular product category promoted 
by different pharmaceutical firms' PSRs.  
 
One mechanism to reduce this uncertainity is the firm's positive image in terms of 
eductional services offered to the physicians and their patients. A firm's positive 
reputation is similar to brand equity that creates customer trust in a firm and in the 
salesperson as a representative of that firm (Ou et al., 2012). Therefore, along with 
PSR's personal (i.e. product, knowledge, ethical behaviour) and relational 
characteristics (such as frequent visits, relationship investments), other factors, such as 
the product's quality that a PSR is promoting and the firm's image that a PSR is 
representing might also be important to develop PSR's RQ with physicians in the 
context of Pakistan. Furthermore, in terms of an open system inquiry it is essential to 
take in to the account all entities within the pharmaceutical selling structure (i.e. PSR, 
the product he or she promotes and the firm he or she represents), which possess their 
causal forces and can influence the PSR-physician's RQ. Thus, based on the prior 
conceptualizations discussed above and considering the assumptions of an open system 
inquiry, the following key determinants are identified for this research: i.e. firm's image, 
product quality, visit frequency, relationship investment, ethical behaviour and PSR's 
expertise. The subsequent sections consider the inter-relationship between the 
identified determinants that leads to RQ (i.e. trust, satisfaction and commitment).  
2.7.1 FIRM'S IMAGE: 
Customers' perception of a firm's image or reputation has been defined as the extent to 
which a customer believes that a supplier firm is fair, honest and concerned about its 
customers’ goodwill (Doney & Cannon, 1997, p. 37). It is not only based on word-of-
mouth and other firms in the industry (Doney & Cannon, 1997); but also customer's 
long-term assessment of a firm's positive actions and performances in favour of a 
customer that engenders customer's trust and satisfaction with a given firm (Ou et al., 
2012). In the  pharmaceutical context, a firm's positive reputation emerges with the 
delivery of excellent products and educational services offered to the physicians 
(Scharitzer & Kollarits, 2000). For instance, pharmaceutical firms may provide 
physicians with free samples, educational materials, support for conferences and 
symposia and funding for continuing educational programmes. Physicians view these 
actions or services of a pharmaceutical firm as beneficial for themselves and ultimately 
for their patients as well (Andaleeb & Tallman, 1996; Wright & Lundstrom, 2004). Thus, 
it leads to a physician's positive perception about a firm's image, trust in and 
satisfaction with a pharmaceutical firm.  
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A customer’s judgment of the positive reputation and trust in a firm has a great 
influence on customer's trust in a salesperson through a mechanism of transference 
(Johnson & Grayson, 2005; Ou et al., 2012) and as a source of a credible firm. This 
implies that the physician's perception of the firm’s reputation (or credibility) that a 
PSR represents has direct impact on the development of the physician's trust in the PSR 
and also the future relationship between them (Wright & Lundstrom, 2004). According 
to Doney and Cannon (1997), source credibility has significant associations with trust 
and buying decision-making, since a communicator is perceived to be a source of valid 
assertions (i.e. credible). Physicians are the customers of pharmaceutical firms and 
prescribe the firm's products for the betterment of their patients. Therefore, a firm's 
image is a part of the physician's perception of a PSR as a credible source of information, 
and is an important factor to a physician  (Wright & Lundstrom, 2004). Therefore, it can 
be anticipated that a PSR's firm image has a direct relationship with the physician's 
trust, satisfaction and hence RQ with the PSR.   
2.7.2 PRODUCT QUALITY: 
The existance of the product in an exchange relationship is a necessary condition for the 
instigation of a relationship around it (Čater & Čater, 2010). Customers do not show 
their motivation for continuing the relationship wholly because of a relationship itself 
unless they also receive a quality product that matches the customers' expectations by 
adding value in one way or another (Human & Naudé, 2014). This implies that whilst a 
salesperson's quality of interaction fulfils the social needs of customers, the quality of 
the product is necessary for their rational (Elsäßer & Wirtz, 2017) or technical need 
fulfilment (Hennig-Thurau & Klee, 1997). While judgements on RQ will be made based 
on the quality of cstomer/salesperson interaction, product or service quality may also 
be influential (Bejou et al., 1998). Therefore, it is probable that the customer will 
associate the performance of a product with the salesperson, which will affect the 
customer's trust in the salesperson (Johnson & Grayson, 2005). For instance, in 
pharmaceutical sales, product related quality is a vital aspect because for the physician 
the ultimate goal is the early recovery of his/her patient. Pateint's response to the 
particular product engenders a physician’s trust in a PSR and satisfaction with the 
information exchanged about the product that a PSR is promoting (Lagace et al., 1991). 
Therefore, product related quality perception can lead to trust and satisfaction and can 
be interpreted as a determinant of RQ (Wong & Zhou, 2006).  Moreover, it has been 
confirmed more recently by Čater and Čater (2010) that product related quality is a 
necessary determinant for successful and quality business relationships that influence 
the buyers commitment. Therefore, it can be anticipated that a PSR's product quality 
has a direct relationship with physician's trust, satisfaction, commitment and hence RQ 
with the PSR.   
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2.7.3 CONTACT OR VISIT FREQUENCY: 
Contact frequency is another important determinant, which is considered by many 
scholars in their studies when modelling RQ in sales contexts (e.g. Boles et al., 2000; 
Crosby et al., 1990; Lagace et al., 1991; Lin, 2013). It refers to the salesperson's 
frequency of face-to-face or indirect communication with customers for either personal 
or business reasons (Crosby et al., 1990). The pharmaceutical context is characterized 
by PSRs’ frequent interactions with physicians, which are needed to keep physicians 
updated about rapid changes in the industry (e.g. new products, product uses and 
interaction, and educational services etc.)  (Lagace et al., 1991). A salesperson's 
frequent interaction with a customer engenders the customer's trust in the salesperson 
(Doney & Cannon, 1997). As a result, customers view salespeople as a source of 
information (de Ruyter et al., 2001) and salesperson's frequent interactions provide the 
customer more of the necessary information, which reduces the customer's uncertainty 
and leads to a quality relationship (Leuthesser, 1997). Therefore, frequent interactions 
provide better opportunity for PSRs to provide information critical to the success of the 
relationship (Lagace et al., 1991). 
Furthermore, visits to a customer provide a salesperson's social settings opportunities, 
in which a more productive information flow can be developed (Doney & Cannon, 
1997). This is because such interpersonal interactions enable the salesperson to collect 
information regarding the customer's personal and professional needs, which is helpful 
in building a closer interpersonal relationship (Crosby et al., 1990). This implies that 
visits not only fulfil the physician's product or service related technical needs, but also 
the physician's social needs. Therefore, interaction with the physician might give 
him/her a sense of obligation and importance and commitment towards the PSR, 
developing an ongoing relationship (Crosby et al., 1990). That leads to the customer's 
(or physician's) affective commitment for a salesperson (de Ruyter et al., 2001) along 
with trust (Crosby et al., 1990; Doney & Cannon, 1997) that have significant impact on 
RQ. Furthermore, Murshid and Mohaidin (2017) as a result of their review of literature 
found that in the context of developing countries, PSRs frequent interaction with 
physicians has a significant impact on physicians' prescription behaviour. Therefore, 
this research proposes that a PSR's appropriate visit frequency influences the 
physician's trust, satisfaction and commitment and thus RQ with a given PSR.   
2.7.4 RELATIONSHIP INVESTMENT: 
Relationship investment is referred to as the time, efforts and resources devoted to 
developing and maintaining a relationship (Smith, 1998b). Although relationship 
investment makes a good reflection of the firm's commitment to the customer (Keating 
et al., 2003) however, the resources invested are irrecoverable once the relationship 
terminates (De Wulf et al., 2001). However, such investments generally generate an 
expectation of reciprocation which provides strength and continuity to a relationship 
and, therefore enhances trust, satisfaction and commitment (Palmatier et al., 2006).  
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PSR visits to the physicians in their areas are the main elements of relationship 
management (Scharitzer & Kollarits, 2000). They spend their time in travelling, 
communication and provide many other benefits (such as educational materials, free 
product's samples, funding for continuing educational programmes, support for 
conferences and symposia), which are provided by the pharmaceutical firms through 
their PSRs who are the primary point of contact with physicians (Andaleeb & Tallman, 
1996). These PSR relationship investments removes the physician's uncertainty (Smith, 
1998b), which creates the emotional or psychological mechanisms through the 
development of trust, satisfaction and commitment (Palmatier et al., 2006) that has 
direct positive influence on RQ (Clark et al., 2011). Therefore, this research proposes 
that higher relationship investment by a PSR influences the physician's trust in, 
satisfaction and commitment and thus RQ with the PSR.  
2.7.5 SALESPERSON'S ETHICAL SELLING BEHAVIOUR: 
The interpersonal interaction implicit in personal selling makes it the setting for the 
transaction of ethical codes of conduct (Chen & Mau, 2009; Lagace et al., 1991). This is 
because salespeople normally perform their role in somewhat unsupervised settings, 
where sales achievements and revenue generation are their primary responsibility, 
which more often can be very hectic (Chen & Mau, 2009). Therefore, this can lead to the 
adoption of unethical selling behaviour for short-term gains (e.g. sales increase) on the 
cost of the customer, such as making false claims about a product or service, giving false 
information about its availability or spreading disinformation about competitors etc. 
(Román, 2003). The salesperson's unethical behaviour and short-term goal orientation 
could subsequently endanger the possibility of developing long-term relationships with 
customers (Wray et al., 1994). Therefore, there is a general consensus in sales literature 
that ethical sales behaviour is vital to foster customers' trust in and satisfaction with a 
salesperson (Cadogan et al., 2009).   
A salesperson's ethical behaviour is referred to as the dissemination of truthful and 
accurate information of products/or services by a salesperson during interaction with 
the customer (Ou et al., 2012). In the pharmaceutical setting the ethical sales behaviour 
is particularly important since this context is involved with the wellbeing of the patients 
and unethical behaviour by a PSR can have unwanted consequences. To avoid such 
consequences, Lagace et al. (1991) elaborate many possible approaches for a PSR, such 
as not to exaggerate product information, avoid dispersing falsified information against 
competitors' brands and also provide the exact information regarding product 
availability. This is because customers make important decisions on the basis of 
information provided by a PSR or salesperson (Ou et al., 2012). For example, when the 
PSR  provides an unbiased accounts of a product’s efficacy, side-effects and availability, 
a physician should be able to make an informed prescription and patient relief is more 
likely to occur.  Since communicating relevant and timely information consistently helps 
customers to perceive salesperson reliability (Morgan & Hunt, 1994), this dissemination 
of information fosters trust and satisfaction with the salesperson (Lagace et al., 1991). 
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Further, previous research in different context also provides the evidence that the 
salesperson's ethical behaviour engenders customer's trust in, and satisfaction with the 
salesperson (e.g. Chen & Mau, 2009; Ou et al., 2012; Román, 2003; Wray et al., 1994). 
Therefore, this research proposes that a PSR's ethical selling behaviour fosters the 
physician's trust in, satisfaction and commitment to a PSR and thus RQ with a PSR.  
2.7.6 SALESPERSON'S EXPERTISE OR PRODUCT KNOWLEDGE: 
A salespersons' expertise regarding their products/or services is widely considered as 
one of the main determinants of RQ by majority of scholars in various sales contexts 
(e.g. Bejou et al., 1998 etc.; Boles et al., 2000; Clark et al., 2011; Crosby et al., 1990; 
Lagace et al., 1991; Lin, 2013; Ou et al., 2012). Expertise refers to the degree of 
knowledge, experience or skills a source possesses related to a specific subject (Lagace 
et al., 1991, p. 3). A salesperson who holds relevant product/market knowledge is 
perceived as expert and competent by customers (Crosby et al., 1990). Therefore, when 
customers interact with an expert salesperson, the value of this interaction increases, 
and the relationship comes to be perceived as more important, leading the customer to 
take steps to strengthen and maintain it (Palmatier et al., 2006). Therefore, a 
salesperson's level of products/or services and selling knowledge is perceived by a 
customer to create trust and satisfaction, which has a direct positive influence on RQ 
(Parsons, 2002; Wong & Sohal, 2002). 
Similarly, in the pharmaceutical setting expertise refers to the level of knowledge a PSR 
possesses around the product class he or she is promoting to the physician (Lagace et 
al., 1991). Ahmed (2016) as a result of his study in the context of Pakistan, found that 
PSRs' expertise or product knowledge has a significant impact on physicians' 
prescription decision making. This is because the PSR's expertise provides physicians 
with a sense of credibility in the information exchanged about a particular product 
class, which is evaluated highly by the physicians in their prescription decision making 
(Clark et al., 2011). As a result physicians provide quality care to their patients, which 
fosters physicians’ trust in and satisfaction with a PSR (Clark et al., 2011; Lagace et al., 
1991). Therefore, this research proposes that a PSR's product knowledge engenders the 
physician's trust in, satisfaction and commitment to PSR and thus RQ with a PSR. 
In the preceding discussion and review of the existing literature, this research has 
identified the determinants necessary to build PSR-physician RQ in the pharmaceutical 
context and proposed their relationships with RQ (i.e. trust, satisfaction and 
commitment) outlined below in figure 2.4 
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Figure 2.4. RQ determinants identified for current research and their inter-relationships 
The prior research on RQ has shown that these constructs have significant influence on 
RQ (i.e. trust, satisfaction and commitment). This includes the salesperson's 
characteristics (i.e. salesperson's contact or visit frequency, relationship investment, 
ethical sales behaviour and expertise) and firm related characteristics (i.e. firm's image 
and product quality). The task of the following sections is to critically evaluate the PSR-
physician's RQ outcomes in terms of physician's prescription decision making in an 
open system under contingent economic conditions of patients.  
2.8 THE CONSEQUENCES OR OUTCOMES OF RELATIONSHIP QUALITY: 
RQ has a critical role in the effective management of customer relationships (Wong & 
Zhou, 2006) to achieve certain performance outcomes (Palmatier et al., 2006; Vieira et 
al., 2014). Therefore, RQ serves as a mediator between relational input factors (i.e. RQ 
determinants) from sellers that produce positive outcomes or consequences in 
customers (Palmatier et al., 2006). Considerable research on RQ has thus reported that 
the quality of the relationship with customers provides a firm with superior outcomes, 
such as: sales effectiveness/business share (i.e. objective outcomes), and anticipation of 
future interaction/or relationship commitment, customer retention, loyalty, word of 
mouth/recommendations and repurchase intentions (subjective outcomes), as shown 
below in table 2.6.  
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Table 2.6: Outcomes of relationship quality 
Outcomes of RQ Study 
Subjective Outcomes:  
Future Interaction/Commitment  (Boles et al., 2000; Crosby et al., 1990; Wong & Zhou, 2006) 
Customer Retention (Hennig-Thurau, 2000; Hennig-Thurau & Klee, 1997; Hennig-Thurau et al., 2001; Ou et 
al., 2012) 
Customer Loyalty (Caceres & Paparoidamis, 2007; Čater & Čater, 2010; De Wulf et al., 2001; Giovanis et al., 
2015; Hennig-Thurau et al., 2002; Hennig-Thurau et al., 2001; Izogo, 2016a; 
Prasertchuwong, 2018; Rauyruen & Miller, 2007; Roberts et al., 2003; Shamdasani & 
Balakrishnan, 2000; Wong & Zhou, 2006) 
Word-of-Mouth/Recommendations (Balaji et al., 2017; Hennig-Thurau et al., 2002; Izogo, 2016b; Ou et al., 2012; Wahid & 
Ismail, 2017) 
Repurchase Intention (Hewett et al., 2002; Izogo, 2016b; Rauyruen & Miller, 2007) 
Objective Outcomes: 
Sales Effectiveness/Business 
Share/purchase share 
 
(Boles et al., 2000; Crosby et al., 1990; Huntley, 2006; Leuthesser, 1997; Palmatier et al., 
2006; Palmatier, Scheer, Houston, et al., 2007; Vieira et al., 2014; Wahid & Ismail, 2017) 
[Source: Author's compilation] 
It appears from RQ literature that most studies concentrate on the subjective rather 
than the objective outcomes of RQ.  This is because the majority of scholars assumed 
that subjective outcomes ultimately lead to objective or financial outcomes (e.g. Vieira 
et al., 2014). Among these subjective outcomes, the impact of RQ on customer's loyalty 
as an outcome has been widely investigated and identified by scholars (e.g. Caceres & 
Paparoidamis, 2007; Čater & Čater, 2010; De Wulf et al., 2001; Hennig-Thurau et al., 
2002; Hennig-Thurau et al., 2001; Prasertchuwong, 2018; Rauyruen & Miller, 2007; 
Roberts et al., 2003; Shamdasani & Balakrishnan, 2000; Wong & Zhou, 2006). A few 
scholars have also investigated whether RQ has significant impact on customer 
retention, word-of-mouth, recommendations, and re-purchase intentions, as shown in 
table 2.6. However, these outcomes can also be considered as a customer's behavioural 
manifestations that emerge through the customer's loyalty (Sirdeshmukh et al., 2002). 
Therefore, customer loyalty can be taken as a positive behaviour exhibited by the 
customer through the repeat purchase of goods/or services and/or holding a favourable 
attitude towards a firm and its goods/or services (Wong & Zhou, 2006).  
Customer loyalty can emerge through the effects of different mechanisms associated to 
customer's overall satisfaction with a product/or service, personal determinism (or 
commitment) and social bonding at interpersonal and/or firm level (Oliver, 1999). 
Furthermore, it also can emerge through the development of psychological bonds that 
enhance the re-purchase intentions of the customer (Jarvis & Wilcox, 1977). Although 
different mechanisms that can influence the customer's loyalty may operate 
simultaneously, Palmatier, Scheer, and Steenkamp (2007) reveal that the customer’s 
loyalty to a salesperson contributes to the overall customer loyalty to a firm. They 
further found that the loyalty owed to a salesperson has an effect on the financial or 
objective performance of a selling firm. Since customer's intention to continue buying 
from the firm may be dependent on the quality of goods/or services, it may also be 
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dependent on the interaction quality and RQ with the salesperson. Previous research 
has proved that RQ influences customer loyalty (Shamdasani & Balakrishnan, 2000; 
Wong & Zhou, 2006). Therefore, it can be expected that salesperson's RQ with the 
customer can foster positive customer behaviour such as loyalty with a given 
salesperson through the effect of underlying cognitive and affective mechanisms. 
Previous research on loyality has considered customer's loyalty as a measure of re-
purchase decision making (Oliver, 1999); thus, it is higly likely that RQ between 
salesperson and customer influences the customer's purchase decision making that can 
lead to increased objective or financial performance outcomes for a firm.  
However, previous research on RQ reveals mixed findings (Casidy & Nyadzayo, 2017) 
on the objective outcomes (i.e. sales effectiveness) based on buyer-seller's RQ. For 
example, Crosby et al. (1990) did not find any noteworthy association between RQ and 
sales effectiveness and similar results were found by Huntley (2006). On the other hand 
Boles et al. (2000) found that RQ had a positive impact on sales effectiveness. Similarly, 
Leuthesser (1997) found that there was a significant correlation between RQ and 
business share. Furthermore, it has been confirmed by Palmatier et al. (2006) that RQ 
mostly influenced objective outcomes.  
Nevertheless, it appears from RQ literature that the objective outcomes of RQ were seen 
as a constant conjunction of variables within a stable environment. The reason for the 
mixed findings on the objective outcomes is perhaps that the previous studies did not 
consider the impact of external (or contingent) factors on the outcomes mediated 
through RQ. In addition to the cognitive and affective mechanisms of RQ, there might be 
other contextual mechanisms that can influence customers' purchase decision making 
(Hennig-Thurau & Klee, 1997). Further decision making can also be influenced due to 
the interaction of other relationships in the value chain (Holmlund, 2001). These 
aspects should also be taken into account in order to verify the effectiveness of RQ and 
their objective outcomes in particular contexts (Casidy & Nyadzayo, 2017; Hennig-
Thurau & Klee, 1997; Odongo et al., 2016).  
Therefore, this current research considers the outcomes of PSR-physician RQ, that is 
physician prescription decision making in an open system where different objects of 
study (i.e. PSR, physician, product and patient) are considered as entities that hold 
causal powers and mechanisms; and decision making is made through the interactions 
of these different mechanisms (Danermark, 2002). The following section examines the 
mechanisms associated with different entities in the pharmaceutical selling structure 
and how they interact to produce physicians' prescription decision making as an 
outcome of PSR-physician RQ. 
2.8.1 PHYSICIANS' PRESCRIPTION DECISION MAKING 
RQ between physician and PSR is very important in the pharmaceutical selling context 
(e.g. Lagace et al., 1991). These quality relationships create bonds of an intra-
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psychological kind (Hennig-Thurau & Klee, 1997) including feelings and emotional 
states (Al-Alak, 2014). In addition, the social bonds that develop through social 
interactions between PSR and physician, also serve as mechanisms (Vieira et al., 2008). 
Previous sections of this chapter have established that the physician's RQ with a PSR 
fosters cognitive (or self-interest) and affective (or emotional) mechanisms that can 
lead to a physician's loyalty (i.e. a measure of purchase intentions or decision making) 
with a given PSR. Loyal customers are less price-sensitive and are less likely to respond 
to alternative promotional initiatives by defecting to competitors (Stank et al., 2003). In 
addition, prior research has proved that PSR-physician RQ influences physicians' 
prescription decision making (e.g. Clark et al., 2011; Lagace et al., 1991). Thus, it can be 
anticipated that the PSR-physician's RQ influences the physician's intentions in relation 
to prescription decision making in respect of the PSR's product. 
However, the extent to which these behavioural intentions (due to the effect of different 
mechanisms, i.e. both cognitive and affective) transcend into actual prescription 
generation (or value adding) activity for a given PSR may be dependent upon their 
interaction with other mechanisms. The forces or mechanisms determining the 
prescription decision making of physicians are complex and numerous (Hellerstein, 
1998). This is because the pharmaceutical selling setting is different to many other 
contexts, as the primary decision makers (i.e. physicians) are not the end users of 
products/or services (Clark et al., 2011). The physician not only has the necessary 
relationship with a PSR but also with the patient and pharmaceutical product that a PSR 
promotes.  
The patients have a contingent association with a PSR in the pharmaceutical selling 
structure, as shown below in figure 2.5. Patients cannot affect the physician-PSR 
relationship directly, but they can produce a set of circumstances that might cause 
change in a physician's behaviour and thus prescription decision making as an outcome. 
Because the pharmaceutical product a PSR promotes has a direct, or necessary, 
relationship with the all other objects of the pharmaceutical selling structure (i.e. PSR, 
physician and patient) that holds its own causal powers.  
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Therefore, product characteristics such as product quality have been considered as a 
necessary determinant for PSR-physician RQ in this research (please see section. 2.4.2.) 
and product price can influence the physician's prescription decision making in relation 
to patients' economic conditions. The physician-patient relationship is represented by 
the thick red line as compared to PSR-physician relationship, which is represented with 
a thin blue line in figure 2.5. 
This is  because, the literature on medical marketing suggests that physicians' hold a 
more favourable attitude towards their patients (e.g. Lundin, 2000). They might 
consider their relationships with PSR while making prescription decisions; but not at 
the cost of their patients wellbeing, because they fully understood the notion of conflict 
of interest and their professional norms (Chimonas et al., 2007). Particularly, 
physicians' who run private clinics have more inducement to satisfy their patients in 
order to maintain them as customers, because a self-interest mechanism to retain their 
patients also exists; as their earnings are dependent upon the number of patients they 
keep (Granlund, 2009). Therefore, physicians seek to develop and maintain their 
relationship with patients, which require physicians to gain patients' trust and 
satisfaction. The patient's satisfaction and trust in a physician can not only emerge from 
the healthcare decision of a physician against patient's response in terms of early 
recovery from disease. This can be positively enhanced; for example, if a physician 
exhibits additional responsiveness and empathy by considering the patient's financial 
circumstances during their prescription decision making or choice of pharmaceutical 
product (Gönül et al., 2001). Therefore, patients trust a competent physician who takes 
appropriate responsibility and control, and makes patient welfare their highest priority 
(Ehsan & Ashill, 2014). Therefore, consideration of patients' price sensitivity and 
economic conditions, while accounting for their medical conditions can further improve 
the physician-patient relationships (Gönül et al., 2001). Thus, it is highly likely to 
increase in repeat patients patronage and decrease in patient's possible switch to 
another physician, which is of equal importance for the private physicians (Lundin, 
2000).  
Patients tendency to choose medical services from private clinics is more common in 
Pakistan and about 75% of the Pakistani population prefer to seek healthcare services 
from private physicians  (Muhammad, 2014), including both the population of urban 
and non-urban localities. This is because of insufficient governmental support that 
results in non-functional primary-care institutions in non-urban areas; and 
dissatisfaction with healthcare services provided by government health institutes in 
urban areas (Akram & Khan, 2007). This increases the overall cost of treatment 
(including the cost of a physician's services and drugs) for patients in Pakistan. 
Pakistan, like other developing countries, has no publicly funded health system and the 
majority of patients are not members of any health insurance provider and thus bear all, 
or part, of the cost of treatment and drugs. This context is likely to influence the 
prescription behaviour of physicians due to patients' poor economic conditions in some 
cases; thus this can interact with the PSR-physician RQ outcomes. Therefore, in the case 
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of a higher price product a PSR promotes this might interact with the patient's economic 
situation or affordability - altering the physician’s behaviour and thus prescription 
decision making. Hence the mechanisms (cognitive and affective) created by RQ (i.e. 
physician's trust in, satisfaction and commitment with the PSR) are dormant within that 
broader 'time-space' and mechanisms related to a patient's economic situation (i.e. non-
affordability), pricing and physician's self interest to maintain relationship with the 
patient. Thus it can result in the substitution of the PSR's product with the alternative 
product of similar category at a lower price that a patient can afford (Al-Areefi & 
Hassali, 2013); even though the physician experiences uncertainty about the 
substitute's efficacy due to its lower price. Thus, it can also be anticipated that higher-
product price in relation to patient's economic conditions can influence PSR-physician's 
RQ outcomes negatively in terms of physician's prescription decision making. 
However, a PSR's RQ with physician might enable PSR's inclusion in physician's priority 
list, as suggested by Dorsch et al. (1998) who found that customers include vendors in 
their priority list on the basis of RQ. Furthermore, given the behavioural loyalty 
intentions due to the presence of cognitive and affective mechanisms there is always a 
chance that a physician recommends the pharmaceutical product that a PSR promotes if 
appropriate to a patient's economic conditions or requirement to treat a patient's 
disease. This is because, physicians interact with patients from different economic 
backgrounds and with different medical needs; in practice, most often physicians regard 
a higher price product to have more efficacy and hence prescribe it to patients with 
critical medical conditions (Gönül et al., 2001) as well as those patients who can afford 
higher-price products (Al-Areefi & Hassali, 2013). This is because patients' wellbeing 
and early recovery from disease is the physician's priority. 
Therefore, based on the discussion above, it can be anticipated that PSR-physician's RQ 
outcome (that is, prescription decision) is contingent upon the patient's economic and 
medical condition. There might be an inconsistent relationship between PSR-physician 
RQ and a physician's actual prescription decision making. Since there are various 
mechanisms operating in this context, prescription decisions that might be made on the 
activation of certain mechanisms as shown below in table 2.7.  
Table 2.7: Mechanisms generated by different objects of pharmaceutical selling structure 
Objects Mechanisms 
PSR-Physician RQ Trust, satisfaction and commitment = Cognitive (or self-interest) and 
affective (or emotional) mechanisms  (please see table. 2.4) 
Pharmaceutical Product 
Price Variation 
Higher and lower prices = efficacy and clinical-experience                                                                                                                                           
  
Patient-physician 
relationship  
Context 
Patient's wellbeing, early recovery from disease, physician's self-interest to 
keep patients 
Patient's economic condition (affordability), patient's medical condition 
need for quality product)  
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2.9 SUMMARY, FINDINGS AND INITIAL CONCEPTUAL FRAMEWORK 
The review of literature has identified that RQ has emerged as a central construct in 
successful business relationships; however, so far, there is no generally accepted 
framework (Hennig-Thurau & Klee, 1997; Holmlund, 2008). The studies on RQ have 
been done in different research settings and the majority are empirically rigorous, yet 
there is no consensus on its formal definition (Izogo, 2016b). It has also been identified 
that there is consensus that RQ is a higher-order or meta-construct consisting of several 
distinct, but interrelated, dimensions; and there is some consensus among scholars on 
its dimensions (e.g. trust, satisfaction and/or commitment) to measure RQ. However, a 
few scholars have also drawn attention to considering the technical (i.e. product-and/or 
service) and economic (i.e. profit or price) dimensions in RQ conceptualization in the 
business-to-business context. It has been argued by many scholars that RQ studies have 
focused more on intangible aspects of relationships, e.g. service quality and 
communication etc. Little attention has been paid to its tangible aspects, such as 
product related quality, pricing, and resource exchange (Hennig-Thurau & Klee, 1997; 
Holmlund, 2001, 2008). Such issues are vital aspects in business exchange relationships 
(Holmlund, 2001, 2008; Huntley, 2006). To this end, by recognizing the focus (i.e. the 
nature of relationship) of different studies; three different contexts were identified from 
the literature where RQ is mostly studied and defined. Subsequently, after comparing 
the nature of different relationships and discussing the important role of PSR's as a 
focus of the current research in pharmaceutical selling, RQ is defined as a higher order 
construct consisting of positive relationship outcomes, i.e. trust, satisfaction and 
commitment that reflect the strength of the relationship and that meet the expectations 
of partners (Smith, 1998b, p. 4). Additionally, the current research views economic 
factors such as product price as an important factor that can interact with the intra-
psychological mechanisms of RQ in the buying decision making of a customer.   
Although RQ has emerged as a central construct in successful business relationships, it 
appears from the literature that some aspects of the notion of RQ need further 
explanation. In particular, studies on RQ in an interpersonal context have focused on 
salesperson's personal and relational characteristics but have not considered the firm's 
specific factors. These factors can possibly interact with the salesperson's personal and 
relational characteristics and can also influence RQ. Therefore, this research considers 
the firm's related characteristics (such as firm's reputation and product quality) along 
with a PSR's personal and relational characteristics (such as contact frequency, 
relationship investment, ethical sales behaviour and expertise) as necessary 
determinants of PSR-physician RQ in the context of Pakistan.  No research has been 
undertaken in this context to date and studies on RQ in the pharmaceutical selling 
context are rare, so there is a need to identify the factors that can influence RQ between 
the PSR and physician (Lagace et al., 1991) in different contexts. 
Finally, the chapter discussed the consequences, or outcomes, of RQ. It has been 
confirmed by many scholars that RQ between partners has a great impact on both the 
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subjective (i.e. anticipation of future interaction/or relationship commitment, customer 
retention, loyalty, word-of-mouth/recommendations and repurchase intentions) and 
objective performance outcomes (i.e. sales effectiveness/business share) of the firm. 
However, it appears from the literature that RQ objective (or financial) outcomes were 
seen within the stable conditions of closed systems without taking into account when 
the relationship interacts with external contingent factors. The majority of previous 
studies on RQ including those of in the pharmaceutical context have been undertaken 
from a positivist philosophical approach using regression techniques. Many scholars 
(e.g. Smith, 1998a; Smith, 1998b; Wray et al., 1994) have argued that the analysis of 
potential confounding variables interaction and their threshold level to each other is not 
possible with the use of regression techniques. Therefore, there is not a single study in 
general that has considered RQ objective outcomes when the relationship interacts with 
external factors, or other contingent relationships, i.e. in the value chain (e.g. the impact 
of patients' economic conditions, particularly in a pharmaceutical setting) or is seen as 
taking place in an open system. This aspect requires immediate attention, as it has also 
been argued that along with the identification of the factors that contribute to RQ, there 
is also need to verify under what conditions RQ provides the expected positive 
outcomes (Palmatier et al., 2006). Similarly, Easton (2002) discusses that rather than 
focus upon performance of the phenomenon, the researcher should study the conditions 
or environment under which the phenomenon can occur (or not). Therefore, it requires 
a methodological approach that is capable of the evaluation of the contextual factors 
and other contingent relationships, e.g. in the value chain (please see chapter 3 on 
methodology for more details) such as patients in pharmaceutical selling structure.  
Therefore, based on the literature review findings, the following conceptual framework 
is devised, as shown below in figure 2.6. The devised conceptual framework is 
consistent with the prior conceptualization of RQ in an interpersonal selling context; 
however, it advances an evaluation of RQ objective outcomes under contingent 
economic conditions of another relationship in the value chain (e.g. PSR-physician-
patient in this case). In addition, it can evaluate the PSR-physician RQ objective 
outcomes through the effect of different mechanisms, i.e. actual prescription generation 
activity rather than positive behavioural loyalty intentions.  
The PSR, the pharmaceutical product and the patients as the objects of this structure 
posses their causal forces or mechanisms, which may interplay in physicians’ decision 
making process (mental processing). These causal forces can be considered as 
'tendencies' (but not as regularities) and their activation depends upon the interaction 
of certain mechanisms (Danermark et al., 2002). These include cognitive, affective (PSR-
physician's RQ related), patient's wellbeing, affordability, patient's need (patient's 
related), and physician self-interest in the case of physician's prescription decision 
making. 
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Figure 2.6: The initial conceptual framework for the current research 
Even if they are not active, the different underlying mechanisms related to the objects of 
the pharmaceutical structure are always present at different levels of reality (i.e. real 
and actual). The manifestations of different mechanisms under a particular patient's 
economic and medical context becomes an observable phenomenon, i.e. physician 
decision making in the empirical domain (Danermark et al., 2002). Therefore, it can be 
suggested that PSR-physician's RQ outcome in terms of prescription decision making is 
contingent upon both a patient's economic conditions and the price of the product, as 
proposed above.  
Thus, if RQ and its outcomes are dependent on wider contextual factors and there is a 
lack of contribution in RQ research from developing countries (Asnai et al., 2009), 
where the economic issues might also have different impact on the exchange 
relationships and on their outcomes, then investigations into these dependencies are 
required. Previous research into RQ has considered objective outcomes, which were 
seen within the stable conditions of closed systems without taking into account when 
the relationship interacts with external contingent economic factors. 
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3 METHODOLOGY AND METHODS 
3.1  INTRODUCTION: 
This chapter describes the research approach and process undertaken to achieve this 
research's aims and objectives, and explore the gaps in current knowledge of RQ identified 
in the literature review. A transparent explanation of the research design and procedure 
contributes to the rigour of research (Yin, 2003, 2012). Therefore, the first section 
provides a statement of the aim and objectives of this study, which were developed 
through the initial conceptual framework drawn from literature review. The next section 
then discusses the philosophical perspective of critical realism, which underlies the 
research process. Next, the reasons for choosing an embedded case study design and 
qualitative research approach are discussed. Details of participant selection and 
recruitment are followed by details of the methods of data generation, preparation and 
analysis. Finally, ethical considerations are addressed. 
3.2  RESEARCH AIMS AND OBJECTIVES: 
The overall purpose of this research is to critically explore the determinants and 
mechanisms that contribute to RQ. Furthermore, the aim is to investigate how far product 
price (and related mechanisms) have an impact on the "outcomes" of PSR-physician's RQ 
under specific patient economic situations - in the context of Pakistan. The following are 
the research objectives that this research has proposed: 
 To identify the key determinants and their underlying mechanisms needed by PSRs 
to build RQ with physicians in the Pakistani pharmaceutical selling context. 
 To explore how physician-medical representative dyadic RQ interacts with product 
pricing and related mechanisms under the influence of contingent patient economic 
conditions. 
 To examine the interplay of the underlying mechanisms and the tendencies they 
exhibit in the physician's prescription decision making in terms of pharmaceutical 
brands. 
 To explore the efficacy of physician-PSR RQ, i.e. under what conditions, or contexts, 
it is more effective in terms of its outcomes. 
3.3   RESEARCH PHILOSOPHY  
The consideration and acknowledgement of research philosophy is of prime importance 
for any research (Saunders et al., 2012). Essentially, all philosophies can be characterized 
on the basis of three questions related to their ontology, epistemology and methodology 
(Guba, 1990). Briefly, at the ontological level there is difference in beliefs: for example, that 
49 
 
there is a social realm waiting to be uncovered by social researchers, which exists 
externally to the actors involved (i.e. an objectivist view of reality). However, the 
proponents of the other domains believe that social reality and its meanings are 
continuously being created by the actors involved (i.e. subjectivist view of reality) (Blaikie, 
1993; Bryman & Bell, 2007).   
At the epistemological level there are differences in terms of an inclination towards 
naturalistic or scientific methods in understanding social phenomena. In scientific 
methods, knowledge comes in the form of general laws (e.g. in positivism), whereas 
advocates of other domains emphasize humans as engaged in constant interpretation of 
their environment, e.g. as in interpretivism (Kazi, 2003). However, there is an alternative 
view (i.e. realism) that stresses the unraveling of structures in order to know the 
influences they have on social relations and that affect the behaviour of actors involved 
(May, 2001). Last but not least, methodology is concerned with how to design the research 
process in order to attain the knowledge preferred by one's acknowledged research 
philosophy, which offers certain approaches, either quantitative or qualitative or both. 
Philosophical assumptions of one particular paradigm support certain methodological 
approaches over others; therefore, as described above, the main difference of opinion is on 
philosophical assumptions (i.e. ontological and epistemological) leading to certain 
methodological preferences  (Bryman, 2008a).  
The final part of the research strategy is linked with the methods, which entail decisions on 
sampling technique, data generation and analysis. Decisions on the different methods 
chosen are not only influenced by ontological, epistemological and methodological 
considerations, but also by the ethical and practical, for instance the availability of 
resources and time. Table 3.1, below summarizes different philosophical assumptions and 
methodological preferences offered by three competing research philosophies.  
Table 3.1.Three main competing research philosophies 
Element Positivism Constructivism Realism 
Ontology "Reality is real and  
apprehensible" 
"Multiple local and 
specific "constructed" 
realities" 
"Reality is "real" but  only 
imperfectly and probabilistically 
apprehensible, so triangulation 
from many sources is required to 
try to know it"  
Epistemology "Findings true-researcher 
is objective by viewing 
reality through a "one 
way mirror" 
"Created findings-
researcher is a 
"passionate participant" 
within the world being 
investigated" 
"Findings probably true-
researcher is a "value-aware" 
and needs to triangulate any 
perceptions he or she is 
collecting" 
Common 
Methodologies 
"Mostly concerns the 
testing of theory. Thus, 
mainly quantitative 
methods such as: surveys, 
experiments and 
verification of 
hypotheses"   
"In-depth unstructured 
interviews, participant 
observations, action 
research and grounded 
theory research" 
"Mainly qualitative methods such 
as case studies and convergent 
interviews" 
Source: Based on (Sobh & Perry, 2006, p. 1195) 
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The subsequent sections examine these three competing research philosophies and by 
comparing them offer the account on why realism, and in particular critical realism, 
provides the appropriate philosophical foundations for this research. 
3.3.1  POSITIVISM: 
Ontologically, positivists believe that reality is external; and epistemologically they believe 
in that reality should be measured by using objective methods or the application of the 
methods of natural sciences to attain knowledge of social reality (Bryman, 2008b; 
Easterby-Smith et al., 2002, p. 28). Therefore, quantitative methods such as surveys and 
experiments are commonly used for the verification of hypotheses developed using 
deductive logic (May, 2001; Sobh & Perry, 2006). In positivism, causation is established 
when effect 'Y' is proved to be the result of cause 'X' in some kind of sequence, such as 
constant conjunction of events to observe empirical regularities (Pawson & Tilley, 1997; 
Robson, 2011). The result of following positivism's philosophical principles in a social 
science research is to produce general precise causal laws of human behaviour as social 
entities (May, 2001).  
Despite being the dominant research philosophy (particularly in marketing scholarship), 
positivism has been criticised due to its inadequate view of social reality in that it cannot 
take into account human intentionality and reflections (Blaikie, 1993; Easton, 2002). 
Furthermore, causality is seen as a constant conjunction between the variables in the 
stable environment of a closed system, which means it cannot take into account external 
contingent factors (Danermark et al., 2002). For example, if following positivism for this 
research, a researcher would focus on the factors, or determinants, that are required to 
develop RQ, which influence physician’s prescription decision making as its objective 
outcome in the stable environment of a closed system.  
However, physician's prescription decision making involves complex mental processing. 
This is because they not only interact with PSRs but also patients as a part of the 
pharmaceutical selling structure. Patients, PSRs and a pharmaceutical product as objects of 
this structure posses their own causal forces, which may, or usually, interplay in 
physicians’ decision making process (mental processing). These causal forces are 
considered as tendencies (but not regularities), which are contingently linked to the 
complex situations and their activation depends upon the activation of certain 
mechanisms; and it is not always necessary that these mechanisms exhibit themselves 
through empirically observed data (Danermark et al., 2002). Maxwell (2012) discusses 
that process explanation is less achievable with the application of positivists' quantitative 
methods because it requires researchers to deal with specific events and the processes 
that connect them. Thus, application of positivist methods cannot take into account these 
complex relationships and causal forces that influence the physician's prescription 
decision making as RQ’s objective outcomes.   
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3.3.2  CONSTRUCTIVISM: 
Ontologically, constructivists believe that social reality is constituted by language or 
discourses, or that reality is socially created and it is in a continuous process of creation 
and recreation by actors involved (Reed, 2009). Constructivists do not consider structural 
constraints or enablement and maintain that social structures do not possess causal 
powers. Moreover, they believe rules and principles are socially manufactured and 
expressed through symbols, and that social actors are participants in the construction of 
their own environment (Peters et al., 2013). Mir and Watson (2000) discuss that 
constructivists are considered as actors rather than information processers or reactors in 
research processes; therefore, constructivist researchers are also fully involved as 
passionate participants in investigating social reality, which is influenced by the 
researcher’s worldview, his or her position and experiences (e.g. Sobh & Perry, 2006).  
The common methodologies used in constructionist approach include participant 
observations, grounded theory, action research, phenomenology and ethnography  (Sobh 
& Perry, 2006). The general mode of  inference for constructivists is induction, which 
requires a researcher to consider the context of a study and the process of qualitative data 
generation and analysis in order to develop an understanding of the meanings that 
humans ascribe to events (Saunders et al., 2012).  
If following constructivism when conducting this research, the researcher should then 
start interviewing the actors involved (e.g. physicians and sales managers or salespeople) 
without already going into available theories of RQ and rules that are practiced. The 
inductive strategy therefore believes in the generation of qualitative data and emphasizes 
more in the theories generated from data, grounded in the research context. However, this 
can create challenges for novice researchers, since it requires time, resources, and 
expertise from researchers (Miles & Huberman, 1994).  
In addition to this, a constructivist researcher will not be interested in examining the 
external factors, such as economic conditions, and other relations in a value chain; instead 
the researcher looks into the actors experiences about social situations and what are the 
meanings that people place upon their experiences of social reality (Easterby-Smith et al., 
2008). Therefore, the task of the researcher is systematic re-description and 
reinterpretation of socially created reality through detailed and careful reconstruction and 
deconstruction of the views of actors involved in a situation (Reed, 2009). However, 
criticism here often rests on how a researcher can come to a conclusion after the collection 
of different views of actors involved in one particular situation, i.e. which view is more 
legitimated, as constructivists believe in several subjectively constructed realities (Sobh & 
Perry, 2006). Furthermore, it is quite possible that the actors are not fully aware of the 
influences of structures and conditions within which they operate. This thus will not 
provide a real understanding of the efficacy of RQ phenomenon in terms of achieving its 
objective outcomes as physician's prescription decision making. This is because the forces 
or mechanisms determining the prescription decision making of physicians are complex 
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and numerous (Hellerstein, 1998), which constructivism's philosophical principles cannot 
take into account. Thus, application of constructivists guiding principles cannot provide 
knowledge about the forces that influence the physician's prescription decision making as 
RQ’s objective outcomes.          
3.3.3 CRITICAL REALISM:    
The latest development in the realist tradition, resulting mainly from the work of Roy 
Bhaskar (1979), has formed another version of realism, i.e. critical realism (Ackroyd & 
Fleetwood, 2000; Carter & New, 2004). The gulf between the competing paradigms on the 
issue of objectivism in positivism and subjectivism in interpretivism is somehow managed 
by the introduction of critical realism (Easton, 2010). Hence, it shares some of its features 
with both schools of thought (Sayer, 1992). Critical realism shares with positivism the aim 
of the explanation of social phenomena (May, 2001) and commitment to the view that 
there is an external reality that is separate from our description of it (Bryman & Bell, 
2007). It shares partly with interpretivism the involvement of social actors in that it 
reflects the conditions in which they are living. The distinction here is, the 
acknowledgement by the researcher to focus on the environment (structures or 
conditions) rather than only the meanings that people give to their environment (May, 
2001). 
3.3.3.1 CRITICAL REALISM'S ONTOLOGICAL ASSUMPTIONS: 
Ontologically, critical realism believes in an external reality and emphasizes ontology more 
than epistemology, and within ontology it shifts focus from events to mechanisms by 
means of what produces the events, not just the event itself (Danermark et al., 2002). In 
other words, critical realism is committed to an extended or anti-reductionist social 
ontology comprising of distinct and stratified domains (i.e. layers or strata) of reality that 
encompass their own features or properties and which cannot be reduced into each other 
(Reed, 2009). Bhaskar (1979) named these three domains (or stratum) of reality as real, 
actual and empirical. The domain of the real comprises the realm of objects (with their 
mechanisms and causal powers). When these causal powers (at the real level) are 
activated, they give rise to patterns of events in the domain of actual. The empirical is the 
domain of sense-experiences and perceptions, either with the real or the actual (Tsoukas, 
2000). Critical realism stresses that social science should not be based only on empirical 
facts (Danermark et al., 2002). This is because reality is not simply comprised of 
experiences and actual events, but also relatively it is comprised of structures, powers, 
mechanisms and tendencies that fortify, produce or facilitate the actual events that may 
(or may not) be experienced (Kazi, 2003).  
These distinct domains move from the real domain to the actual and then the empirical 
domain in a contingent way (Tsoukas, 2000). As discussed, each domain contains its own 
specific objects and mechanisms holding their own powers and tendencies that come into 
a highly complex interaction with each other to generate certain outcomes (Reed, 2009). 
This complex interaction gives rise to the emergence of new entities or powers with their 
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capacity of irreducibility to their basic constituents, which is the core ontological belief of 
critical realism. Therefore, the new entities are the product of the combination and more 
than the sum of their constituents entities  (Carter & New, 2004).  
In this respect critical realism is committed to an 'open system' social inquiry, where 
different uncontrolled mechanisms operate simultaneously at different stratified domains 
of reality. And their effect or outcome is dependent on the activities of these different 
mechanisms (Reed, 2009). Therefore, the events (or outcomes) we observe are a complex 
combination of mechanism activities, where different mechanisms interact or interplay 
with and are influenced by each other. Some of these mechanisms are reinforcing, while 
others counteract each other's manifestation in the observed events or outcomes (Ackroyd 
& Fleetwood, 2000; Lawson, 1997; Reed, 2009). Therefore, critical realists believe in that it 
is not possible to study human societies in the way natural science is carried out in closed 
systems such as positivism, where the objects of study are kept in isolation, and studied 
without the interference of uncontrolled mechanisms (Carter & New, 2004; Danermark et 
al., 2002).  
3.3.3.2 CRITICAL REALISM'S EPISTEMOLOGICAL ASSUMPTIONS:  
Critical realism offers a number of epistemological implications. One of them is critical 
realists’ emphasis on the anteriority of structures (Carter & New, 2004). Structures are 
collections of interrelated objects (Sobh & Perry, 2006) and could serve as "a 
portmanteau", a term used by Fleetwood (2005, p. 201), which refers to "configurations of 
causal mechanisms, rules, resources, relations, powers, positions and practices" related to 
different objects. For critical realists, objects or entities in a specific structure may be 
anything that possesses causal powers, or has an ability to change human behaviour; or 
makes a difference in a particular situation (Fleetwood, 2005). Objects are also liable in the 
sense that they are vulnerable to coming under the influence of other objects. Therefore, 
the understanding and explanation of relationships among objects is of vital importance 
for critical realists, i.e. the necessary or internal, and contingent or external relations 
(Easton, 2002). This is because structural analysis not only helps research in the 
identification of objects, but also the mechanisms associated with them.  
Mechanisms are "nothing other than the ways of acting of things" (Bhaskar, 1978, p. 14). 
They consists of structures, powers and tendencies that "makes things happens in the 
world" (Danermark et al., 2002, p. 206) and lie under the surface level of experienced 
events and form their occurrences (Ackroyd & Fleetwood, 2000). Critical realists believe 
that we can observe directly that both nature and human society is generated by hidden 
mechanisms, but we cannot observe those hidden mechanisms directly (Lawson et al., 
1998).  
However, we can infer them by using the most important tool of abstraction, i.e. the 
abstraction of structures and mechanisms from theories and empirical observations. In 
this respect, Sayer (1992) suggests that a researcher should start by abstract theory 
analysis of objects with respect to their overriding structures, as part of wider structures 
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and in terms of the causal powers they possess. Therefore, a researcher can use conceptual 
abstraction that provides a way in which he or she can isolate certain aspects of social 
reality by using thought-abstraction, rather than isolating them by manipulating events 
(Danermark et al., 2002). Hence, abstraction is a useful tool that involves isolating or 
analysing social structures at any level, e.g. the social structure of dyad or triad 
(Danermark et al., 2002, p. 47), to identify their associated mechanisms through the help of 
theories related to these objects. This aspect of identification of mechanisms has already 
been examined in chapter 2 (literature review) through discussion of theories on RQ and 
physician's prescription decision making by means of structural analysis of PSR-physician-
patient triadic relationship and pharmaceutical product as objects for the current research 
(please see figure 2.6).  
However, Sayer (1992) also suggests that concrete research should explain mechanisms 
(i.e. identified from structural analysis as well as theories) and their interaction, which 
causes certain outcomes in different contexts. Thereby, context is simply the relevant 
circumstances, i.e. relationship between different objects and the relevant environment in 
which these relationships exist (Carter & New, 2004; Pawson & Tilley, 1997). Unlike 
positivism, outcomes or consequences can be seen as tendencies but not as regularities, 
since reality is constituted by strata of different mechanisms that interact to produce 
particular outcomes in a particular context (Pawson & Tilley, 1997). Therefore, central to 
critical realism is the related issues of causality and the explanation of mechanisms (Carter 
& New, 2004; Kazi, 2003; Reed, 2009; Sayer, 1992). These antireductionist ontological 
assumptions allow the critical realist to develop a model of causality where the social 
phenomenon can be explained with the logical identification and mapping of mechanisms 
consisting of structures and objects (Reed, 2009). The important point here is, the 
investigated structures and mechanisms are only real in their effects, they are not constant 
and contingent, or dependent on their environment or context. Consequently, the context 
of the social phenomena under observation is vital for research endeavours that follow 
critical realism  (Sobh & Perry, 2006).    
Causation is of a distinctive nature in critical realism as compared to a positivist approach, 
which is explained by Pawson et al. (2005) more appropriately. In positivism, causation is 
established when the cause 'X' is switched on and effect 'Y' follows. Many scholars explain 
this sort of causation by using the example of a match, which when lit and applied directly 
causes gunpowder to explode (e.g. Sayer, 1992; Sobh & Perry, 2006). However, in the case 
of a critical realist approach causation is established quite differently. That is, "to infer a 
causal outcome "O" between two events "X" and "Y", the researcher needs to understand 
the underlying mechanism "M" which connects them; and context "C" in which this 
relationship occurs" (Pawson et al., 2005, p. 2). There might be many mechanisms 
operating in an open system with respect to the particular context. However, which 
mechanisms under study are more important can only be decided with respect to the 
objects under study in a particular case through empirical evidence and in relation to the 
problem a researcher is addressing (Danermark et al., 2002).  
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The preceding pages provide the philosophical assumptions of critical realism; the 
following section explains the methodological implications of these philosophical 
assumptions, i.e. what tools it offers that can be used in addressing the objectives of this 
research.  
3.3.3.3 METHODOLOGICAL IMPLICATIONS OF CRITICAL REALISM  
As discussed above, in critical realism, "ontology precedes the epistemology that helps 
researcher, where to look and what to look" (Reed, 2009, p. 438). Thus, the aim of a critical 
realist researcher is to explain what mechanisms are involved behind the processes and 
events observed. This explanation involves the researcher firstly, in the identification of 
mechanisms that requires an intensive and careful analysis of pre-existing contexts, 
structural, relational conditions and interpretive schemes; and secondly, in the description 
of outcomes or events, when they interact, in a particular context (Sayer, 1992).  
Therefore, retroduction is a methodological approach favoured by critical realists, which is 
capable for providing an in-depth understanding of underlying mechanisms and their 
explanation (Ackroyd, 2009; Carter & New, 2004; Danermark et al., 2002; Lawson, 1998). 
Retroduction is a mode of inference that has an intellectual ability that helps researcher to 
abstract, complex causal mechanisms contingently linked to the researcher's beliefs, 
perspectives and experiences based on empirical evidence (Lawson, 1998; Sobh & Perry, 
2006). Retroduction is not a formalized mode of inference as compared to deduction, 
induction and abduction, which are used in different traditions. However, it resembles 
them insofar as "it is a thought operation that helps a researcher to move from acquiring 
knowledge of one thing to arrive at knowledge of something else" (Danermark et al., 2002, 
p. 96). That is to say, it enables the conceptualization from "knowledge of some 
phenomenon existing at any one level of reality to knowledge of mechanisms at deeper 
level or stratum of reality that contribute to the generation of the phenomenon concerned" 
(Lawson, 1997, p. 26).  
Abduction is also favoured by a few critical realists to use in combination with 
retroduction, insofar as abduction can help a researcher to re-describe or re-contextualize 
the different aspects of the objects under study from available theories and hypothetical 
conceptual frameworks (Ackroyd, 2009; Danermark et al., 2002). However, abduction, and 
other alternative modes of inference, such as deduction and induction used in different 
paradigms, do not have such an ability to identify and explain underlying mechanisms 
(Danermark et al., 2002; Fleetwood, 2005; Kazi, 2003; Pawson et al., 2005; Reed, 2009; 
Sobh & Perry, 2006). Nevertheless, in addition to retroduction, deduction and induction 
can also be used in a research endeavour followed the guiding principles of critical realism 
(Danermark et al., 2002; Easton, 2010).  
More simply, with a retroductive strategy a researcher could start research by acquiring 
knowledge from available literature about the phenomenon under investigation (Sobh & 
Perry, 2006). Alongside literature, a researcher may also acquire knowledge by interacting 
with people having experience of phenomena, prior to data generation (Miles & 
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Huberman, 1994). However, it is the only first step for critical realist research analysis, the 
logic here is concerned with what is known about an area of investigation by invoking 
abstract theory analysis and/or by asking people or using ethnographic methods. This 
therefore helps the researcher to build propositions on how the mechanisms are 
introduced by different available cases and outcomes they produce in certain contexts. 
Furthermore, it involves the researcher in the construction and application of theoretical 
models or conceptual frameworks (Reed, 2009), in which the researcher not only 
evaluates the potential causal mechanisms but also the prospective counteractive causal 
mechanisms of his/her context, which when they interact, certain predicted outcomes will, 
or will not, be obtained (Kazi, 2003). This exercise leads to further rounds of improved 
conceptual framework building, where the researcher applies disciplined imagination and 
analyses of empirical investigation from previous rounds and incorporates the 
understanding into the next round of theoretical abstraction and elaboration (Pawson & 
Tilley, 1997; Reed, 2009; Sobh & Perry, 2006). In this connection, retroduction emphasizes 
gradual theory development, which is subjected to conformity in the next step. Moreover, 
the knowledge produced within the retroductive strategy will always be context specific 
(Reed, 2009). Having established a conceptual framework or theoretical model, the next 
step is then the choice of methods for data generation (Kazi, 2003).  
3.3.3.4 CRITICISM OF CRITICAL REALISM 
Apart from the above discussion on how critical realism influences this research, it comes 
under critique from the proponents of other philosophical approaches. One of the major 
criticisms from its opponents is that the theory of critical realism has evolved from the 
natural to the social sciences (Pawson & Tilley, 1997); therefore, they question how far it 
can be applied to the activities of researchers studying social phenomena (Mingers, 2004). 
They argue that the effects of deep structures and mechanisms are unquestionable in the 
natural world; for instance, gravitational force and magnetic fields cannot be seen but can 
be inferred through their effects; such systems of the natural world therefore can exist 
independently of our knowledge (Porter & Ryan, 1996). However, they confront critical 
realism's similar ontological position of social structures' causal efficacy in terms of 
mechanisms that make an observable change to human action. For them, social structures 
are associated with agency and therefore they are embedded in human practices (Lewis, 
2000).        
Positivists argue that critical realism focuses on causal complexity (such as in open 
systems), however, it lacks in providing the procedures or methodological tools that can 
handle such causal complexity in a sophisticated manner (Kurki, 2007). This is because 
retroduction, which has been advocated by critical realists as an essential tool for 
identifying mechanisms, is fundamentally an intuitive and creative process rather than a 
logical mode of inference, such as deduction in positivism. Therefore, use of retroduction 
can lead to many possible unverified explanations of phenomena under study (Mingers, 
2004). Moreover, positivists also criticise critical realism on the grounds that does not 
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provide empirical studies, and therefore its contribution to concrete research is 
insufficient (Kurki, 2007).   
There is no doubt that critical realism's ontology is not straightforward to apply; however, 
it is capable of studying complex interrelationships (Ryan et al., 2012). Most of the 
methodological issues can be managed if diligently applied. For instance, the issue of many 
possible explanations of a particular mechanism can be resolved by further data 
generation for their verification (please see section 3.8.1). Furthermore, critical realism 
allows the use of other modes of inference, such as deduction, induction and abduction 
along with retroduction (Danermark et al., 2002; Easton, 2010), therefore it can provide a 
more in-depth examination of social phenomena.      
3.3.3.5 UTILIZATION OF CRITICAL REALISM FOR THIS RESEARCH 
There are some critical voices, nevertheless critical realism is most appropriate in 
addressing this study’s research objectives, since social science should be studied in open 
systems, because humans have the power of reflection, intentionality, language and the 
ability to adopt change (Carter & New, 2004; Danermark et al., 2002). For example, we 
cannot study the current research by considering the dyadic relationships of physician and 
PSR as the only factor that contributes to physician prescription decision making in a 
closed system (i.e. the correlation between two variables, if 'x' increases, 'y' also increases, 
as in positivism). For real understanding of the efficacy of RQ phenomena and their 
contribution to prescription decision making, we also need to consider other operating 
mechanisms within the context (e.g. related to patients' economic condition, product 
prices etc.), which when combined, might allow some new tendencies or powers to emerge 
to shape a physician's course of action. Therefore, this will provide the study not only ways 
to understand and explain the phenomena going deeper into contextual and structural 
issues; but also its analysis goes further down to the underlying mechanisms and 
tendencies manifested.  
In following this approach, the study can explore the reality of the interplay of PSR-
physician's RQ and pricing mechanisms in physicians' prescription decision making, or 
choice of a product, in a context where patients’ economic status might be important (in 
developing countries, e.g. in Pakistan). Therefore, having acquired structural knowledge of 
mechanisms, the driving forces behind physicians' actions can then be estimated. 
Therefore, this may help to evaluate the possibilities, deficiencies, and limitations 
(Danermark et al., 2002) of the existing relationship quality phenomenon in the Pakistani 
pharmaceutical context. In doing so, the task of this study is not to falsify or prove existing 
knowledge of phenomena (or RQ theories); but to produce a fresh insight or alternate RQ 
conceptual model in different conditions or contexts of Pakistan (Sobh & Perry, 2006; Yin, 
1994).  
It appears from the literature that RQ objective outcomes (i.e. sales increase) were seen 
within the stable conditions of closed systems without taking into account when the 
relationship interacted with external contingent factors. Many scholars have argued that 
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the analysis of potential confounding variables’ interaction and their threshold level to 
each other is not possible with the use of positivism's quantitative regression techniques 
(e.g. Smith, 1998b; Wray et al., 1994). Furthermore, it has also been argued that along with 
the identification of the factors that contribute to RQ, there is also need to verify under 
what conditions RQ provides the expected positive outcomes (Palmatier et al., 2006). In 
addition, Easton (2002) discusses that rather than focusing upon the performance of a 
phenomenon, the researcher should study the conditions or environment under which the 
phenomenon can occur or not. The acknowledgement of the environment (structures or 
conditions) is not possible by following constructivism's guiding principles. As researchers 
following constructivist approach focus only the meanings that people give to their 
environment (May, 2001). Therefore, this research requires a methodological approach 
that is capable of the evaluation of contextual factors and other contingent relationships in 
the value chain, which critical realism can provide.  
3.4 RESEARCH DESIGN AND STRATEGY: 
Critical realism emphasises that a researcher should not only take into account the 
research aims and objectives but also maintain the ontological and methodological link in 
their choice of research design and methods (Danermark et al., 2002).  Therefore, 
researcher's choice of methods depends upon how a particular method can express 
knowledge about mechanisms. For this reason, critical realism allows researchers to use 
an extensive range of research methods, either quantitative or qualitative (Kazi, 2003). 
Quantitative methods require "an extensive research design" and qualitative require "an 
intensive research design" (Kazi, 2003; Lawson et al., 1998; Sayer, 1992). Critical realism 
also favours the mixed method research design, where researchers can use both intensive 
and extensive research design in their research process. 
The quantitative methods (e.g. large-scale surveys, surveys of small representative groups 
with questionnaire or standardized interviews and statistical analysis) are more 
appropriate for extensive research design (Ackroyd, 2009; Sayer, 1992). This allows the 
researcher to investigate the regularities and patterns produced by a particular (or 
known) mechanism or structure of mechanisms (Danermark et al., 2002). However, an 
extensive research design does not provide an in-depth explanation of causal mechanisms. 
Instead, it provides descriptive representative generalization (Sayer, 1992). For example 
by using questionnaires or standardized interviews in a survey, it is possible to infer 
certain context mechanisms and their impact on outcomes (i.e. impact of RQ on 
prescription decision). However, this does not help in examining how these mechanisms 
manifest themselves in different situations or contexts (e.g. physicians may or usually 
come across different situations). Motives for actions or causal mechanisms are regarded 
as tendencies, which are contingently linked to complex situations; and it is not always 
necessary that these mechanisms exhibit themselves in empirically observed data. 
Maxwell (2012) discusses that the process explanation is less achievable with quantitative 
methods because it requires researchers to deal with specific events and the processes 
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that connect them. Therefore, the quantitative methods of data generation in extensive 
research design in relation to my research questions would have been unable to provide 
the thick description of the prescription decision making and the processes involved.   
Qualitative methods of data generation (e.g. interactive interviews, observations etc.) in an 
intensive research attempt to answer questions like why a certain change, rather than any 
other, is produced in a particular situation. This makes it more significant in investigations 
of how mechanisms exhibit themselves in different contexts and requires a combination of  
textual, historical and structural data, which make it possible to recognize the patterns, 
relations and underlying mechanisms that produced them (Reed, 2009). That is, to identify 
how mechanisms work in a concrete situation requires a researcher to map out the causal 
powers research objects possess and how they interact to produce a social phenomenon. 
This requires intensive research design and qualitative methods of data generation. 
Therefore, critical realists reject positivists’ concept of instrument formation and 
causation, where causation is seen as a constant relationship between two variables and 
can be discovered using quantitative methods. Instead, critical realists see theoretical 
concepts as properties and features of the real world. They also believe that mental states 
and processes are also part the real world and cannot be explained by quantitative 
methods  (Maxwell, 2012). Therefore, critical realists propose that objects and social 
relations possess causal powers, which may or may not produce regularities and can be 
explained better through intensive research (Sayer, 1992).  
It has already been discussed that to know the impact of PSR's RQ on physician’s 
prescription decision making is not possible using quantitative methods, as it involves the 
complex mental processing of the physicians. They not only interact with the PSRs but also 
with patients as a part of pharmaceutical selling structure. The patients, medical 
representatives and products as objects of this structure posses their causal forces, which 
may or usually interplay in physicians’ decision making process (mental processing). This 
interplay requires an intensive research design, such as in-depth interviews with a few or 
a small sample of physicians and qualitative textual data generation through interviews 
that will retain the chorological and contextual connections between the events (Maxwell, 
2012). Thus, taking into account all these considerations, an intensive research design was 
considered to be most appropriate for this research. 
The most common intensive approaches are ethnography and case study; however, the 
choice of a particular approach depends on the research aim and researcher's position (e.g. 
Ackroyd, 2009; Porter, 1993; Reed, 2009). An ethnographic approach seeks to describe 
and explain the culture of a group (Porter, 1993), whereas a case study approach enables a 
researcher to analyse the objects under study, the relationships between them and the 
causal powers they hold in a particular context (e.g. Easton, 2010). The purpose of this 
research was to critically evaluate RQ between PSR and physician and its impact on the 
physician's prescription decision making under contingent patient economic conditions in 
relation to the product's price. Therefore, case study research was chosen, since it provides 
the means to investigate a particular complex social phenomenon, while considering the 
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important circumstances in which it exists (Baxter & Jack, 2008; Stake, 1995; Yin, 2012). 
The following section further explains why case study approach is appropriate for the 
purposes of this research.  
3.5 CASE STUDY RESEARCH: 
Case study research has become a widely accepted research method among researchers in 
social science (Creswell, 2007; Easton, 2010; Easton & Harrison, 2004). There are many 
definitions of case study research and these definitions came from the different 
perspectives of its proponents. Therefore, there is still a lack of a definitive definition 
(Appleton, 2002). For example Yin (2003, 2012) views case study research as an inquiry or 
a method; however, Stake (1995) describes it not as a methodology but a choice of 
studying a phenomenon of interest as a case within its bounded system i.e. bounded by 
time and place (Creswell, 2007). Nevertheless, there is a consensus that the case study 
provides a form of intensive analysis of the phenomenon of interest, by considering and 
examining the key variables important to understand the dynamics of a situation, to 
provide a detailed account of the phenomenon (Appleton, 2002). Based on the 
perspectives discussed this research considered case study as a form of research strategy 
or "a research method that involves investigating one or small number of social entities or 
situations about which the data are collected using multiple sources of data and 
developing a holistic description through an iterative research process" (Easton, 2010, p. 
119).  Therefore, the participants of this research are seen as multiple sources of data,  
rather than the application of various methods (i.e. both qualitative and quantitative) in 
order to generate different types of data (Sobh & Perry, 2006).     
  
The case study methodology offers a flexibility to take into account and unravel complex 
factors related to the phenomenon under investigation and relationships involved through 
one or a small number of cases (Easton, 2010). Therefore, it enables this research to 
analyse the objects under study (i.e. PSR, physician, patient and product) their 
relationships and the causal powers they hold, which can affect the physician's 
prescription decision making. In addition, it not only helps to acquire multiple viewpoints 
of participants on a single reality of factors required to develop PSR-physician RQ but also 
its effects on physicians’ prescription decision making under contingent patient economic 
conditions in the bounded context of Pakistan. Thus, case study research helps in meeting 
the aims and objectives of this research by following the philosophical commitments of 
critical realism.  
3.5.1 CASE STUDY APPROACHES: 
The literature offers different approaches to conducting case study research, advocated by 
its two main authors (Stake, 1995; Yin, 2003, 2012), which reflect their philosophical 
commitments. For example, Yin (2003) offers a more positivist standpoint, and espouses 
the use of theoretical prepositions to guide the research through analytic generalization 
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and then to relate the findings of the case with theory to offer generalizations (Appleton, 
2002). However, he advocates the use of both quantitative and qualitative approaches to 
case study (Creswell, 2007). Conversely, Stake (1995) shows his commitment to 
interpretivism and promotes theory development in case study through the use of 
qualitative methods (Baxter & Jack, 2008). 
 
Both of these approaches have their advantages and disadvantages with respect to 
addressing the aims of this current research and following the guiding principles of critical 
realism. Critical realism suggests that our concepts are theory-laden (Sayer, 1992) and 
considers prior theoretical concepts as real features of the world (Maxwell, 2012). 
Therefore, prior theories on RQ phenomenon can be used to identify the inter-relationship 
between different variables (i.e. RQ determinants) introduced by these theories to infer 
their related mechanisms. Moreover, theories on pharmaceutical marketing and 
physicians' prescription decision making can also be used to discover the important 
variables related to the research questions. These theories from different scholarships can 
be used to form the preliminary conceptual framework, before entering the field for data 
generation (Sobh & Perry, 2006). Therefore, the current research is informed by the initial 
conceptual framework drawn from the literature review and follows Yin (1994, 2003, 
2012) prepositions on use of theories. However, to infer the underlying mechanisms, 
retroduction will be used, which is more compatible with the methods of qualitative data 
generation and analysis (e.g. Easton, 2010; Reed, 2009; Sayer, 1992). Therefore, the 
current research follows Stake (1995) suggestion to use a qualitative approach for case 
study. Critical realism offers a flexibility of "critical methodological pluralism", where a 
researcher can adopt any method, on the basis of what is appropriate, to establish the 
relationship between meta-theory and methods (Danermark et al., 2002, p. 152). 
Therefore, this research adopts a hybrid approach to case study drawn from the 
perspectives of both Stake (1995) and Yin (1994, 2003, 2012), i.e. a choice of elements 
from each approach thought to be more relevant with respect to critical realism's 
standpoints.    
3.5.2  DEFINITION OF A CASE: 
One of the vital aspects of case study research is the identification of a particular case 
bounded within certain parameters, such as a particular place and time (Creswell, 2007). 
This could be a concrete entity, for example an individual, organization or a group of 
organizations, a group of individuals, an industry, a programme, a relationship, an activity, 
a decision process or an event (Appleton, 2002; Baxter & Jack, 2008; Creswell, 2007; Yin, 
2012). Moreover, Miles and Huberman (1994, p. 25) define a case as "a phenomenon of 
some sort occurring in a bounded context. The case is in effect your unit of analysis". 
Likewise Appleton (2002, p. 86) discusses "it is the phenomenon of interest and context 
that constitutes the case". He further states that the important aspect in defining a case 
should be how the particular case will aid the data generation and improve knowledge 
about the phenomenon of interest. Therefore, in the conduct of this research, a case is 
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construed on a geographic/industrial basis and defined as the pharmaceutical industry's 
PSR-physician RQ development process and its outcomes, on the basis of physicians' 
prescription decision making in the bounded context of Multan, Pakistan, as illustrated 
below in figure 3.1.  
 
In Pakistan, due to intense competition, the pharmaceutical industry relies on the frequent 
interaction of PSRs with physicians to develop RQ and as a result to achieve prescriptions 
from physicians. All this development of the PSR-physician RQ and its outcomes in the 
form of physicians' prescription decision making occur in the bounded context of Multan in 
Pakistan. However, the pharmaceutical context is further particular in a sense that there is 
also a necessary relationship between patients and physicians. This relationship cannot 
affect PSRs-physicians RQ; however, patients' particular economic conditions can influence 
RQ's objective outcomes in terms of physicians' prescription decision making. Therefore, 
the context includes the overall economic conditions of patients of Multan, in Pakistan; and 
the variations in price of products that the PSRs represent, promote and seek prescriptions 
on the basis of their RQ with physicians.   
 
 
 
 
 
 
 
 
 
 
        Figure 3.1 Case definition, design and selection for current research 
3.5.3 RATIONALE OF CASE DESIGN, AND CASE SELECTION: 
Another task for a researcher who conducts a case study research is to decide on its design 
or type, which depends on the overall purpose of research (Baxter & Jack, 2008). 
According to Stake (1995), a case study should be either intrinsic or instrumental. He 
discusses that intrinsic cases facilitate researchers to investigate a particular case in order 
to develop in-depth understanding because the case is of unusual interest, e.g. the 
Pakistani pharmaceutical industry. Instrumental cases on the other hand assist 
researchers when the intent of a research is to gain an understanding of a phenomenon of 
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interest such as PSR-physician RQ development and its outcomes in terms of physician's 
prescription decision making. The intent of this research was to conduct a case study to 
gain an in-depth understanding of PSRs-physicians RQ development and its outcomes, in 
terms of physicians’ prescription decision making, in the context of Pakistan rather than 
Pakistan as a case itself. Therefore, the case study was treated in this research as an 
instrumental rather than an intrinsic case study. Furthermore, for a researcher there is 
also a choice to conduct a single (or holistic) and  collective (or multiple) case study (Stake, 
1995; Yin, 2003). The conditions in Pakistan facilitate an understanding of the 
phenomenon under investigation in a context different to usual research endeavours 
undertaken in western developed countries. Collective or multiple case studies offers a 
researcher a way to investigate a phenomenon; therefore, a researcher selects many case 
studies rather than a single case to illuminate that particular phenomenon (Creswell, 
2007).  
 
Nevertheless, there is a common critique that case study research lacks in generalizability 
and in this regard, particularly a single case offers less generalizability than multiple cases 
(Yin, 2003). Therefore, an increased number of cases can overcome this common critique 
(Yin, 2003). Notwithstanding this, Creswell (2007) argues that for a majority of qualitative 
researchers, the term generalizability holds little meaning. He further argues that the 
investigation of more than one cases offers less depth, and hence weakens the overall 
analysis, and there is also no absolute answer on how many cases should be enough for 
generalizability (Creswell, 2007). Likewise Easton and Harrison (2004, p. 196) argue that 
"the use of the multiple cases more often results from the nervousness of the researcher 
than from any profound concerns about epistemology or methodology. The decision to use 
multiple cases should not be taken lightly, since how many and which cases are to be 
investigated will fundamentally affect the outcome of the research."  
 
The case studies based on the guiding principles of critical realism investigate how and 
why particular complex events occur in a specific context (Wynn Jr & Williams, 2012). 
Thus, for a critical realist generalizability is not the outcome of statistical inference from a 
particular sample to a wider population; instead, it is achieved through the identification of 
the deep processes at work under contingent conditions via particular mechanisms, which 
requires intensive investigation (Easton, 2010). Therefore the dominant approach in the 
critical realism tradition is to study a single case, as it helps a researcher to develop rich, 
context specific causal explanations of phenomenon under investigation (Wynn Jr & 
Williams, 2012). Therefore, generalization within a critical realism based case study can 
achieve theoretical generalizability (Wynn Jr & Williams, 2012; Yin, 2003). Consequently, 
Easton and Harrison (2004) propose that the choice of conducting single or multiple cases 
depends on the nature of contingencies and the deep processes involved in different 
situations. 
 
The purpose of this research was to identify the factors or determinants, and their 
underlying mechanisms that help PSRs to develop RQ with physicians. Further aim was to 
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investigate how this influences physician's prescription decision making as an outcome in 
an open system. The commitment to an open system based inquiry requires a researcher 
to identify the mechanisms posed by the different contingencies of pharmaceutical selling 
structure, such as: patient-physician relationship, patients' economic conditions and 
product price. The inclusion of many cases (such as other cities of Pakistan and similar 
countries such as Bangladesh and India) to this research would perhaps add further 
complexities but provided shallower rather than in-depth analysis, as well as 
understanding of RQ and its outcomes. Therefore, one case was thought to best serve the 
identification of mechanisms and their explanations for the purpose of the current 
research.                
 
A researcher can choose a case study as a holistic case with an embedded design, when 
attention is also paid to subunits within a single or holistic case or multiple cases (Yin, 
2003). This research used an embedded design, as it facilitates the conduct of research 
within different comparable contexts embedded in the same setting (Fitzgerald & Dopson, 
2009). Critical realism suggests that the research design needs to be sensitive to the 
stratified nature of reality to be capable of identifying causal powers and their 
interaction(s) at different levels (Kessler & Bach, 2014). Therefore, embedded cases are 
situated at lower hierarchal levels within the overall case (Easton & Harrison, 2004) and 
hence provide the opportunity to extend the investigation of the central issue to a deeper 
level to understand the salient aspects of the case (Vincent & Wapshott, 2014). However, 
for analysis the whole case study will be considered as a single entity (Easton & Harrison, 
2004). Figure 3.1 shown above that the case study here is construed on a geographic and 
industrial sector basis, i.e. the case is the processes required for Pakistani pharmaceutical 
industry PSRs to develop RQ with physicians. Its outcomes are therefore physicians' 
prescription decision making in Multan, with its urban and rural sales areas as embedded 
subunits. In this respect Multan as a pharmaceutical sales division was selected purposely 
for three reasons. 
 
Firstly, Multan is one of largest divisions in Pakistan and it is also the capital city of 
Southern Punjab (a province in Pakistan) with a diversified population. That is to say, the 
population is divided into urban and rural areas. Patients’ economic conditions often vary 
in these different geographic areas. Fones (2003) suggests rural areas are generally more 
deprived economically than urban areas, and that agriculture is still the main source of 
earnings, resulting in the lowest income per person in the Multan division. Families have 
more economically dependent members compared to those in of urban areas (Jones, 
2003). The outcomes of the PSR-physician RQ will be investigated within these 
comparative embedded subunits. This will enable a focus on the impact of contingent 
patients’ economic situation (based on their residence in either an urban and rural areas of 
Multan) in terms of physicians’ prescription decision making. 
 
Secondly, most patients approach Multan city (urban area) of Multan division from its 
rural peripheral areas (nearby small towns and villages) in seeking medical assistance due 
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to the availability of a major medical institution, named as "Nishter Medical Hospital", for 
secondary care treatment. This is the reason all the major national and multinational 
pharmaceutical organizations operate actively in sales promotions of their products. 
Therefore, physicians who are practicing and providing health care assistance in Multan 
are seen as more suitable for data generation in relation to addressing the research 
objectives. This is because they deal with patients from a range of different economic 
conditions and are also exposed to RQ development activities from PSRs of all the major 
pharmaceutical organizations. 
Thirdly, the selection of case site is influenced by both what is ideal and also what is 
feasible in terms of access to its participants (Bryman, 2008b; Stake, 1995). Thus alongside 
other reasons discussed above, one of the reasons to select Multan division was its 
feasibility in terms of access to participants, which was secured through professional and 
personal networks.      
3.6 PARTICIPANTS RECRUITMENT & SELECTION: 
Along with the selection of the case(s) site, one of the important decisions that a 
researcher also has to make is the selection of the participants, and how many participants 
are sufficient. According to Flick et al. (2004), for effective selection in qualitative research, 
the researcher must be satisfied of two necessary conditions: first, a clear understanding of 
the case(s) under investigation and second, proper documentation of reasonable 
procedures or methods employed in selection of participants related to the case(s) under 
investigation. In this research the data were generated in two sequential phases (see 
below, section 3.7.2) therefore different participants were selected for both phase one and 
two of data generation. 
The most common kind of the participant selection in qualitative research is purposive, 
where researcher decides upon the participants on the bases of the research questions 
(Bryman, 2008b). Furthermore, to ensure quality Creswell (2007, p. 127) suggests many 
other techniques (e.g. setting up some criterion or features) that can be used beside the 
purposive sampling strategy, which are designed to ensure the researcher recruits 
individuals with the surety that the participants' selection provides the best understanding 
of the central issue under investigation (Creswell, 2007; Silverman, 2010). Therefore, 
participants' selection for both phases was purposive along with a set criterion (please see 
below section 3.6.1 & 3.6.2).  
Moreover, in a qualitative study the decision regarding how many individuals should be 
recruited is quite different from quantitative research, where the focus of the research is 
on statistical generalizations from a large sample size (Bryman, 2008b; Creswell, 2007; 
Flick et al., 2004; Maxwell, 2012). Instead the focus of qualitative research is to acquire an 
in-depth understanding of the processes and the local contextual influences involved in 
phenomena under study from a few selected individuals (Danermark et al., 2002; Maxwell, 
2012). In this respect the most common strategy employed in qualitative study is 
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theoretical sampling. Bryman (2008b) discusses that the theoretical sampling strategy 
uses the criteria of sampling until theoretical (or thematic) saturation is reached. He 
further states that even if a researcher decides upon sample size on a theoretical basis, it is 
difficult to say after how many interviews theoretical saturation will be achieved (Bryman, 
2008b). However, many qualitative researchers believe that saturation is achieved 
between 12-20 interviews (e.g. Baum, 2003; Guest et al., 2006; Warren, 2002). 
Furthermore, in deciding about the number of participants, researchers should also 
consider the practical aspects, e.g. the finite amount of time, access to respondents and 
logistical issues etc. (Miles & Huberman, 1994). Therefore, in this research the number of 
participants was determined mainly on the basis of thematic saturation while taking 
account of practical considerations. Thus, a total of 22 participants were recruited across 
both phases, i.e. 8 participants for phase one and 14 participants for phase two of data 
generation.   
3.6.1 PHASE ONE PARTICIPANTS: 
For phase one data generation, participants from two different groups were recruited i.e. 
pharmaceutical salespeople and physicians. In this regard, there was a choice to select 
either PSRs or pharmaceutical sales managers (PSMs) to gather their views on RQ with 
physicians and on its outcomes. However PSMs were seen as more appropriate and chosen 
due to two main reasons. Firstly, they had worked as PSRs in their sales territories and 
therefore had many years of experience working as a PSR. Secondly as PSMs they have to 
work in different sales territories with different PSRs as their junior colleagues. Therefore, 
they not only had more exposure to dealing with physicians practicing in different 
locations with different needs, but were also in a better position to discuss what a PSR 
needs to do in order to build RQ and how far RQ influences physicians in their prescription 
decision making. Therefore, they were selected purposely and reminded that they should 
talk about their experience of being and working with PSRs rather than their roles as 
managers. Moreover, their selection was based on the criterion that they had at least more 
than ten years combined experience as both a PSR and PSM.  
Based on the experience criterion discussed above, and using professional networks, nine 
PSMs from different national and multinational firms were initially contacted through a 
phone call in the month of March 2016. Finally, five PSMs agreed to participate in this case 
study research. They were all male because of the lack of availability of female PSMs in the 
Multan sales territory. This is possibly because women tend to be less interested in 
working as PSMs as it involves considerable travel, with overnight stays outside the home. 
Furthermore, culturally women in Pakistan, after their marriages, are expected to become 
more involved with their families’ commitments, therefore they either opt to continue 
working as a PSR or leave the profession. Due to these issues, the selected male PSMs were 
then sent the interview consent form comprising of invitation and research related 
information via email (see appendix-1). They were requested to provide their details and 
send it back by replying to the email. A further appointment was then made with each PSM 
for data generation. The recruitment period lasted from March 2016 to April 2016 as all 
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the interviews were conducted within this time period due to the flexibility provide to 
PSMs by the interview mode (please see section 3.8.1). Each pharmaceutical sales manager 
was given a unique code, 'PSM' for simplicity, along with a number that shows the 
chronological order in which they were contacted, which is outlined below in table 3.2 
along with their features. 
Table 3.2 pharmaceutical sales managers recruited from Multan city 
 
Similarly, there was also a choice to select among general physicians and specialist 
consultant physicians or surgeons, who deal with patients having particular advanced 
levels of disease. The general physicians (GPs) were thought to be more appropriate to 
investigate the influence of product price on RQ outcomes because when a patient 
approaches a specialist consultant physician with an advanced disease, the price of the 
product becomes secondary. Moreover, GPs represent one of the major contributors in 
terms of pharmaceutical prescription market share and therefore they usually are the 
primary target for almost all the pharmaceutical firms and their PSRs as potential 
customers. Furthermore, they practice in different locations, e.g. urban and rural areas, 
therefore they were in a better position to discuss how product price interacted with the 
RQ they had with PSRs during their prescription decision making under patients' 
contingent economic conditions.  
Therefore, for phase one data generation three physicians were purposely selected based 
on the criterion of their practice size in Multan city. That is to say, a criterion was set that 
they should deal with at least a hundred patients per day in order to obtain sufficiently 
diversified views on RQ and its outcomes. The access to these physicians was secured 
through personal networks. They were already knew about the interview because I made 
these physicians' recruitment possible before my arrival in Multan through one of my 
family members who works as their colleague, he is a consultant pathologist in Multan. 
Upon my arrival at Multan, the physicians were first contacted through a phone call 
followed by personal visit upon their agreement to participate in this case study. They 
were provided with a similar interview consent form to that used for the PSMs, which they 
read, filled and returned on the same day (see appendix-1). A further appointment was 
then made with each physician for data generation. The recruitment period was June, 2016 
and all the interviews were conducted within this time period. Similar to PSMs, each 
physician was given a unique code 'GP' for a simplicity along with a number that shows the 
Interviewee Group & No. Code Gender Organization 
Name 
National/
MNC 
Service 
Experience 
Contacted 
Through 
Pharmaceutical Sales Manager-1 PSM-1 Male CCL National 16 years 
Professional 
Networks 
 
Pharmaceutical Sales Manager-2 PSM-2 Male Barrette 
Hodgson 
National 18 years 
Pharmaceutical Sales Manager-3 PSM-3 Male GSK MNC 16 years 
Pharmaceutical Sales Manager-4 PSM-4 Male  OBS  MNC 16 years 
Pharmaceutical Sales Manager-5 PSM-5 Male Sanofi-Aventis MNC 20 years 
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chronological order they were contacted, which is outlined below in table 3.3 along with 
their features.  
Table 3.3 physicians recruited from sales areas of Multan city 
 
All the physicians interviewed for both phase one and two were male. This is because male 
doctors predominantly work as general physicians in Pakistan, whereas female doctors 
mostly opt to work as gynaecologists or in other specialities. Therefore, despite strenuous 
efforts to recruit female doctors, it was not possible to persuade any to participate in the 
study.    
3.6.2 PHASE TWO PARTICIPANTS (URBAN AND RURAL AREAS): 
The second phase was conducted in the two embedded subunits of the overall case, i.e. 
urban and rural sales areas of the Multan division. Altogether fourteen physicians were 
selected, seven physicians from each urban and rural sales area of Multan division; none of 
these physicians had participated in phase one of data generation. Similar to phase one, the 
physicians for the second phase were also selected on the basis of a set criterion of 
physicians' practice size, which was at least one hundred plus patients per day. The 
recruitment period lasted from June 2016 to July 2016 and all the interviews were 
conducted within this time period. The access to the second phase participants was 
secured by using both personal and professional networks as outlined in below table 3.4 
and 3.5, along with participant features.   
Table 3.4 physicians recruited from urban sales areas of Multan division 
 
 
Interviewee Group & No Code Gender Number of Patients Practice Location in Multan Contacted Through 
General Physician-1 GP-1 M 100 plus per day Urban  
Personal networks 
 
General Physician-2 GP-2 M 150 plus per day Urban and rural (Mixed) 
General Physician-3 GP-3 M 200 plus per day Urban and rural (Mixed) 
Interviewee Group & No Code Gender Number of 
Patients 
Practice 
Location  
Contacted through 
Urban General Physician-1 UGP-1 M 100 plus per day 
Multan City 
Personal Networks 
Urban General Physician-2 UGP-2 M 100 plus per day Personal Networks 
Urban General Physician-3 UGP-3 M 150 plus per day Personal Networks 
Urban General Physician-4 UGP-4 M 100 plus per day Personal Networks 
Urban General Physician-5 UGP-5 M 100 plus per day Personal Networks 
Urban General Physician-6 UGP-6 M 200 plus per day Professional Networks 
Urban General Physician-7 UGP-7 M 150 plus per day Personal Networks 
69 
 
 
Table 3.5 physicians recruited from rural sales areas of Multan division 
3.7 METHOD OF DATA GENERATION: 
The case study approach facilitates an in-depth investigation of a phenomenon under 
study, therefore a researcher can use any method of data generation in order to capture 
the complexity of the situation in which the phenomenon exists (Easton, 2010; Johnston et 
al., 1999). However, critical realism proposes that the researcher's choice of methods 
depends upon how the use of the particular method can express knowledge about 
mechanisms (Danermark et al., 2002; Easton, 2010; Kazi, 2003; Sayer, 1992). It is already 
discussed in section 3.4 above that quantitative methods are more appropriate for 
extensive research design (Ackroyd, 2009; Sayer, 1992). Conversely, qualitative methods 
of data generation in an intensive research attempt to answer questions such as why a 
certain change occurs rather than any other, and why it is produced in a particular 
situation or case (Reed, 2009). That is, it is more significant in investigations of how 
mechanisms exhibit themselves in different contexts (please see section 3.4). The aim of 
this research was to identify the determinants and processes, i.e. the underlying 
mechanisms, needed to develop PSR-physician RQ and its objective outcomes in the form 
of physicians' prescription decision making within a bounded system, which is the 
socioeconomic context of Pakistan. Therefore, qualitative methods of data generation were 
identified as most appropriate.   
There are a variety of different qualitative methods (such as interactive interviews and 
observation etc.) available; however, the interview method was thought to be more 
feasible and appropriate for the purpose of this research. This is because with the use of 
observations, it was not possible to identify the interviewees’ mental processes and related 
psychological or emotional mechanisms, which may be involved in the development of RQ, 
as well as influencing outcomes in terms of physicians' prescription decision making. 
Moreover, an interview method can help to ask interviewees questions about the events 
and actions that took place in the past, which are not accessible through observational 
methods (Maxwell, 2012; Saunders et al., 2012). 
Interviewee Group & No Code Gender Number of 
Patients 
Practice 
Location  
Contacted Through 
Rural General Physician-1 RGP-1 M 100 plus per day 
Various Rural 
areas of Multan 
division 
Personal Networks 
Rural General Physician-2 RGP-2 M  100 plus per day Personal Networks 
Rural General Physician-3 RGP-3 M 150 plus per day Personal Networks 
Rural General Physician-4 RGP-4 M 100 plus per day Professional Networks 
Rural General Physician-5 RGP-5 M 100 plus per day Personal Networks 
Rural General Physician-6 RGP-6 M 200 plus per day Personal Networks 
Rural General Physician-7 RGP-7 M 150 plus per day Professional Networks 
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3.8  INTERVIEWS:  
There are many forms of interview design (e.g. structured, unstructured and semi-
structured interviews) but the selection of which type depends upon the research purpose 
and strategy (Saunders et al., 2012). Structured interviews (also known as quantitative 
interview method) are more often used to obtain data subjected to quantitative analysis as 
a part of a survey strategy. An unstructured interview is an open ended interview where 
the researcher may have just a single question, to which the interviewees respond freely 
and researchers then build their research work on the responses of respondents (Bryman 
& Bell, 2007). Unstructured interviews are mostly used in an exploratory study as a part of 
grounded-theory and case studies strategies with an inductive approach (Saunders et al., 
2012).   
The semi-structured interview method is another form of qualitative interviews that 
facilitates data generation in which the researcher already holds a list of specific questions 
informed by the conceptual framework and/or research questions (Miles & Huberman, 
1994). This helps a researcher to gather a manageable amount of data for later analysis 
(Bryman & Bell, 2007; Miles & Huberman, 1994). Moreover, semi-structured interviews 
provide a flexibility to researchers because they can be used for both exploratory and 
explanatory purposes (Easton, 2010; Saunders et al., 2012). This is because the researcher 
holds the list of questions that seek some explanations; however, the interviewees are able 
to respond to open-ended questions with full liberty. This may also provide an opportunity 
to consider some new dimensions or issues regarding the phenomenon under study.   
Since this research was informed by the initial conceptual framework, which was drawn 
from literature review, a semi-structured interview method of data generation for both 
phase one and two was thought to be more suitable for the research purposes.    
3.8.1  INTERVIEWS SEQUENCE, MODE AND SCHEDULE: 
Maxwell (2012, p. 103) discusses that “the main implication of realism for qualitative data 
collection is that data are usefully seen, not simply as texts to be interpreted or the 
constructions of the participants (although they are this) but as evidence for real 
phenomena and processes (including the mental phenomenon and processes) that are not 
available for direct observations. These data are used to make inferences about this 
phenomenon which can then be tested against additional data”. Therefore, maintaining 
that critical realism emphasizes a stratified reality, the interviews were conducted in two 
sequential phases. The first phase was conducted in the city of Multan in Pakistan in order 
to validate the initial conceptual framework drawn from the literature review. The aim of 
this phase was to avoid the risk of personal biases and overlooking any local causal factor 
or mechanism, and to develop a more concrete (or revised and improved) conceptual 
framework (Miles & Huberman, 1994). The second phase was conducted in two embedded 
subunits of the overall case, i.e. urban and rural sales areas of Multan division. This phase 
was conducted to verify the revised conceptual framework, i.e. how the mechanisms 
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related to PSR-physician RQ identified in phase one interact with product price and the 
patient's economic conditions within these two different geographic areas. 
3.8.2 PHASE ONE INTERVIEWS 
The first phase of one-to-one semi-structured interviews were conducted with five PSMs 
from Multan in Pakistan via the internet by using 'Skype'. Braun and Clarke (2013) discuss 
that telephone, emails and online interviews are not regarded as substitutes for face-to-
face interviews. However, they are considered as an appropriate, different type of one-to-
one interview method. Nevertheless, with the advancement of information and 
communication technology in past decades, software like Skype provides an alternative or 
supplemental choice to qualitative research for data generation (Janghorban et al., 2014). 
The use of Skype for interviews provides a synchronous or real time environment where a 
researcher and participant can interact simultaneously by choosing both audio and video 
calls in order to generate qualitative data (Janghorban et al., 2014). The further advantages 
of using Skype for interviews included the easy access to geographically dispersed 
participants, and the availability of a recording facility as one does in face-to-face 
interactions. Moreover, it helps a researcher to manage time and financial constraints 
during qualitative data generation (Sullivan, 2013).  
Considering all these benefits, Skype was used as a viable option to conduct the first phase 
interviews with PSMs, along with taking into account several other practical reasons. 
Firstly, I was studying in the UK and as an international student there was a constraint that 
I could not spend more than three months outside the UK during my study period. 
Secondly, it was thought the Skype interviews could help me not only to refine first-phase 
interviews with physicians (which was done face-to-face) but also plan the second phase 
interview schedule in advance by the initial analysis of data generated from PSMs. 
Therefore, I discussed via phone call with all the five PSMs first whether they were able to 
use Skype for interview purpose. All the PSMs showed their willingness to conduct 
interviews through Skype as they were frequent users; and it was also convenient for them 
because they were able to participate in this case study after their working hours at their 
homes. The first interview was conducted at 2nd of April, 2016 and rest of interviews were 
also conducted within the same month, according to the appointment time and date set 
with each PSM. The average time for these interviews was approximately 99 minutes 
(please see appendix-4). These in-depth semi-structured interviews were recorded (with 
the consent of PSMs by using the software 'AMOLTO call recorder for Skype, version 
3.0.6.0'), which was later used for transcription and analysis purposes. 
Subsequently, as part of the first phase interviews, three physicians were interviewed face-
to-face upon my arrival in June, 2016 at Multan, Pakistan. The decision to conduct the 
interviews with physicians face-to-face was partly based on their reluctance to interact 
through Skype. Due to their busy schedules they were less familiar with using Skype than 
PSMs, who used this technology to interact with their senior managers at head-offices 
away from Multan. 
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All the interviews for phase one were conducted in the Urdu language for better 
understanding of the questions asked. If the interviews had been conducted in English 
there would have been a risk that misunderstandings could occur, and that conceptual and 
emotional nuances of both expression and understanding could have been missed. These 
interview questions were first developed in English, then translated into Urdu. Interviews 
were held at physicians' clinics and the average length of these interviews was about 43 
minutes (please see appendix-4). The interviews were recorded on two recording devices 
with the consent of physicians, which was later used for transcription and analysis 
purposes. 
The interview schedule for both the PSMs and the physicians was the same and was 
developed by considering the research objectives (see section 3.2) and the initial 
conceptual framework drawn from literature review outlined above in figure 2.5 (Miles & 
Huberman, 1994). Moreover, the interview schedule was pre-tested by interviewing two 
former PSMs from Pakistan residing in the UK via telephone in order to make sure the 
questions were easily understood by the respondents; and their responses achieved the 
objectives of this research. After making slight language adjustments in line with 
respondents' queries and suggestions, the interview schedule for the PSMs was finalized. 
However, the questions used for physicians were slightly updated because of ongoing 
initial analysis of the first five interviews of PSMs.   
The final schedule used in this research for each interview commenced with an 
introduction, explanation about the purpose of the interview and acquiring interviewees' 
consent for recording. This was followed up by the questions like 'How are you today’ and 
‘Can you describe yourself a bit' in order to establish a rapport with interviewees (Braun & 
Clarke, 2013). The main body of interview questions was divided into three main parts 
(please see appendix-2 for schedule). 
Firstly, to identify the RQ determinants, it was essential to know about the interviewees’ 
perception about RQ (i.e. trust, satisfaction and commitment). Therefore, the focus in 
initial discussion was placed on what RQ meant to them through questions such as when 
they considered that there was a strong relationship between a PSR and physician. The 
main questions were also followed by some follow-up probes for further clarification.   
They associated RQ with either good or strong relationships; however, they described that 
good or strong relationships developed when all these three constructs, trust, satisfaction 
and commitment, were established.  
After attaining their views on RQ, the focus of the discussion shifted to what determinants 
a PSR needed to develop RQ. During the interviews the interviewees were at full liberty to 
answer questions; however, in this phase some follow-up question were administered to 
explore the conceptual framework I had developed and also for clarity on the words or 
phrases interviewees' used. For example, one physician discussed the PSR's presentation 
as a RQ determinant, which can be perceived either as the PSR's overall appearance or 
communication. To make clearer such ambiguous phrases I asked a follow-up questions 
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like 'Can you please clarify a bit what do you mean by a PSR's presentation'. Furthermore, 
to identify the underlying mechanisms associated with each RQ determinant, interviewees 
were asked follow-up questions such as 'Why they think that a certain determinant leads 
to RQ?’ By adopting the ‘peeling-the-onion-layers’ analogy during interviews, I was able to 
identify the mechanisms and establish the causal relationships between different 
constructs. 
Having established the RQ determinants, the discussion then turned towards the topic of 
PSR-physicians' RQ outcomes. Firstly, how RQ helps a PSR to achieve its outcomes, and 
then how the product price a PSR promotes interacts in relation to patients' economic 
conditions; and what would be the outcomes of this interaction in terms of physician's 
prescription decision making. Again, to identify the underlying mechanisms that cause a 
change in physician prescription behaviour and consequently to RQ objective outcomes, 
follow-up questions were asked of interviewees. For example, 'Why do you think that a 
higher product price can cause a barrier for a PSR to achieve his RQ outcomes from a 
physician'? At the end of each interview the physicians were asked if they wanted to add 
anything to the discussion in order to avoid anything important being excluded.  
3.8.3 PHASE TWO INTERVIEWS:  
To confirm the findings of phase one, the second phase of face-to-face semi-structured 
interviews was then conducted to generate data on how the mechanisms identified in 
phase one interact with product pricing and patient economic conditions within two 
different geographic areas [Multan city ('urban') and Multan division ('rural') sales 
territories] as embedded cases. These went similar to phase one interviews with 
physicians, except that a few interviews were held at physicians' clinics, and others were 
held at physicians' residences because some physicians were practicing in rural areas but 
living in Multan. All second phase interviews were also conducted in the 'Urdu' language. 
The average length of these interviews was about 33 minutes for urban and 54 minutes 
with rural sales area physicians (please see appendix-4). Similar to the phase one 
interviews with physicians, these interviews were recorded on two recording devices for 
safety, with the consent of physicians, and later used for transcription and analysis 
purposes.  
The interview schedule for the second phase interviews was quite different from the first 
phase interviews (please see appendix-3), which was developed with the help of the 
revised conceptual framework outlined in the following chapter in figure 4.4 (please see 
page 137). Therefore, similar to the first phase the interview schedule for second phase 
was also initially pre-tested through interviewing one physician in Multan, the same 
interview schedule was used as no changes were seen as needed. The aim of these 
interviews was to investigate the interaction of mechanisms identified in phase one 
interviews in two different contexts for comparative analysis. However, there was a 
considerable overlap in questions. For example, the interview started with the same 
rapport-developing questions, as was done in phase one. Then, to create a context of 
74 
 
research, the physicians were very briefly asked about what they thought about RQ and 
what determinants are needed by a PSR to develop RQ with a physician, followed by some 
follow-up questions to identify and verify the mechanisms identified through phase one. 
This not only helped me to create a context of discussion and research topic for physicians, 
but also the data generated was used as evidence to verify the determinants and their 
associated mechanisms needed by a PSR to develop RQ and achieve its outcomes. 
The discussion then shifted to the main topic of these interviews, i.e. how PSR-physician 
RQ interacts with the product price in relation to the economic conditions of patients living 
in both rural and urban areas of Multan division. Furthermore, how and why patients' 
economic conditions influence physicians' prescription decision making as an objective 
outcome of RQ. Therefore, the data generated helped me to identify the efficacy of RQ, i.e. 
for whom and under what conditions RQ works more effectively in achieving its objective 
outcomes. Similar to the phase one interviews, at the end of each interview the physicians 
were asked if they wanted to add anything to the discussion in order to avoid anything 
important being left out.   
3.9 DATA ANALYSIS: 
3.9.1 DATA PREPARATION: 
Data organization and preparation is one of the important aspects of qualitative research 
(Braun & Clarke, 2013). The data generated from PSMs was recorded on an AMOLTO call 
recorder for Skype and the interviews with physicians were recorded on an OLYMPUS 
DIGITAL VOICE RECORDER and IPHONE 6. These recordings were then transferred to a 
personal computer and used for the transcription process. Each interview was listened to 
and transcribed verbatim in Urdu language manually (on paper) by me. These hard copies 
of each transcript were then typed using Microsoft Word by downloading another 
software, 'Pak Urdu Installer', which has the inbuilt ability to synchronize with Microsoft 
Word, which enables a typist to type in the Urdu language. I then typed eight interviews 
and an expert Urdu typist in Pakistan typed 14 interviews. This effort to type up the 
interviews was because the intention was to use a computer assisted software program for 
convenient data analysis, which required importing a Microsoft Word document. After 
matching the hard copies of transcripts with the typed Microsoft Word documents and 
upon satisfaction that these typed documents had no inconsistencies, they were then 
imported to computer assisted qualitative data analysis software. 
There are many types of computer assisted qualitative data analysis software available. 
Among these QSR NVIVO, and Atlas ti are predominant in the market. Both share almost 
the same features in terms of storing and managing data efficiently, labelling the data 
chunks with a code, searching the textual data chunks through code labels quickly, 
memoing and grouping similar codes into a one category or theme (Gibbs, 2007). However,  
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Atlas ti has the advantage that it can be used for text written in many languages, including 
Urdu; however, QSR NVIVO does not provide facility for the analysis of Urdu language text. 
In this research analysis of the interviews in its original language of Urdu was under taken 
to avoid losing the original meanings that could lead to misinterpretation of the text during 
the translation process.  
However, Atlas ti offers its interface in English for coding, memoing and grouping similar 
codes into categories and themes (known as families and super-families in Atlas ti 
parlance). I used Atlas ti to store, manage, code, and group the similarities into categories 
or families. This helped me retrieve the data segments quickly, whenever I needed them 
for analysis, and display the quotes after translating them into English. It also offered the 
ability to view many hermeneutic project files at the same time, which made for 
convenient comparative analysis. However, I did not use it to draw networks or displays, I 
did this task manually as I found it little complex using Atlas ti. 
3.9.2 DATA ANALYSIS:  
The qualitative data generated comprises a huge amount of textual material that cannot be 
analysed straightforwardly and requires a specific strategy, or strategies, for its analyses 
(Bryman, 2008b). Therefore, to analyse both the first and second phase interview data, a 
thematic analysis strategy was considered as it provides a convenient data analysis 
structure to novice qualitative researchers (Braun & Clarke, 2013). Furthermore, it is also 
appropriate for data analysis of research following critical realism's guiding principles, as 
it can produce explanation that looks beyond the surface level appearances to the 
underlying social processes or mechanisms (Braun & Clarke, 2006).  
Thematic analysis is a form of recognizing, analyzing and reporting patterns or themes 
salient in the text at different levels (Attride-Stirling, 2001; Braun & Clarke, 2006; Fereday 
& Muir-Cochrane, 2006). In this respect Braun and Clarke (2006) discuss that themes (or 
patterns) can be identified and analyzed either by adopting an inductive or deductive 
(more theoretical) approach. In an inductive approach the themes are recognized from the 
data itself; however, they may represent only a small link between the questions asked of 
participants and the researcher's own theoretical interests. On the other hand, a deductive 
or theoretical thematic analysis approach facilitates a researcher to pursue his/her 
theoretical interests and focus can be placed on more detailed analysis of an area of 
interest (Braun & Clarke, 2006).  
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Table 3.6 Initial data analysis framework of provisional themes, sub-themes, categories and sub-
categories 
Themes Sub-themes Categories Sub-categories 
RQ 
Determinants 
Firm-related 
Determinants 
Firm's Image 
 
Product Quality  
PSR's Related 
Determinants 
PSR's Visit Frequency  
Relationship Investments  
Product Knowledge  
Ethical Selling Behaviour  
RQ Dimensions 
 Trust Cognitive Trust 
Affective Trust 
Satisfaction  
Commitment 
Calculative 
Commitment 
Affective Commitment 
RQ Outcomes  
Physician's Prescription Decision 
Making 
 
I endeavoured to follow critical realism's guiding principles by considering prior 
theoretical concepts as a real feature of the world (Maxwell, 2012). Therefore, for the 
phase one interviews the themes were created with a deductive approach, which was 
informed by the initial conceptual framework. Each theme was then further organized by 
creating a set of sub-themes, which were then allocated the relevant data categories and 
sub-categories prior to analysis. This provided a pre-existing coding framework, which 
facilitated organizing the data according to its relevance to a particular category or sub-
category connected to a particular sub-theme and theme. The initial themes, sub-themes, 
categories and sub-categories developed for phase one interviews are outlined above table 
3.6. 
In the next step the transcripts were then read repeatedly for further data familiarization, 
which helped me make annotations on each transcript's hard copy and the creation of 
short summaries of transcripts. This exercise enabled not only the verification of the 
categories or sub-categories connected to particular themes and sub-themes outlined 
above in table 3.6, but also the recognition of new emergent categories and sub-categories 
from the data, which facilitated me in the coding process. The final themes, sub-themes, 
categories and sub-categories developed for phase one interviews are outlined below in 
table 3.7. 
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Table 3.7 Final data analysis framework of themes, sub-themes, categories and sub-categories for 
phase one interviews 
 Themes Sub-themes Categories Sub-categories 
RQ Determinants 
Firm-related 
Determinants 
Firm's Image  
Product 
Product quality 
Product Price* 
PSR Related 
Determinants 
PSR's Visit Frequency  
Appearance  
PSR's Flexible Responses to Varied 
Situations 
 
Communication  
Product Knowledge  
Ethical Selling Behaviour  
Relationship Investments 
Generalized Services 
Personalized Services 
RQ Dimensions  
Trust 
Cognitive Trust 
Affective Trust 
Satisfaction  
Commitment 
Calculative Commitment 
Affective Commitment 
RQ Outcomes 
Subjective or 
Behavioural 
Outcomes 
Recognition  
Time and Priority  
Objective or 
Actual 
Outcomes 
Expected increase in PSR's sales or 
Prescription share 
 
Prescription for Alternative  
Patient economic 
and medical 
conditions 
 
Patient-Physician Relationship, 
satisfaction and Practice viability 
 
Product Price  
Exposure of alternative products and 
relationship with other PSR 
 
*Product price was not considered as an RQ determinant but a product's property that acts as a barrier and interacts 
with RQ's Objective outcomes under contingent patient economic conditions (see section below 4.5.1-2.2 on product 
price)     
 
As in other qualitative methods of analysis, coding is an essential part of the of thematic 
analysis strategy, whereby the data is broken down into separate units on the basis of 
similarity and given a label or a name (Braun & Clarke, 2013; Bryman, 2008b; Maxwell, 
2012). For coding, all the Microsoft word documents (i.e. interview transcripts) were then 
imported to Atlas ti by creating a hermeneutic project file that was given the name 'QDA-
786'. The codes were then generated by breaking up interviews into chunks of data, such 
as a sentence or entire paragraph, which were allocated labels or close code names in 
relation to their relevance with a particular data category or sub-category from the 
existing coding framework. 
There are different methods of creating codes either by using an inductive or deductive 
method. In the inductive method the codes are generated during the data collection. 
Deductive coding can be done prior to data generation, informed by the researcher's 
conceptual framework, and research questions or objectives but with the risk of losing 
important grounded data (Miles & Huberman, 1994). In this research the coding of data 
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generated through phase one and phase two interviews was done during the data analysis 
rather than by using a coding list prior to data analysis. However, the coding was informed 
by the pre-existing framework of data categories or sub-categories connected to particular 
themes and sub-themes, as discussed above. Furthermore, there are many forms of coding 
such as open, axial and selective coding (Gibbs, 2007). In an open coding, coding is done on 
the basis of the data itself, without considering any prior theoretical concept, i.e. research 
that follows a grounded theory or constructionist approach. However, when following the 
critical realist approach, codes are usually generated by following the conceptual 
framework; therefore, axial codes are created, that is to say codes from the conceptual 
framework are assigned to a chunk of data (Sobh & Perry, 2006). As discussed above, in 
this research the coding was done through a coding framework, informed by the initial 
conceptual framework, therefore axial codes were generated first, which led to selective 
coding for comparisons and interpretations. 
Gibbs (2007) discusses that axial codes can be generated for six different elements within 
the data. These are: causal conditions, phenomenon, strategies, context, intervening 
conditions, action/interaction and outcomes or consequences. He further exemplifies axial 
coding as "the causal conditions produce the phenomenon, which in turn causes the 
strategies in the context. These are mediated by intervening conditions and produce action 
and interactions that result in consequences" (Gibbs, 2007, p. 87). For the purpose of this 
research the codes were generated in similar fashion. However, to establish associations 
with a particular data category, each code label starts with the letters that represent its 
parent data category or super code.  For instance, to label data chunks that identified 
product quality as important for physicians because it is required for patient welfare, the 
code ‘FRD-PQ-patient welfare’ was used. Similarly, data chunks in which the physician 
establishes his trust in PSR due to product quality were coded as ‘Trust=FRD-PQ-Phy-
trust-PSR-PQ’ and the data chunks that represented the consequences of physician's trust 
as a component of RQ were coded as ‘RQOO-Sales’.  
After labelling and coding, all the similar individual codes were brought under one 
particular data category or sub-category by creating code families. Each category was then 
named or labelled by a super or selective code. Related data categories were brought 
under particular themes or sub-themes by creating super families in Atlas ti. This cyclic 
process of manual and computer assisted work helped me to gather all the similar data 
quotes (labelled with a particular code) related to each category (in connection to a 
particular theme) in one place, for further in-depth review and analysis. Table 3.8 outlines 
some of the themes, sub-themes, categories, sub-categories and codes or labels used as an 
example. Appendix 5 further provides a list of all codes that were created during first 
phase interview analysis and the coded screen print captured from Atlas ti respectively.  
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   Table 3.8 Final categories, sub-categories and example of some codes generated for phase one data 
analysis 
Theme Sub-theme Category Sub-Category Super-Code Codes 
RQ 
Determinants 
PSR's related 
determinants 
PSR's visit 
frequency 
 
PSR-VF 
PSR-VF-for reminder 
PSR-VF-physician felt obliged 
PSR-VF-for PSR's recognition 
PSR's ethical 
selling behaviour 
 
PSR-ESB 
PSR-ESB-Avoid False Claims 
PSR-ESB-inform side effects 
PSR's flexible 
responses to varied 
situations 
 
PSR-ASB 
PSR-ASB-Detailing 
PSR-ASB-VF and time 
PSR-ASB-Postman call 
Firm related 
Determinants 
Product 
Product 
Quality 
FRD-PQ 
FRD-PQ-compliance 
FRD-PQ-Patient Welfare 
FRD-PQ-Packaging 
RQ 
Dimensions 
 
Trust 
Affective 
Trust 
Trust=Phy-A-trust-PSR-VF 
Trust=Phy-A-trust-PSR-ASB 
Trust=PSR's commitment 
fulfilment 
Trust= PSR's Sincerity 
Cognitive 
Trust=FRD-FI-Phy-trust-PSR-FI 
Trust=FRD-PQ-Phy-trust-PSR-PQ 
Trust=Phy-trust-PSR-ASB 
RQ Outcomes 
Subjective 
Outcomes 
Time and Priority 
 
RQSO 
RQSO-Priority over other PSRs 
RQSO-time 
Objective 
Outcomes 
Expected increase 
in PSR's 
Prescriptions 
 
RQOO 
RQOO-RX-Frequency 
RQOO-Sales 
    
Similar to the phase one interviews, coding for the sequential second phase interviews was 
also done by combining both deductive and inductive approaches. However, to organize 
the data all the sub-themes, categories and sub-categories were first created deductively, 
which was informed by revised conceptual framework developed through the analysis of 
first phase interviews. These categories and sub-categories connected to a particular sub-
theme were then further verified by the ongoing data analysis during coding process with 
the help of Atlas ti. After labelling and coding, all the similar individual codes were brought 
under one particular data category or sub-category by creating code families. Table 3.9 
outlined the sub-themes, categories, sub-categories and codes or labels used as an 
example. Appendix 6 further provides a list of all codes that were created during the 
second phase interview analysis and the coded screen print captured from Atlas ti 
respectively. 
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    Table 3.9 Final categories, sub-categories and example of some codes generated for phase two data 
analysis 
Theme Sub-themes Categories Sub-Categories Codes 
RQ Objective 
Outcomes 
As 
Physicians' 
Prescription 
Decision 
Making 
 
(Prescription 
for PSR's 
Product or 
Switch for 
Alternative)  
PSR's-Physician 
RQ 
  
RQ developing determinants 
FI and PQ 
PSR's PQ 
PSR's VF 
PSR's RI 
PSR's P-services 
Phy-technical-need-fulfilment 
RQSO 
Product-Price 
Price and RQ interaction 
RQOO=Rx when price is 
competitive 
RQ+HPPR=No RX 
RQ+HPPR=RX for affording class 
RQ+HPPR=Switch  
Patients' 
Economic 
Conditions 
 
 
 
 
 Patient's economic cond 
Phys sensitivity of P-Econd 
Pat-eco-benefit  
Mech-Affordability 
Mech-Patient's Affordability  
Patient-
Physician 
Relationship 
Physicians' 
Professional Ethics 
 
Phy-Prof-ethics 
RX-DM=Quality and Economy 
Physician's 
Humanity, empathy 
and sympathies 
 
Phy-Humanity 
Phy-Sympathies 
Phys-Empathy 
 
Patients' 
Satisfaction & 
Practice Viability 
Competition within 
Physician's Practices 
Patient's Satisfaction 
Patient is Priority  
Practice Viability 
Physician's awareness 
of pharmacies 
behaviour 
RQ+HPPR=RX dishonour 
Patients Adoption of 
other routes of 
treatment 
Patient's switch to Quack or Hakim 
Pat-switch-spiritual treatment 
Physician's 
Interaction or 
Relationship 
With Other 
PSRs 
Exposure of firms' 
and experience of 
alternative 
products 
 
Phy-Plist-Relation-other PSR's 
Efficacy-doubt-clinical-exp 
Mech-clinical-exp 
 
3.9.3  DATA INTERPRETATION 
In qualitative data analysis, coding is seen as one important and integral part of the 
analysis that facilitates the researcher in managing the bulk of data into reduced and 
meaningful form for further analysis (Bryman, 2008b; Miles & Huberman, 1994). However, 
there are a few limitations with coding as well, e.g. losing the context of what is said and 
fragmentation of data, that is, the disconnection in the flow of narrative (Bryman, 2008b; 
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Layder, 1998). Therefore to deal with these limitations with coding, Maxwell (2012) 
suggests combining coding with connecting strategies.  
The most common of these strategies are narrative descriptions and memo writing (Miles 
& Huberman, 1994). In the narrative description a researcher can set up the narrative 
summaries code by code (Miles et al., 2013) and the focus is on what is said by the 
participants in their stories (Riessman, 1993). This helps the researcher to interpret the 
data within the context of a story and its association with other aspects of the story. On the 
other hand, the memo is considered as extension of narrative summaries as it is an 
analytical document (Miles & Huberman, 1994). According to Layder (1998, p. 58)  "memo 
writing involves researcher in creating the notes, which ask questions, pose problems, 
suggest connections, and so on about how the properties of concepts or categories are 
revealed, exemplified or contradicted in some way by the incoming data and the process of 
coding". This requires on the part of the researcher a continual assessment with reflexive 
thinking of what the data means (e.g. by asking how, what and why questions) in order to 
produce explanations (Layder, 1998; Miles & Huberman, 1994). According to Miles et al. 
(2013) good explanations require the researcher to link the explanation by combining 
coding with the connecting strategies (narrative description and memos). 
 
As previously stated, short summaries of each interview were developed. Furthermore, 
memos were also written by considering the relationship between the data categories 
within one theme or sub-theme but also with the categories of other themes or sub-
themes. This helped me to analyse and interpret the data by considering critical realism's 
account of relationships between different data categories to produce explanations 
through the effects of their associated underlying mechanisms (Maxwell, 2012). That is to 
say I identified the key relationship or underlying mechanism that connected two themes 
or its categories together, which required retroductive inferences that helped me in 
moving from the data in the empirical domain to the actual and real domain to identify the 
underlying causal factors or mechanisms (Danermark et al., 2002; Lawson et al., 1998; 
Sayer, 1992). 
 
For example, empirical data were interpreted by asking questions such as why PSR's visit 
frequency was needed to develop PSR-physician's RQ, which helped me to identify the 
underlying mechanisms. This is because an appropriate visit frequency (i.e. at least 
fortnightly or, if possible, weekly) was actually required to fulfil the physician's 
professional technical, and social needs. The fulfilment of the different level of needs by a 
PSR through visits, led to the physician's trust in, satisfaction with, and commitment to the 
PSR. However, different levels of trust (i.e. cognitive and affective) and commitment (i.e. 
calculative and affective) emerged due to the activation of different mechanisms. That is, 
self-interest comes to the fore due to the cognitive evaluations of the PSR's performance in 
fulfilling the physician's professional and technical needs in terms of updating physician's 
knowledge of particular product for patients' wellbeing and retention. Emotional 
mechanisms appear due to the level of psychological satisfaction and extent of social need 
fulfilment resulting from the PSR's visits. Both of these, physician's self-interest and 
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emotional mechanisms, engendered the reciprocity mechanisms that influenced the 
physicians' prescription decision making in terms of a PSR's product. The process of data 
interpretation and causal explanation through identification of mechanisms is outlined 
below in figure 3.2.  
 
 
Figure 3.2: Data interpretations and causal explanations by identifying mechanisms 
The adoption of such stated processes (i.e. coding and interpretations) not only helped me 
identify RQ determinants, and underlying mechanisms, but also the interaction of 
mechanisms related to product price and patient's contingent economic conditions in the 
context of Multan, Pakistan (see chapter 4).  
 
Similar to phase one, second phase data was also analyzed with the help of written 
summaries and memos, which were developed throughout the reading and coding process 
to develop sub-themes, categories and sub-categories. In terms of my critical realist 
position, these sub-themes, categories and sub-categories were analyzed and their 
interpretations made by considering them at the domain of the actual to verify and identify 
their associated mechanisms at the domain of the real. Therefore, the main units of 
analysis were the mechanisms linked with different data categories and their interaction 
under particular patients' economic context (i.e. urban and rural areas) to discover 
outcomes in the form of physicians' prescription decision making. That is to say, the 
physician's particular prescription decision that can be observed in the empirical domain 
is activated by the presence of different mechanisms and their activation at the domain of 
the actual and the real. RQ objective outcomes were then assessed by comparing and 
configuring mechanisms confirmed from the physicians’ responses operating in two 
different contexts, i.e. rural and urban sales areas of Multan division (see chapter 5).  
3.9.4  DATA PRESENTATION 
The findings presented in chapters four and five are supported by verbatim quotations 
from participants, which were translated from Urdu to English. Although the translation 
was made literally, some words were added when clarification was needed about the topic 
that participants were referring to. Furthermore, irrelevant segments of narrative that 
produce confusion were skipped or removed, which is indicated by an ellipsis [...]. Finally 
at the end of each quotation the unique identifier or code used within the square brackets 
[GP-1] for instance, to show the source of the quote. 
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3.10 QUALITY OF RESEARCH 
Braun and Clarke (2013) discuss that there is no universal assessment of quality but 
various criteria are available to ensure and judge the quality of qualitative research. This is 
because of differences in the philosophical underpinnings, such as ontology and 
epistemology, which guide the methodology  of particular qualitative research projects 
(Robson, 2011). Therefore a researcher's "adoption of critical realist approach has an 
impact upon the criteria used to ensure rigorous and meaningful results" (Neergaard & 
Ulhøi, 2006, p. 412).  From a realist point of view, Healy and Perry (2000) identified six 
criteria that can be used to evaluate and establish the quality of a case study research 
conducted by following critical realism's ontology, epistemology and methodology 
(Neergaard & Ulhøi, 2006).              
 
At the ontological level Healy and Perry (2000) develop two criteria, i.e. ontological 
appropriateness and contingent validity. The implication of ontological appropriateness is 
that the research deals with complex social phenomenon and the focus of contingent 
validity is on the validity of mechanisms that operate in an open system and their 
activation contingent upon a particular context. Therefore, consideration of the context 
that makes mechanisms contingent is the central criterion (Neergaard & Ulhøi, 2006). 
 
The third out of six criteria related to critical realism's epistemology is multiple 
perceptions of participants and of peer researchers. Healy and Perry (2000) discuss that 
unlike constructivists, a critical realist researcher does not consider a participant's 
perception as reality but as a window to reality that can be triangulated with perceptions 
of other participants in order to generate multiple perceptions about a single reality. This 
can be further triangulated with the interpretations of other peer researchers. 
 
The final three quality criteria are related to the realist's methodological principles i.e. 
methodological trustworthiness, analytical generalization and construct validity. 
Methodological trustworthiness deals with the description of rigorous procedures such as 
the development of a case study database, case selection and interview protocols etc. 
(Neergaard & Ulhøi, 2006). According to Healy and Perry (2000, p. 125) analytical 
generalization deals with the initial theory development that can be confirmed or 
disconfirmed through data generation, and a resulting theory or model should be 
presented that can be tested further at a later stage. Finally construct validity refers to 
"how well information about the constructs in the theory being built are ‘measured’ in the 
research" (Healy & Perry, 2000, p. 125).  Table 3.10 below outlines how these quality 
criteria were addressed in this research.  
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Table 3.10 Quality criteria based on critical realism used in this research. 
Level Criteria Strategy in this Research 
Ontology 1. Ontological 
appropriateness 
 
2. Contingent 
validity 
Research problem is based on why RQ between PSR-physician is needed and how far 
product's price has an impact on the PSR-physician's RQ objective outcomes, under 
contingent economic conditions of patients in the context of Pakistan (see chapter 1, section 
1.2). 
The research questions are in-depth in that they not only seek the exploration of 
determinants that a PSR needs to develop RQ with a physician, but also why they were 
needed by means of identification of underlying mechanisms and their explanation in the 
contingent context of Pakistan (see chapter 1, sections 1.2 and 1.3).       
Epistemology 3. Multiple 
perceptions of 
participants and of 
peer researchers 
Multiple interviews were undertaken with PSMs and physicians in Multan (both from urban 
and rural areas). Triangulation was done in terms of multiple views of participants about 
reality of the RQ phenomenon, its impact on objective outcomes in terms of physician's 
prescription decision making under contingent patients economic condition in the context of 
Multan, Pakistan.  All the constructs that constitute the initial conceptual framework were 
based on peer reviewed literature on RQ and on physician's prescription decision making 
(see chapter 2).   
Methodology 4. Methodological 
trustworthiness 
(the research can 
be audited by 
third person) 
5. Analytic 
generalization 
 
 
6. Construct 
Validity 
Case study database was developed with the help of Atlas ti. All the procedures of case study 
approach, case selection and design, participants’ selection, interview mode, process and 
schedule were informed (see chapter 3, section 3.5-3.6 and also appendices). Furthermore, 
steps undertaken for data analysis were discussed (see chapter 3 section 3.9). Finally findings 
are supported with relevant quotations from data. 
Based on research questions, a literature review was done to develop initial conceptual 
framework, which was used for first phase data generation leading to the development of a 
revised conceptual framework. Further, data was generated on the basis of this revised 
conceptual framework and theory was refined. 
All the constructs that constitute the initial conceptual framework were based on the review 
of literature on RQ and on physician's prescription decision making (see chapter 2) and 
triangulated from the findings of this case study, which resulted in the revised conceptual 
framework (see chapters 4 and 5).   
[Source: cited in (Neergaard & Ulhøi, 2006, p. 413), based originally on (Healy & Perry, 2000, p. 122)] 
3.11 ETHICAL CONSIDERATIONS: 
The entire research was undertaken by conforming to the University of Gloucestershire's 
Handbook of Research Ethics. The participants were informed about the research prior to 
data generation and provided with an informed consent form including the information 
provided in this document. The data generation proceeded upon their willingness and 
audio recordings were made, when allowed. Participant's identities, specific job titles etc. 
or organization were not mentioned in the transcripts or the research outputs. The 
participants were informed about their full authority to not answer any of the questions or 
to withdraw from the research at any time. They were also informed that everything 
would be kept confidential and all information will be destroyed on the completion of the 
research work. Finally, physicians were also informed that this research did not require 
them to divulge any particular details on the part of any specific case or group of patients. 
Rather, it only dealt with the general economic conditions of the patients in their area as 
this pertained to their prescription decision making.  
 
 
85 
 
3.12 CONCLUSION: 
This chapter has described the rationale of procedures that were used to derive the 
findings of this research. The overall aim of this research was to critically explore the 
determinants and associated mechanisms that contribute to PSR-physician's RQ. A further 
aim was to investigate how far product price (and its related mechanisms) had an impact 
on the 'outcomes' of PSR-physician's RQ, in terms of physician's prescription decision 
making under patients' specific economic situation - in the context of Multan, Pakistan.  
 
Initial sections of this chapter provided the perspectives of three competing research 
philosophies and expressed why critical realism rather than positivism or constructivism 
was more suitable for the purpose of this research. Critical realism believes in an open 
system of inquiry and emphasises outcomes resulting from contingent conjunctions of 
mechanisms. Later sections established that underlying processes or mechanisms can be 
better explored and explained through qualitative methods. Such explanations first require 
the identification of underlying mechanisms and then verification of how these 
mechanisms interact within different contexts to produce certain outcomes. Furthermore, 
this also established that critical realism lends itself to a case study strategy that enables 
the analysis of the objects under study, the relationships between them and the causal 
powers they hold. Therefore, an embedded qualitative case study approach was 
considered and semi-structured interviews were adopted in order to address this 
research's aims and objectives. Last but not least, participant (i.e. PSMs and physicians for 
phase one and two of data generation) selection, rationale for semi-structured interviews 
and procedures for thematic data analysis have been described.     
 
The next two chapters provide the findings, analysis and discussion that were achieved by 
following the analytical processes described in this chapter. Following the initial 
conceptual framework drawn from the literature review, chapter 4 provides the findings 
from the PSMs and physicians of Multan city, which helped in the identification of the 
mechanisms related to RQ, its determinants, impact of the price of a PSR's product and 
patients' economic situation to form the revised conceptual framework. Chapter 5 then 
extended the investigation one step further by means of the verification of the factors 
identified in chapter 4, and identification of a few more salient aspects from the 
perspective of physicians who operate in rural and urban sales areas of Multan division in 
Pakistan.  
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4 MULTAN SALES AREA  
4.1 INTRODUCTION: 
In this case study the determinants of relationship quality (RQ) will be identified from the 
respondents. Part A of this chapter begins by presenting the profile of the healthcare 
sector Multan Division; and details how pharmaceutical sales organizations and their 
pharmaceutical sales representatives (PSRs) approach physicians in order to establish the 
context of the findings that follows. Following this part B examines the pharmaceutical 
managers' (PSMs') and the physicians' understanding of RQ itself; and the determinants 
needed to build RQ between the physician and the PSR. Part C then moves on to examine 
respondents' perception of expected outcomes of RQ. Finally part C also examines 
respondents' explanation for the expected outcomes when RQ interacts with the higher 
price of a brand that a PSR promotes given the contingent patient's economic conditions 
that the physician is working with.  
4.2 PART A CONTEXT OF MULTAN DIVISION: INTERACTION OF THE 
PHARMACEUTICAL ORGANIZATIONS AND THE GENERAL PHYSICIANS 
4.2.1  GEOGRAPHIC LOCATION AND POLITICAL ADMINISTRATION OF MULTAN 
DIVISION: 
Pakistan is divided into four major political administrative units known as provinces (i.e. 
Punjab, Sindh, Khyber Pakhtunkhwa and Blouchistan). Each province is subdivided into 
divisions and currently there are 36 divisions in the four provinces. Divisions are further 
subdivided to smaller administrative units known as a district (156 in total) and each 
district spilt further into 'tehsils', (596 at present).      
The Multan division is situated in the south of the Province of Punjab in Pakistan. The 
divisions adjacent to Multan are D. G. Khan, Bahawalpur and Sahiwal, which have their 
own districts and tehsils. Multan division comprises four districts: Multan, Vehari, Lodhran 
and Khanewal. Each of these districts have tehsils such as Multan city, Multan Saddar, 
Jalalpur Pirwala and Shujahabad, which collectively comprise the Multan district. Similarly, 
Vehari district comprises of the tehsils Burewala, Vehari and Mailsi. Likewise Lodhran 
district comprises tehsils Dunyapur, Lodhran and Kahror Pacca. Finally Khanewal district 
comprises tehsils Jehanian, Kabir Wala, Khanewal, and Mian Channu (Pakistan Bureau of 
Statics Government of Pakistan).     
Multan city is also the capital of the South Punjab, it is the fourth largest city in Pakistan, 
and together with other areas of Multan district it has the total area of 3720 km². It is a 
very densely populated district with the average of 837.9 persons per km². According to 
the census in 1998, the total population of Multan district was over 3.1 million (i.e. 42.18% 
urban and 57.82% rural) with an average annual population growth of 2.73% (Pakistan 
Bureau of Statics Government of Pakistan). 
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4.2.2 MULTAN DIVISION AS A GEOGRAPHIC SALES REGION: 
Multan as a pharmaceutical firms' sales territory is quite different from the political 
administrative region, as it includes some areas from the other political divisions 
discussed above. It comprises Multan city and its urban areas, which includes the 
physicians, consultants and professors working in Nishter Hospital (one of the major 
hospitals in south Punjab region) and other those practicing in different streets of the city. 
The sales areas other than Multan city are situated at considerable distance from Multan 
city and considered rural or in peripheral towns. Peripheries, or rural sales areas, are 
regarded by pharmaceutical companies as more deprived economically than the urban 
areas of Multan. In these rural areas, agriculture is still the main source of earnings, 
resulting in the lowest income per person not only in Multan but also overall among other 
rural areas of Pakistan. Families have more economically dependent members compared 
to those in urban areas (Jones, 2003). These areas consist mainly of Jalalpur Pirwala' 
Shujahabad, Muzaffar Garh, Khanewal, Jehanian, Kabir Wala, Mian Channu, Vehari, 
Burewala and Mailsi. These towns outside of Multan also have many adjacent smaller 
towns and villages, which are also included as a part of the pharmaceutical sales area or 
territory controlled by a PSM based in Multan. The usual sales areas are divided between 
the PSRs within the Multan division, giving each PSR some rural areas and some urban, as 
shown below in table 4.1a. 
Table 4.1a Usual sales areas or territories in Multan sales division  
Sales Area or 
territory 
Sales Areas Covered By Report to 
Sales Area or territory-
1 
Local Multan city (urban areas) + Khanewal, 
Kabir Wala, Mian Channu, Abdul Hakim & 
Tulamba (rural areas) 
PSR-1 
PSM-1 Sales Area or territory-
2 
Local Multan city (urban areas) + Jalalpur 
Pirwala, Shujahabad, Muzaffar Garh, Khan Garh, 
Ali Pur & Karor Pacca (rural areas) 
PSR-2 
Sales Area or territory-
3 
Local Multan city  (urban areas)+ Vehari, 
Burewala, Mailsi, Jehanian,  Pul Baghar (rural 
areas) 
PSR-3 
 
Apart from the sales areas or territories of Multan division discussed above, some 
pharmaceutical firms also cover D.G.Khan division from Multan either through the PSR 
based in D.G. Khan division; or through the PSRs based in Multan, who along with work in 
the local Multan city area, visit the D.G.Khan division on a weekly basis.       
4.2.3 HEALTHCARE FACILITIES, GOVERNMENTAL SUPPORT & PATIENTS GENERAL 
ECONOMIC CONDITIONS IN MULTAN DIVISION AND ITS PERIPHERIES: 
The ministry of health government of Punjab Pakistan is responsible for health care 
delivery to patients through all hospitals, division health quarters (DHQs), tehsil head 
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quarters (THQs), basic health units (BHUs) and rural healthcare centres (RHCs). The total 
numbers of health facilities that the government provides are shown in table 4.1b below.                             
Table 4.1b Government health facilities available in Multan Division  
Division/District Hospitals DHQs THQs RHCs BHUs 
Multan 3 0 4 8 76 
D.G.Khan 0 1 1 9 51 
Muzaffar Garh 0 1 2 13 71 
Khanewal 0 1 3 4 82 
Vehari 0 1 2 10 77 
Layyah 0 1 3 4 40 
Total 3 5 15 48 397 
[Source: Punjab Health Department (2017)] 
Government healthcare support for patients is often seen as inadequate both in the urban 
and rural areas of Multan, which results in the patients seeking services for their primary 
healthcare from private local physicians (e.g. Akram & Khan, 2007). This increases the cost 
of their overall treatment, which includes the physicians' fee and the cost of the medicines 
being prescribed by physicians. The overall cost further increases in the case of secondary 
care treatment because, in such situations, patients need to move from rural areas to 
urban Multan, because the secondary care treatment in rural areas is often unavailable and 
also where present, is considered unsatisfactory by patients (e.g. Akram & Khan, 2007; 
Muhammad, 2014). 
Therefore, both in urban Multan and its rural peripheries, a huge number of private 
physicians' practices exist. Consequently, there is healthy competition between these 
physicians’ practices, which are located outside of the government hospitals on different 
roads and streets. There are many private clinics in a single road or street, therefore, 
patients have easy access to numerous physicians in their local areas, as patients do not 
require any prior appointment to see these physicians. Physicians normally charge 
patients for their consultation, also for any internal dispensing of medicines and they 
prescribe other medicines on their letter head that the patient can buy from pharmacies.  
4.2.4 PHARMACEUTICAL ORGANIZATIONS SALES OPERATIONS IN MULTAN SALES 
TERRITORY: 
As a potential drug prescription market almost 700 licensed, and also a huge number of 
non-licensed firms, operate in Multan, which includes MNCs, national firms and franchise 
setups of national firms. However, the two major categories of the pharmaceutical firms 
(i.e. MNCs and national) comprise the vast majority of the Pakistani healthcare market. 
Table 4.2 below outlines the top 50 pharmaceutical firms along with their sales 
performance and ranking in terms of their value, given in Pakistani-rupees. 
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MNCs established their operations after the independence of Pakistan and they are based 
on their research products, therefore enjoy a more trustworthy image among healthcare 
professionals. National companies, however, started their operations later in the early 
1970s and they are entirely based on generic, or me-too, products. Franchise setups 
include those who buy a marketing right to a product(s) for certain allocated area(s). 
Almost all of the MNCs and national firms have divided their product portfolios in 
different groups; therefore, there is a huge sales-force from these firms that interacts 
with physicians in order to sell their products and there is intense competition between 
the firms mainly due to the presence of the generic or me-too products.    
Pharmaceutical sales representatives who are based in Multan by different firms not only 
cover local sales territories of Multan but also frequently visit physicians in their 
allocated peripheral rural sales areas. PSRs are responsible for promoting their products 
and also developing their relationships with the local physicians to generate higher 
prescription share to achieve their allocated sales quotas (Andaleeb & Tallman, 1996; 
Scharitzer & Kollarits, 2000). Thus, relationship based selling becomes more important 
for PSRs, especially when physicians have hundreds of brands available to prescribe 
under one product category with varying prices. Therefore, pharmaceutical firms 
through their PSRs apply many tactics to build their relationships with physicians as their 
potential customers. Mainly, this includes the delivery of product-related information 
services through PSRs, knowledge-based clinical meetings, seminars, educational 
scholarships, free product samples, clinical support equipments, gifts, business and 
family dinners etc. These services facilitate PSRs to build relationships with physicians 
who have the prescription decision making power on behalf of patients.  
The above section has outlined the background of this case study in order that the 
perceptions of the interviewees can be better understood in context. The following 
section describes the interviewees.  
4.3 INTERVIEWEES 
Five pharmaceutical sales managers and three physicians from city of Multan were 
interviewed for phase one data generation to gather their perceptions of RQ with 
physicians, in terms of the determinants involved and the expected outcomes. Both PSMs 
and physicians were also asked about the expected outcomes when RQ interacts with 
product price under the contingent patient economic conditions. Their characteristics are 
outlined above in table 3.2 and 3.3 (please see section 3.6.1 in chapter 3).   
4.4 PART B: INTERVIEWEES PERCEPTION OF RQ DIMENSIONS & 
DETERMINANTS:  
The primary focus of part B of this chapter is to examine the pharmaceutical sales 
managers’ (PSMs) and the physicians’ (GPs) perception of RQ and its dimensions and 
their understanding of the RQ determinants that develop RQ with the physicians. Firstly, 
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section 4.4.1 examines the dimensions of RQ. The subsequent section, 4.4.2, then 
examines the determinants that influence these dimensions of RQ in the context of 
Pakistan.   
4.4.1 INTERVIEWEES PERCEPTION OF RQ DIMENSIONS: 
In order to explore the determinants of RQ, it was crucial to evaluate the PSMs' and 
physicians' perception of RQ itself. Therefore, the scope of this section is to understand 
the respondents' ideas about what they meant by RQ and accordingly what determinants 
are required to develop RQ. The following sections provide the respondents' views on RQ 
(i.e. trust, satisfaction and commitment). The themes, categories and sub-categories 
identified are outlined in figure 4.1.  
 
The sub-categories of trust (i.e. cognitive and affective trust) and commitment (i.e. 
calculative and affective commitment) are explained from the responses of the 
respondents in the section 4.4.2, as these sub-categories emerge from the effect of the 
different RQ determinants. 
 
4.4.1.1 TRUST:  
The PSMs measured their RQ with the physicians in terms of the RQ outcomes, such as 
sales or prescriptions share, more time with physicians, recognition and personal 
information sharing with the PSR etc. However, when probed with the questions like 
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'why you observed such RQ outcomes' and 'what is their basis', the PSMs provided the 
following responses:  
The doctor will judge that how the person (PSR) is coming to visit him addresses his concerns. And if 
the person addresses the doctor's concerns then the doctor will develop his trust in the person. 
Therefore, the doctor thinks, if the PSR is good enough, it means his medicine will also be good. Let's do 
business with him, and that is why relationships with physicians are very important [PSM-1]. 
The above quote from the PSM signifies that he had an understanding about trust as a 
necessary construct for the development of RQ as he directly uses the word 'trust'. For 
instance, the quote gives the impression that the physician trusts the PSR, when he 
addresses the physician's concerns. This implies that the products or services offered 
must meet the physician's expectations developed as a result of the claims made by the 
PSR. The literature on buyer-seller relationships also suggests that trust develops as a 
result of buyer's evaluation of promised versus delivered performances by the seller's 
products or services (Wray et al., 1994). The physicians are then involved in evaluations 
of the interaction episodes and it takes time to develop trust in the PSR (Lagace et al., 
1991). Therefore, if the PSR fulfils the promises made, they will gain the physician's trust. 
As the physician develops his perception about the PSR’s sincerity, this is integral in 
order to develop trust. The PSMs frequently stated the word 'sincerity' to interpret the 
trust in their responses as illustrated in the following quote: 
 
Because in pharmaceutical sales we keep meeting with the same customer continuously -in order to 
develop the customer's confidence- that shows we are with you and we are sincere to you [PSM-2].   
 
This also reflects that the PSMs were aware that the demonstration of the sincerity and 
benevolent (caring) intentions from the PSR during the interactions are very important 
to develop RQ with the physician. The significance of the statement from the PSM 'we are 
with you' also shows that the PSR's integrity or honesty with the physician is also 
required in order to develop the physician's trust. This is also in line with the literature, 
where trust is also seen as beliefs, sentiments or expectations of the individual on the 
honesty and the trustworthiness of his/her partner (Crosby et al., 1990; Moorman et al., 
1992; Morgan & Hunt, 1994; Rasila, 2010). Further, this also accords with Morgan and 
Hunt (1994, p. 23) who define trust as "one party's confidence in the exchange partner's 
reliability and integrity". A similar assertion was given by the physicians in their 
responses as illustrated in the following quote: 
 
 I will say that they should be honest to their profession [GP-3]. 
 
The PSMs also related trust with its outcome in terms of the exchange of personal 
information alongside professional discussions by the physician with the PSR.  
 
When there is a good relationship between doctor and PSR, then the doctor can share his personal 
information with the PSR. Therefore, basically development of the doctor's trust in the PSR is required 
[PSM-3]. 
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The meaning of this statement is that trust must be present in order to enable the 
customer (physician) to take risks (McAllister, 1995). Therefore, this enables customers 
to exchange their concerns and needs openly, which helps the salesperson in better 
meeting customer needs and consequently enhancing RQ (Boles et al., 2000). The above 
quotes from the PSMs and the physicians reflect that they had a clear idea of the necessity 
for a physician's trust in the PSR for the development of RQ.  
 
4.4.1.2 SATISFACTION: 
The PSMs were also aware that not only physician's trust in but also satisfaction with the 
PSR is also needed in order to develop quality relationships. The following is illustrative 
of many similar quotes that demonstrate the importance of satisfaction along with trust 
in order to develop RQ. 
    
   Customer satisfaction is most important when we talk about the development of the strong 
relationships with the customer. This point is most important and if we discuss any relationship other 
than the physician-PSR relationship, the notion of trust and satisfaction is also very important [PSM-
4]. 
 
However, their explanations give the impression that trust and satisfaction are 
interrelated but distinct constructs. As satisfaction is not only required for the quality 
relationships but also trust cannot be developed until, and unless, the physician feels 
satisfied with the PSR's previous interaction history. The literature on satisfaction also 
suggests that quality of interaction between customer and service provider influences the 
customer satisfaction (Shamdasani & Balakrishnan, 2000). Therefore, cognitive and 
affective assessment is based on a customer's personal experiences across all the 
interaction episodes within the relationship (Storbacka et al., 1994). Moreover, it is 
'human psychology' to keep evaluating on other's actions or behaviour both consciously 
or unconsciously, as stated by one of the PSMs:       
 
Relationships cannot be developed and nobody can benefit in the absence of the mutual trust in each 
other. And trust can only be developed when somebody is satisfied with your previous history. That is 
how you behaved previously and how you are behaving now. Every one evaluates and this is the 
human psychology that he or she always in the process of the evaluations of others [PSM-2]. 
 
This quote provides the explanation regarding the quality of interactions between the 
PSR and the physicians in order to achieve the physician's satisfaction, which leads to the 
trust. Similarly, another PSM associated trust with the satisfaction that can be achieved 
through product related quality and additional services. This is similar to findings of 
Crosby and Stephens (1987) that the customer's satisfaction can emerge from three 
different levels, which are: satisfaction with interpersonal interaction; satisfaction with 
the intangible aspect such as service; and satisfaction with the firm. The following quotes 
reflect the view of trust’s linkage with satisfaction emerges through the fulfilment of the 
physician’s needs and wants from the PSR in terms of services and product related 
quality or efficacy offered by the firm.  
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Relationships are always based on trust but if the PSR is fulfilling the needs and wants of the physician 
with the efficacy of the drug and also adding value with other efforts then definitely it helps to develop 
the physician's trust in the PSR [PSM-5]. 
 
Trust and satisfaction are definitely required in order to establish good relationships. And there are 
multi-functions and multi-factors involved in it, i.e. not only the PSR's own personality but also 
product quality, both affect trust and satisfaction.[GP-1]. 
 
Similarly, the physicians were not only aware about the importance of trust but they also 
stated that satisfaction with the PSR was essential in order to develop RQ. But they were 
also conscious that trust and satisfaction are affected by multiple factors e.g. quality of 
the products or services and the PSR's personality. 
 
4.4.1.3 COMMITMENT: 
The PSMs were also cognisant about the reality that the physician's commitment with the 
PSR is a much more important construct that is needed to build and maintain quality 
relationships. They explained that trust and satisfaction are the first steps that facilitate 
the PSR to ask for a physician’s verbal commitment to a product, as illustrated in the 
following:   
Trust and satisfaction are the first steps to get inside. [...] however, business will only come when you 
receive a physician's verbal commitment against the features and benefits of your product; [...] and 
when doctor gives the verbal commitment he or she becomes morally bound-the doctor thinks ‘I have 
a good relationship and I have given the commitment also and he is the person I trust’. Then these 
things trigger him [PSM-1]. 
The above statement is quite similar previous findings as commitment cannot exist 
without trust between the partners (Naudé & Buttle, 2000). The significance of the above 
statement is that by gaining the physician's trust and satisfaction, the PSR can ask for the 
physician's commitment. This is because the physician has developed trust in the PSR 
after having satisfaction with the products and services on offer. Apart from the verbal, 
commitment can also be engendered naturally because of the PSR’s efforts in fulfilling the 
commitments on his own part. Consequently, the physician will reciprocate the PSR’s 
efforts in terms of a high share of prescriptions to the PSR, as illustrated in the following 
quote:   
When the PSR fulfils the commitment on his part, it develops the physician’s satisfaction with the PSR 
then the physician does not count the number of prescriptions he writes for the PSR's product. 
Because, he thinks positively about the PSR's efforts, for instance, physician thinks when he requested 
samples for the patient; PSR provided them on the same day. [...] Physicians note down everything and 
develop a perception of how sincere the PSR is with his job and in the development of quality 
relationships with the physician [PSM-1]. 
 
This quote also echoes the findings of Gounaris (2005) who found that by delivering 
excellent products or services and effective relationship management, this helps 
customers in developing trust in and satisfaction with a salesperson. This thus leads to 
the customer's affective commitment with a salesperson; because, it emerges from the 
emotional sort of sentiments that come with the physician's evaluations of the PSR's care 
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and sincerity with the physician. However, another PSM viewed the commitment in terms 
of physician's cost-benefits analysis (i.e. more rational) of the PSR's inputs in terms of 
relationship investments. Upon satisfaction with the investments or benefits received, the 
physician's commitment to the PSR is achieved:     
 
It is natural that a person accommodates to someone whenever he or she feels satisfied with that 
person; [...] therefore, the physician will accommodate the PSR’s commercial benefits in terms of sales. 
This is because the physician develops his trust in the PSR, when he or she has fulfilled physician's 
needs now it is the physician's turn to reciprocate. And it is not possible to maintain the relationships 
until both parties in relationships felt satisfied with each other. [...] If the physician is not committed to 
the PSR, he or she will not be committed to doing business with the PSR. In that case all your efforts 
have gone in vane-you will get nothing from him or her [PSM-2]. 
 
The physician's commitment to the PSR is necessary in order to achieve the firm's core 
objectives (i.e. sales). Therefore, according to the responses from the PSMs, a physician's 
commitment to the PSR is an indispensable condition otherwise there is no benefit to 
develop such relationships. Moreover, this can possibly lead to the relationship’s 
termination. The literature on commitment also suggests that commitment is important 
in order to maintain the relationship (e.g. Moorman et al., 1992). The following quotes 
from PSMs provide explanations with regards to the importance of the physician's 
commitment to the PSR. However, they measure the physician's commitment in terms of 
the physician's share of prescriptions to the PSR.  
If there is no business activity from the physician then it means that he is not committed to the PSR 
and the relationships between the PSR and physician is only limited to chit-chat.   [PSM-2] 
 
Being a salesperson your ultimate goal is to achieve the company's commercial benefits. After all our 
efforts, if we are not converting our strong relationships into business then it might be that we are not 
converting our personal relations into professional. So, definitely, if relationships convert into 
prescriptions or business then we can say that we hold strong relationships with the physician and 
also that the physician is committed to us [PSM-4]. 
 
Physicians also acknowledged that the PSR receives the relationship benefits in terms of 
prescriptions. And if a physician does not cooperate in this regard it will lead to 
relationship termination:  
The PSR receives the benefits of relationships in the form of sales but if they do not get the 
prescriptions they feel disheartened- and doctor also feels their loss of motivation [GP-3]. 
 
The physician used the word disheartened to give the impression that the physician's 
commitment to the PSR in terms of prescriptions is a necessary condition for the 
relationship’s durability and maintenance. Otherwise, this leads to a fall in the PSR’s 
motivation to continue the relationship and it can be terminated ultimately.      
In summary, there was a clear perception amongst PSMs and physicians that linked to the 
impression the trust, satisfaction and commitment were distinct but interrelated 
constructs that constitute RQ. Physicians trust in a PSR can be developed through 
satisfaction with the product(s) or service(s) offered by the PSR and sometimes trust in 
PSRs leads to the physicians' satisfaction with product(s) or service(s) the PSR offers. 
Similar to Crosby et al. (1990) their explanations also suggested that trust and 
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satisfaction are only the entry conditions that enables the PSRs to take physicians' 
commitment (in terms of giving their prescription to PSRs). Moreover, in line with 
literature they also confirmed that physicians' commitment to a PSR is also a vital 
construct in order to maintain RQ in the longer-term (e.g. Ivens & Pardo, 2007). This 
therefore, established that trust, satisfaction and commitment were the necessary 
conditions in order to develop long-term quality relationships between PSRs and 
physicians. The next section examines the determinants of RQ that are required and how 
they affect trust, satisfaction and commitment, including their sub-categories.  
4.4.2 INTERVIEWEES PERCEPTION OF RQ DETERMINANTS: 
In order to identify RQ determinants, the following section examines the views of the 
pharmaceutical sales mangers (PSM) and general physicians (GP) concurrently. The 
themes, sub-themes, categories and sub-categories identified are outlined in figure 4.2. 
The categories shown in dark blue coloured blocks emerged from the respondents' 
responses; whereas the categories in turquoise blocks were considered in the initial 
conceptual framework drawn from the literature review and verified by the respondents 
as RQ determinants.   
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4.4.3 FIRM RELATED RELATIONSHIP QUALITY (RQ) DETERMINANTS: 
The firm related determinants (FRD) sub-theme connects to the RQ determinants theme 
and has two categories, which are: firm image; and the product offered by the firm. The 
data category product has two further sub-categories, which are: product quality, which 
is identified as one of the RQ determinants; however, the second, product price, is shown 
in a red colour block and indicates that this is one of the barriers that can interact with 
RQ outcomes in terms of a physician's prescription decision making. The firm and its 
product(s) as the entities of the pharmaceutical selling structure have their own causal 
powers or properties. This can affect the relationship between the physician and the PSR 
as evident by the responses of the interviewees. The following subsections examine the 
influences of these constructs in the development of RQ between the PSR and the 
physician.  
4.4.3.1 FIRM IMAGE: 
All the PSMs and the physicians accepted that the firm image was a necessary 
determinant to develop RQ between the physician and the PSR. This is because, in 
Pakistan there are more than seven hundred licensed pharmaceutical companies, ranging 
from multinationals to nationals and franchised setups. The PSMs reported in their 
responses that in Pakistan physicians have more trust in the MNCs and the top ten 
national organizations, compared to newly formed or unknown firms (e.g. franchised-
setup) due to their image. In this context, the MNCs started their operations immediately 
after the creation of Pakistan in 1947, and the national firms started their operations 
nationwide in the early 1970s. However, the franchised-setups are small firms and every 
year there is a tremendous growth of such new firms. Furthermore, unlicensed 
companies also operate in Pakistan. This leads to physician uncertainty, therefore the 
level of the physicians' trust in firms is quite different depending on the age and the level 
of the firm's operations.  
The MNCs and the top ten national firms, through their PSRs, generally interact and 
provide the physicians with medical information services and products for many years. 
Therefore, physicians already know about firms, the quality of their products and the 
PSRs (in terms of product knowledge) compared to the newly launched firms in Pakistan. 
Consequently, with the passage of the time physicians develop positive image perception 
of these firms based on their performance criterion of product related quality and their 
medical information services. This tendency is confirmed by Ou et al. (2012), who 
suggest that a firm’s image develops as the result of a customer's long-term assessment of 
the firm's positive actions and performance in favour of a customer, which engenders the 
customer's trust and satisfaction with a given firm. Therefore, the PSRs who represent 
these firms develop RQ with the physician much earlier than competitors' PSRs, as 
illustrated in the following quote:      
Now if you see the level of physician's trust in the PSR of the top ten national or multinational firms 
will be something else as compared to the PSR of the newer company or franchise set-up. Therefore 
99 
 
the company behind the PSR has a huge impact because the confidence level of the PSR of a good 
company as compared to the company that has no good reputation as their product knowledge will 
not be sound. Secondly, doctors hold great confidence in a firm that has a good image-that helps a PSR 
in early development of the relationships [PSM-5]. 
 
The above quote from the PSMs signifies that the physician's perception of a good firm 
image can be derived from the PSRs' level of the product knowledge (examined later in 
section 4.4.3.2 (a) on product quality) communicated to the physicians. It appears that 
physicians in Pakistan believe that the good firms invest much more in their PSR's 
training. Therefore, a physician's confidence and reliance in the information 
communicated by the PSRs of such firms is much higher compared to new or unknown 
firms. This is especially true because physicians make their day to day prescription 
decisions for patient wellbeing, based on the information provided by PSRs. Physicians 
perceive this sort of investment in the PSRs’ training as valuable for them and it leads to 
the development of physicians' perception of the firm's good image. The literature on 
firm image has also discussed that the customers' perceived firm image can be seen as 
the extent to which customers believe that a supplier firm is fair, honest and concerned 
about its customers goodwill (Doney & Cannon, 1997, p. 37). The physicians also stated 
in their responses that the MNCs, and a few national firms are better reputed as 
compared to the others, as demonstrated in the following quote:    
 
You know a company's name counts and it takes many years to develop that sort of standing in the 
market. MNCs hold their own worth as when you prescribe their products and patient does not 
recover, then you feel there is a something wrong with the diagnosis of the disease. But if the same 
situation happens while you have prescribed the product of a national firm or a firm that does not 
hold any worth, you feel that the medicine is the problem. But, now the top ten Pakistani firms have 
also improved their efficacy [GP-3]. 
 
In their explanations the physicians associated the firms' reputation or image more with 
the delivery of superior product quality for the patients' benefits (examined in next 
section). As discussed above they believe in the MNCs and the top ten national firms' 
product quality much more as they have the experience of many years of prescribing the 
products. The above explanations reflect the views of both the PSMs and physicians, 
which link the impression of firm image with the quality of the product and the quality of 
the PSR in terms of the effective knowledge delivery. The literature on the physician-PSR 
relationships provides similar assertions. For instance Scharitzer and Kollarits (2000) 
discuss that in the context of pharmaceuticals a positive firm image emerges with the 
delivery of excellent products and medical information services offered to the physicians. 
Therefore, depending upon the satisfied interaction history with the quality of the 
product and the PSR, a physician maintains or holds a good image of the firm that helps 
the PSR develop RQ with physician earlier, as illustrated in the following, which 
represents the many other quotes (please see appendix-8, Q.1.):  
Definitely, if the PSR approaches the physician with a good firm image then 50% of their job will be 
done. This is because the doctor is sold on the company and knows its brands already therefore, 
developed his trust in PSR due to this good image of the firm. [...]. Otherwise if the firm image is not 
good then definitely, the PSR will have to wait for six months to gain trust. [...] Therefore, if the firm 
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image is good, physician will give the PSR more prescription share, and will develop more trust in the 
PSR [PSM-1]. 
 
PSMs further explained that the trust in the firm then transfers to the PSR and helps in 
early development of physician's trust in the PSR, because the firm's name is attached to 
the PSR. Similarly Johnson and Grayson (2005) discuss that a customer’s judgment of the 
positive reputation and trust in a firm has direct impact on the trust in a salesperson 
through a mechanism of transference as the source of a credible firm. This implies that 
physician's perception of the firm’s image or credibility that a PSR represents has direct 
impact on the development of the physician's trust in the PSR and also the future 
relationship between them (Wright & Lundstrom, 2004). Similar explanations from the 
PSMs are illustrated in the following (please see appendix-8, Q.2 for another example):  
Physician trust in firm also transfers in the PSR because first of all a physician sees the PSR's visiting 
card with the firm's name on it. Therefore, firm's image definitely counts, as physician develops his 
perception in that form, which firm the PSR represents and how other people belonging to the firm 
work. But, this happens if they were working well and providing services as well [PSM-1]. 
 
Although the PSMs agreed that the firm’s image was helpful for the PSRs initially in order 
to gain a physician's trust, they also pointed out that this was an advantage that added 
value. However, to develop RQ further with the physician much more depends on the 
efforts of the PSR.  
 
A company's good image is a plus point, but it depends how the PSR uses this plus point. If the PSR is 
not well trained or skilful- the firm image will become negative for him or her [PSM-3]. 
 
The physicians through their responses also confirmed the above explanations from the 
PSMs that the firm image helped the PSR at the initial level of trust development.  
However, they also stated this is not the only factor in the development of RQ. They 
reported that the role of the PSR and the quality of the products they sold counted much 
more in this respect, as illustrated in the following (also see appendix-8, Q.3): 
Yes I will say it will help a PSR initially as the company he or she represents exists for number of years; 
therefore I develop my initial trust due to the company's name. However, this will not be the stand-
alone factor in the development of strong relationships. If the company is newer and unknown then I 
will see how the PSR introduces it and how the medicine he is promoting performs. Because, you 
cannot trust in a new company [GP-1]. 
 
From the above assertion it is clear that in the context of Pakistan the image of the firm is 
particularly important due to the remarkable growth of new firms into the industry. This 
leads to uncertainty among physicians. The firm image removes that uncertainty from the 
physicians by involving physicians in the evaluation of performance of the firm that leads 
to cognitive trust in the PSR (e.g. Johnson & Grayson, 2005). This implies that, based on 
the previous performance of the firm (in terms of product(s) and services), a physician 
develops his positive expectations regarding the PSR’s future performance. The 
physicians require a professional orientation from the PSR, as they are working for the 
wellbeing of the patient. Therefore, physicians' self-interest is involved here in order to 
ensure the quality of the products and information services that are offered to them in 
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achieving their goal of patient wellbeing. This is because they have to prescribe 
pharmaceutical products on the basis of the information communicated from the PSR. 
According to Doney and Cannon (1997), source credibility has significant associations 
with trust and buyer decision making since a communicator is perceived to be a source of 
valid assertions. However, in the instance of a new or unknown firm, it is difficult and 
time consuming for the PSR to develop relationships. The explanations regarding why this 
is linked again with the physician's concerns about the quality of the product and also 
about the PSR promoting the product. Consequently, a physician will evaluate how a 
product, as well as a PSR, performs in order to develop trust in the PSR and then in his 
firm. Nevertheless, according to explanations, firm image alone is not sufficient but that 
the way the PSR conducts in providing services and the performance of the product he or 
she promotes is also important. Since a physician operates in an open system and every 
entity (e.g. firm, product and the PSR) has to play its role in the development of RQ, the 
role of the product related quality is examined in the next data category i.e. product. 
However, factors i.e. determinants related to PSRs are examined in subsequent sections.  
 
4.4.3.2  PRODUCT: 
The data category of product is also linked with the sub-theme 'firm-related RQ 
determinants' and has two further sub-categories: product quality and product price. 
Product quality is identified as one of the determinants of RQ. However, product price is 
shown as a red colour block in figure 4.2, indicating it is one of the barriers that interacts 
with RQ objectives or actual outcomes, according to the respondents. The following 
sections will examine the role of these constructs in the development of RQ.   
A) PRODUCT QUALITY: 
All the PSMs and the physicians (or GPs) in this study accepted that product quality was 
necessary and the most important determinant to developing RQ between PSR and the 
physician (i.e. GP). This implies that whilst the salesperson's quality of interaction fulfil 
the social needs of the customers, quality of the product or service is necessary for their 
technical needs fulfilment (Hennig-Thurau & Klee, 1997). One of the main reasons was 
the promotion of drugs by large numbers of different pharmaceutical organizations, as 
discussed in the section above. Consequently, this leads to the physician's uncertainty in 
deciding what brand should be preferred that can fulfil their technical needs. The MNCs 
have established an image of superiority in terms of quality control among the physicians 
in Pakistan. Therefore, physicians trust in the product quality of MNCs more than the 
national companies and the franchised setups (see section 4.4.3.1 above). However, when 
it comes to prescription decision making; the issue of the higher cost of the MNCs' 
products in relation to a patient's economic condition becomes relevant, and that forces 
the physician towards alternative products (please see more details below in the price 
interaction section 4.5.3). Therefore, the national firms, as well as franchised-setups, as 
producers of alternative products have to meet the physician's criteria of product related 
quality. That is, at least acceptable in terms of efficacy, in comparison with the MNC's 
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product quality. The following quote from one PSM is illustrative of the perception of 
product related quality provided by different firms.    
In Pakistan more than 700 companies are registered and I don't know about the un-registered 
companies, but 700 companies are registered. These firms do not all have the same level of product 
quality [PSM-1]. 
 
The above statement signifies that product quality issues come to the fore, at least on the 
psychological level of the prescribers, with respect to the many firms that are promoting 
the same product with different brand names. This is because, all the respondents in this 
study were well aware that the government was issuing licences to a large number of 
firms without any strict regulations. There was also a lack of Governmental control over 
those that were unlicensed. This resulted in higher prescription share from physicians 
and the other prescribers to the top twenty pharmaceutical organizations. This 
orientation towards the top-twenty firms' products indicates the physicians' sensitivity 
towards the image of a firm. Consideration of the firm's image psychologically ensures 
physicians of the product’s quality as the physician cannot compromise on product 
quality.  
 
If you make a comparison of the Pakistani market, the top 20 companies are getting almost more than 
50% market share. This is because they never have to make a compromise on their quality of product 
[PSM-2]. 
 
The above quote demonstrates the physicians' professional orientation towards patient's 
healthcare delivery. Being a healthcare professional, a physician's primary priority is to 
secure the patient's wellbeing at any cost. Therefore, product quality is required as it 
fulfils the physician's technical needs (Hennig-Thurau & Klee, 1997) in order to recover 
the patient from a disease or ailment as early as possible. The following quote is 
illustrative of many of similar comments from the GPs that provide their concerns and 
consequences regarding the absence of product quality with respect to the patient.                    
Product quality has a direct relation with human life. Suppose a patient comes to me with typhoid 
infection and I prescribe him an antibiotic on the basis of PSR's claim that the ciprofloxacin he or she is 
promoting is very good in treating typhoid. However, this does not have any efficacy, despite the 
product pack claiming that it contains 500mg of ciprofloxacin but in actuality it does not. Therefore, 
the patient will not recover from typhoid and secondly it will cause drug resistance. And due to this, 
the next time it becomes very difficult to treat that patient. So, I have to take account of all such things 
[GP-3]. 
Although, all the PSMs acknowledged the physicians’ professional orientation with 
respect to patient benefits or wellbeing, however, they also provided another explanation 
that is linked with the physician's own-benefits. This is illustrated in the following quote 
which represents others (see appendix-8, Q.4):    
The patient is the physician's customer [...], so, definitely why would a physician prescribe a product 
that does not have quality as he or she will never want to lose the patient. Patient is physician's bread 
and butter because the patient pays the physician, so, physician's whole earning is dependent on 
patients. So, physician always wants patients to recover. Therefore, product quality matters a lot and 
it is in a benefit to the physician [PSM-4]. 
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The afore-mentioned quote from the PSM reflect the views on physicians' professional 
orientation, not only in technical but also in financial terms, which the physician achieves 
by ensuring product quality. In Pakistan there is also competition among physicians in 
terms of their practices (see section 5.4.2.3). If a physician fails to cure a patient quickly, 
there is a potential risk of the patient's withdrawal and shift to another physician. Hence, 
to make a practice viable, a physician must ensure product quality, as his or her earning 
is dependent on the number of patient visits to that particular physician. Physician trust 
in the product's quality is required to enable him in making a choice of the brand for the 
patient in order to avoid the risks discussed above.  
 
Patient satisfaction with a physician is thus required in order to make a practice viable. 
The patient's satisfaction with the physician fosters physician's trust in and satisfaction 
with not only the product but also the PSR representing the product. The following quote 
from PSMs demonstrates the process of trust and satisfaction development with the 
product, and through the product with the PSR (please see appendix-8, Q.5 & 6): 
 
If the doctor is confident about the quality of product then he or she will prescribe. Because, the doctor 
will be confident enough in the details given by the PSR about the properties of the product. And if the 
doctor finds the same then definitely this will help in the development of the relationship. Therefore, 
the doctor will develop his or her trust and satisfaction due to the patient's recovery from the disease. 
[PSM-4] 
 
The above quote signifies the development of the physician's cognitive trust in the PSR. 
This involves physicians in the evaluation of what the PSR claimed and how the product 
performed accordingly. On finding a satisfactory response from patient's feedback 
regarding recovery from disease, the physicians’ trust and satisfaction are developed 
both with product and the PSR (Lagace et al., 1991). However, in the event of non-
compliance in terms of product quality the physician's trust and satisfaction with the PSR 
will never be developed. According to Human and Naudé (2014) customers are only 
motivated to continue a relationship if they receive a quality product that matches their 
expectations of added value in some way. Therefore, a PSR cannot continue the 
relationships with the physician without having a quality product. The importance of 
product quality and efficacy for the continuation of physician-PSR relationship was 
highlighted by PSM-2, 4, and 5 and is best summarized in the following quote (please see 
appendix-8, Q.7 & 8):   
If the doctor's trust in the medicine is shaken it will also be shaken in the PSR and their situation will 
not remain the same. Because, if the product quality is not good, it will be associated with a poor PSR. 
The doctor will think: this PSR comes from company X and has brought a non-efficacious medicine. So 
product quality is very important to achieve doctor's trust and satisfaction with the PSR because 
without this it is not possible to develop a good relationship with the doctor [PSM-2]. 
The physicians also stated clearly that patient satisfaction with the physician is 
dependent upon product quality in terms of patient's recovery from a disease. And if the 
product does not respond according to expectations, the relationship between the PSR 
and the physician cannot develop, because the physician's trust and satisfaction with the 
104 
 
PSR will be distorted due to the product's ineffectiveness. The performance of the 
product will be attributed to the salesperson, and thus affect trust in the salesperson 
(Johnson & Grayson, 2005). The following quote from one GP show similar explanations 
(please see more in appendix-8, Q.9): 
It is very difficult to develop a relationship with the PSR if there is a problem in the quality of the 
product that a PSR is promoting. I will listen to his sales call but I will not prescribe a product that 
does not have any efficacy... that kind of product cannot come into my prescription because I cannot 
trust it and it cannot satisfy me. Therefore it is also not possible to develop trust and satisfaction with 
the PSR [GP-3]. 
 
This quote indicates that the physician's trust and satisfaction with a product is required 
in order to achieve the physician's commitment to the product that a PSR is promoting. 
This implies that if the product works according to the physician's expectations (i.e. the 
patient recovers); then he or she will continue to extend the product's benefits to the 
patients in future and this reflects the physician's commitment to the product. 
Consequently, physician's commitment is given to PSRs promoting quality products. A 
similar assertion can be found in the findings of Čater and Čater (2010), who found 
product quality to be a necessary determinant of a successful and quality business 
relationship, influencing buyers' commitment that then further leads to their loyalty. The 
following quote from the PSM is illustrative of such a view (please see more in appendix-
8, Q.10):  
 
If the patients are recovering it boosts the physician's confidence and the physician continues the 
product in succeeding patients [PSM-1]. 
 
The above assertion clearly demonstrates that in the context of Pakistani pharmaceutical 
selling, product quality is a crucial construct in order to develop physician's RQ with the 
PSR. Since judgements on RQ will be made based on the quality of cstomer/salesperson 
interaction, product or service quality may also be influential (e.g. Bejou et al., 1998). This 
is because product quality is related to the physician's professional orientation towards 
the patient's wellbeing. This professional orientation is not only related to the physician's 
self interest to ensure the patient's wellbeing, but also the patient's retention as his 
potential customer. Patient retention is also dependent on patient satisfaction. This only 
can be achieved with the patient's early recovery from the disease, which is associated 
with the quality of the product prescribed by the physician. However, another important 
factor in prescription decision making regarding the product is its price, which emerged 
through the responses of the respondents. The role of the product price in this respect is 
examined in the following section. 
 
B) PRODUCT PRICE 
Product price is identified as a second sub-category of the category 'product'. However, it 
is not considered as one of the RQ determinant in this study. This is because, according to 
the respondents, it has no direct effect on the development of RQ between the physician 
and the PSR, rather it has more effect on RQ outcomes. The following quotes indicate the 
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effect of higher product price on the outcomes of RQ that the PSR is expecting in terms of 
prescriptions from physicians.   
A strong relationship with the PSR can be developed due to the factors that I have discussed with you. 
But higher price can deter me in my prescription decision making [GP-3]. 
A strong relationship can be developed even though the price of a product is high. This is because the 
PSR may have a good personality; therefore the physician develops a good relationship with the PSR. 
And the physician will become involved in the discussions, perhaps offering the PSR tea. However, this 
relationship cannot be transformed into the form of prescriptions if the price of the PSR's product is 
high [PSM-1]. 
The above quotes reflect that if the product price is high it will create a barrier in the 
physician's prescription decision making, as a majority of patients in Pakistan cannot 
afford high product prices. Previous studies have also identified that price does not have 
a significant effect on buyer-seller RQ development. For instance, the findings of a study 
carried out by Lin (2013) identified that customers’ perceived price to not produce any 
barriers in developing RQ with customers. In fact, customers perceive high price as a 
signal of quality (Gönül et al., 2001). The notion of price and quality becomes clearer 
when physicians respond to lower product price:   
If the price is very low, then one cannot trust in it. For example, medicines come from China, India and 
Afghanistan ...... all these things are available [GP-2]. 
The quote above shows the physician's perception that lower product quality is 
associated with lower product price and also in terms of the country of its manufacturing 
(e.g. China, India and Afghanistan). In Pakistan, products from these countries are 
believed to be low in quality, because they are sold at very low prices. Therefore, the 
physician becomes involved in price comparisons of the products of these countries with 
the available alternative products from other firms (MNCs and nationals) that have a 
good image. A large price difference between the products creates uncertainty for the 
physician and thus diminishes the development of trust in low price products. The 
following quote from a physician offers such a comparison for conflict resolution (i.e. 
deficit of trust) in order to make a prescription decision making for a patient having 
financial difficulties.              
There is efficacy doubt when you shift to alternatives (i.e. low price). But I try to prescribe any national 
company's product that has an efficacy near to the MNC or at least the raw material is bought from 
the same source the MNCs use. This gives me satisfaction [GP-3]. 
The physician must be satisfied with the quality of the low price of product. Initially, the 
satisfaction is derived from the source of the raw material used, in comparison with the 
brand leader (usually an MNC) as stated in the above quote. It is similar to the assertion 
made by Doney and Cannon (1997) that source credibility has a greater influence on the 
buyers' trust that leads to their satisfaction. However, later satisfaction and trust in the 
product is derived from the patient's recovery from the disease. Therefore, given the 
above explanations from the respondents, it is clear that product price is associated with 
the quality of the product, which is considered a RQ determinant (already examined in 
4.4.3.2 a). Hence, product price is considered a barrier for physician's prescription 
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decision making, contingent on the patient's needs and economic conditions. This results 
into the switch of the PSR's product with the alternative product of similar category at 
the lower price that a patient can afford (e.g. Al-Areefi & Hassali, 2013) even though 
physicians experience some uncertainty about its efficacy due to its lower price. This 
aspect is examined in more detail later in section 4.5.3 of part C of this chapter and then 
in chapter 5. The next section examines the perception of the PSMs and the physicians 
about the sub-theme 'PSR-related RQ determinants'. 
4.4.4 PSR'S-RELATED RELATIONSHIP QUALITY (RQ) DETERMINANTS: 
The sub-theme PSR-related determinants (PSR-RD) is also connected to the theme RQ 
determinants and has seven further categories, which are: the frequency of PSR's visits, 
appearance, expertise or product knowledge, communication, relationship investment, 
adoptive selling behaviour,  and ethical selling behaviour, as shown in fig. 4.2. The 
subsequent sections examines the contribution of these constructs in the development of 
the RQ between the physician and the PSR.  
A) PSR'S VISIT FREQUENCY: 
All the PSMs and the physicians in this study reported that an appropriate visit frequency 
(i.e. at least fortnightly or if possible, weekly) by PSRs was very important to develop RQ 
with the physicians. In their explanations they stated that in Pakistan the number of the 
PSRs visiting physicians is extremely high due to the presence of large number of 
pharmaceutical firms. As already mentioned, on an average 50-60 PSRs visit a physician 
on the daily basis, therefore, it is very difficult for the physician to remember the PSRs 
and also their products’ name. Furthermore, in such a competitive environment it is 
indispensable to keep in touch with the physicians in order to fulfil their needs and wants 
to develop RQ.  
The PSR's visits are required because there is a huge competition and 50-60 PSRs visit the physician in 
a day. If a PSR does not visit a physician, their selling skills and product knowledge cannot be applied. 
And if the PSR visits within the proper intervals, the physician will be familiar with the face of the PSR. 
But this does not mean to visit on a daily basis, this would make him or her annoyed [PSM-3]. 
Similarly, the physicians confirmed the explanations presented above from the PSMs 
regarding PSR visits frequency. The following statement from the physician gives the 
impression that they were also very clear regarding the competition among the firms and 
their PSRs. And consequently, about the large number of brands under the same product 
category being promoting to them. Therefore, they needed regular visits from the PSRs in 
order to memorise and prescribe their brands.          
The regular visits are important because there are a huge number of companies and their PSRs. And 
everybody asks for prescription of their products. Well in all this, many companies are at the same 
level and their product prices are also similar. Therefore, those who visit will get prescribed because 
there must be a product reminder [GP-3]. 
The above quote from the physician signifies that it is the PSR's job as the firm’s 
representative to address all the physician's concerns regarding the products and 
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services offered in order to develop RQ (Crosby et al., 1990). By conforming to these 
obligations, the PSR fulfils the commitment on his own part with the physician. 
Otherwise, physician feels that the PSR is not performing their role and in such a 
competitive environment somebody else (i.e. the competitor) can fulfil the physician's 
needs. Such conduct of the PSR fosters the physician's negative perception about the 
PSR's non-serious attitude. Therefore, a quality relationship cannot be developed due to 
the lack of regular visits and fulfilment of physician’s needs and wants. So, in order to 
meet the physician's expectations and the market's competitive situation, an appropriate 
number of visits (fortnightly or weekly) by PSRs to the physician are necessary to 
develop RQ, as illustrated here: 
Your commitment is not fulfilled until you give proper visits to the physician. If you do not, there will be 
a gap in your consistency that will naturally be filled by someone else. The competitors will become 
active and fill this gap and they will gain a winning situation due to this [PSM-2]. 
The PSR fulfils his or her commitment by providing product-related information during 
visits to the physicians (Lagace et al., 1991). The PSR's visit also provides the opportunity 
for the physician to evaluate not only the quality of the information provided but also the 
conduct of the PSR's own role during these interactions. The greater the amount of 
information that the customer benefits from in frequent interactions, there is reduction 
in the customer's uncertainty and thus this leads to a high quality of relationship 
(Leuthesser, 1997). However, this is only possible if these interactions achieve the 
physician's positive value judgement about the information provided. That is how far it is 
helpful in the betterment of physician’s professional orientation for the patients' benefit.  
The extent of the physician's expectation of the PSR’s visits is stated by the PSM in the 
following quote.  
The physician is expecting that the PSR will provide some valuable information during the interaction 
that will add some value in clinical practice. And if so, it will increase the physician's level of trust in 
the PSR [PSM-5].  
The above quote signifies that the PSR's visits are not only important to meet the 
competitive environment but most importantly to fulfil physicians' technical needs (e.g. 
Hennig-Thurau & Klee, 1997). This is because the pharmaceutical industry is a highly 
dynamic in terms of new product innovations and advancements in the ways of treating 
diseases (e.g. Lagace et al., 1991). Therefore, physicians perceive the PSRs' visits to be 
very important for them because they consider PSRs a primary source of information 
(e.g. Wright & Lundstrom, 2004). As physicians are busy in their clinical practices, to 
keep themselves updated, they therefore seek out valuable information from the PSRs 
(Murshid & Mohaidin, 2017). Moreover, frequent interactions provide better opportunity 
for the PSR to provide information critical to the success of the relationship (Lagace et al., 
1991). According to Doney and Cannon (1997), a  salesperson's frequent interaction with 
a customer engenders customer trust in that salesperson. These interactions help 
physicians to acquire necessary information for their patients' wellbeing. And if the PSR's 
visits meet this physician's objective, it will not only help to develop the physician's trust 
but also create satisfaction with the PSR.  
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The physicians do not have time to stay updated with all of the current information. And 
pharmaceutical industry is very dynamic and dosage schedules also change rapidly. If a physician gets 
feedback from the patient, this needs to be passed on to the PSR to add in against the feedback. 
Therefore, if the PSR visits the physician often you can discuss more and satisfy the physician's queries. 
Then in this way you can develop the physician's trust in you [PSM-3]? 
The quote above indicates that regular visits foster a cognitive form of trust between the 
physician and the PSR. They involve the physician in evaluations about the benefit he or 
she is receiving from the PSR's visits. If the benefits received are more than the time given 
to the PSR during interaction then this leads to the physician's trust and satisfaction with 
the PSR (e.g. Leuthesser, 1997). As, the PSR's visits fulfil the physician's self-interest in 
improvement in his or her professional orientation. Therefore, the physician grants 
respect and regard to such a PSR. This is because the physician develops a positive 
impression about the PSR's sincerity to his duty, as illustrated in the following quote from 
a PSM.  
The physician pays regard and respect to a PSR who visits the physician regularly. This is because 
physician thinks, the PSR is sincere to him or herself and also with the company. And it is quite possible 
that the physician does not want to give a share of prescription, but due to the PSR’s regular visits he 
or she starts [PSM-4]. 
Similar kinds of responses to those stated above were also given by physicians in general. 
Their explanations give the impression that regular visits affected the cognitive level 
evaluation of the PSR's honesty to his job (in fulfilling physician's self-interest) and trust 
and satisfaction development. And consequently, the physician offers his or her respect to 
the PSR:   
A PSR's regular visits show that the PSR is honest and fulfils his or duty. I respect such a PSR [GP-3]. 
Moreover, their explanations give the impression that regular visits have an effect beyond 
the cognitive level evaluation and trust development. Even if a physician is not actively 
assessing the PSR's interactions and performance, regular visits also influence the 
physician psychologically. As one of the physicians stated, regular visits by a PSR give the 
feeling that the physician is someone special to the PSR. And in reaction the physician also 
gives special treatment to such a PSR, as illustrated in the following:   
Even if it is not proactive, trust develops as a reaction to a PSR's regular visits. There is psychological 
action involved in it [...]. This compels me to feel I am someone special to the PSR and he or she is giving 
me special treatment. Therefore, I will also give special treatment to the PSR. There is no doubt this is 
my reactive response, but I do this. Second, you also review the PSR's own and the performance of the 
product he or she is promoting. If the PSR is treating you in a good manner and performance of the 
product is also good then you will also treat him or her in a respected way, won’t you [GP-1]? 
The above quote suggests that regular visits also engender the physician's emotional 
sentiments too regarding the PSR's efforts in developing RQ. Physicians tend to be very 
busy with their patients as a result the PSR's time with the physician is very limited (e.g. 
Wright & Lundstrom, 2004). In such a small time it is very hard for the physician to give a 
full attention to sales calls. Furthermore, many firms sell more or less the same generic 
brands under one product category and similar information is communicated by the PSRs. 
Therefore, often there is less time for the physician to cognitively evaluate the PSR's 
109 
 
performance on the basis of information shared. However, the regular presence of a PSR 
in the physician's consulting room gives him or her psychological reinforcement of the 
PSR's honesty, which fosters emotional mechanisms leading to affective trust, as 
illustrated by another physician: 
Definitely regular visits help to develop trust in the PSR, and because of these visits, emotional feelings 
for the PSR also develop. When the quality and standard of products is similar, preference will be given 
to the PSR who visits more. For instance, when one PSR visits once and the other ten times, then there 
is a huge difference between the two [GP-2]. 
This quote shows that in addition to the physician developing trust due to the quality of 
the products being promoted by different PSRs (cognitive aspect), the regularity of a 
PSR's visits engender emotional feelings (or mechanisms) that lead to the physician’s 
affective trust in the PSR. Consequently, the PSR is preferred by the physician in terms of 
getting a higher prescription share, if the product he or she promotes possesses the same 
level of product quality in comparison to its competitors. This also signifies that the 
quality of the product must be present (as examined above) along with regular visit 
frequency. Apart from the above explanations, one of the physicians expressed the 
importance of a PSR's visits in terms of fulfilment of social needs: 
If the PSR does not provide any new information, then visits do not matter. However, you spend the 
time in some interesting conversation with the PSR. And secondly, frequent interactions always affect 
you and then, as a gesture of goodwill, you start giving prescription share to the PSR, because he or 
she comes consistently and provides me services. Therefore, I have to look after him or her [GP-1]. 
The above statement also provides the impression that although the physician expects 
value addition in terms of his product related technical needs, the PSR's visits are also 
very important for the physician’s social needs fulfilment. This includes the physician 
spending time with the PSR if possible, (i.e. in less busy times). Doney and Cannon (1997) 
suggest visits to a customer provide a salesperson's social settings opportunities, in 
which a more productive information flow can be exchanged. As a result a customer not 
only acquires technical information but also shares the personal information with the 
salesperson (e.g. Crosby et al., 1990). Several interactions of this sort help in the 
development of RQ. The physician is likely to give privileged to such interactions or PSR 
visits, in the shape of prescription share. Moreover, such acts by the physician also give 
the impression that the PSR's visit frequency fosters his commitment to the PSR, as 
illustrated in the following quote.  
The biggest resource is time investment, although others are also important. But in this case the PSR 
goes to the physician, which is valuable for the physician. It gives the physician the idea that the PSR 
has invested his time on the physician. Therefore, the physician definitely realizes and memorizes it 
and then converts it into prescriptions share [PSM-1]. 
This signifies that the physician considers the PSR’s visits valuable because the PSR 
invests his time (in travelling, in waiting and in communication) to do so. Therefore, the 
development of such sentiments or emotional mechanisms also engenders or triggers the 
physician's positive perception of the PSR's benevolence or generosity. This leads to 
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physician's affective commitment to the PSR. The next section will examine the role of the 
PSR's appearance in the development of RQ between the PSR and the physician. 
B) PSR'S APPEARANCE: 
The data category PSR's appearance emerged outside of the initial conceptual framework 
from the responses of both the PSMs and the physicians. All the PSMs suggested that the 
PSR's appearance was a part of his or her overall personality and a necessary factor to 
developing RQ between the PSR and the physician. This is illustrated in the following 
quote, which is representative of many similar responses from PSMs. 
 It is very important to be well dressed because the PSR is going to see a very highly educated class of 
society [PSM-3]. 
In Pakistani society physicians are considered to belong to a highly educated professional 
community. Therefore, the PSR's appearance should be such that it can aid the 
physician's assessment of a similarity with the PSR as a professional. Smith (1998b) also 
found similar results in her study, suggesting that customers are less likely to develop 
relationships with sellers if their attitudes, such as professionalism and work ethics, are 
not mutually held. Similarly, the PSMs considered appropriate dress code (i.e. formal 
business attire, which includes trousers, shirt, tie and/or full suit) for the PSR's important 
to improve the PSR's appearance in totality. An inappropriate dress code could cause a 
delay in the development of quality relationships with the physician, as illustrated in the 
following quote. 
Usually the PSRs go to see physicians in a ‘rough and tough’ style, this creates delay in your customer 
relationships. Therefore, as much as your getup is appropriate and professional, the earlier you will 
win your customer [PSM-2]. 
The above quote illustrates the PSM's concern regarding the PSRs' inappropriate or 
informal ('rough and tough') dress code practices generally in Pakistan. Normally the 
PSRs visit the physician alone without any management control over their field work 
(Lagace et al., 1991). This can make the PSRs a somewhat relaxed and they take their 
dress code for granted. As, a result such PSRs can be perceived as non-professionals by 
the physician and thus this leads to delay in the formation of relationships. The physicians 
also provided the same responses on appearance and discussed what a PSR should look 
like: 
I think the PSR is an educated person, so his appearance [...] should be like an educated person. So, 
from clothes or dress it should reflect that he or she is a PSR but not the patient, because the PSR also 
waits with the patients. Therefore, he or she needs to look like a pharmaceutical person [GP-3]. 
The physician's quote above also confirmed the PSMs' assertions that the PSR's 
appearance serves as non-verbal communication of his professional attitude towards the 
job role. In addition to this, the PSMs also provided explanations of the aesthetic effects of 
the PSR's dress on physicians. Appropriate dress code (i.e. formal business attire, which 
includes trousers, shirt, tie and/or full suit) can create a pleasing first impression on the 
physician, as illustrated in the following:  
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A good look always impacts others. And your personality or dress would be your first impression while 
entering in a doctor's chamber. If your first impression is nonsense, that makes him or her irritated. 
Then what will the doctor discuss with you [PSM-2]? 
Therefore, an appropriate dress code (i.e. formal business attire, which includes trousers, 
shirt, tie and/or full suit) for a PSR's is also necessary to build a physician's positive 
image perception. It helps in removing the physician's uncertainty due to the 
development of positive expectations regarding the PSR's future performance (e.g. 
Ahearne et al., 1990). Even if it is subconscious, appropriate appearance (i.e. a PSR in 
formal business dress code) gives the physician psychological corroboration for the PSR's 
positive behaviour. Similarly, Kim et al. (2009) as a result of their study, found that 
professional looking sales associates influence the consumer's positive emotions not only 
for their selves but also the image of stores they represent. Therefore, if the physician is 
uncertain about the PSR based on non-professional appearance (i.e. an informal dress 
code), it could possibly lead to an unresponsive physician. And that certainly leads to 
inertia in the development of the relationship with the PSR or even no relationship 
development activity at all, as stated below.   
A doctor who sees 50-60 PSRs in a day can easily scan the PSR and develops image perception about 
the PSR's capabilities. Definitely, when a well-dressed PSR enters the chamber, doctor will perceive 
him or her as knowledgeable and skilled and then talk at the level of the PSR. On the other hand, a 
negative impact will be developed when a PSR enters in inappropriate attire, therefore a physician will 
avoid talking with him or her [PSM-5]. 
The importance of the statement above is that the physical attractiveness of the PSR's 
formal business attire gives physician an emotional reassurance that plays an important 
role in the improvement of future relationships. The physician develops a positive value 
judgment about the PSR's professional appearance and starts making assumptions about 
the knowledge and skills he or she possesses. This positive evaluation then leads to the 
development of physician's initial trust in the PSR (e.g Ahearne et al., 1990). The 
following quote demonstrates the link between appearance in terms of dress code with 
the development of trust and satisfaction.  
Your dress will leave a pleasant impression on the doctor. And if your impression on the doctor is good 
then all the other factors will also be developed with the passage of time i.e. trust and satisfaction 
[PSM-2]. 
The formation of this initial trust then enables the physician to have open communication 
with the PSR in terms of his or her concerns regarding products or services. 
Consequently, the PSR will address the physician's concerns more appropriately; that is 
necessary to develop further trust, satisfaction and hence RQ (Boles et al., 2000). A 
physician who feels more comfortable in discussing issues will likely want to establish RQ 
with the PSR, as stated in the following:  
The good dress of the PSR impacts very much. Because we wear a little bit casual because we want to 
be relaxed during our practice in the clinic. I often discuss with the PSR, as a bit of fun, about his shirt 
colour and about the knot in the tie he is wearing. If the PSR looks fresh and better than the patients, 
the doctor feels comfortable [GP-2]. 
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Given the contextual situation, the PSR's appearance is important in developing an initial 
trust level; this emerges from the physician's cognitive assessment of the PSR's similar 
professional attitude. This then enables the physician to communicate product(s) and/or 
service(s) related technical needs openly with the PSR. Otherwise, an inappropriate PSR's 
dress code will not allow him or her to develop relationships because of the physician's 
uncertainty and lack of trust in the PSR's future conduct. Although results suggest that 
appearance facilitates the physician's initial trust in the PSR as an initial non-verbal 
communication form, the development of RQ also depends on the other conducts of the 
PSR during interactions with the physician. Therefore, the next section examines the role 
of the PSR's verbal-communication in the development of RQ between the PSR and the 
physician.  
C) PSR'S COMMUNICATION:  
The data category PSR's communication also emerged outside of the initial conceptual 
framework from the responses of both the PSMs and the physicians. All the PSMs noted 
that the PSR's communication was a part of an overall effective information exchange and 
important to developing RQ between the PSR and the physician. In their explanations they 
pointed out again that it is necessary because the PSR interacts with a highly educated 
professional class: 
In other factors PSR's communication is very important. There is no doubt about it that the PSR is 
going to interact with very highly professional persons that are considered from the finest class of our 
society [PSM-1]. 
The above quote from the PSM indicates that physicians occupy an elevated position in 
the social order, where it is believed that physicians are more educated than those below, 
including the patients. Therefore, the mode of the communication by the PSR should be 
one that can help in maintaining this notion of the physician's social status. In their 
explanations the PSMs expressed their view that although it is not the native language, if 
the PSR communicates in English, this will have more of an effect in the development of 
the RQ between them.       
If you use English language words at the right place- this is an important factor in development of 
good relationships. In fact, the community you deal with observes the calibre of the people you interact 
with. And in reality, this not the doctor's own requirement but it is about his or her internal 
satisfaction in that the way PSR communicates in front of the patient should be on the level above that 
of the patient [PSM-2]. 
In Pakistan it is believed that more educated people communicate in the English language. 
Due to a lower education level in general, the majority of the population including the 
patients communicates in the local native languages. Because PSRs normally make their 
sales call to the physician in the patients' presence, in order to sustain or maintain a high 
status perception of the physician, it is advantageous for the PSRs to communicate their 
messages using English. Apart from the internal or psychological level of need 
satisfaction, an appropriate use of communication also fulfils the physician's professional 
needs. This implies that development of relationships depends not only on the quality of 
the exchanged information but also how it was exchanged (e.g. Parsons, 2002) Thus, it is 
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imperative to communicate with the physicians not only in English language but also in 
their own professional medical terminologies. 
I am referring to communication in terms of how successful the PSR is in delivering a message 
effectively. That is, are the words he or she is using appropriate or not? Are the words true medical 
language? Therefore, you have to communicate at the level of the customer (or physician) [PSM-5]. 
The above statement from the PSM is linked with the impression above (i.e. concerning 
PSR's appearance) that a PSR's communication should fulfil the physician's assessment of 
similarity with the PSR as a professional. This is again similar to assertions made by Smith 
(1998b) who found as a result of her research that buyers are more likely to develop 
relationships with sellers when they share similar attitudes, such as professionalism and 
work ethics. Therefore, physicians take more interest in the interaction when the PSR 
exchanges information in professional medical language. Otherwise, the PSR will be 
perceived as a less credible source of information (e.g. Lagace et al., 1991), which leads to 
the physician being unresponsive in the information exchange. And that certainly will 
leads to disinterest in the development of the relationship with the PSR or even no 
relationship. Physicians gave similar response in terms of professional conduct in 
communication with a PSR, stating it is important in order to establish friendly relations 
with physicians, as reflected in the following quote. 
I really dislike the PSRs who just ask for favours with their heads down looking at their prescriptions ... 
I really hate them. I really like those who communicate with me in an honourable and professional 
way [GP-2]. 
The use of the word 'hate' in the above statement signifies that this physician really has 
an aversion to a non-professional attitude by the PSRs in terms of the information 
exchange during the sales call. Such an attitude came to the fore due to the PSR's lack of 
product knowledge. On many occasions, when the PSRs have an opportunity to discuss 
their products' features and benefits with the physician in more detail, they failed to do so 
because of their limited product knowledge (examined in the next section). However, the 
pressure of achieving sales quotas led to the PSRs asking for favours and this leads to the 
physician's uncertainty, as stated in the following quotes.                
You can better communicate when you have good product knowledge. Because then you will have the 
appropriate set of words. And this is very important to achieve physician's trust and satisfaction [PSM-
2]. 
When a PSR has a good grip on product, disease and competition knowledge, he or she will 
communicate with more confidence. Otherwise, in the case of hesitance during communication, this 
will foster the physician's perception that the PSR does not have any knowledge   [PSM-5]. 
As for better professional communication, the PSR needs the appropriate language or 
words, and that is only be possible if the PSR has the necessary product, disease and 
competition knowledge as well. This is recently confirmed by Balaji et al. (2017) that the 
language divergence leads to the reduction in customer's trust in, satisfaction with, and 
commitment to service provider. Therefore, a PSR who communicates more in the 
language that appeals to the physician's professional orientation leads to the physician's 
trust in, satisfaction with, and commitment to the PSR (Clark et al., 2011). This is because 
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the PSR fulfils the physician's technical needs more confidently and without exhibiting 
any hesitations while communicating valuable information.  
Although, there is need to be more professional or formal, however, it is equally 
important to use greetings while communicating with the physician in order to gain the 
physician's trust and satisfaction, and thus RQ, as stated in the following quote. 
The greetings and rapport building are also very important in the development of the physician's 
trust. They provide an impression that the PSR is not always about to make a sales call. And it gives the 
physician a sense of appreciation of the PSR's interest in relationship formation [PSM-1]. 
This is because communication of the greeting words engenders the physician's feelings 
that the PSR not only exhibits a sales orientation but also gives a sense of the PSR's 
customer (or physician) orientation. This leads to the PSR's creating an impression of 
caring or benevolent intentions for the physician; that is important in order to gain the 
physician's trust and satisfaction (e.g. Moorman et al., 1992). Similar responses about the 
PSR's communication variants during the interaction were also given by the physicians, as 
illustrated in the following:   
I will say the PSR communication should not only be focused on product related discussion, but should 
also be bit relaxed. That is, the presentation shouldn't be very tight or rigid but it should also be 
flexible, with some humour in it. I mean to say that it does not sound well if the PSR just talks around 
the product literature or whatever he or she memorized about it [GP-1]. 
The above quote indicates that the physicians knew that the purpose of the PSR's visit is 
to provide information. However, the busy routine of their clinical practices demands a bit 
of pause for relaxation. Therefore, the PSR should be flexible enough to judge and behave 
according to the situation to fulfil the physician's particular need at a particular time. As 
already discussed, in order to develop RQ both the physician's technical and the social 
needs must be fulfilled (e.g. Hennig-Thurau & Klee, 1997). Therefore, if the PSR behaves 
inflexibly by just focusing on communicating product related information, it may cause 
psychological frustration then evident in the physician's behaviour. On the contrary, if the 
PSR adds some greetings to the communication it gives some psychological relief to the 
physician that engenders emotional feelings; that leads to the affective trust in and also 
satisfaction with the PSR, which is also the emotional state of the physician during 
interaction. 
Similar to PSR appearance, communication is also required in order to gain a physician's 
trust and satisfaction, as it also shows the PSR's similarity to the physician. When the PSR 
uses an appropriate mode of language, for instance English and medical language that 
also provides psychological reassurance to the physician that his or her social class is 
recognised. Furthermore, it also gives the impression to physician that the PSR is a 
credible source of information. However, it is also explained by respondents that the PSR 
can only communicate an appropriate use of medical terminologies if he or she has a good 
breadth of product knowledge. Therefore, the next section examines the role of product 
knowledge in the development of PSR-physician RQ. 
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D) PSR'S PRODUCT KNOWLEDGE OR EXPERTISE: 
All the interviewees in this study stated that the PSR's product knowledge was a part of 
overall effective information exchange, and was important to developing RQ between the 
PSR and the physician. The physicians reported that although it was a baseline, they had 
concerns about the lack of product knowledge among a majority of the PSRs in Pakistan. 
The PSR should have complete knowledge of the product, as this is the baseline. But unfortunately, 
here we do not have this. 90% of PSRs act like a hawker who just tells the customer that I am offering 
you a potato and it cost 10RS per KG etc. So, they just knew that they are selling the potatoes but they 
do not know about what nutritional value it has [...]. This is because of the flood in terms of low 
standard companies in Pakistan [...]. Unfortunately, the PSRs from these companies do not arrive with 
training. They only care about their sales, no matter what ways they can achieve it [GP-2]. 
This signifies that most of the PSRs provide minimal information about the product rather 
than offering detailed accounts. This gives the physician the perception that the PSR is not 
a product expert as the salesperson who exhibits relevant knowledge of their product or 
service is considered competent by customers (e.g. Crosby et al., 1990). However, the 
physician linked his impression with the problem of the increasing number of low 
standard national firms registering in Pakistan that not care much about PSRs' training. 
Therefore, they do not have product knowledge and leave themselves asking for favours 
in terms of prescriptions (also examined in above). However, the PSR's product 
knowledge is crucial for physicians as their busy clinical practice schedule leave little time 
for them to consult with other sources of information (Murshid & Mohaidin, 2017). 
Therefore, they consider knowledgeable PSRs as a primary source of information and 
seek knowledge transfer from PSRs to keep them updated, as illustrated in the following:  
Doctors do not have time to keep themselves updated with the product and disease related current 
information. The people from the pharmaceuticals are there to inform them [PSM-4]. 
Similar to the above explanation the physicians also said that they not only sought 
current, updated information as a result of the ongoing research, but also wanted to be 
able to ask about any aspect of the product. For instance, a product's usage, side effects, 
contra-indications, to refresh their knowledge. A PSR's product knowledge is very helpful 
in this regard, as illustrated below: 
They should provide new information. Because there is a flood of new research and companies are 
launching new products. Or, there might be the new indications for their already existing product(s) 
and/or the side effects they found, which mean they withdraw that particular product as a result of 
the research. So, the PSRs are very helpful in providing such valuable information [GP-3]. 
The above quotes from both the PSM and physician suggest a similar assertion to that 
made by Lagace et al. (1991), that the main reason for the physician to meet up with the 
PSR is to make informed prescription decision making. Therefore, high quality 
information is required in order to address any of the concerns regarding the product 
that a physician raises during their interaction with the PSR. This quality information can 
only be delivered when the PSR has knowledge of the product and the related disease or 
ailment for which that product can be prescribed. This is illustrated in the following quote 
from a physician: 
116 
 
Definitely, the PSR's product knowledge is very important and that is why I meet and give my time to 
him or her. The relationship will be built when the PSR is capable of improving my professional 
orientation [...]. Therefore, if the PSR does not have good product knowledge I will keep my 
relationship very limited in terms of chats. Because, if he or she doesn’t help me to treat my  patients 
better, I do not have any benefit in keeping such relationships [GP-1]. 
This physician’s observations suggest that the PSR's product knowledge is linked with the 
physician's professional orientation enhancement. Palmatier et al. (2006) found similar 
results in their study that when customers received increased value from information 
from the salesperson, they invest more efforts to strengthen their relationships with him 
or her. Similarly, physicians see the PSR as an expert who is responsible to help in the 
improvement of their clinical practice technical needs. And, if the PSR successfully 
provides the required information to the physician it will lead to RQ between them. 
Similar assertions were also made by the others in the literature, who found that the 
PSR's. expert knowledge of a product leads to RQ with physicians (e.g. Clark et al., 2011; 
Lagace et al., 1991). This is because valuable information given fulfils the physician's self-
interest in providing quality and secure care for the patient. Therefore, the PSR who does 
not have good product knowledge cannot ensure the self-interest in the physician, which 
consequently leads to a lack of relationship development. This is because such PSR will be 
perceived as an incompetent source of information by physicians. Since salesperson's 
level of products/or services and selling knowledge perceived by a customer create a 
customer's trust and satisfaction (e.g Parsons, 2002; Wong & Sohal, 2002). Similarly, the 
PSR's product knowledge is vital in order to gain physician's trust and satisfaction with 
him or her. As, PSRs who possess a breadth of product knowledge will communicate it 
with more confidence, self respect and ego, as illustrated in the following quote from the 
physician. 
Product knowledge is very important for the development of trust and satisfaction with the PSR. 
Because a knowledgeable PSR will come with an ego and self-respect [GP-2]. 
A physician's impression of the PSR's product knowledge and the way he or she interacts 
means that the knowledgeable PSR tries to convince the physician to give a prescription 
based on the product's benefits to the patients. In this way the presentation by the PSR 
not only meets the physician's own technical need requirements but also transfers to the 
patient's benefit. Therefore, this sort of knowledge, transferred to the physicians gives 
them a confidence in the PSR that thus helps him or her to gain the physician's initial 
trust, not only in the product but also in the PSR. This helps in removing the physician's 
uncertainty regarding the benefits of the product for the patient.  
However, the initial trust then shifts on to intense levels after a comparative analysis of 
the information given by the PSR and the patient's response. That is when the physician 
finds satisfactory results in terms of the improvement in a patient's condition- the trust in 
the PSR moves onto stronger levels; or it may distort if the physician does not observe 
any improvement in the patient (e.g. Lagace et al., 1991). This tendency was also reported 
by the PSM: 
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If the physician finds the results as per the given information from the PSR, he or she will develop more 
confidence in the PSR, which will also lead to the physician's satisfaction with the PSR. Consequently, 
the physician will develop a relationship with such a PSR and will extend the benefits to his or her 
patients. This leads to a higher prescription share for the PSR [PSM-1]. 
Thus, positive feedback from patients not only helps in the development of the physician's 
cognitive trust in the PSR, it also leads to satisfaction and the physician's calculative 
commitment to the PSR in terms of the higher prescription share. This is due to the 
fulfilment of the physician's self-interest (i.e. in terms of the technical or professional 
needs) in assuring the patient's wellbeing. Since customer trust in the salesperson is 
developed on the basis of customer's evaluation of promised versus delivered 
performances (Wray et al., 1994).  
Thus, The PSRs who fulfil both the physician's self-interest and the patients' wellbeing 
will achieve his or her trust, satisfaction and commitment, which is necessary in order to 
develop RQ. The next section examines the role of the PSR's flexible responses to varied 
situations in the development of RQ between the PSR and the physician. 
E) PSR'S FLEXIBLE RESPONSES TO VARIED SITUATIONS: 
The data category PSR's flexible responses to varied situations emerged outside of the 
initial conceptual framework from the responses of both the PSMs and the physicians. All 
the interviewees in this study reported that the PSRs needed to be flexible in their 
responses during interactions with physicians. This was seen as crucial to developing RQ 
between the PSR and the physician. This is because, physicians normally have a busy 
schedule in dealing with patients and PSRs. There is no appointment system for the PSR 
to see the physician as a rule and they normally see the PSRs while having a short break 
from patients. This sometimes leaves very little time for the physician to deal with the 
PSRs. Therefore, the PSR's flexibility in handling such a brief interactions with the 
physician is very important. 
Situation handling is very important - if the physician is busy and allows the PSR to detail the product 
within 5 minutes.... and the PSR is careless about this in his detailing then their relationship might 
never develop. The physician will be annoyed with such behaviour by the PSR. Conversely, the PSR who 
acts according to the situation ... will achieve benefits in terms of relationship development. It will give 
the physician a feeling that the PSR is sensible; otherwise, he or she will feel there is no benefit in 
developing the relationships with such non-sense PSR [PSM-5]. 
The significance of this is that the PSR should act according to the physician's situation in 
terms of his product detailing during the sales call and also in terms of overall visit 
frequency, allocated days and timings. Non-compliance with a physician’s wishes can 
cause anger or frustration that thus creates a barrier in the development of RQ, as 
illustrated in the following quote by one physician (please also see appendix 8, Q-11): 
Well, some PSRs start irrelevant kinds of conversations. I don’t know what they have in their minds but 
they start discussing unrelated things, e.g. they ask about my clothing and then come back to 
discussing the product. Often my schedule is very tight... I have to see huge numbers of patients and 
also take sales calls of a large number of PSRs. So these irrelevant kinds of discussion mentally irritate 
me, although I listen in courtesy. I even do not like over detailing of a product by PSRs [GP-3]. 
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This suggests that the PSR's flexible behaviour is important for the development of RQ in 
terms of handling the situation while interacting with the physician. Physicians relate this 
to their business of dealing with patients, which can be complicated if PSRs visit at 
awkward times or indulge in irrelevant kinds of discussion during their sales call. The 
most important entity in a physician’s chamber is the patient and physicians keep more 
favourable attitude for patients (e.g. Khatri et al., 2017; Lundin, 2000). This is because 
they want to see a maximum number of the patients to address their health concerns. 
Therefore, if a PSR shows his cooperation with the physician's priority of dealing with the 
maximum number of the patients without any extra pressure, then it leads to the 
physician's trust in and satisfaction with the PSR. Similarly Crosby et al. (1990) identified 
that salesperson's relational selling behaviour such as cooperation along with his or her 
personal characteristics are important in influencing customer's trust and satisfaction. 
Conversely, a physician can develop the impression that the PSRs is more sales oriented 
rather than customer oriented. That is to say, the PSR is protecting his or her own self-
interest in either job requirements by undertaking sales calls or trying to develop 
relationships by praising physician’s clothing rather than realizing that the physician’s 
self-interest is to deal with patients. This thus also leads to the physician’s frustration, 
which deteriorates the physician’s trust and satisfaction development and hence RQ. 
However, this cooperation can also work conversely; for example, when the physician 
wants to spend time with the PSR, as illustrated in the following quote from a PSM, which 
is illustrative (please see appendix 8, Q-12): 
When the physician has only a little time the PSR should show awareness by only taking a little time. 
Now, if the physician has a little time, you honour him or her by listening and sitting. So both of these 
factors are important, in order to show your sincerity for the development of physician's trust [PSM-2]. 
This signifies that the PSR should judge the situation and act accordingly while 
interacting with the physician. Khatri et al. (2017) in their study found that for employees 
work in healthcare context, flexibility to adapt to changing situations has chief 
importance. This impression is also similar to the literature on adaptive selling, which 
suggests that the salesperson should alter their sales calls during interaction with 
customers and behave according to the situation by perceiving its nature (e.g. Spiro & 
Weitz, 1990). Therefore, the PSR should be careful in fulfilling the physician’s specific 
needs at the specific time, as explained above. This kind of PSR's flexible responses in 
varied situations reassures the physician about the PSR's sincerity, care, and the 
benevolent intentions towards the physician. It shows the PSR not only cares about the 
physician's social needs by spending time, but is also focused on the physician’s 
professional self-interest in dealing with the maximum number of patients by avoiding 
unnecessary time communicating the product’s detail if not required. When a physician 
gains this impression of the PSR it leads to his or her affective trust in and satisfaction 
with the PSR. The literature on trust also suggests that affective trust is based on 
emotions that arise from customer's perceived personal experience with the 
salesperson's care and obligations (e.g. Johnson & Grayson, 2005; McAllister, 1995). 
Similar explanations were also provided by physicians: 
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Definitely, if the PSR acts according to the situation it will lead to my trust in and satisfaction with the 
PSR. And I will feel that the PSR is caring for me [GP-3]. 
This is a quite clear response by a physician that the flexible behaviour adapted by a PSR 
to handle varied situations shows his or her care in dealing with physician. Creating such 
an impression in the physician fosters both affective trust and satisfaction with the PSR, 
which leads to RQ due to the activation of emotional mechanisms favourable to the PSR. 
Although the PSR’s flexible responses to varied situations is necessary, the development 
of RQ is also dependent on other aspects of the PSR's conduct during their interactions 
with the physician. Therefore, the next section examines the role of the PSR's ethical 
selling behaviour in the development of RQ between PSRs and physicians. 
F) PSR'S ETHICAL SELLING BEHAVIOUR: 
All the interviewees in this study accepted that the PSR's ethical selling behaviour was a 
part of the overall effective information exchange. Ethical selling was seen as crucial to 
developing RQ between the PSR and the physician. PSM-1 provided his account of the 
importance of a PSR’s ethical selling behaviour towards the physician and also its 
contribution to the development of trust: 
The PSR should not only openly describe the product’s benefits but also its demerits or side effects. [...]. 
Therefore, if the PSR reveals any drug interaction or side effect on his own to the physician, it helps to 
gain the physician's trust because he or she will then feel good about the PSR's neutral intentions. And 
conversely, if the physician finds about this from any other source then his trust in the PSR will be 
altered. This is because the physician is concerned about the patients as he or she is earning from the 
patients and if not sincere with them, then definitely will suffer in terms of loss of patients as clients 
[PSM-1]. 
The significance of the above assertion is that the PSR should be honest when 
communicating product benefits in conjunction with its side effects. If the PSR avoids 
mentioning any of the product's side effects in order to maximize prescription share, it 
can lead to serious consequences for the patient. It has been already examined above that 
the patient is the chief priority for the physician, both as a professional and also as a 
human. The latter deals with the physician's emotional sentiments to alleviate the 
patient's misery. And the former is associated with the physician's role as a healthcare 
provider, as well as a seller of professional services to the patient as a client. So, the 
patient's health outcomes are crucial for the physician in all these respects. Not only on a 
humanitarian and professional basis but also to ensure his self-interest in terms of 
economic gains. In the context of Pakistan, patients not only pay for health advice but also 
provide free word-of-mouth recommendation to their friends and family, when they feel 
satisfied with a physician. Therefore, if the PSR intentionally hides any of the product's 
side effects that the physician finds later, this can cause conflict. The physician will likely 
develop a perception that the PSR is dishonest and lose his trust in the PSR. Furthermore, 
the physician will perceive that the PSR is protecting his or her own self-interest to 
maximize prescription share rather than to protecting the physician's self-interest in 
patient's wellbeing and his own earnings. Conversely, if the PSR tells the truth regarding 
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the product, he or she will gain the physician's trust. Sanchez-Franco and Rondan-
Cataluna (2010) in their study also found that salespersons, who valued costumer's 
interests and welfare more as compared to their own are highly likely to gain a 
customer's trust. PSM-3 offered similar views on the PSRs’ ethical selling behaviour by 
giving the example when a physician is not prescribing the product according to the given 
guidelines by the PSR as illustrated in the following quote: 
For example, if the physician is prescribing a PSR’s product where it is contra-indicated or in the 
wrong age group. No doubt in guiding him or her about this, the PSR will lose prescription share [...]; 
however, when he or she lets the physician know about this and guides him or her about the right 
usage then such acts give the physician a feeling about the PSR’s integrity in caring for the patients’ 
wellbeing. And this helps the PSR in the formation of a relationship with the physician [PSM-3].  
It is the PSR’s responsibility to guide the physician about the proper use of the product, in 
particular disease indication or the delivery of the right dosage to achieve maximum health 
benefits for patients. Since the physician’s ultimate goal is to provide the best healthcare 
advice to the patients, therefore a PSR’s ethical behaviour shows his or her integrity in 
achieving the physician’s goal. And such cooperation or customer-orientation and 
willingness to accept prescription loss then provokes the physician’s positive sentiment for 
the PSR’s care about the patient’s wellbeing. Thus, the physician develops affective trust in 
the PSR. This is because the PSR who exhibits more customer-orientation rather than sales-
orientation will likely to gain customer's trust (e.g. Bejou et al., 1998; Dorsch et al., 1998).  
Similar to the above explanations from the PSMs, the physicians also confirmed that the 
PSR's ethical sales behaviour has a crucial role in the physicians’ prescription decision 
making: 
I myself request the PSRs to tell me about any side effects. That is, shall I prescribe their product in 
pregnancy or to lactating mothers? That is because there might be adverse reactions of a product on 
many occasions, therefore the physician should be ready to handle any reaction that occurs [GP-3]. 
This signifies the importance of PSR's ethical selling behaviour for the physician in order to 
ensure his self-interest in the patient's healthcare and wellbeing. As a result, the physician 
will avoid prescribing the product to a particular patient or be ready for any adverse drug 
reaction if the drug needs to be administered. However, the above statement does not 
provide any idea of the physician's self-interest in terms of economic gains through 
satisfying their patients by achieving their safe recovery from a disease or ailment. It is 
likely that the patient will be highly satisfied, if the physician cures the patient early and 
safely as patients’ trust a physician who gives their patients’ welfare the highest priority 
(Ehsan & Ashill, 2014). Therefore, there is less chance of the patient switching to another 
physician and both patient's retention and positive word-of-mouth would be ensured. As a 
result, the physician will automatically gain economic rewards. Consequently, it leads to a 
quality relationships between the PSR and the physician. The physician develops his trust 
when the PSR openly communicates the demerits of the product along with its benefits, as 
illustrated in the following: 
If the PSR properly tells me his or her product's merits and demerits, then I can trust in such a PSR [GP-1].  
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On the contrary, in the case of any unwanted adverse event, a physician will discover a 
drug’s demerits anyway, which leads to distrust and ultimately no relationship can be 
developed between the physician and the PSR,  as explained by another physician:           
Physicians themselves find the bad points of product. And if a PSR hides them from me, I lose my trust and 
I put the break on everything at once [GP-2]. 
Besides the above explanation, the PSMs also mentioned that PSRs should avoid making 
negative comments about competitors and their products as an ethical selling behaviour, as 
illustrated in the following quote. 
The ethics that the PSR should perform are.....they should be honest and not to tell a lie.... that is they 
should not exaggerate stories about their product and avoid discussing things about competitors that do 
not exist. Because, if the PSR claims anything about a competitor and physician afterward finds this is not 
true, ....this will yield very damaging consequences for the PSR [PSM-5]. 
Therefore, PSRs should not exaggerate the benefits of their product and avoid criticising 
competitor's products in order to maximize prescription share. Making false claims against 
the competitors' products or exaggerating his or her own product will lead to the 
physician's distrust when he or she finds the opposite to whatever was claimed by the PSR. 
Similar explanations were also provided by the physicians:  
The means to get prescriptions are to discuss the quality of the product rather than the PSR discussing 
other products. So, the PSR should discuss the quality and efficacy of his or her own product and this is 
the way [GP-3].  
The above quote accords with the explanation provided by PSM-5 above, where the 
physician perhaps is expressing his feelings about the prescription decision making role he 
holds. That is to say the physician is a better judge in deciding the correct product for the 
patient. And when the PSR highlights the negative points of a competitor, it almost gives the 
physician an impression that the PSR is forcing him to choose his or her product. 
Consequently, this again leads to the physician’s impression of PSR's sales orientation as 
being beyond the ethics of drug promotion. And according to the PSMs, the physician 
perceives such an attitude negatively rather than positively and dislikes the PSR.  Thus, this 
creates a barrier in the development of trust, satisfaction and hence a quality relationship 
between the physician and the PSR. 
Last but not the least, in the context of Pakistan another aspect of ethical selling is also 
crucial for the development of RQ. It is important that the PSR does not promise any 
personalized or generalized services (examined in the next section) that the firm cannot 
provide. Not only the physicians, but all the PSMs, reported that the PSR should take into 
account the firm's code of ethics regarding services (i.e. gifts, medical equipment and 
others) that the firm can provide. Moreover, if the PSR commits to something on the 
physician's behalf that is not listed in the firm's codes of ethics, and cannot fulfil his or her 
commitment, this can damage RQ: 
The PSR should know about his or her boundaries and code of ethics and then must stay within those. 
If the PSR makes a commitment to something which does not fall within the code of ethics then how he 
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or she will fulfil that commitment? And when the PSR does not fulfil that, the physician's trust and 
satisfaction will drop [PSM-3].  
The notion here is that the PSR should fulfil the promises he or she makes to the physician 
regarding services. The reason PSMs view this aspect as being important may be that in 
Pakistan there is a trend to offer personalized services (i.e. academic scholarships, clinical 
equipment, family dinners and so on) and sometimes physicians themselves demand 
services that are not general. The PSRs sometimes make promises to deliver these services 
due to sales pressure and to maintain a relationship with the physician without taking into 
account the firm's policy. Consequently, the PSR would not be able to fulfil this promise or 
commitment, leading to the physician's distrust, dissatisfaction and ultimately unwanted 
termination of the relationship with the PSR. This is because a physician will gauge such 
incidents as unethical behaviour and develop the impression that the PSR is not a 
trustworthy person. This gives the impression to the physician that the PSR has made a false 
commitment in order to boost prescription share. A similar assertion was made by Wray et 
al. (1994) that the salesperson's unethical behaviour and short-term goals orientation could 
subsequently endanger the possibility of developing long-term relationships with 
customers. Therefore, if the physician demands something that is not included in the firm's 
policy, PSR should make this clear in order to secure the physician's trust, satisfaction and 
valuable relationship. The next section examines the role of the PSR's relationship 
investments in the development of the RQ between the PSR and the physician. 
G) PSR'S RELATIONSHIP INVESTMENTS: 
The data category PSR's relationship investments refers to the different services offered 
by the PSRs to physicians. All the PSMs stated that these investments were very important 
in order to develop and maintain high-quality relationships with the physicians:  
Once the relationships are developed we have to renew them so that the relationships can last longer-
term. To say 'renew', we have to do the little supporting promotional activities such as Continuing 
Medical Education events (CMEs) or something like that to bind the physician with us [...]. Therefore, 
you have to think of any innovative activity that helps you to have proper time with the physician [PSM-
5]. 
This signifies the vital role of relationship investment or services in the development and 
maintenance of an enduring relationship, which is similar to the literature on RQ (e.g. 
Keating et al., 2003; Smith, 1998b) which suggests that these investments exhibit the 
sellers' commitment to their buyers. The PSM here again pointed out the competitive 
environment of Pakistani pharmaceuticals, where the physician cannot afford to provide 
much time to the PSR during routine sales calls, but where the PSR is responsible for the 
management of their relationships with physicians (e.g. Scharitzer & Kollarits, 2000). 
Therefore, services can be used as an early effort to develop a quality relationship and 
later on in its maintenance. Some of these services are more helpful in the development of 
strong relationship bonds (or commitment) between the physician and the PSR than 
others.  
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Therefore, according to the respondents, the data category relationship investment can be 
divided further in two sub-categories, i.e. generalized services and personalized services. 
Generalized services were identified as services like product samples, gifts or give 
away(s) and CMEs etc. However the sub-category personalized services was identified as 
non-routine services. These are the services demanded by the physicians or offered by the 
PSR to a specific physician in order to maintain their relationship quality. The following 
sections examine the role of these different sorts of service in the development of RQ 
between the physician and the PSR. 
G1 GENERALIZED SERVICES: 
All the PSMs reported that although generalized services are an important and integral 
part of a drug promotion strategy, they are not sufficient to develop and maintain RQ 
between the physician and the PSR in the context of Pakistan. The following illustrates 
PSMs' views on CMEs: 
In the current scenario services like CMEs do not have much role to play. Before, physicians liked to 
come on CMEs to learn but nowadays they have become very busy. Secondly, there is a saturation of 
these services as almost every firm is offering them. Although these are integral part of our 
promotional activities I don't think these services play any role in the development of quality 
relationships. However, a new topic may add some value to it [PSM-5].  
The above quote from the PSM provides the impression that services like CMEs are 
important; however, physicians take such services for granted as every second firm 
provides similar services. The majority of firms are effectively promoting the same 
products with different brand names under a particular disease area; therefore, these 
CMEs provide symmetric information, thus leaving less impact on the physician. 
Therefore, the physicians consider these as the fundamental obligations that the 
pharmaceutical firms and their PSRs have to provide. Furthermore, physicians' busy 
schedules do not allow them to attend such CMEs very frequently and this is why they 
seek much more product related information from the PSRs during their in-chamber 
interaction. Another reason physicians do not value CMEs is that they are normally 
carried out with a group of physicians, where a senior physician gives a lecture on the 
particular disease area and methods of treatment. Although it is one of the sources of 
information exchange that fulfils the physician's technical needs, because it is done in a 
group physicians do not take it as a service personalized to him or her. This is illustrated 
in the following: 
If you invite a physician for a CME in a group he or she will come, because of your relationship. 
However, this will not produce the feelings in the physician that you are doing this only for him or her 
[PSM-1].  
Similar to the above explanation, all the PSMs explained that physicians consider product 
samples as a service for the patients. Moreover, almost all the PSRs provide their product 
samples to the physician, so this also does not have much effect when compared to gifts. 
Gifts with the product's name on it are also very commonly given to physicians. Although 
this sort of gifting is a common promotional strategy, according to the PSMs physicians 
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consider gifts as a personal obligation for them from the PSR. They therefore contribute 
much more in the development of quality relationships, as illustrated in the following:  
Samples have an effect, but not much in the development of relationships. However, physicians 
somehow take and feel gifting as a personalized investment in them that leads to relationships [PSM-
1].  
However, according to PSMs the delivery of product samples is very important early on in 
order to develop physician's trust, satisfaction and commitment. A similar response was 
also provided by physicians:   
Services and samples definitely help, but only if there is positive feedback from the patient. Therefore, 
if feedback on samples is good enough then it helps in the development of trust and satisfaction both in 
the product and the PSR [GP-1].  
The meanings of the physician in the above illustration reflects the view that services 
positively affect the development of relationships. Such services are required to mitigate 
the customers' uncertainty (e.g. Smith, 1998b). For instance, product samples play an 
important role in the trial phase of the product for the development of trust and 
satisfaction. However, once the physician found satisfactory results during the product's 
trial, their effects did not play much role unless the physician demanded any personally or 
for the patients’ use. The next subsection examines the role of personalized services in the 
development of PSR-physician RQ.   
G2 PERSONALIZED SERVICES: 
All the PSMs identified personalized services as playing an important role in the 
development and maintenance of RQ between the physician and the PSR. This is 
illustrated in the following, which represents many similar quotes from PSMs: 
If we rank the services, personalized services are at the top. This is because a physician will weigh it as 
personal and this will create the perception that the PSR has done this only for him or her [PSM-1]. 
The above quote gives the impression that personalized services are valued more by the 
physician because such services give him or her a feeling that the PSR is doing something 
out of the ordinary. Likewise, sometimes a physician also demands some personalized 
service from the PSR. And if the PSR makes the commitment and then provides the 
particular service, this will lead to physician's trust, satisfaction and commitment with the 
PSR, as illustrated below:      
Yes, any personal service or clinical support plays important role. For instance, let’s say a physician 
needs some blood pressure measuring equipment and demands it from the PSR. If the PSR makes the 
commitment and provides it, then definitely the PSR will gain both the physician's trust and 
satisfaction and the physician will relate this with more prescription share. This is because the PSR 
has fulfilled the physician's demand, therefore, the physician starts to think that it is his or her moral 
duty to secure the PSR's commercial objectives of prescriptions as well [PSM-4].  
Therefore, by fulfilling the physician's personalized need in the shape of clinical 
equipment, the PSR not only gains the physician's affective trust and satisfaction, but also 
affective commitment in terms of more prescription share. PSM-4 expressed why this is 
by identifying 'physician's moral duty'; this reflects that the PSR's conduct in fulfilling the 
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physician's need engenders emotional sentiments or mechanisms that lead to the 
physician's affective trust, satisfaction and affective commitment to the PSR. However, 
another PSM viewed this as the physician's cognitive evaluation of the benefits received 
from the PSR: 
With personalized services physician trusts in and feels satisfied with the PSR. This is because both the 
PSR and the physician are taking care of their benefits. The PSR fulfils the physician's benefits and as a 
result, the physician gives benefits to the PSR. He or she therefore reciprocates the benefits to the PSR    
[PSM-2].  
This quote links personalized services with the impression that the physician develops, 
which in turn enhances trust and satisfaction after cognitive assessment of benefits 
received. The physician reciprocates these benefits back to the PSR in terms of 
prescriptions, showing the physician's calculative commitment. The PSM's feeling that 
these services ensure a physician's self-interest reflect its status as a mechanism of 
relationship continuation. This further engender the reciprocity mechanism therefore, 
physician shows his or her efforts in terms of an increase in prescription share to 
maintain the relationships with the PSR. Palmatier et al. (2006) also found that these 
investments positively influence trust, satisfaction and commitment, which engender 
sellers' expectations of reciprocation from buyers to strengthen the relationship between 
them. Moreover, physicians' views on the role of personalized services are illustrated in 
the following: 
It depends on how someone perceives the value of personalized services, family dinners etc. If these 
services are valuable for someone then it definitely helps the PSR, but they are useless if somebody 
does not care. However, if there is a service that can be used for the patients' healthcare, this will 
definitely help PSR to develop good relationships. Because he or she provides at least some service(s). 
However, it will help initially but later on depends on its error free delivery by the PSR. And if the PSR 
continuously provides the service without error it will leads to longer-term quality relationships [GP-
1].  
In the above quote the physician segregates personalized services into two different 
aspects. The first of these personalized services (i.e. family dinners and trips, physician's 
personal event celebrations) deals with his own-self and the second deals with the 
patients' healthcare (e.g. free camping for patients' awareness of disease, clinical support 
etc). The physician’s view of the effects of the latter help the PSR in the development of 
quality relationships; however, the former varies from physician to physician. Therefore, 
he did not deny the effects of such personalized services to a physician’s own-self in the 
development of RQ. However, he did not discuss this in detail in comparison to the 
personalized services offered for patients’ healthcare. A similar kind of reserved 
behaviour from the other physicians was also observed during the interviews. The reason 
might be that a physician feels that to receive exclusive personalized services is 
professionally unethical.  
Nevertheless, in the later part of the above quote the physician confirmed that 
personalized services that benefit patients positively affect the development of RQ 
between PSR and the physician. Early on it helps because it shows the PSR's commitment 
and efforts, as the physician expressed in his impression "at least he or she provides some 
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service(s)". And his expression gives the impression that such services trigger underlying 
emotional sentiments or mechanisms that lead to the physician's affective trust, 
satisfaction, which further engender physician's commitment. This is similar to the 
assertion made by Hennig-Thurau and Klee (1997, p. 752) that the customer's 
commitment is essentially a combination of his or her affective and cognitive evaluation 
of benefits gained by the relationship with a seller. This is because customers' positive 
experiences of relationship benefits and the effect of gratitude psychologically trigger 
them to reciprocate (Lee et al., 2014). Consequently a customer reciprocates in order to 
maintain the relationship with the seller (e.g. Palmatier et al., 2006) through the 
activation of a reciprocity mechanism.  
However, the physician also expressed the effects only last over the long-term if the PSR 
continuously delivers the service(s) without error. This gives the idea of his assessment of 
the benefits received from the service(s) that links with the impression of development of 
physician's cognitive trust and satisfaction with the PSR when he or she ensure 
physician's self-interests that leads to the physician's commitment. 
These explanations from the respondents suggest that all generalized services play a role 
in the development of RQ, as they show the PSR's commitment or efforts to the 
development and the maintenance of the relationships with the physician. If the PSR 
repeatedly offers such services it helps to gain physician's cognitive trust and satisfaction. 
Moreover, commitment is shown through the effect of such trust and satisfaction. 
However according to the respondents, personalized services contribute much more to 
the development of quality relationships in the context of Pakistan, because personalized 
services affect the physician's affective and cognitive trust, satisfaction and commitment 
with PSR through the activation of emotional and self-interest mechanisms respectively.  
4.6. Outcomes of Part B: in terms of RQ its Determinants and associated Mechanisms:  
The above two sections have examined the respondents' perceptions and understanding 
of RQ, the determinants required to develop a physician's trust satisfaction, commitment 
and hence RQ with PSR. The explanations confirmed that development of trust, 
satisfaction and commitment depends upon the activation of many mechanisms at one 
time, which are linked with the RQ determinants as shown below in table 4.3. 
Table: 4.3: Mechanisms associated to the RQ determinants, leading to RQ 
Determinants Mechanisms Outcomes 
RQ determinants ensure physician's 
professional or technical social as 
well as economic needs. 
Cognitive: Self-interest (i.e. Patient's 
wellbeing and retention of practice 
viability) 
RQ [trust (cognitive & affective) , 
satisfaction &  
Commitment (calculative & affective) 
Cognitive: Self-interest plus affective or 
emotional mechanisms lead to 
reciprocity 
Affective or Emotional (Emerged due 
to the PSR's efforts in achieving 
physician's self-interest and fulfilling 
social needs)   
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Table 4.3 suggests that the combination of the identified determinants fulfil the physician's 
professional or technical and economic needs that he or she assesses cognitively. Repeated 
episodes of such fulfilment of self-interest from PSR leads to physician's cognitive trust, 
satisfaction and calculative commitment. Similarly, the physician develops emotional 
mechanisms that were linked with the physician's sentiments, which emerged 
psychologically through the PSR's efforts to ensure physician's self-interests and fit their 
moral compass. The activation of these emotional mechanisms leads to the development of 
affective trust, commitment and satisfaction. Smith (2011, p. 79) also asserts that for any 
trust relationship, both self-interest and emotional mechanisms are simultaneously 
coactive and indeed, the simultaneous cooperation of these mechanisms is often 
necessary". This is because according to the findings trust also fosters the satisfaction, 
which is a customer's emotional state derived through his or her cognitive assessment of 
expected product or service performance and actual consumption experience (e.g. 
Westbrook & Oliver, 1991).  Furthermore, both trust and satisfaction foster the customer's 
commitment (Caceres & Paparoidamis, 2007; Hennig-Thurau et al., 2001) i.e. the affective 
and calculative commitment. As these high-order constructs of RQ are distinct in nature 
but interrelated with each other (e.g. Clark et al., 2011; Mullins et al., 2014; Smith, 1998b), 
both cognitive and emotional mechanisms linked to trust, satisfaction and commitment to 
engender a physician's mechanism of reciprocity, which leads to further positive RQ 
outcomes for the PSR examined in the following section. 
4.5 PART C: INTERVIEWEES' PERCEPTION OF RQ EXPECTED OUTCOMES: 
The following section examines the views of the pharmaceutical sales managers (PSMs) 
and general physicians (GPs) on the outcomes that the PSR is expected to receive from the 
physician after the establishment of RQ. These are divided into two further subthemes, 
which are: subjective or behavioural outcomes; and objective or actual outcomes.  
However, product price has been identified as a barrier that can affect the objective 
outcomes of RQ therefore, interviewees were asked what would be the outcomes when the 
price of the product that the PSR promotes is high to identify the expected outcomes and 
their underlying mechanism. All the themes, subthemes, and their identified categories are 
outlined below in figure 4.3.    
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4.5.1 THE SUBJECTIVE OUTCOMES OF RQ: 
All the respondents reported that the development of RQ (i.e. trust, satisfaction and 
commitment) and their underlying mechanisms further manifest themselves in some 
behavioural changes within the physician. Therefore, similar to the previous research, this 
study considers these behavioural changes as subjective outcomes that a physician exhibits 
positively through his or her actions during the interaction with the PSR. These are shown 
above in figure 4.3. where the sub-theme subjective or behavioural outcomes is connected to 
the theme RQ outcomes and has two further categories, which are the physician's 
recognition and willingness to allocate more time and priority to interact with the PSR. The 
following subsections will examine how RQ between the PSR and the physician contributes 
to providing these subjective RQ outcomes for the PSR.  
A) PHYSICIANS' RECOGNITION: 
According to all the PSMs, one of the subjective RQ outcomes was that the physician 
recognizes the PSR. That is to say, the physician welcomes the PSR by name when he or she 
enters the physician's chamber. This is illustrated in the following quote, which is similar to 
many others: 
When the physician calls the PSR by name this shows the PSR has a strong relationships with the 
physician. This is because there is huge competition and on average about fifty PSRs visit the physician on 
a daily basis and therefore the physician cannot remember all of them by name. So, if the PSR is called by 
name this means the PSR has a strong relationships with the physician [PSM-1].  
The PSMs regarded this recognition very important given the amount of competition a PSR 
faces. It is very difficult for the physician to remember every PSR’s name and also their 
product(s). Therefore, if the physician recognizes the PSR, it suggests familiarity and when 
the PSR enters in the physician's chamber, not only his or her brand but also firm's name 
will come to the physician's mind, as illustrated in the following quote.  
The PSR's personality and the brand he or she is promoting will come top of the physician's mind as a 
result of a strong relationship. This is because the physician trusts in the PSR and also in the product, 
because he is convinced of the solution the PSR has communicated for physician's patients [PSM-3]. 
The above quote suggests that the physician evaluates the information a PSR communicates 
regarding a brand and the results he or she finds in patients. And upon gaining his or her 
satisfaction and trust, the PSR receives special treatment, as illustrated below: 
Whenever I visit the physician, he or she recognizes me because of my previous history as a PSR and RQ. 
Because of this recognition, physician will give me care and offer me tea or some refreshment and will say 
to me: what can I do for you? And such an impression shows full sincerity to me [PSM-2]. 
As examined previously, the physician expects error free delivery of product(s) or services 
to ensure his or her self-interest and related economic benefits, as well as patients' 
wellbeing. This quote signifies that the physician recognizes the PSR after the achievement 
of trust and satisfaction through his previous interaction history. The physician evaluates 
the PSR's efforts in helping the physician meet these goals. And if the PSR and the product 
meet the physician's expectation, both cognitive and affective mechanisms related to trust, 
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satisfaction and commitment are engendered for the PSR. As a result, physician gives special 
treatment to acknowledge the PSR's efforts and also to show his or her sincerity to the PSR. 
Furthermore, to preserve the relationship and to show commitment, the physician asks how 
he or she can help to achieve the PSR's goals. This is because a customer's recognition (or 
gratitude) of a seller's efforts foster positive reciprocal behaviour (Lee et al., 2014). 
Consequently, such physician's behaviour helps to achieve the PSR's objective to increase 
share or sales of prescriptions.   
B) PHYSICIAN'S PRIORITY AND TIME: 
All the PSMs reported that the PSR who gains more of the physician's time and priority over 
other PSRs has achieved an important RQ outcome. Their explanations were based on an 
argument similar to the one presented in the last section about the physician's need to deal 
with large number of PSRs. Therefore, a physician cannot afford to give much time to each 
PSR for a detailed sales call. However, a PSR who has RQ with the physician enjoys more 
time and priority to discuss product(s) or service(s) in detail. This is illustrated in the 
following quotes, which are different in their emphasis but similar in meaning. 
If physician asks the PSR to wait and then takes sales pitches from the rest of the PSRs to free himself, and 
then discusses with the PSR in detail about any study related to disease or about any services he needs, 
this means the PSR has a strong relationships with the physician [PSM-4]. 
If the PSR does not have RQ, physician will not give much time to him or her. This is because nowadays 
many physicians have fixed the days and time to see PSRs. The PSR only can see the physician once in a 
month and a second visit is not allowed [...]. This is only possible when he or she has quality relationships, 
otherwise physician will not see the PSR. As the physician has many options [PSM-1]. 
In the opinion of PSM-4 it is essential that PSR gets appropriate time and priority from 
physician to discuss the product(s) or service(s) properly. Likewise PSM-1 viewed this RQ 
outcome as being able to see physicians more frequently than others who do not hold RQ. 
This finding is similar to the literature on RQ, where different scholars state that RQ as an 
outcome helps salesperson to attain customer's intentions of future interactions (e.g. Boles 
et al., 2000; Crosby et al., 1990). Likewise the quotes above offer a detailed account of the 
importance of RQ in getting a physician's time and priority as an outcome in the context of 
Pakistan. The quotes provide the idea that the physician has many options to get the 
required product(s) or services(s) as a result of market competition. However, time and 
priority is only given to a PSR who has RQ with the physician. The increased sales call time is 
much needed in order to emphasise the product's or service's benefits for the physician's 
patients. RQ with a physician also enables the PSR to gain priority time to discuss and 
reinforce the physician in extending the product or services to patients. Frequent meetings 
and additional time also create the opportunities for socialization (e.g. Doney & Cannon, 
1997), such as sharing personal information with each other, as illustrated in the following 
quote. 
When the PSR has a good relationship, while seeing patients the physician interacts with the PSR in 
discussions about PSR's future plans or shares his own personal information. The physician gives the PSR 
preference over others and gives his personal time to the PSR [...]. So this all represents the signs of 
quality relationships [PSM-5]. 
131 
 
PSM-5 viewed this as an opportunity where the PSR can fulfil the physician's social needs of 
spending some time out of routine. This helps the PSR not only keep in touch with the 
physician but also in taking physician's commitment in the form of prescriptions, as 
illustrated in the following:  
If the physician is listening to the PSR, this means he has developed a soft corner for the PSR. Now the PSR 
can tell what his or her needs are that the physician has to fulfil [PSM-2]. 
The quote above from the PSM gives the impression that the physician shows his or her 
willingness to listen the PSR after gaining satisfaction with the PSR's performance. And 
repeated episodes of this cognitive evaluation then trigger the physician’s emotional 
connection to the PSR. This leads to a change in physician's behaviour and motivates him or 
her to provide priority the PSR in preference to other PSRs. 
Similar to the above explanations from PSMs, all the physicians confirmed that PSRs got 
more priority and time as an outcome of RQ, with two physicians illustrating this in the 
following:    
When there are good relationships, the PSR presents the right information. He or she does not show 
attitude and gives the physician due respect and honour. It helps to produce more understanding and 
reduces the gap between them; therefore, the physician prefers the trials of that PSR. And if the physician 
gets a positive response to the product trial then he starts prescribing it [GP-2]. 
When PSRs do all the factors that I have discussed appropriately then he or she gets preference and 
prescription share. If you just imagine, in normal routine life we prefer our relationships too [GP-3]. 
Both the quotes above from physicians give the impression that they prefer PSRs who fulfil 
all the decisive factors (i.e. determinants) according to the physician's expectations and 
developed RQ. This clearly indicates that the physician cognitively evaluates all the 
parameters and upon reaching satisfaction and trust, the physician exhibits such behaviour; 
for instance, priority in terms of frequent interaction and more time. This is helpful for the 
physician in order to ensure his self-interest in either professional (i.e. technical) or social 
needs. These self-interest mechanisms are not exclusively responsible for changes in a 
physician's behaviour towards a PSR. Emotional mechanisms are also involved in this 
process that are engendered through the activation of cognitive processes, as illustrated in 
the following quote from a physician.            
If the PSR is fulfilling all the parameters and my patients are getting benefits then definitely, emotional 
feelings will be developed for him or her since the PSR is working hard [GP-3]. 
The above quote clearly indicates that emotional sentiments that act as mechanisms are also 
present; however, they develop through the presence and activation of cognitive or self-
interest mechanisms. Therefore, satisfaction and trust with the PSR's efforts also gives the 
physician an impression of PSR's cooperation and customer orientation towards 
achievement of physician's core objective of patient wellbeing.      
This section has provided the impression that RQ helps the PSR in gaining physician's 
recognition due to acknowledgement of the efforts he or she is putting into achieving 
physician's goals. However, this finding as a subjective outcome is quite different from the 
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existing RQ literature. This might be because of the context specificity, since there are few 
studies on RQ in a pharmaceutical context (e.g. Lagace et al., 1991). Furthermore, there is 
limited contribution from studies on RQ within developing countries (e.g. Asnai et al., 2009). 
However, according to findings a physician's recognition allows the PSR to stand out from 
the competition between the PSRs and receive special treatment from the physician because 
different intangible aspects of the relationship (e.g. interaction quality) cannot easily be 
duplicated by competitors  (e.g. Roberts et al., 2003). Consequently, the PSR becomes closer 
to the physician due to cognitive and emotional mechanisms (i.e. related to RQ). These 
mechanisms change physician's behaviour positively for the PSR, and this change in 
physician's behaviour due to RQ leads to further outcomes; for instance, gaining more time 
and priority during the interaction. From the above explanations, it can also be asserted that 
although these outcomes are distinct in nature, they are interrelated with each other. As 
both cognitive and emotional mechanisms present at different psychological or behavioural 
levels of a physician, which are further responsible for the achievement of objective or 
actual RQ outcomes. These are examined in the following sections. 
4.5.2  PHYSICIAN'S PRESCRIPTION DECISION MAKING AS THE EXPECTED OBJECTIVE 
OR ACTUAL OUTCOME OF RQ: 
The sub-theme objective or actual outcome is connected to the theme RQ outcomes and has 
one data category, which is increased sales and prescription share. The following subsection 
examines how RQ between the PSR and the physician and related mechanisms contribute to 
providing these objective outcomes to the PSR.  
A) EXPECTED INCREASE IN SALES OR PRESCRIPTION SHARE:  
All the PSMs reported that the PSR achieves his or her firm's core objective of increasing 
sales or prescription share as an outcome of RQ with the physician. Their explanations were 
based on arguments that the main objective of the PSR, and the firm, are put into its efforts 
to develop RQ to achieve increased prescription share or sales. And RQ with a physician 
facilitates the PSR in achieving the firm's goals: 
Company's core objectives in terms of sales will follow automatically once the PSR develops good 
relationships with the physician. Because the core objective is to secure the business and the PSR is 
putting all the hard work into achieving sales; therefore, the PSR starts achieving his or core objectives 
[PSM-2]. 
In the above quote the PSM used the word "automatically" in connotation to sales 
achievement as a result of RQ. This gives an impression similar to the discussion above that 
RQ (due to the presence of its related mechanisms) causes a positive change in the 
physician’s behaviour towards the PSR. This in turn leads to expected sales returns in the 
form of more prescription share from the physician. All the PSMs reported that there are 
expectations that the PSR receives about 50-60% of prescriptions under a particular brand 
category. The reasons or mechanisms that motivate physicians to be a frequent prescriber of 
the PSR's brand are illustrated in the following quotes:    
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Once RQ is established the physician will give about 50-60% prescription share to the PSR's brand of a 
particular product category, because he or she is convinced with the product and the PSR. As the PSR 
provides the required extra services at the satisfaction level of the physician, the physician counts all 
these factors, such as performance, of the PSR and the brand and thinks he or she should give maximum 
benefit to the PSR [PSM-5]. 
This signifies that physician's trust and satisfaction with the PSR and the brand he or she is 
promoting leads to the physician's commitment. And physician exhibits his or her 
commitment by frequently prescribing the PSR's brand. The finding is also consistent with 
the RQ literature, where scholars found that the objective or financial outcomes of RQ were 
mostly influenced by customer's commitment with the salespersons (e.g. Palmatier et al., 
2006; Vieira et al., 2014). This is because, both physician's cognitive or self-interest (related 
to patients' wellbeing) and psychological level emotional sentiments (related to PSR's 
efforts) act as mechanisms to engender the reciprocity mechanism that motivate physician 
to such actions, as illustrated below:  
Both kinds of things are there: I mean first, a physician will see the quality of a product and then will be 
indulged emotionally due to the efforts of the PSR. Physician will then see product quality because does 
not want to lose the patient and when he or she will see the PSR's effort thinks “why shouldn't I prescribe” 
[PSM-4]. 
Similar to the above explanations, PSM-2 further explained this as the physician's natural 
behaviour due to the PSR's efforts for the development of RQ, as illustrated in the following 
quote:       
It is natural to have more sales because you put in effort and after meeting all the physician's criteria, you 
reach the stage where you are receiving benefits from the physician in terms of sales. In fact this is the net 
result of your efforts and this shows how consistently you worked and how you were behaving with your 
customers in the past [PSM-2]. 
PSM-2's explanation gives the sense that as a result of the PSR's efforts (that shows his or 
her commitment) to develop and maintain RQ, the physician naturally reciprocates in the 
shape of a larger share of prescriptions. When the PSR has fulfilled all the physician's 
technical and psychological level needs consistently, the physician reciprocates to 
accomplish PSR's objectives in return. This also gives the impression that the mechanism of 
reciprocity to the PSR that engenders the physician's commitment is required to keep their 
relationship alive. Therefore, the physician wants to preserve his or her RQ in order to 
continuously receive relationship benefits from the PSR. This is because a customer's 
commitment to the salesperson is indispensable to maintain the enduring relationships (e.g. 
Parsons, 2002). Similar explanations were also gathered from the physicians, for example: 
When you develop trust and satisfaction with the PSR, you felt inclination and commitment towards the 
PSR. Therefore, I will be committed when I have analysed each and every angle; [for example, the PSR and 
his product performance] and if I am committed then I will give prescriptions to the PSR [GP-1]. 
The above quote confirms that physicians involve themselves in the cognitive evaluation of 
each and every aspect, whether related to the quality of the product or the PSR's own efforts. 
If everything meets with the physician's expectations, he or she will develop trust in and 
satisfaction with, the PSR, which leads to commitment to the PSR. Moreover, the physician 
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clearly linked his prescription decision making with commitment, which gives the 
impression that the prescription decision is mostly influenced by the presence of 
commitment through the activation of mechanisms of reciprocity. However, the above quote 
also demonstrates that RQ played a role in the physician’s decision making and suggests 
they frequently prescribe where they feel it is appropriate to prescribe the PSR's product, as 
illustrated in the following quotes: 
Strong relationships play their role and we frequently prescribe the product of those PSRs with whom we 
have strong relationships [GP-2]. 
Well, I would definitely prescribe the PSR's product because I have a quality relationship, but only where I 
find a place for that particular product [GP-3]. 
Both quotes above signify that although RQ and its related mechanisms play a role in the 
physician's decision making, there are other mechanisms that the physician takes into 
account. In the quotes above physicians use certain phrases; for instance, GP-2 used "play a 
role in prescription decisions” and GP-3 expressed "where he finds the place he will 
prescribe". These phrases suggest there might, or definitely will be, medical conditions and 
secondly, socio-economic issues that need the physicians’ attention before they make 
prescription decisions.  
In summary, sections above examined the expected outcomes of the physician-PSR dyadic 
RQ. The physicians and the PSMs confirmed that RQ between the PSR and the physician 
fosters positive behavioural changes (i.e. subjective outcomes) in the physician; which 
further leads to the objective or actual outcomes in terms of increased in prescription share 
or sales for the PSR. The above explanations also provide the idea that the subjective or 
behavioural RQ outcomes are stable if the PSR meets all the physician's criteria and then 
maintains RQ with the physician. However, the objective or actual prescription decision 
making that leads to value adding activity in terms of sales increase as an outcome can only 
be observed if everything seems appropriate for the physician. Because, the forces or 
mechanisms determining the prescription decision making of physicians are complex and 
numerous (e.g. Hellerstein, 1998). Since the physician operates in an open system, there 
might, or will be, medical conditions and the socio-economic issues that also need 
physicians' attention before they make an actual prescription decision making. Medical 
reasons and the technical aspect are understood; for example, the physician has to see which 
disease indications apply before he or she can prescribe the PSR's product. However, the 
socio-economic condition in terms of the patient’s ability to afford the PSR’s product is 
another matter that the physician has to consider in the context of Pakistan. This aspect was 
already identified and examined in the section 4.5.1-2.2 on the 'product price', where 
respondents perceive the higher product price as a barrier to the objective outcomes of the 
RQ. The following section briefly describes the effects of the higher product price on RQ’s 
objectives outcomes and underlying mechanisms identified through the data generated from 
the first phase interviews. These aspects are incorporated in the revised conceptual 
framework but are explained in more detail in chapter 5 in order to avoid repetitions in the 
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text. The explanations of these aspects by the phase one interviewees were similar to those 
generated in phase two interviews.    
4.5.3 INTERVIEWEES PERCEPTION ON RQ ACTUAL OR OBJECTIVE OUTCOMES IN 
THE CONTEXT OF HIGHER PRODUCT PRICE: 
Two variant responses were identified by the respondents with regard to PSR’s high price 
product and physicians’ prescription outcomes: either they give a prescription to the PSR or 
switch to an alternative. These outcomes were contingent upon the patient’s particular 
economic and medical contexts or conditions. This is because the economic conditions of the 
majority of patients in Pakistan are not sound (please see appendix 8, Q-13a & b). Therefore, 
if the PSR's product price is higher than the patient can afford, it causes a change in the 
physician's prescription decision making and he or she will switch to an alternative low 
price product, as illustrated in the following quote: 
The relationships with the PSR are there and I mean them but if the PSR's product price is too high then 
definitely I will not prescribe it [GP-2]. 
All the PSMs and physicians provide many reasons to switch on an alternative product such 
as: physicians have a strong relationship with patient and they care more about their 
relationship with patients than a PSR. Because if they do not cares about the patient's 
economic conditions, there is a fear that the patient will switch physician. Furthermore, on 
professional grounds they should also care more about the patient's wellbeing. Finally, they 
have emotional sentiments for the patients on the grounds of humanity (please see chapter 
5 for more detail). Therefore, both their self-interest and emotional sentiments for patients 
act as mechanisms and interact with PSR-physician's RQ, which causes the change in a 
physician's behaviour and he or she switches to an alternative more economic product 
(please see quotes 13c, d, e in appendix-8 on these aspects).  
Nevertheless, respondents accepted that the physician will prescribe the PSR's more costly 
product where a patient can afford it or when he or she comes with a more serious illness, as 
illustrated in the following quote, which is representative: 
If a PSR's product price is high I will prescribe it to patients where affordability is not an issue. [GP-3].  
This suggests that physicians feel confident to prescribe the PSR's costly product when the 
patient can afford it. This is because the physician trusts in the PSR's product’s efficacy, 
which in turn acts as a mechanism that ensures the physician’s self-interest in the patient’s 
wellbeing. Furthermore, other RQ related mechanisms (i.e. emotional and reciprocity) 
become more active and the coexistence or activation of all these mechanisms helps the 
physician to choose the PSR's more costly product; so that he or she can achieve self-interest 
in the patient's wellbeing, retention and therefore income.   
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4.6 SUMMARY & REVISED CONCEPTUAL FRAMEWORK: 
In summary chapter 4 has examined the respondents' perceptions and understanding of RQ 
its determinants and outcomes. By and large, respondents have confirmed all the RQ 
determinants that constitute the initial conceptual framework. Furthermore, from their 
responses a few more PSR related determinants emerged outside of the initial conceptual 
framework, outlined below with dark blue colour blocks in figure 4.4, which shows the 
revised conceptual framework as an outcome of these findings.  
The development of RQ, which encompass trust, satisfaction and commitment, depends upon 
the simultaneous activation of many underlying mechanisms of the identified RQ 
determinants revealed above. The most prevalent mechanism was self-interest, associated 
with the physician's professional, technical, and economic needs. The professional needs 
have a relationship with the patient's wellbeing and the economic needs are associated with 
the physician's practice viability in terms of patient retention and physician's earnings. 
Moreover, the emotional mechanisms that are linked with the physician's sentiments also 
emerged psychologically through the PSR's efforts to ensure the physician's self-interest and 
also the physician's moral compass. These cognitive and emotional mechanisms engender 
mechanisms of reciprocity that further lead to positive RQ outcomes for the PSR i.e. 
subjective or behavioural and objective or actual.  
The subjective outcomes are those that a PSR benefited from during the interaction with the 
physician in terms of physician's positive behaviour, such as time priority over other PSRs, 
and recognition. The objective RQ outcomes are linked with the physician's actual increased 
prescription decision making of the PSR's product. According to the respondents, the 
subjective outcomes of RQ are stable; however, its objective outcomes in terms of 
prescription decision making are not consistent, particularly when the PSR's product price is 
high. Objective outcomes are contingent to the patient's economic and medical conditions.  
The different economic contexts of patients also produce different mechanisms (i.e. patient's 
affordability and non-affordability). The other most prevalent mechanisms were physician's 
self-interest towards the patient at two different levels i.e. the patient's wellbeing which had 
its links with physician's professional ethics and also with patient's satisfaction, retention for 
physicians' own practice viability. Physicians' also had sentiments of humanity, empathy and 
sympathy for the patient, which act as mechanisms. Furthermore physician's clinical 
experience of alternative products also serve as mechanisms in physicians' prescription 
decision making in different conditions of patients (please see chapter 5 for more detailed 
examination).  
The combination and activation of specific mechanisms give rise to different physician 
decision making outcomes. When the patient's economic conditions are sound, the PSR gets a 
prescription from the physician. However, if the patient cannot afford the PSR's product, a 
physician switches to the alternative, more economical product. However, the physician's 
regular switching towards the alternative economical product can weaken the RQ that can 
ultimately leads to relationship termination. Since according to the respondents physician's 
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prescriptions of the PSR's product reflect physician's commitment to the relationship, which 
is necessary to maintain enduring relationships. 
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Figure. 4.4: Revised conceptual framework for the current research 
The above explanations and the evidence result into the revised framework, which shows 
that if the product's price is high, the PSR's RQ performs more effectively (in terms of the 
physician's prescription decision making) when the patients' economic conditions are sound. 
However, to further verify the efficacy of RQ and the revised framework, the next chapter 
examines all the mechanisms identified above and their configurations in two different 
economic patient contexts (i.e. the urban and rural sales areas of Multan, Pakistan). This not 
only enables the study to verify for whom and in what economic context RQ works more 
effectively in terms of achieving its objective outcomes but also establishes the authenticity 
and viability of resultant revised conceptual framework. 
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5 RURAL & URBAN SALES AREAS WITHIN DIVISION OF MULTAN 
5.1 INTRODUCTION 
The previous chapter explored and examined the required determinants and their 
underlying mechanisms that lead to RQ between the PSR and physician. It also examined 
how RQ, through the effects of its underlying mechanisms, produces objective outcomes 
under the patient's contingent economic conditions. The results indicated that PSRs who 
promote a high price product achieve RQ's objective outcomes more effectively when a 
patient has sound economic conditions, as compared to a less affluent patient, due to the 
interaction of various mechanisms. Therefore, in order to verify the  presence of the 
underlying mechanisms identified, which cause certain outcomes, this chapter further 
investigates these mechanisms' interaction in two different patient economic contexts. In 
doing so, the overall aim was to find when, and how, particular patients' context and above 
identified mechanisms interact to produce change in a physician's prescription decision 
making; in order to verify for whom and under what conditions, or contexts, RQ is more 
effective in terms of achieving its objective outcomes. This was done through extending the 
investigation further by considering two embedded sub units, i.e. urban and rural sales 
areas of Multan, due to the different economic conditions of patients living in these areas 
(please see detail in chapter 3 on methodology).  
This chapter begins by describing the physicians interviewed in rural and urban sales areas 
of Multan. Following this, the next section provides physicians' confirmation on their RQ 
with PSRs and underlying mechanisms associated, which lead to expected objective 
outcomes in terms of physicians' prescription decision making of the PSR's product. In order 
to verify further mechanisms, the subsequent sections then examine the physicians' 
explanation for their RQ's expected outcomes, when RQ interacts with the price of a product 
that a PSR promotes. This leads to the next section, in which physicians explain the overall 
economic situation of the particular area they are practicing in, which leads to further 
emergent sub-themes and categories. This leads to consideration of the physicians 
explanations of for whom and under what conditions, or contexts, RQ is more effective in 
terms of achieving its objective outcomes. Finally the chapter provides the summary of its 
outcomes.  
The categories and sub-categories confirmed and/or emerged from the resultant data, with 
associated mechanisms outlined in figure 5.1 below. In terms of a critical realist position, 
these categories are present at the domain of actual and real. That is, the physician's 
particular prescription decision that can be observed in the empirical domain is activated by 
the presence of different mechanisms and their activation is at the domain of actual and real.  
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5.2 INTERVIEWEES: RURAL AND URBAN AREA PHYSICIANS   
Altogether fourteen physicians were interviewed face-to-face, i.e. seven in both rural and 
urban sales areas, in order to confirm physicians' explanations about the causes (or 
mechanisms) of their RQ with PSRs and its expected outcome for PSRs. Similar to the phase 
one interviews, physicians were also asked about the expected outcomes when RQ interacts 
with a high product price under patients’ contingent economic conditions of rural and urban 
sales area of Multan. The characteristics of the rural and urban sales area physicians are 
outlined in tables 3.4 and 3.5 (please see section 3.6.2 in chapter 3). 
5.3 PHYSICIANS' EXPLANATIONS ON THE RQ & ITS MECHANISMS LEADING TO 
OBJECTIVE OUTCOMES:   
In general, all the physicians practicing in rural and urban areas of Multan confirmed that 
the RQ determinants in the revised conceptual framework, were necessary to develop RQ 
between the physician and PSR. Similar to the findings of chapter 4, and existing literature 
on RQ, their explanations also confirmed that all the determinants were required to ensure 
the development of trust (i.e. cognitive and affective), satisfaction and commitment (i.e. 
calculative and affective). That is to say, when the PSR fulfils the physician's technical or 
professional self-interests; they also develop affective or emotional sentiments that act as 
mechanisms for the PSR when the physician recognises the PSR's efforts in the 
accomplishment of technical or professional self-interest that also fulfils a physician's social 
needs (e.g. Hennig-Thurau & Klee, 1997). Consequently, the PSR develops RQ and receives 
both subjective and objective benefits from physicians. The following quote from one of 
physicians from a rural area illustrates the subjective benefits or outcomes of RQ for a PSR 
during his or her interaction with a physician, and also the objective outcomes:  
This is natural, when 5-6 PSRs come together at the same time for their sales calls, I ask all the other PSRs 
to discuss their products first. However, I ask the one I have a good relationship with to sit and I give him 
or her more time and prescriptions [RGP-4]. 
This clearly indicates both the subjective and objective outcomes a PSR receives as a result 
of RQ with a physician. Therefore, based on the findings of the previous chapter and also on 
the above explanations; physicians were asked if they held emotional sentiments for the PSR 
or they saw all the PSR’s efforts rationally in order to verify the presence of self-interest and 
emotional mechanism leading to RQ. Their responses are illustrated in the following quote, 
which represents other physicians' views (please see appendix 8, Q-15): 
I will prescribe the PSR's product because the PSR visits me and he or she works hard, the product also 
has quality, therefore I will definitely prescribe [RGP-7]. 
This clearly signifies that the physician cognitively evaluates not only the PSR's efforts but 
also the performance of the product. If all the PSR and product related factors are at 
satisfactory level in terms of the physician's expectations, the physician will be more likely 
to develop RQ with a PSR. This is because the PSR ensures the physician's professional or 
technical self-interests by delivering effective knowledge of the product or by offering a 
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quality product or by adapting his or her behaviour during a sales call, etc. Repeated 
episodes of such conduct by a PSR as a result of frequent visits not only gives the physician a 
sense of accomplishment of his self-interest, but this also engenders the physician's 
emotional sentiments that act as mechanisms in favour of the PSR. This is illustrated in the 
following quotes:  
I cannot say that I develop emotional feelings for the PSR. However, I think there is a high rate of 
unemployment here, and the PSR is working hard for his or her job to earn and survive. We should 
acknowledge his or her efforts [RGP-2]. 
There is no doubt that we develop emotional feelings for some PSRs. This is because they work with 
sincerity. They may be not only bringing up their children but also taking care of their parents. Therefore, 
they should be cared for by us [UGP-6]. 
These quotes signify that physicians not only take account of the patients' economic 
conditions but also the PSRs’, when they have RQ. Their explanations give an impression 
about their knowledge of competition within the pharmaceutical industry and level of 
unemployment in Pakistan. They expressed their full awareness regarding the role of the 
PSRs in terms of achieving their sales quotas to survive within this profession. They also 
showed their concern about the PSRs with whom they have RQ, and who work hard, with 
sincerity, in order to fulfil their responsibilities towards their families. All these factors lead 
to the physicians' emotional feelings for the PSRs as they developed strong psychological 
bonds with the PSR, as illustrated in the following quote:          
There is not only rational assessment but emotional feelings are also present for the PSR with whom you 
have RQ. That is to say, a pleasant relationship is developed with a PSR and he or she comes into your 
liking. In fact this is due to the development of strong psychological bonds with a PSR [RGP-6]. 
This signifies that physicians take care of the PSR's job survival because physicians like him 
or her due to the exhibition of persistent efforts they make, not only to fulfil the physicians' 
technical self-interest but also their social level needs. The fulfilment of the social level 
needs leads to the development of physicians' strong psychological or emotional bonds for 
the PSR. These findings are similar to the existing literature on RQ, where different scholars 
asserted that RQ between buyers and sellers creates the bonds of intra-psychological kind 
(e.g. Hennig-Thurau & Klee, 1997), which include emotional sentiments (e.g. Al-Alak, 2014). 
Therefore, these emotional sentiments act as mechanisms, along with the self-interest 
mechanisms, to further foster the physicians' reciprocal actions in terms of their care for the 
PSR's objectives of an increased share of prescriptions from them. This is illustrated in the 
following: 
PSRs trust in us and we trust in PSRs. They honoured us, therefore we have to give honour to them [UGP-
6]. 
Thus, this confirms the findings of previous chapter that the presence and combination of 
RQ related mechanisms fosters the physician's reciprocity mechanism, which leads to both 
the subjective (i.e. physicians' time and priority) and objective or actual outcomes (in terms 
of prescription share from physicians (please see section 5.6)). However, in order to verify 
the interaction of PSR's high product price with PSR's RQ under particular patient’ economic 
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context, the physicians were asked what happens, if the price of the PSR's product was high. 
This involved questioning whether they would prescribe products sold by PSRs with whom 
they had RQ. Both rural and urban physicians' responses were negative: these responses are 
examined and are discussed in the following section. 
5.4 PHYSICIANS' EXPLANATIONS ON RQ OBJECTIVE OUTCOMES IN TERMS OF 
THEIR PRESCRIPTION DECESION MAKING WHEN THE PRODUCT PRICE IS TOO 
HIGH FOR PATIENTS  
Similar to phase one interviewees, all the rural and urban area physicians unanimously 
confirmed that they would not prescribe a PSR's product if the price was too high for 
patients and would switch to an alternative, more economical product. They explained that 
the economic contexts in which they operated did not let them prescribe PSRs’ products on a 
regular basis that patients cannot afford. The following sections examine the explanation of 
the contexts of the rural and urban areas in which physicians were operating to identify the 
contextual mechanisms.   
5.4.1 PHYSICIANS' EXPLANATIONS OF THE ECONOMIC CONTEXT IN WHICH THEY ARE 
PRACTICING: 
All the physicians confirmed that in general, the economic conditions of patients were not 
sound in rural areas and that it was vital to consider those conditions during the choice of a 
product. The following quote illustrates their sensitivity and awareness of the general 
economic conditions of patients living in rural areas, it represents other similar quotes 
(please see appendix 8, Q-16): 
The economic conditions are not good here in general. Patients sometimes sell their assets, e.g. their 
cattle or something else, to bear the cost of treatment [RGP-3].  
This response suggests that they were aware of their patients’ poverty in terms of how 
difficult it was for them to bear the cost of treatment, and patients were sometimes forced to 
sell their assets to have healthcare services. Since in rural sales areas the Government health 
facilities are not adequate (e.g. Akram & Khan, 2007); therefore, patients seek healthcare 
services from local physicians (e.g. Muhammad, 2014), this is also illustrated in following 
(please also see appendix  8, Q-17): 
Here in Pakistan, people even cannot afford their food because they are so poor and poverty is increasing 
day-by-day. Government is not providing enough health facilities and if I as a physician do not take care 
of patients, where will they then turn? [RGP-2]. 
This signifies that physicians know that the Government health facilities are not satisfactory 
and in such conditions while prescribing a product they have to take care of their patients 
who may not have enough to spend on their food. Therefore, physicians keenly investigate 
patients’ affordability to provide them the best solution for their particular disease or 
ailment within their budgets, as illustrated in the following: 
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I always find and keep the economic conditions of the patient in my mind [...], I always look at the patient's 
pocket. No matter how strong the relationship I have with the PSR, I always focus on patient's 
affordability. I only prescribe the PSR's product when it is required, but in conjunction with the patient's 
affordability [RGP-6].  
This signifies that the patients' non-affordability mechanism, due to the PSR's high price 
product, leads to a change in physicians' behaviour and hence their prescription decision of 
an alternative product that the patient can afford.  
Similar to the explanations from the rural area physicians, the physicians from urban areas 
also confirmed that there was no doubt they frequently prescribed the products of PSRs with 
whom they had RQ. However, they explained that this was only possible if the product price 
was competitive compared to those available under the same product category on the 
market. They would not prescribe the PSR's product on a regular basis if the product price 
was high, and instead switch to an alternative product. Physicians’ reasons for this course of 
action are outlined in the following quotes: 
The majority of people here are not economically sound, even sixty percent of the urban population are 
below the poverty line. The remaining forty percent of the population has some other commitments e.g. 
they have to maintain a good life standard and they have to spend on the education of their children. 
Therefore, we have to be careful during prescription decision making [UGP-5]. 
There is a misconception that people living in posh areas are economically well-off and therefore they can 
afford to buy everything. These are white-collar people. Even though they are earning well, if I prescribe 
two to three thousand rupees worth of medicines on a daily basis, they cannot cope with this. For instance, 
if I myself earn fifty thousand rupees a month and a physician prescribes me fifteen thousand rupees 
worth of medicine for a month, how will I managed the rest of the other household expenses? I cannot 
afford it [UGP-6]. 
These quotes from urban area physicians clearly indicate the physicians’ awareness, 
sensitivity and reservations to prescribe high price products. UGP-5 explained the overall 
economic conditions of the people living in urban areas and reported that only forty percent 
of people could not be considered as poor. However, both UGP-5 and UGP-6 provided an 
explanation about the forty percent of the population who were considered to be from a 
well-off economic class; and exhibited their awareness about other household financial 
commitments of people living in urban areas. UGP-6 puts himself into the patient's situation, 
which implies the physician's empathy for patients in urban areas that then influences his 
reservations to prescribe the PSRs' high price product, even when they had RQ. 
In summary the economic conditions in rural and urban areas were not similar in that the 
population in rural areas simply cannot afford high priced products, because their income is 
dependent primarily on agriculture. On the other hand, the population in urban areas 
generate more income; however, their other household financial commitments also make 
the PSR's high priced products unaffordable for them. Physicians who had been practicing 
for more than ten years in both these areas had full awareness about their patients' limited 
ability to afford healthcare related services, which led to physicians' unwillingness to 
prescribe PSR's high price products. Thus, according to the above explanations, the patient 
non-affordability mechanism was prevalent in both the rural and urban areas due to 
different reasons as explained by the physicians. These findings are also similar to Al-Areefi 
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and Hassali (2013), who found that physicians switch to an alternative cheaper product that 
a patient can afford in the context of Yemen due to his or her non-affordability of a quality 
product with a high price.  
Moreover, in accordance with the findings and to verify other mechanisms identified in 
chapter 4, physicians were also asked why they cared more about their patients' economic 
conditions rather than the PSR with whom they had RQ. Physicians explained the reasons or 
causes were quite similar to those revealed in chapter 4, which were categorised further into 
two themes. These were: physicians' relationship with patients; and physicians' 
relationships with other PSRs. Each is examined in the following sections. 
5.4.2  PHYSICIAN-PATIENT RELATIONSHIP:  
Similar to phase one interviewees, all the physicians in rural and urban areas confirmed that 
they also had a relationship with patients, therefore patients' satisfaction was a vital aspect 
for them. This is illustrated in the following:  
Patients come repeatedly to you as a family physician. Seventy percent of patients are those who regularly 
come to you for their treatment, which leads to a sort of relationship between us, therefore you think more 
about patients' benefits than PSRs’ [UGP-3]. 
Patients' trust in physicians, all this system between the patient and physician depends on a patient's 
trust in a physician [RGP-5]. 
This signifies that there is a presence of strong physician-patient relationship and physicians 
do not want to distort patients' trust in them. This is because, patients’ trust a competent 
physician who takes appropriate responsibility and control, and makes patient welfare their 
highest priority (e.g. Ehsan & Ashill, 2014). Thus, they care more about patients' satisfaction 
in order to retain patients' trust level since both trust and satisfaction are necessary for 
enduring relationships. Three further categories were identified in relation to the emergent 
sub-theme ‘physicians' relationship with patients’, i.e. physicians' moral or professional 
ethics as an agent of the patient; physicians' humanity, empathy and sympathies as an agent 
of the patient; and physicians' professional relationship with patients in term of their 
practice viability. These identified categories are examined below. 
5.4.2.1 PHYSICIANS' MORAL OR PROFESSIONAL ETHICS AS AGENTS ON BEHALF OF 
PATIENTS:  
All the rural and urban area physicians confirmed that there were some moral or 
professional ethical reasons that they had to comply with during the prescription decision 
making process. The rural area physicians explained it was part of their professional ethics 
to consider patients' welfare as a first priority, as illustrated in the following quote, which 
represents similar views (please see appendix 8, Q-18): 
It is because of my medical ethics that I consider the patients' benefits first as I know about the economic 
conditions of my patients in terms of which family and economic class they belong to  [RGP-1]. 
This quote above suggests physicians’ feelings that they act on behalf of the patients, 
therefore they have to consider not only the patients' physical and mental but also their 
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economic conditions as well. Since physicians know about the patients' family or economic 
class, if the physician prescribes, due to RQ, a PSR's product that is beyond the patient's 
affordability, this act will be considered as unethical, as illustrated in the following quote: 
My relationships with PSRs and professional ethics should coincide. If you leave professional ethics and 
give your relationships priority, this would be an injustice to your profession [RGP-4]. 
The quote above suggests that the PSR's RQ related mechanisms are present; however, they 
are affected when the physician's follows his professional ethics regarding patient wellbeing. 
They might consider their relationships with PSR while making their prescription decisions; 
but not at the cost of their patients’ wellbeing. Because they fully understood the notion of 
conflict of interest and their professional norms (Chimonas et al., 2007). This implies that 
physicians can only oblige the PSR (due to the presence of the reciprocity mechanism) when 
they feel that by obliging the PSR, they are not being unethical. Similarly, all the physicians 
from urban areas explained that it was against their professional ethics if they knowingly 
prescribed a PSR's costly product to a patient who cannot afford it, as illustrated in the 
following quote:   
One of the reasons to not consider the PSR's product is the overall social-economic conditions of the 
patients. Even some patients belonging to the middle class cannot afford the cost of medicines. We do not 
want to make our patients a victim. Therefore, it is a basic of our professional practice to take account of 
the economic consequences for patients [UGP-4]. 
Therefore, because even some middle class patients struggle to afford medicines, physicians 
provide economic compliance to their patients, so that they can meet their other financial 
commitments:  
Because of professional ethics, I do not consider the PSR's costly products. Because I mentally calculate the 
patient’s income, my fee, and the cost of medicine, therefore, I try to accommodate the patients, so that 
they do not feel an extra load. This is what we have to see at GP level practice [UGP-2]. 
The physician assesses the patient's overall cost of treatment and then chooses a product 
that is commensurate with the patient's financial situation, to avoid unnecessary load on him 
or her in meeting other commitments. Therefore, for physicians it is entirely unethical to put 
an extra burden on the patient for the sake of their RQ, since a physician is there to ensure 
the patients' wellbeing, as illustrated in the following:       
There is no doubt we have good relationships with some PSRs but the basic theme in our mind is to ensure 
patients' benefits. Therefore, I respect my relationships with PSRs. However, if their product price is high 
and the patient cannot afford it, then we have to act accordingly [UGP-6]. 
Thus, the physician has RQ with the PSR but they consider their relationship with patients as 
a priority. This is similar to the explanation from the rural areas physicians that RQ related 
mechanisms are present; however, they are affected when the physician prioritises 
professional ethics with regard to a patient's wellbeing. This further illustrates the 
reciprocity mechanism that a physician engenders for the PSR due to RQ will only activate to 
affect physician's prescription for the PSR's product when he or she feels their professional 
ethics towards patient's wellbeing will not be compromised. The following illustration gives 
further clarification:  
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We prescribe the PSR's costly product either to patients who can afford it or where we feel it is 
appropriate. We favour the PSR because both the PSR and the product he or she promotes are excellent. 
This is a sort of favour that one can do for his friend, i.e. this is helpful for the PSR in terms of career 
promotions, as his product's sales will be increased. However, one should only favour a PSR in a way that 
nobody else has to bear the burden of this decision. I mean if I overlook the patients’ wellbeing,  this is 
totally unethical [UGP-6]. 
This implies that the physician cognitively and affectively evaluates the PSR's and his 
product's performances, which leads to trust, satisfaction, commitment and thus RQ. 
Consequently the physician reciprocates by prescribing the PSR's costly product when he or 
she feels it is appropriate, i.e. either to the most affluent patients or where a patient's 
medical condition demands a higher quality product. The physician explanation of this 
behaviour indicates that he holds good wishes for the PSR's promotion, which further 
implies that the physician develops emotional sentiments due to the PSR's honesty, integrity 
and reliability. Therefore, both rational and emotional mechanisms related to RQ are present 
and further foster the reciprocity mechanism that leads to the physician's prescription 
decision making of the PSR's product. However, the physicians clearly explained that it is 
only possible if there is no burden on the patient, otherwise it would be considered as an 
unethical conduct by the physician.  
In summary, the general economic conditions of the urban areas were slightly better than 
the rural areas in terms of income; however, the urban area patients had to fulfil other 
financial commitments that engendered reservations in the physician to consider the PSR's 
costly product. These explanations confirmed that patient's wellbeing mechanism (in terms 
of patient's disease or ailment recovery by means of economic-compliance) comprises the 
core professional ethics of physicians both from the rural and urban areas. Beside this self-
interest in the patient's wellbeing, physicians also develop emotional sentiments that act as 
mechanisms in favour of patient's wellbeing, as examined in the next section.  
5.4.2.2 PHYSICIANS' HUMANITY, EMPATHY AND SYMPATHY AS AGENTS OF PATIENTS: 
All the rural and urban area physicians confirmed that they also developed emotional 
mechanisms, which were linked with their sentiments of humanity, sympathy and empathy 
with the patient. These sentiments emerge because of the serious consequences if the 
patient did not receive the proper medication due to its non-affordability. The emotional 
sentiments or mechanisms that emerge through physicians' humanity for patients are 
illustrated in following quotes: 
For a physician, humanity has a top priority as this is the first step and we should focus on it. If you do not 
understand the patient's entire problems, I do not think you would be successful in this profession [RGP-
5]. 
In actuality, it is humane to care about patients' ability to afford as an important aspect during 
prescription decision making. Because, if you do not care about this and prescribe costly medicines that 
leave the patient in a miserable condition, this is an unkind behaviour towards the patient [UGP-6]. 
These above quotes from both the rural and urban areas physicians illustrate that they have 
emotional sentiments, which are linked with their humanity for their patients. Therefore, 
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physicians prioritise their relationship with patients rather than with PSRs and ensure 
patients’ welfare by prescribing products that a patient can afford to avoid serious health 
related consequences. The literature on medical marketing also echoes to the above 
explanations that physicians' hold more favourable attitude towards their patients (e.g. 
Lundin, 2000). Physicians also confirmed their humanity through the responses showing 
their empathetic sentiments for patients, as illustrated in the following quote, which is 
representative of many others (please see appendix 8, Q-19 and 20): 
I am living in the same society; I myself feel the effect of costly medicines when I buy for somebody ill in my 
family even though I have a better economic status than the majority of patients [RGP-3]. 
The quote above signifies that they place themselves in the patients' economic situation. 
They psychologically develop emotional sentiments that act as mechanisms about how they 
feel in a situation when they buy costly medicines for themselves, even though they have 
good economic conditions. Thus, such empathic behaviour for patients and presence of 
psychological emotional kind of mechanisms also develop physicians' reservations to 
consider the PSR's high price product. Besides the physicians' humanity and empathy, they 
also confirmed that they develop sympathies for patients: 
They can't afford each and every thing; they can't enjoy air conditioning or even air coolers. They just use 
fans in summer. So I can’t put them under too much pressure of cost of medicines or costly medicines  
[RGP-1]. 
There is no doubt we develop sympathies for patients [...]. This is because if a patient has already suffered 
with a disease for a week or ten days (e.g. such as typhoid), his or her parents have also suffered with this 
and they want the patient to get well overnight. Furthermore, they also spend a lot of money for the 
treatment [RGP-6]. 
These quotes from the rural areas physicians signify their psychological corroboration about 
their sympathies for patients facing economic difficulties. RGP-1 provided an explanation of 
what he feels about his patients' overall socio-economic conditions particularly those who 
cannot afford household essentials that can make their lives easier. For instance he referred 
to air-conditioners, which becomes necessary in summer because of very hot weather in 
Multan. RGP-6's explanation on the other hand gives the impression that physicians' develop 
sympathies for not only the patient but also his or her family members (e.g. parents), who 
also go through psychologically tense period due to the patient's disease and their own 
inability to afford related expenditures. Thus, physicians' in such events develop their 
sympathies for patients that engender emotional mechanisms that leads to physicians' 
reservations to prescribe the PSR's high price product, as illustrated in the following quote 
from urban areas physician:  
Both my ethics and sympathies for the patient are at work. The ethics deal with our evaluations of a 
product's economy, efficacy and compliance but you cannot rule out the role of sympathies. The PSR does 
his or her job but I have to do mine and in all this the emotional connection with a patient also works to 
consider his or her economic condition [UGP-3]. 
In the above illustration the physician acknowledged that there is no doubt the PSR does his 
or her job in a good manner; however, the physician has to make a prescription decision in 
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an ethical way by considering all the factors, i.e. product's efficacy, compliance and economy. 
This therefore confirmed the presence of the mechanisms related to physicians' ethics (i.e. 
self-interest in the patients' wellbeing). However, it also confirmed the presence of 
mechanisms of an emotional kind linked with their sympathies for patients due to their poor 
economic conditions. That leads to a change in physicians' behaviour of their choice of a 
product and they switch to an alternative of a low price rather than consider the PSR's 
product, in order to provide economic benefit to patients. Apart from the ethical and 
emotional considerations, physicians also explained that they also have a professional 
relationship with patients, which is linked to their practice viability.           
5.4.2.3 PHYSICIANS' PROFESSIONAL RELATIONSHIP WITH PATIENTS IN TERMS OF 
PATIENTS' SATISFACTION, THEIR RETENTION AND PHYSICIANS’ OWN 
PRACTICE VIABILITY: 
All the physicians in rural and urban areas confirmed that patients' satisfaction was a vital 
aspect for them. Therefore, in order to achieve patients' satisfaction they had to provide 
economic compliance to the patients, not only because of their professional ethics and 
sympathies but also to retain and maintain patients as their clients.  
Three further sub-categories were emerged and identified in relation to the category 
physicians' professional relationship with patients in terms of patients' satisfaction, their 
retention and physicians' own practice viability. Firstly because of competition within the 
physicians' practices; secondly, physicians' awareness of pharmacies behaviour; and thirdly, 
patients’ adoption of other routes for treatment due to a lack of education. These identified 
categories are examined in following sections.  
A) COMPETITION WITHIN PHYSICIANS' PRACTICES AND POSSIBILITY OF PATIENTS 
SWITCHING PHYSICIAN: 
As mentioned above (chapter 4), in Pakistan there is competition among physicians in terms 
of their practices. Many physicians practice in the same locality (i.e. on the same road or 
street), therefore patients have easy access to approach a range of physicians near their 
local residences. If a physician fails to cure a patient quickly within their budget, there is a 
potential risk of the patient's withdrawal and shift to another physician. Hence, to make a 
practice viable, a physician must ensure both the quality and economy of a product, as his 
earnings are dependent on the number of patient visits to that particular physician. This 
aspect was best explained by one of the urban area physicians, as illustrated in the following 
quote which represents many others:  
 
If you are practicing alone in the entire location, patients have to come to you anyway; it is up to you, 
whatever you want to prescribe you can. In such a situation all the PSR relationship related factors will 
influence the prescription decision more. But, when you know that patients have many options, then in 
this situation you have to consider the patient's economic conditions [UGP-2].  
This signifies that physicians were facing competition from other physicians and patients 
had the opportunities to switch physician if they perceive the one is too expensive for them. 
This therefore creates reservations in the mind of physicians when considering a PSR's 
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expensive product, and they prefer to provide economic compliance to the patients to 
achieve their satisfaction in order to retain and maintain patients as their clients. In such 
conditions physicians still have RQ related reciprocity mechanisms for a PSR; however, its 
effects are mitigated due to the PSR's product price and patients' inability to afford it. This is 
illustrated in the following quotes from two rural physicians: 
No matter how much the PSR is a favourite of mine, I prefer the patient more, because if the patient does 
not recover, he or she will not come back, nor refer others to me. In this way I will lose patients [RGP-4]. 
I always make efforts to prescribe a good, economical product, so that the patient can buy it and take a 
full course of treatment. If I prescribe a costly product of best quality, the patient will run away from me 
and will say this physician is very expensive, because he prescribes costly medicines [RGP-1]. 
The above quotes from the rural physicians clearly show that they were well aware of the 
consequences in terms of patient loss if they consider the PSR's costly product. This is 
because they have to cure their patients' disease or ailment; therefore, they prescribe the 
medicines that the patient can afford. The patient's wellbeing will only be achieved when he 
or she completes the full course of treatment, which is only possible when the patient is able 
to buy the medicines prescribed. Similar to the above explanations, the urban physicians 
also confirmed that they definitely had RQ with PSRs but they also had to analyse each and 
every aspect before taking decisions on prescription, including the patient's economic 
conditions or product affordability. This was important in retaining their patients: 
If I prescribe the PSR's costly product, next time the patient might not come to me as an outcome. Morally I 
have to cure my patient but also retain him or her professionally [UGP-1]. 
Definitely the patient can switch when you prescribe a PSR's expensive medicines. This is because when a 
patient cannot afford, they do not say to their physician that they cannot buy this medicine to avoid 
embarrassment, ultimately, they silently move to somebody else [UGP-6]. 
These quotes from the urban physicians also give clear impression that on ethical or moral 
grounds they have to ensure a patient's wellbeing. Secondly, they have to achieve patients' 
satisfaction by giving them economic compliance. They expressed their experiences that if 
they did not care about the patients' economic compliance this led to patients switching to 
other physicians and they cannot achieve their self-interest in patients' retention or practice 
viability. Their explanations also give the impression that unlike rural area patients, urban 
patients might afford the product but their other household financial commitments make the 
PSR's product unaffordable. And because they belong to the white-collar class, they switch 
physician without notice to avoid humiliation. Therefore, these sort of cognitive evaluations 
and also the presence of self-interest mechanisms engender reservations in prescribing the 
PSR's product. Patient retention is a very vital aspect for physicians, since their earnings 
depend upon the number of patients visiting them. These earnings are necessary to run a 
private clinic and to cover its administrative costs, as illustrated in the following quotes from 
both rural and urban areas physicians: 
You have to manage your clinic at the minimum level in terms of charging to retain the maximum number 
of patients. Because you have to maintain your system; for instance you have to pay salaries to staff. Since 
150 
 
you have to manage all this, therefore, if you provide the maximum relief to patients, it will bring you 
success [RGP-5]. 
This entire clinic's setup will only be sustained if you maintain patients' satisfaction. Because of this setup 
I am able to have paramedic staff working for me, and PSRs come to see me. If I did not have a good 
number of patients, I would not be able to keep my paramedic staff and no PSR would come to see me. 
Conversely, I would sit alone in my clinic and become frustrated psychologically. Because you will think, 
did I graduate to face this situation to sit in my clinic alone [UGP-2].  
These quotes give the clear impression that the physicians not only manage patient 
healthcare but they also act like the owner of small business enterprises in the form of 
private clinics. Their explanations give the idea that in order to maintain the smooth running 
of their businesses, they need the maximum number of patients, which can only be possible 
by providing maximum economic satisfaction to new patients and by retaining existing 
patients. As their earnings are dependent upon the number of patients' they keep (Granlund, 
2009). Therefore, for the physician it becomes vital to cure the patients early within their 
ability to spend on the cost of the treatment. In this way the physician achieves maximum 
satisfaction and therefore retention of the patients, as explained by an urban area physician 
in the following quote, which is representative of many others (please see appendix 8, Q-21): 
I analyse each and every aspect i.e. quality and cost of the product, as I have to satisfy my patient in order 
to maintain a high number of patients. Therefore, being a physician I have to provide both kinds of 
compliance, i.e. disease recovery within economic means as my top priority [UGP-1]. 
The quote above clearly signifies that physicians make their decisions rationally by 
considering all the disease-related and economic issues. An appropriate rationale helps 
physicians to achieve patients' wellbeing, satisfaction; and thus it is highly likely to increase 
in repeat patronage and decrease possible switch to another physician that is of equal 
importance for the private physicians (e.g. Lundin, 2000). Therefore, if the PSR's product is 
appropriate in their assessments, they will prescribe it due to the presence of RQ, as 
illustrated in the following quote: 
Physicians consider the patient's welfare because if the patient recovers this provides economic benefits 
to physician. Now in achieving this, if a PSR's product you have RQ with fits this is fine, otherwise you have 
to switch to an alternative product [RGP-4]. 
The patient's satisfaction and trust in the physician not only can emerge from the healthcare 
decision of a physician against patient's response in terms of early recovery from disease; 
but also can be enhanced  positively if a physician exhibits additional responsiveness by 
considering patient's financial circumstances during their prescription decision making  
(Gönül et al., 2001). However, physicians further explained that even if they prescribe the 
PSR's high price product, the prescription might be dishonoured; this aspect is examined in 
the following section.  
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B) PATIENTS' EDUCATIONAL STATUS AND PHYSICIANS' AWARENESS OF 
PHARMACIES’ BEHAVIOUR 
All the rural areas physicians explained that they also had reservations when prescribing a 
PSR's costly product, fearing their prescription would ultimately be dishonoured when taken 
to a pharmacy, as illustrated in the following quote: 
Suppose, if I prescribe a PSR's costly product to a patient and when he or she approaches the pharmacy to 
buy it, the pharmacist can provide an alternative low price product when the patient says ‘I do not have 
enough money’ [RGP-4]. 
This signifies that physicians expressed their experience about the behaviour of pharmacies 
in terms of developing uncertainty about whether the patient would buy the PSR's product 
or not. Because there is a tendency in Pakistan for pharmacy staff to sell products to patients 
which earn them more profit. This is illustrated in the following quote: 
The area in which I practice, the pharmacy’s staff changes the prescription a hundred percent of the time. 
They provide the medicine to patients that generates the most profit. This is because patients are not well 
educated here [RGP-6]. 
They further explained that patients were not well educated in the rural sales area therefore 
it was quite difficult for them to manage their treatment and therefore the physicians had to 
make extra efforts to ensure their patients were able to buy the same product they 
prescribed. Thus, not only the patients' non-affordability but also their educational status 
and pharmacies personnel's behaviour, which sometimes influence the physicians' 
prescription behaviour engender reservations in prescribing costly product. Moreover, 
physicians explained that this was a waste in terms of effort and time, when they prescribed 
a PSR's costly product to a patient who could not afford it:  
It is a failure when your prescription is dishonoured at the pharmacy because all your efforts and time 
become useless when you prescribe a costly product and there is no benefit in doing so [RGP-4]. 
This signifies that physicians feel it is disrespectful to them if pharmacists change the 
products that a physician prescribed for a patient. The physician has to invest his time in 
diagnosing the patient's disease and prescribing a product that can best serve the patient's 
particular condition. When prescribing a costly product, physicians remain uncertain about 
whether the same product will be provided by the pharmacy staff; therefore, they prescribe 
alternative, less expansive medicine they have clinical experience of. This makes physicians 
confident that the patient will get the same product since the patient can afford to buy it. 
However, this issue was not mentioned by the urban area physicians. This perhaps, is the 
result of the population in urban areas being more educated than in the rural, and more 
aware of the harmful consequences for their health. Therefore, they might be more conscious 
with respect to buy the product(s) prescribed by physicians. Moreover, it might be possible 
that the drug control authority manages the issue more actively in urban areas as compared 
to remote rural areas. Thus, not only the patients' non-affordability but also their 
educational status and other members in value chain (i.e. pharmacies personnel) behaviour, 
which sometimes influence the rural areas physicians' prescription behaviour engender 
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reservations in prescribing costly products. Nevertheless, all the urban and rural sales area 
physicians explained that they also had reservations about prescribing the PSR's costly 
product because patients can seek out other ways of treatment if they cannot afford the 
proper medical treatment.  
C) PATIENTS' EDUCATIONAL STATUS AND ADOPTION OF DIFFERENT ROUTES OF 
TREATMENT   
All the rural and urban area physicians explained that they also avoid prescribing a PSR's 
costly product because patients sometimes adopt other routes of treatment due to non-
affordability, as illustrated in following quotes:  
When patients cannot afford medical treatment they sometimes consult with a 'Hakim or Quack'. They 
just like to spend ten or 20 rupees and avoid buying costly medicines and ultimately they face very serious 
consequences. Therefore, it is better to prescribe a product that they can afford [UGP-6]. 
If I do not take care of my patients their care can become neglected. They will not want to consult with a 
professional physician, instead they will be more likely to consult with a Quack [RGP-1]. 
This demonstrates the physicians’ awareness of patients' tendencies to take healthcare 
assistance from Hakims or Quacks, who are not considered qualified by medical science, as 
an economical alternative. Hakims treat their patients with natural herbs or plants, however 
they have no advanced diagnostic techniques to find out the actual cause of patients’ disease 
or ailment. Moreover, many diseases cannot be treated with natural herbs. Quacks on the 
other hand use modern medicines; however, they are non-qualified personnel, who have 
very limited knowledge of pharmaceutical products that can be used within particular 
disease indications. This can lead to the misuse of drugs and patients more often face very 
serious consequences. Similar to the above explanation, one of the rural area physicians 
explained another source of treatment, when a patient cannot afford the cost of medical 
treatment, as illustrated in the following quote: 
If I do not look after of my patients they may move to religious persons for spiritual treatment. I don't 
know how they are treated but my patients are not well educated and they may prefer to get their 
treatment in this way [RGP-2]. 
This again signifies the physicians’ uncertainty about the patients’ disposal to have spiritual 
treatment. In his explanation he does not explain this; however, he pointed out that the rural 
areas population was not educated. This implies that physicians' were well aware that their 
patients' educational status was not adequate to make comparisons about the negative 
consequences of these routes of treatment. In the above quote, perhaps he tried to express 
his feelings that the majority of professionals who offer spiritual treatment do not have a 
good breadth of knowledge about the religion; they are professionals who treat patients just 
because of the income. There is no doubt Muslims believe in spiritual treatment; however, 
there are very few experts in this area and patients mostly fall victim of the fake ones. This 
therefore, leads to the patient being in a worse condition in terms of their disease or ailment 
and to avoid such unwanted consequences, physicians switch to less expensive alternatives. 
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One of the rural area physicians explained that there was no alternative but to overlook the 
PSR's product and to prescribe an alternative, as explained in the following quote: 
There is no doubt you have RQ with the PSR but a higher product price is a hindrance. Only possibility to 
prescribe the PSR's product is if his or her firm reduces the price or patients' ability to afford increases. I 
am helpless to increase patients' buying power and it is not in the PSR's hands to reduce the price. 
Therefore, the middle way is to prescribe a low price alternative, it will take few more days to cure the 
patient with but he or she will at least recover [RGP-4]. 
This signifies that physicians can have RQ with PSRs, however its outcomes in terms of 
prescriptions from the physicians depends upon the patients' affordability and the price of 
the product that the PSR promotes. For physicians, patients' wellbeing is the critical priority 
and in the situations where the patient has economic constraints the physician has to 
prescribe something that a patient can buy to recover his or her disease or ailment. By doing 
so, physicians not only achieve patients’ satisfaction and retention, and thus make their own 
practice viable, they also reduce the chances of patients’ seeking other ways of treatment 
and mitigates the unethical behaviour of the pharmacies. 
In summary the above explanations from both rural and urban area physicians confirm that 
they cannot always meet the objective outcomes of RQ as per PSR's expectations if he or she 
promotes a high price product. This is due to the intense level of competition within the 
physicians’ practices, located nearby to each other. If the physician cares about his or her RQ 
with the PSR and prescribes the PSR's costly product beyond the reach of a patient, this will 
leads to the patient's dissatisfaction with the physician. Since, the patient might perceive the 
physician is quite expensive and he or she cannot afford the health care solution provided by 
the physician, the patient will switch to another physician. The above explanations provide 
the idea that physicians had full awareness of their patients' switching behaviour due to 
non-affordability and educational status (particularly in rural areas). Therefore, even though 
they had RQ with a PSR, they would prescribe less expensive alternatives to avoid potential 
loss of patients, not only because they switch to another physician but also to avoid patients' 
adoption of other routes of treatment. Therefore, they have to provide maximum patient 
satisfaction by curing them earlier and also by means of giving them economic compliance. 
This is because physicians want to ensure their self-interest through their patients' 
wellbeing, their retention or earnings and practice viability. In such a situation the PSR-
physician RQ related underlying mechanism of reciprocity remains dormant and physician's 
self-interest in terms of patient wellbeing becomes more active, which leads to the 
physicians' prescription decision making of an alternative low price product. It is thus 
confirmed that physicians' self-interest with patients was highly prevalent mechanism due to 
huge competition among the physicians practicing in both rural and urban sale areas and 
because of the patients' adoption of other routes of treatment. 
However, as explained by respondents, the self-interest in maintaining patients' wellbeing 
for their satisfaction, retention and practice viability was not only achieved by providing 
economic compliance; it also depended on the quality of a product so that the physician was 
able to cure the patient earlier. Therefore, similar to the findings in chapter 4, physicians 
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were asked, when they switched to a low price alternative, how they ensured the product’s 
quality or efficacy to cure their patients’ disease. Their explanations are examined in the 
following section. 
5.4.3 PHYSICIANS' INTERACTION WITH OTHER FIRMS' PSRS AND THEIR 
  EXPERIENCE OF ALTERNATIVE PRODUCTS  
All the rural and urban area physicians explained that they had long experience of using 
alternative products from various firms' PSRs, who promote the same product with different 
brand names. Therefore they were well exposed to different alternative product prices and 
their efficacy, as illustrated in the following quotes:  
When you prescribe a low price product on trial basis in two to three patients, you develop your trust and 
satisfaction when you find recovery from patients’ disease. Therefore, we prescribe alternatives on the 
basis of our clinical experience [RGP-2]. 
Some national companies are good enough in Pakistan. Secondly, I have been prescribing their medicines 
for a long-time now. For instance I know that the injection I am going to prescribe is good enough. So, all 
this process is fed by my clinical experience [RGP-7]. 
This suggests that on finding satisfactory results in terms of patients’ recovery from disease, 
physicians also develop their trust in lower price alternatives. Furthermore, as they gain 
experience of some firms producing economical products over the long term, therefore their 
trust is also strengthened and they can prescribe them confidently. However, they also 
confirmed that this is their course of action for mild to moderate infections. If the patient 
does not recover with a lower price alternative or a patient has a severe infection, then they 
switch the patient to a product they have more trust in. This is illustrated in the following 
quote, which is representative of many others: 
During my prescription decision making I definitely think which PSR loves me more, who interacts with 
me frequently but I also have my clinical experience about which brand is suitable for a patient. For 
example: If I prescribe 'CARICEF' would my patient be cured by it? If I know that my patient has already 
been suffering with the disease for the last ten days then on the basis of my investigation, I prescribe the 
research brand 'CEFSPAN' from the very first day. But I counsel the patient that at the moment this 
product is more suitable [RGP-6]. 
The above quote from a rural area physician clearly indicates that during the prescription 
decision making process all the following mechanisms are present: PSRs' RQ related (i.e. 
physicians' reciprocity for the PSR): patient's medical and economic context related (i.e. 
patient's wellbeing, and non-affordability): and physicians' own experience of different 
products (i.e. physicians' clinical-experience). However, the choice between the alternative 
and the PSR’s product was contingent to the patients' particular medical or economic 
conditions. This implies that the choice of the PSR's high price product will be done when 
necessary for the patient in terms of the patients’ disease severity. However, in normal 
situation physician will prescribe a product that provides an economic benefit to patients. 
This is because they operate in an open system and patients' different economic and medical 
conditions demand that they keep their options open in order to achieve their self-interest in 
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patients' wellbeing, economic-compliance and their own practice viability. As examined 
above, this is important for physicians to survive within a particular patient's condition and 
in all, the physicians' clinical-experience plays an important role, as illustrated in the 
following quotes:   
After such a long-time in practice you become enabled, which gives you confidence that the product you 
are going to prescribe will provide efficacy to a patient [UGP-5]. 
Definitely, there is an efficacy doubt that is why I do not use franchisers and try to use MNCs and a few 
national firms' medicines. I try with a medicine at a reasonable price; if that cures the patient then it is 
fine. If not then I switch to the brand leader [RGP-6]. 
This implies that physicians, based on their clinical-experience in both sales areas, prefer to 
prescribe an economical product first to achieve their self-interest in terms of patient's 
wellbeing, both medically and economically. This fulfils all their ethical, emotional and 
practice viability objectives. However, a PSR who promotes a high price product will only be 
considered for prescription if the physician feels it appropriate, i.e. when the patient does 
not recover. In such cases patients' wellbeing mechanism becomes more active, since 
physicians' self-interest in terms of practice viability is achieved when a patient recovers. 
However, many physicians explained that patients' non-affordability mechanism could be 
handled by either physician’s counselling to patients or patients' own understanding of the 
severity of their disease.  
In summary, the above explanations from both the rural and urban area physicians give the 
idea that due to intense competition in the Pakistani pharmaceutical industry, physicians 
were exposed to many alternative products because of regular contact or visits from other 
PSRs. Therefore, they also expressed their trust in MNCs and some of the national firms’ 
products and relative prices because of their many years of clinical-experience. As a result 
they also developed relationships with the PSRs representing these firms, since these other 
PSRs were also providing services and visiting physicians.  
Their explanations also give the impression that they develop a priority list of few PSRs for a 
particular product category with different brands at varying prices. By having RQ with the 
physicians, PSRs find a place in the physicians’ priority list. Consequently, even if the product 
price is high, the physician looks after the PSR due to the presence of a reciprocity 
mechanism. However, the reciprocity mechanism becomes more active when a physician 
finds a feasible situation medically or when he or she has patients of sound economic means 
in terms of prescribing the PSR's product. This is not only because of the PSR's RQ with 
physician but also the physician has more trust in the PSR product's efficacy compared to 
lower priced alternative products, as this achieves physician's self-interest in patient's 
wellbeing and practice viability, when a patient comes with a severe infection. The next 
section provides physicians’ explanations about for whom and under what conditions RQ 
works more effectively in terms of achieving its objective outcomes.  
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5.5 FOR WHOM AND UNDER WHAT CONDITIONS OR CONTEXTS DOES RQ 
WORK MORE EFFECTIVELY IN TERMS OF ACHIEVING ITS OBJECTIVE 
OUTCOME  
All the rural and urban area physicians confirmed that the PSR's RQ with them worked more 
effectively when the PSR promotes a competitive product in term of its price and quality. That 
is to say, the PSR will achieve RQ’s objective outcomes consistently (in terms of prescription 
share) when there is a quality product and its price is affordable to a majority of the patients in 
the context of Multan in Pakistan. This is illustrated in the following quote, which represent 
other rural area physicians' quotes (please see appendix 8, Q-22 and 23): 
If the PSR's product price is competitive in comparison to alternatives, my prescription frequency will 
increase. Therefore, the PSR will attain more benefit from RQ when he or she offers an economical, quality 
product [...]. Because mentally I evaluate the firm's image as well, therefore, such a PSR achieves more 
prescription share you can say he or she will get six out of ten prescriptions [RGP-6]? 
Similar to the above quote from rural areas physicians, the physicians from urban areas also 
confirmed that they prescribed the PSRs product more frequently when the PSR provides a 
product with both quality and economy. This is illustrated in following quote, which represents 
the many other quotes of similar meanings (please see appendix 8, Q-24 and 25): 
If the PSR's product price is competitive then he or she will achieve all the benefits. This is because the PSR 
fulfils all our social and psychological needs. He or she not only fulfils the primary criteria but also 
appeals to me aesthetically and therefore I will have RQ with that PSR [UGP-4]. 
The quote above from physician give the impression that PSR's RQ related emotional and 
self-interest and reciprocity mechanisms became more active when the product price was 
not high. This is because the PSR fulfils all their technical, social, economic and aesthetic 
criteria. Moreover, because physicians have more trust in the PSR's product’s efficacy, 
therefore they have more confidence that they will achieve their self-interest in patients’ 
wellbeing and practice viability. Moreover, in such a situation the physicians do not feel any 
pressure about patients' ability to afford and therefore, the patient's non-affordability and 
emotional mechanisms due to sympathies for a patient remain dormant. That leads to 
frequent prescriptions for the PSR and the PSR achieves the objective outcomes of RQ in the 
form of an increase in the product’s sales.  
To further verify the effect of RQ and its mechanisms on the increase in prescription share 
or sales, physicians were also probed on how they decide on a brand for patients that offers 
low price and good quality when they do not have RQ with the PSR. Their responses are 
illustrated in the following:    
If you do not have RQ with the PSR, but he or she offers a quality and economical product, it will be 
prescribed where needed. This is because I have to take care of the patient's welfare [RGP-3]. 
Yes I will prescribe where it is required but not frequently as compared to the PSR with whom I have RQ. 
He or she will get the bulk of prescription share in the longer-term. Therefore, he or she will get the 
prescription share about six out of ten times [UGP-3]. 
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These quotes above from both the rural and urban area physicians clearly signify that the 
PSR will not achieve the maximum prescription share just on the basis of quality and 
economy of a product. However, if the physician has RQ with the PSR, he or she can achieve 
an increased prescription share. This implies that PSR's RQ related emotional, self-interest 
and reciprocity mechanisms in combination of patient's affordability and product's efficacy 
mechanisms assist in achieving higher prescription share and sales.  
However, physicians’ explanations also give the idea they have to limit their prescriptions of 
the PSR's product due to various other reasons. That is to say, physicians do not want to 
leave any perception of unethical behaviour (for instance accepting financial incentives from 
the PSR) for other physicians, pharmacists, PSRs and patients.  
It is against my conscience or principles to give a one hundred percent prescription share to the PSR with 
whom I have RQ or friendship. This is the way of those who make unethical financial arrangements with a 
firm or its PSR [RGP-6]. 
This is because you have to be careful, if you prescribe only the PSR's product the other people around in 
the market may suspect bribery [UGP-3].   
This signifies that a physician also has to take care of their own reputation as it can lead to a 
negative impression of the physician within the community they deal with if they only 
prescribe products of PSR’s with whom they have RQ. This can be perceived as an unethical 
sort of relationship between the physician and PSR by others. Since there was tendency of 
unethical marketing practices by few companies to achieve maximum prescription share, as 
explained by physicians in above illustrations. Therefore, to avoid the repercussions of such 
perceptions they keep themselves under their self-imposed limits in terms of giving 
prescription share.  
Apart from this, physicians explained that they also did not prescribe the same product 
every time to patients. If a physician prescribes the same product repeatedly, patients might 
remember the product or brand name. This could lead to them self-medicating by buying the 
same product from pharmacies for their own use or that of any family member with the 
same condition, without getting a diagnosis from the physician. As explained above, there 
were not strict rules and regulations or monitoring of pharmacies in both urban and rural 
areas. Patients were able to buy any medicine without physicians’ prescriptions. Therefore, 
this leads to physicians’ reservations and in order to provide a psychological change to 
patients, physicians prescribe different brands under same product category; and hence 
they cannot always prescribe only the PSR's product.  This is illustrated in the following 
quote: 
You have to provide a psychological change to your patients, therefore you have to prescribe some other 
PSR's product. In that way you also oblige him or her [UGP-3].  
Furthermore, as physicians explained above they have more than one PSR in their priority 
list, and this creates an opportunity to oblige the other PSRs by dividing the rest of the 
prescription share between them. In that way they achieve other PSRs’ commitment in order 
to retain relationships with them to meet their own technical and social self-interests with 
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other PSRs as well. However, they confirmed that they provided the higher prescription 
share (i.e. six out of ten prescriptions) when they had RQ with the PSR and the PSR offered a 
quality and economical product. Hence, the above explanations from both the rural and 
urban area physician of Multan confirmed that the PSR's RQ works more effectively in terms 
of achieving its objective outcomes i.e. an increased prescription share or sales, when he or 
she offers both quality and economy with a product. The next section provides the summary 
of the findings of chapter 5.   
5.6 CHAPTER SUMMARY  
The mechanisms verified through explanations from the sections above are outlined in table 
5.1. These mechanisms can coexist; however, their activation depends upon the patient's 
particular context. When the PSR's product price is high he or she can only get a prescription 
from physicians in one of two contexts: either the patient can afford to buy the product; or 
when it becomes essential to prescribe due to the severity of the patient's medical condition. 
Table 5.1: Mechanisms verified from two different contexts and outcomes they produced 
            Context Mechanisms Outcomes 
 
 
Patients' Affordability and/or 
severe medical condition  
PSR's RQ related reciprocity, 
Ensured product efficacy,  
Physician's self-interest in patients' wellbeing, 
Patients’ non-affordability 
Physician's counselling of patients  
Physician's self-interest in  practice viability    
 
 
Physician's prescription for the 
PSR's high price product  
 
 
 
Patients' non-Affordability  
And/or mild to moderate 
Medical conditions 
PSR' RQ related reciprocity, 
Physician’s interaction with other firms' PSRs  
& exposure of alternative products  
Physician's clinical experience  
Physician's self-interest in patients' wellbeing, 
Physician's emotional sentiments for patients, 
Physician's self-interest in  practice viability    
 
 
 
Physician's prescription for the 
alternative low price product  
 
 
 
In the case of severe medical conditions or infections the efficacy of the PSR's product turns 
out to be more active since physicians trust in the PSR's product more than alternative 
products in order to achieve patients' wellbeing and their own self-interest in practice 
viability. This is also supported by the physician-PSR RQ related reciprocity mechanism; 
however, in such situations patients' wellbeing mechanism is more active and physicians 
counselling of patients to buy the PSR’s costly product mitigates the effects of the non-
affordability mechanism. Therefore, patients' non-affordability mechanism is present, 
however, it remains dormant in that particular time and space, which is shown by the 
turquoise blue colour in table 5.1. The PSR' RQ related reciprocity mechanism becomes more 
active if patients' affordability mechanism is also present. This is because these mechanisms 
are also supported by the ensured efficacy of the PSR's product, which helps physicians to 
achieve their goal of patient wellbeing and therefore physicians also achieve their self-
interest in practice viability.       
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However, as confirmed by the physicians above, overall their patients' economic conditions are 
not sound, therefore this leaves less chances for the physicians to prescribe the PSR's costly 
product frequently because of patients' non-affordability mechanism, which was highly 
prevalent in both the rural and urban areas. Moreover, physicians’ assessment of patients’ mild 
to moderate infection and activation of patients' non-affordability mechanism further fosters 
other related mechanisms. As a result, physicians' self-interest in patients' wellbeing leads 
physicians to prescribe an alternative product that the patient can buy and use. The patients’ 
wellbeing mechanism emerges because of the physicians’ professional ethics; which is also 
supported by the activation of emotional mechanisms that have their link with physicians’ 
humanity, empathy and sympathies for the patient’s non-affordability. Therefore, the PSR-
physician RQ related reciprocity mechanism is present; however, it remains dormant in such a 
particular time and space, which is shown by the turquoise blue colour in table 5.1. 
The patients’ wellbeing mechanism is also highly active because of physicians’ own self-interest 
in patient satisfaction, retention and physicians’ practice viability. In the event of non-
affordability patients are not only able to switch their physician, they can also adopt alternative 
routes of treatment. Furthermore, pharmacies’ behaviour of dishonouring physicians’ 
prescriptions also develops physicians’ reservations in considering the PSR’s costly product. 
The presence and activation of all these mechanisms guide physicians to evaluate alternative 
products. Finally, the mechanisms of clinical-experience, due to physicians’ exposure to 
alternative products and relationships with other PSRs in the priority list, also mitigate the 
effects of the PSR’s RQ related reciprocity mechanism. Thus, the physician switches to a low 
price alternative that a patient can afford to buy and use so that they can ensure their self-
interest in patients’ wellbeing, satisfaction retention and their own practice viability.  
The above findings therefore suggest that there is an inconsistent relationship between the 
PSR's RQ and physicians' prescription decision making of the PSR's product. This confirms 
that physicians cannot always meet with the objective outcomes when the PSR's product 
price is not competitive. These explanations also confirm that PSR’s RQ related mechanism 
is always present but its effects depend on patients’ particular economic conditions. This is 
because physicians are only able to prescribe the PSR's product when they find a patient 
with sound economic conditions or on the basis of patients' disease severity.  
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6 CONCLUSION:     
The overall purpose of this research was to critically explore the determinants, and their 
associated underlying mechanisms, that contribute to a PSR-physician's RQ. Furthermore, 
the aim was to investigate how far product pricing (and related mechanisms) has an impact 
on the outcomes of RQ i.e. objective outcomes in terms of physicians' prescription decision 
making under patients' specific economic situation - in the context of Pakistan. In pursuit of 
this, the research adopted critical realism's guiding principles to shed light on the 
phenomenon of RQ in an open system where different uncontrolled underlying mechanisms 
interplay or interact with each other to either support or constrain the development of RQ, 
and also to achieve RQ’s objective outcomes in different contexts. Because context specificity 
and mechanisms associated with it become essential, the research endeavours followed the 
guiding philosophical principles of critical realism (e.g. Danermark et al., 2002). This 
therefore led this research firstly to the identification of mechanisms and then verification of 
how these mechanisms interact to produce outcomes in terms of physician's prescription 
decision making within different contexts (e.g. Sayer, 1992).  
In doing so, the previous two chapters, comprising the embedded case study, have provided 
the findings and analysis of this research based on the structure provided first by initial 
conceptual framework, which was drawn from literature in chapter 2; and then based on the 
findings of chapter 4, produced the revised conceptual framework. The revised conceptual 
framework (outlined below in figure 6.1) as a product of this research is indicative of the 
interpretations of the data generated.  
The resultant revised framework was then verified later in chapter 5 by generating further 
data from two different contexts in order to ensure its authenticity and validity in terms of 
presence or stability of mechanisms identified in chapter 4. The subsequent findings of 
chapter 5 fully support the framework’s viability or practicability in terms of an open system 
inquiry that can become the impetus for further research on the notion of RQ in similar, or 
different, research settings or contexts.  
The following section presents the contribution to knowledge. The section after that 
discusses the research questions that drove this research in order to relate the findings 
accordingly, and the contribution they make to knowledge. The subsequent section then 
moves on to the limitations of the research. The following sections then provide the 
implications for practice. Finally, suggestions for future research, reflection on research 
approach and a few final comments are discussed. 
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Figure. 6.1: Verified: 'Revised conceptual framework' using evidence from both urban and rural sale 
areas 
6.1 CONTRIBUTION TO KNOWLEDGE  
One of the contributions of this research is the identification of the key determinants that 
contribute to PSR-physician RQ with respect to the Pakistani pharmaceutical and socio-
economical context, which can also be applied in the context of other developing countries 
such as India, Sri Lanka and Bangladesh or where there are similar socio-economic issues 
and healthcare structures present. Although most of the studies on RQ in general deal with 
developed countries, including those conducted in the pharmaceutical context (e.g. Clark et 
al., 2011; Lagace et al., 1991), this research confirms many other scholars' findings that RQ 
determining factors are contingent on wider contextual factors (e.g. Hewett et al., 2002; 
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Naudé & Buttle, 2000). However, this study has revealed a further determinants, which are: 
PSR's flexible responses to varied situations; appearance in terms of dress code (i.e. formal 
business attire, which includes trousers, shirt, tie and/or full suit); and the use of English 
and specialised medical language as a mode of communication. Both the PSR's appropriate 
appearance in terms of dress code and mode of communication discussed above gives the 
physician a perception of similarity and that the PSR has a professional attitude, which 
influences the RQ between them. Therefore, these aspects might also be important to 
consider for the development of salesperson and customer RQ in other professional 
product/services selling context. These findings suggest customers are less likely to develop 
relationships with sellers if their attitudes, such as professionalism and work ethics, are not 
mutually held (Smith, 1998b). Moreover product quality, which has not been considered in 
previous studies on RQ in pharmaceutical selling, emerged as a vital determinant in a 
pharmaceutical sales context. This is because product quality in this setting has some 
rational and emotional properties in relation to patients' wellbeing that affects the PSR-
physician's RQ, which might not be as crucial in the exchange of other product categories.  
Another major contribution of this research is that it has provided a deeper understanding 
of RQ’s objective or  financial outcomes while considering the impact of contingent economic 
factors. Previous studies (including those conducted in a pharmaceutical context) have seen 
RQ objective outcomes within the stable conditions of closed systems, without taking into 
account when these quality relationships interact with external contingent factors. 
Therefore, previous researchers have predicted that the establishment of buyers-sellers' RQ 
will achieve objective outcomes for sellers, i.e. sales effectiveness and/or increased business 
share (e.g. Boles et al., 2000; Crosby et al., 1990; Huntley, 2006; Leuthesser, 1997; Palmatier 
et al., 2006; Palmatier, Scheer, Houston, et al., 2007; Vieira et al., 2014). However, this 
research indicates that RQ's objective outcomes in terms of increased sales were not 
consistent when the product price was high. There is no doubt that a salesperson’s RQ with 
a customer influences the latter’s buying decision making due to the presence of self-
interest, emotional and reciprocity mechanisms. However, the actual purchasing decision, 
which leads to sales increase, also depends on the cooperative activation of other contingent 
mechanisms related to the overall economic conditions of customers. That is to say, the 
consistent achievement of objective outcomes or sales increase is only possible when the 
product price is affordable to customers, which mitigates the effects of these other 
confounding mechanisms. The overall economic conditions and the price of the product in 
terms of achieving RQ’s objective outcomes should not be under-estimated. 
Therefore, it can be anticipated that RQ’s objective outcomes cannot be seen within the 
stable environment of a closed system without taking into account the other confounding 
factors or mechanisms significant to the particular research context (i.e. firm-to-firm, firm-
to-consumer, and interpersonal selling context). Particularly, in selling products or services, 
the effectiveness of RQ cannot be understood by just predicting that RQ between a 
salesperson and customer will lead to its objective (i.e. sales increase) outcomes. For a 
comprehensive or better understanding and implementation, it is necessary to investigate 
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how far other mechanisms related to particular research contexts support or constrain the 
objective outcomes of RQ between a salesperson and customer.      
Furthermore, the majority of previous studies (particularly in pharmaceutical context) have 
seen the development of a dyadic RQ between buyers-sellers (Odongo et al., 2016), when 
observing its objective outcomes. However, Holmlund (2001) argued that buyers' purchase 
decision making can also be influenced by the interaction of other relationships in the value 
chain; therefore these aspects should also be taken into account in order to verify the 
effectiveness of RQ in terms of achieving its objective outcomes (e.g. Hennig-Thurau & Klee, 
1997). This research also fulfils this call in the RQ literature by considering the 'PSR-
physician-patient' triadic relationships, which confirmed that PSR-physician's RQ outcomes 
are contingent on patient's relationship with physician. Patients' particular medical and 
economic conditions cannot affect the development of RQ; however, these factors influenced 
the physicians' prescription decision making and thus PSR’s prescriptions as an objective 
outcome of RQ. Moreover, physician's prescription decision making as an objective outcome 
of PSR-physician RQ is not only influenced by the patient-physician relationships but can 
also be affected by the physician's awareness of other value chain members' behaviour, such 
as pharmacy personnel's ability to dishonour the physician's prescription. Therefore, along 
with the identification of contextual mechanisms discussed above, the interaction of other 
relationships in the value chain should also be taken into account in order to determine the 
effectiveness of RQ in achieving its objective outcomes in similar or different contexts of 
firm-to-firm and firm-to-consumer RQ, subjected to study.   
Finally, this research has also contributed to knowledge because it went beyond the 
identification of what determinants are needed but also highlighted why these determinants 
are required, how they help to develop RQ and what outcomes can be achieved. That is to 
say, the application of critical realism's principles allowed this research to explore the 
underlying processes or mechanisms associated to determinants that influence RQ. This 
research confirmed that all the RQ determinants engender the cognitive, or self-interest and 
emotional sentiments that act as a mechanisms, which help a PSR to gain the physician's 
trust, satisfaction and commitment that comprise RQ. These mechanisms further foster the 
reciprocity mechanism that influences RQ’s subjective and objective outcomes. 
Furthermore, by identifying the other objects of the pharmaceutical selling structure, the 
relationships between them, causal forces they possess, and overall conditions in which they 
operate, this research discovered several additional mechanisms that either support or 
constrain RQ’s related mechanisms to achieve its objective outcomes. Previous research on 
RQ has just focused on the interrelationship or constant conjunction between the variables 
by simply measuring their effects on each other in stable conditions. In this respect, this 
research has advanced existing knowledge of RQ one step further by providing a way to map 
out deep processes or underlying mechanisms, which is important for better understanding, 
and implementation of RQ in a specific context, to assist achieving it in its expected objective 
outcomes. This has the potential to reduce the theory and practice gap, a common criticism 
raised by scholars concerning the profitable application of relationship marketing 
scholarship (Ashley et al., 2011). 
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To further explain how this research made contributions to knowledge, the following 
section discusses the research questions that drove this research in order to relate the 
findings and contribution to knowledge accordingly.  
6.2 ASSESSMENT OF FINDINGS WITH RESPECT TO RESEARCH QUESTIONS: 
The following subsections of this section start by evaluating, or comparing, the findings 
against the initial research questions. These are: 
1) What determinants are needed and why are they required to build up RQ between 
PSRs and physicians in a Pakistani pharmaceutical context? 
2A) How does PSR-Physician RQ (i.e. trust, satisfaction and commitment) interact with the 
product price in relation to patient's economic status?   
2B) What are the outcomes of this interaction in terms of physicians' prescription 
decision making and tendencies in their choice of pharmaceutical products? 
6.2.1 RESEARCH QUESTION 1 
In general, all the interviewees (including those in both phase one and two of data 
generation) in this research confirmed the RQ determinants that constitute the revised 
conceptual framework outlined above in figure 4.4 (see p. 137). The respondents explained 
that both firm-related RQ determinants (i.e. PSR's firm image and product quality) are 
important to developing PSR-physician RQ in the Pakistani pharmaceutical context. 
Similarly, respondents confirmed that a few PSR related determinants (i.e. PSR's visit 
frequency, appearance, communication, product knowledge or expertise, flexible responses 
to varied situations, ethical selling behaviour, and relationship investments) were also 
necessary for PSRs to develop RQ with physicians.  
However, some of these findings expand the scope of previous studies on RQ. For instance, 
product quality, which has not been considered in previous studies on RQ in pharmaceutical 
selling, appears to be a vital determinant. This is because product quality in this setting has 
some rational and emotional mechanisms in relation to patients' wellbeing that affects the 
PSR-physician's RQ, which might not be as crucial in the exchange of other products or 
service i.e. other than medicines. Therefore, product quality can be considered as a vital RQ 
determinant in the context of other developed and particularly in developing countries, 
where physicians' have less trust in the quality control mechanisms of medicine 
manufacturing. Moreover, the importance of product quality in RQ development efforts 
should not also be overlooked in other research settings, where buyers evaluate their 
relationship with sellers through both rationally and emotionally driven mechanisms with 
respect to the performance of the product exchanged. Therefore, quality not only influences 
the image of the firm that produces it but also the image of the salesperson who represents 
it in terms of customer's overall trust, satisfaction and commitment, which is important for 
the development of RQ. As a result, customers' judgements on RQ will be made based on the 
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quality of cstomer/salesperson interaction, product or service quality may also be 
influential (e.g. Bejou et al., 1998). 
Findings suggest that an appropriate visit frequency (i.e. at least fortnightly or if possible,  
weekly) is required to fulfil the physician's technical, social and psychological needs, which is 
consistent with the literature (e.g. Crosby et al., 1990; Hennig-Thurau & Klee, 1997; Lagace et 
al., 1991). However, this research also suggests that an appropriate visit frequency by the 
PSRs discussed above is also vital in order to make it possible for physicians to memorize 
their product names, which might also be a case in other developing countries or where 
many products with different names are available under one product category. This could 
also be true for other research contexts where the salesperson does not need any prior 
appointment to visit a customer and frequent interaction between salespersons and the 
customer is required. Similarly, study participants confirmed PSR's flexible responses to 
varied situations as one of the RQ determinants primarily because of context specificity. 
While it is the case that in Pakistan physicians have to see patients and PSRs simultaneously, 
such practices might also be present in some other developing countries or other research 
contexts, this requires extra care from PSRs in terms of their flexibility in handling situations 
during interactions. Conversely, this might not the case in developed countries due to the 
presence of different rules, practices or structures, which might not allow salespeople to 
interact with physicians either frequently or in the presence of patients (e.g. in the UK, PSRs 
follow strict rules and practices developed by the NHS).    
Furthermore, a PSR's appearance in terms of an appropriate dress code (i.e. formal business 
attire, which includes trousers, shirt, tie and/or full suit) has never been considered 
exclusively as a RQ determinant in previous studies; however, in this study physicians 
considered dress code to be a part of the salesperson's similarity to them. This is a novel 
contribution because previous studies have identified other characteristics by which 
customers relate to salespeople, including age, attitude and beliefs, which influence the RQ 
between them (e.g. Boles et al., 2000; Crosby et al., 1990; Smith, 1998b). Nevertheless, the 
findings of this research suggests that an appropriately dressed PSR has a significant role in 
the development of RQ with physicians. Likewise, communication has been considered in 
literature as a RQ determinant as a result of its openness (e.g. Smith, 1998b) and content 
clarity (e.g. Parsons, 2002). Furthermore, in a recent investigation conducted in Malaysia in 
the banking industry Balaji et al. (2017) found that service providers' use of second (or non-
native) language during interaction leads to less responsiveness from customers and 
prevented RQ development between them. However, participants in this study emphasised 
the opposite; they stated that skills in English together with specialised or technical medical 
language were crucial as a mode of communication. In Pakistan it is believed that more 
educated people communicate in the English language. Due to a low education level in 
general, the majority of the population, including the patients, communicate in the local 
native languages. Physicians occupy an elevated position in the social order, where it is 
believed that physicians are more educated than those below them, including their patients. 
Because PSRs normally make their sales call to the physician in the patients' presence, in 
order to sustain or maintain a perception of the high social status of the physician, it is 
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advantageous for the PSRs to communicate using English. Apart from the internal or 
psychological level of need satisfaction, an appropriate use of communication also fulfils the 
physician's professional needs. The PSR's use of English together with specialised or 
technical medical language fulfil the physician's assessment of similarity with the PSR as a 
professional. Physicians take more interest in the interaction when the PSR exchanges 
information using professional medical language. Otherwise, the PSR will be perceived as a 
less credible source of information (e.g. Lagace et al., 1991), which leads to the physician 
being unresponsive in the information exchange. This will certainly lead to a lack of interest 
in the development of the relationship with the PSR, or even no relationship. This implies 
that development of relationships depends not only on the quality of the information 
exchanged, but also how it was exchanged (e.g. Parsons, 2002). Thus, it is imperative to 
communicate with the physicians not only in English, but also using their own professional 
medical terminologies. Both salesperson's appearance in terms of dress and mode of 
communication (including language) might be important to consider as RQ determinants in 
similar, or some other professional, selling contexts of developing countries such as India, Sri 
Lanka, Bangladesh and other contexts similar to Pakistan. This is because of the socio-
cultural similarity physicians feel towards PSRs in terms of wearing similar dress and using a 
language associated with the medical profession. In most of the developed world such issues 
might not appear, as the official dress code of salespeople is a suit and they tend to speak 
English if they do not share a mother tongue. However, in line with literature (e.g. Lagace et 
al., 1991), the findings of this research also suggest that a good breadth of product 
knowledge helps salespeople to use technical language, which coupled with English usage, 
facilitates their RQ with customers.         
Nonetheless, all the respondents who participated in phase one and two of the interviews 
proposed all the identified determinants to be crucial in the development of the physician's 
trust, satisfaction, commitment and hence RQ with the PSR in the context of Pakistan. 
Consistent with RQ literature, their explanations indicate that trust, satisfaction and 
commitment, although distinct, are interrelated with each other (Clark et al., 2011; Mullins et 
al., 2014; Smith, 1998b). Moreover, similar to the literature on trust and commitment, the 
findings also confirmed that trust can be of two different forms i.e. cognitive and affective 
trust (e.g. Arnott et al., 2007; Johnson & Grayson, 2005; McAllister, 1995). Commitment can 
also be of two different forms, i.e. calculative and affective commitment (e.g. Kumar et al., 
1994). Their development depends upon the activation of many mechanisms at a time, which 
are linked with the RQ determinants. In that sense, this research has unearthed that these 
determinants engender some underlying mechanisms, which helps a PSR to develop RQ with 
physicians.    
Chapter 4 highlights throughout that the most significant mechanisms of RQ were self-
interest (i.e. associated with physician's professional orientation in terms of his or her 
technical and economic needs). The professional needs to have a relationship with the 
patient's wellbeing and the patient’s economic needs were associated with the physician's 
practice viability in terms of patient retention and physician's earnings. Physicians 
developed cognitive trust, satisfaction and calculative commitment through the activation of 
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self-interest mechanisms. They also developed satisfaction, affective trust, and commitment 
through emotional mechanisms; which were linked with the physician's sentiments, and 
which emerged psychologically through the PSR's efforts to ensure physician's self-interests 
and also when the PSR fulfilled the physician’s social needs through regular contact. This is 
also consistent with the literature, where Smith (2011, p. 79) also confirmed that for any 
trust relationship, “both self-interest and emotional mechanisms are simultaneously coactive 
and indeed, the simultaneous cooperation of these mechanisms is often necessary". 
Similarly, commitment is also considered by literature to be a combination of both rational 
self-interest and the evaluation of the emotional benefits of a relationship by customers (e.g. 
Hennig-Thurau & Klee, 1997). Therefore, respondents further confirmed that these self-
interest and emotional mechanisms engender a physician's mechanism of reciprocity, which 
led to further expected positive RQ outcomes for the PSR. These could include subjective or 
behavioural and objective or actual outcomes of RQ in terms of an increased prescription 
share and sales.  
Thus, for the development of PSR-physician RQ, it can be concluded that both self-interest 
and emotional mechanisms might be relevant in similar contexts such as other developing 
countries or where a physician's earning depends upon the number of patients, which itself 
depends on patients' satisfaction that emerges through their early recovery and wellbeing. 
Since it is evident that these mechanisms influence the customer's reciprocity mechanism for 
the salesperson at most. Therefore, the RQ determinants that can influence or trigger these 
mechanisms in a range of sales contexts need to be identified in order to translate RQ into 
tangible sales benefits or to achieve its objective outcomes.    
6.2.2 RESEARCH QUESTION 2A 
Nevertheless, findings further revealed the subjective or behavioural outcomes were stable 
due to PSR-physician RQ related (self-interest, emotional and reciprocity) mechanisms. 
However, the objective or actual outcomes in terms of physician's prescription decision 
making that leads to increase in sales was not consistent, when the PSR's product price was 
too high for patients. This is because of the overall poor economic conditions of patients in 
the Multan sales areas in Pakistan. Chapter five highlights that physicians who are practicing 
for more than ten years in both these areas are fully aware of patients' limited ability to 
afford their healthcare related services. This leads to physicians' reservations when 
considering a PSR's product at a high price due to presence of the patient's non-affordability 
mechanism.  
These reservations to prescribe the PSR's high priced product emerged due to the presence 
of strong patient-physician relationships. Therefore, physicians' hold a more favourable 
attitude towards their patients (e.g. Lundin, 2000). They might consider their RQ with PSR 
while making prescription decisions; but not at the cost of their patient's wellbeing, because 
they fully understood the notion of conflict of interest and their professional norms 
(Chimonas et al., 2007). If a physician fails to cure a patient quickly within his/her budget, 
there is a potential risk of the patient's withdrawal and shift to another physician. Thus, 
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physicians' professional ethics, and physicians' professional relationship with patients in 
term of their own practice viability, came to the fore during physicians' prescription decision 
making. Physicians further explained their experience of the behaviour of pharmacies, as 
when prescribing a costly product, physicians remain uncertain about whether the same 
product will be provided by the pharmacy staff. Physicians also identified a tendency in 
Pakistan for pharmacy staff to sell products to patients which earn them more profit, 
particularly in rural areas. Moreover, physicians also confirmed that they avoided 
prescribing a PSR's costly product because patients sometimes adopt other routes of 
treatment (e.g. Hakims, Quacks and religious spiritual treatment) due to non-affordability. 
Respondents also confirmed that physicians also develop emotional sentiments that were 
linked with their sentiments of humanity, sympathy and empathy as agents of patients. 
These sentiments emerged because of the serious consequences if the patient did not receive 
the proper medication due to his or her non-affordability. All these stated factors act as 
mechanisms and interact with PSR-physician RQ related underlying mechanism of 
reciprocity. In such a situation the PSR-physician RQ related underlying mechanism of 
reciprocity, although present, remains dormant and physician's self-interest in terms of 
patient wellbeing becomes more active, which leads to physicians' reservations, as well as 
unwillingness to consider the PSR's costly product. 
6.2.3 RESEARCH QUESTION 2B 
Therefore, if a PSR promotes a high price product, a physician may feel unable to meet with 
the objective outcomes of RQ as per PSR's expectations, due to constraints such as the 
economic status of the patient they are prescribing for. The different economic and medical 
contexts of patients also produce different mechanisms that interact with the PSR's RQ 
related mechanisms to determine physician's actual prescription decision making.  
If the patient cannot afford the PSR's product, the physician switches to an alternative, more 
economical product in order to achieve patient's wellbeing within the patient's budget. In this 
situation PSR's RQ related reciprocity mechanism remains dormant; however, physicians' 
clinical-experience, which also act as a mechanism, becomes more active and facilitates their 
choice of alternative products. Respondents of this study explained that the physicians were 
exposed to many alternative products from many different firms PSRs' through regular 
interactions. Findings also revealed that physicians' had trust and satisfaction with a few firms' 
(i.e. multinational and top ten national firms) products and their PSRs' services. Physicians 
confirmed that they had long-term clinical-experience of using the products of these PSRs, 
therefore, they were able to make their choices of products according to patients' economic and 
medical conditions. In this way they achieve patient's wellbeing (i.e. linked with physicians' 
professional ethics and with their emotional sentiments) by providing them economic 
compliance. Furthermore, they were able to achieve their self-interest in terms of patient 
satisfaction, their retention and physicians' own practice viability by mitigating the patients' 
potential switch to other physicians, adoption of other routes of treatment and unethical 
behaviour of pharmacies (e.g. dishonouring of physicians' prescription that is changing the 
physician's prescribed medicine with a low price alternative product). Therefore, simultaneous 
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cooperation and activation of all these factors and their associated mechanisms caused a 
change in physicians' behaviour, which led to physicians' prescription of alternative, more 
economical products. All these mechanisms, with their order effects, are outlined below in table 
6.1, where the active mechanisms are highlighted in black; however, the dormant mechanisms 
in a particular time and place are shown with turquoise blue colour. 
Table 6.1 Contexts, mechanisms, their interaction and outcomes 
Context Mechanisms Outcomes 
PSR's high product price & 
patients' poor economic 
conditions and/or mild to 
moderate medical conditions 
PSR' RQ Related Reciprocity [dormant mechanism] 
Patients' non-Affordability  
 
Physician's self-interest in Patients' wellbeing, 
Physician's emotional sentiments for patients, 
Physician's self-interest in  practice viability 
 
 Physician's-clinical experience 
 
 
 
 
 
Physician's prescription for the 
alternative low price product  
PSR's high product price  & 
patients' sound economic 
conditions  and/or  
severe medical condition  
Patients’ non-affordability [dormant mechanism] 
Patients' Affordability 
 
Physician's self-interest in Patients' wellbeing,  
Physician's counselling of Patients 
Physician's self-interest in  practice viability 
 
PSR's RQ Related Reciprocity, 
Ensured Product efficacy, 
 
 
 
 
 
 
 
Physician's prescription for the 
PSR's high price product  
 
However, as highlighted in table 6.1, when the patient's economic conditions were sound or 
when his or her medical condition was severe, the PSR with a costly product got a 
prescription from the physician. In such a situation, PSR's RQ related reciprocity mechanism 
became more active if patients' affordability mechanism was also present. This is because 
these mechanisms were also supported by the ensured efficacy of the PSR's products, which 
helps physicians to achieve their goal of patients early wellbeing and therefore physicians 
also achieve their self-interest in practice viability. In addition, physicians also want to 
continue their relationships with PSRs, which is only possible if physicians reciprocate in 
terms of prescription share as a result of all the PSR's efforts to develop and maintain RQ 
with physicians. If physicians do not provide the PSRs an appropriate prescription share 
(ideally 50% in a particular product category), it leads to the weakening of RQ and 
ultimately its termination. However, as findings revealed, the overall economic conditions of 
both rural and urban area patients' were not sound, therefore this leaves less chance for the 
physicians to prescribe PSRs' costly products frequently because of patients' non-
affordability mechanism. Nonetheless, respondents confirmed that they would regularly 
prescribe the products of PSRs with whom they had RQ, if the price of the product was 
competitive at similar levels of quality. In this situation, PSR-physician RQ related emotional, 
self-interest and reciprocity mechanisms in combination of patient's affordability and 
product's efficacy mechanisms helped in achieving more prescription share and sales. 
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In the course of this research, it appeared that overall economic conditions had a great 
impact on the objective or financial outcomes of RQ. These findings therefore suggests that 
RQ expected objective (or financial) outcomes are not always consistent, even though the 
PSR-physician RQ related reciprocity mechanism is always present during physicians' 
prescription decision making. As a result, not only RQ’s determining factors but also its 
outcomes are contingent on wider contextual factors (Hewett et al., 2002; Naudé & Buttle, 
2000) as in an open rather than a closed system. These findings might also be relevant to 
other developing countries such as India, Sri Lanka and Bangladesh, or where similar socio-
economic issues and healthcare structures are present. Moreover, unlike developing 
countries, developed countries might have some different arrangements for the 
pharmaceutical sales structure. For example, in the UK economically deprived patients can 
be supported by the NHS and in US or other developed countries the cost of the treatment of 
majority of patients might be paid by insurance firms. However, both the NHS in UK and 
insurance firms in US, or health systems in other parts of the western world might have their 
own structures and mechanisms, which should be identified. This is important because they 
can also interact with the PSR-physician RQ related reciprocity mechanism due to higher 
product price and influence its objective outcomes in terms of physicians' prescription 
decision making. Therefore, the dimensions of both the salespeople/customer relationship 
and the customer/consumer relationship need to be considered in conjunction, not in 
isolation, when seeking the development of the RQ phenomenon, because the issues of each 
relationship are interdependent and represent vital aspects of the business exchange 
relationship.  
Moreover, the findings of this study reveal that the sales relationship can include even more 
layers. For example, in addition to the relationship between PSR and physician on the one 
hand, and physician and patient on the other, the physician and patient also have the 
intermediary in the form of the pharmacist. The pharmacist can make choices that may have 
an effect on outcomes; for example, physician decision making or patient satisfaction. As a 
result, the tangible financial benefits of RQ can not only be affected by the overall economic 
conditions but also by other members of value chain (Holmlund, 2001, 2008). In this respect 
the earlier assumptions by Fichman and Goodman (1996) hold true, that a better 
understanding of RQ, and its effectiveness in buyer-seller relationships, requires the 
analyses of contextual factors that structure the exchange process. Therefore, in seeking to 
ensure the objective outcomes of RQ it is imperative to consider the specific sales structure 
(i.e. its objects and relationship between them and causal powers they possess). It is also 
necessary to consider overall conditions holistically to understand the range of interacting 
mechanisms that could either support or constrain the effectiveness of customer/ 
salespeople RQ. RQ works more effectively in terms of achieving its objective (or positive 
sales) outcomes in a context where overall economic conditions and product price related 
mechanisms support salespeople-customers' RQ, contingent on other objects in the value 
chain. 
In spatial-temporal terms the findings of this study are context specific – they pertain to a 
snapshot of Pakistan at a particular time and place. If economic conditions in Pakistan were 
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to change, or the healthcare system were to be reformed, it is likely that the effects of the 
mechanisms (related to patients' economic condition) driving prescription decision making 
would change, or at least change in the relationship to each other. Moreover, individual cases 
of a relationship between a physician and a patient might change over the course of their 
treatment. For example, the physician-PSR RQ (and related mechanisms) might be the 
determining factor in the decision taken; however, if the patient’s condition worsened or 
their economic status changed, other mechanisms might become more important and come 
to dominate the prescription decision. What is clear is that according to the study findings, at 
the current time and in the study context of Multan, Pakistan, in aggregate the mechanisms 
dominating the physician’s relationship with the patient are more influential than those with 
the PSR, and this is likely to persist as long as Pakistan’s healthcare system remains as it is.  
6.3 LIMITATIONS OF THE RESEARCH 
The findings of this research should be considered in the light of following limitations. 
Although, generalizability and representativeness is not of concern to the qualitative 
research, however from a critical realist point of view the context of research is of most 
importance. Therefore, one of the limitations of this research concerns participant selection 
(i.e. PSMs and general physicians), which was taken only from city of Multan in Pakistan. It is 
highly possible that the economic, cultural conditions and working patterns may have 
differed from other potential settings, particularly of developed countries. In addition, the 
findings may not be fully transferred (with respect to patients' economic conditions) to 
consultant physicians or surgeons, who deal with more serious conditioned patients i.e. with 
serious illnesses as compared to general physicians.  
The second limitation concerns the participants of this research – who were all male. It is 
highly possible that female physicians or PSMs have different perceptions on the notion of 
RQ and therefore some different findings may have been achieved. This may limit the 
transferability of this study to similar or other sales contexts with a more mixed gender 
balance. 
The third limitation is concerned with the data generated from the physicians. Although, the 
average time of the contact with physicians lasted approximately about 43 minutes; 
however, they have been relatively brief compared to PSMs and therefore the focus was 
placed on semi-structured interview questions to cover the most prevalent issues related to 
the both initial and then revised conceptual frameworks. Therefore, this perhaps has limited 
the findings with regards to uncovering some of unexpected topics and associated 
mechanisms. 
Finally, as critical realism focuses on extended layers of reality, the data was therefore 
analysed carefully by moving from the empirical to the actual and to the real domain, by 
verifying data based on the principles that underpin critical realism (please see section 
3.9.3). However, as there were few concrete empirical examples in the literature to follow, 
therefore the research process might be different from other researchers following critical 
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realism's guiding principles. For example, the coding process adopted for the raw data was 
valid for this study (please see section 3.9.2), but given the nature of qualitative data and the 
range of analytical tools available to the critical realist it may not be directly transferrable to 
other studies.       
Nevertheless, the limitations discussed above aside, this research has extrapolated the 
discovery of insightful factors that are necessary in order to know the reality of the RQ 
phenomenon and its objective outcomes in an open system. The verified revised conceptual 
framework as a product of this research offers impetus for further research on the notion of 
RQ in similar, or indeed different, research contexts as the verified revised conceptual 
framework is comprehensive in the sense that has included not only the important factors, 
their interrelationships but also the mechanisms they engendered, which interact with each 
other in particular time and space to produce certain RQ outcomes.              
6.4 IMPLICATIONS AND SUGGESTIONS FOR PRACTICE 
The research is also of value as studies on the RQ phenomenon in the context of 
pharmaceutical selling are rare (Clark et al., 2011; Lagace et al., 1991) and it contributes to 
practice in general and particularly for Pakistan's pharmaceutical industry; as no research 
has been undertaken in this context to date. The following subsections offer the practical 
implications from this research first for management and then for PSRs. 
6.4.1 PRACTICAL IMPLICATIONS AND SUGGESTIONS FOR MANAGEMENT 
This research indicates many practical implications for management. Firstly, management 
must focus on the recruitment and training of their PSRs. Management should develop the 
recruitment and training policies by setting up the required criteria, which helps to develop 
RQ with physicians. Findings of this research revealed that physicians were highly likely to 
develop RQ with PSRs who could communicate not only in English but also using the 
appropriate medical vocabulary. This implies that management should setup criteria of 
hiring and hire PSRs who have an academic background in science subjects, such as 
pharmacists or those who know about the human anatomy. Also, those who have been more 
exposed to English language during their academic qualifications. Furthermore, they should 
develop an intensive training program to focus on the training of their PSRs with respect to 
products they have to promote in order to communicate accurate product knowledge for 
particular disease areas. Furthermore, there is also need for PSRs to be trained; for example, 
how to behave flexibly during their sales calls. Management should arrange some 
workshops for PSRs, where different physicians, in chamber situation handling sessions, can 
help them to improve their skills in dealing with these different real-time situations flexibly. 
Management should also develop a set of codes of ethics, which guide their PSRs to avoid 
exaggerating their products’ benefits, rather they should themselves inform physicians 
about the side effects and contra-indications of their products. Management should also 
make sure that their PSRs have full awareness of their firms' core code of ethics to avoid 
making false commitments when physicians may demand personalized services. Finally, 
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management should decide on an appropriate dress code (i.e. formal business attire, which 
includes trousers, shirt, tie and/or full suit) and also keep checks on PSRs dress and overall 
physical appearance. This can also be done by either arranging some exclusive training 
sessions on appearance improvements or by random checks during their fieldwork. By 
setting up both recruitment and training criteria, management can create a sales force that 
can achieve their firms' objective of longer-term quality relationships with physicians.  
Management should also make sure of an appropriate use of their companies’ services. The 
generalized services, for example samples and CMEs, can be used in the earlier stage of 
relationship development with physician. This is because physicians require these services 
early on for product trials and they might need some more product related information in 
order to develop their trust and satisfaction with the product. However, this research 
indicates that once physicians' trust and satisfaction has been established, product samples 
and CMEs do not have great impact, and that personalized services (such as clinical 
equipment gifts or family dinners, foreign academic scholarships etc.) have a greater 
influence on maintaining RQ in the later stages. Samples or other generalized services can be 
supplied when physicians request them for patients or for their own personal use. In this 
way, management can use or allocate firms' resources cost effectively by considering the 
particular need of individual physicians at a particular stage of a relationship with them.        
This research also indicates that firms' image development is essential to gain physicians 
overall trust and satisfaction. This is particularly important for relatively new firms. 
Management of these firms can arrange production plant visits for physicians, where they 
can provide necessary information on the manufacturing techniques of drugs for quality 
control and the sources of raw materials they use.                
One of the major findings of this research indicates that overall economic conditions have a 
large influence on physicians’ prescription decision making; therefore, for management 
setting up a competitive price for product in terms of achieving RQ objective outcomes is 
crucial. This implies a balance between both the relationship marketing approach to develop 
RQ mentioned above, and a traditional marketing mix in terms of setting up a competitive 
price through cost leadership. Both of these aspects are important for management in order 
to achieve firms' financial core objectives under the current intense competition within the 
Pakistani pharmaceutical industry. Lowering the product price or total dependence on the 
quality of relationships are not enough to achieve handsome financial returns. This requires  
a hybrid approach from management in terms of focusing on both the cost structures and 
also RQ development between the PSRs and physicians. The findings revealed that PSRs' RQ 
with physicians was able to mitigate a slight price difference. However, if the price was too 
high, this mitigated the effects of PSRs' and physicians RQ and consequently physicians may 
prescribe an alternative, more economical product. This aspect is of importance for the 
management of multinational firms, who have greater acceptance in terms of their image, 
products' quality and thus relationships with their PSRs. However, their product prices are 
relatively high, which creates a barrier for physicians in prescribing their products. 
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Therefore, the overall patients' economic conditions, pricing of products and RQ with 
physicians in terms of achieving increased sales outcomes should not be neglected. 
6.4.2 PRACTICAL IMPLICATIONS AND SUGGESTIONS FOR PSRS 
Although the management should provide training opportunities for their PSRs through 
continuous professional development, PSRs’ development as managers of their own sales 
territories depends more on their own motivation and interests. This research indicates that 
there is no doubt that PSRs’ firms' image and product quality influence the development of 
RQ. However, PSRs' own conduct during their sales calls is also critical in capitalizing on 
these firm-related advantages. In this respect, they should identify an appropriate visit 
frequency for individual physicians according to their particular needs and wants (at least 
fortnightly or if possible, weekly) by adopting physicians' set criteria in terms of visiting 
days and time. Furthermore, to fulfil their technical or professional needs in terms of 
exchange of product related information PSRs should improve their product and related 
disease knowledge. However, they should also judge the physicians' situations and avoid 
over detailing product information if physicians are busy dealing with their patients. In this 
regard PSRs can request a special appointment, i.e. relatively free time, for detailed 
discussions on all relevant points including adverse reactions, contra-indications and dosage 
schedules. PSRs should improve their English communication skills and try to emphasise 
medical language terminologies in their communications. Moreover, PSRs should not take 
for granted their dress code, since the findings of this research revealed that PSRs dress 
code has significant influence in the development of quality relationships with physicians. 
This gives the idea to physicians that the PSR is knowledgeable person and an expert of his 
or her products or services. Last, but not least, PSRs should avoid false promises with 
respect to provide any of services that are not the part of their firms' policies. By following 
all these above mentioned factors, PSRs highly likely to develop RQ with physicians. 
However, as PSRs have no control on the prices of their products, therefore they should 
allocate or target their products by segmenting physicians according to their patients' 
economic class as managers of their sales territories. That is to say PSRs should target their 
high price product for the physicians who deal with the patients' of sound economic class; or 
PSRs can take commitment from the physicians by emphasizing to prescribe their high price 
to affording patients. Since this research indicates that physicians prescribe the high price 
products to those patients who can afford them when they have RQ with PSRs. In this way 
PSRs can better achieve the sales outcomes as a result of their RQ with physicians.   
6.5 SUGGESTIONS FOR FUTURE RESEARCH 
This research offered an open system inquiry that may become the impetus for further 
research on the notion of RQ in the contexts of developed countries (e.g. UK and US) by 
identifying the different contextual contingencies and their impacts on the overall 
effectiveness of RQ in achieving its objective outcomes. 
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Particularly, researchers in critical pharmaceutical studies may be inspired to further 
explore role of PSRs-physicians' RQ in achieving its objective outcomes under the setting of 
consultant physicians, surgeons who deals with more seriously ill patients. 
One of the interesting and challenging topics worthy of investigation might be the impact of 
unethical marketing practices by some firms' PSRs on the PSRs-physicians' RQ in terms of its 
objective outcomes i.e. physicians' prescription decision making in the context of developing 
countries such as Pakistan. 
Another, interesting topic might be the use of discount to individual physician as one of the 
RQ determinants to develop RQ due to increasing trend of physicians' owned pharmacies 
particularly in Pakistan. This might mitigate the overall impact of a product's high price to 
achieve RQ's objective outcomes.    
6.6 FINAL REMARKS   
This research followed the guiding principles of critical realism, which enables it to 
investigate the notion of RQ and its overall effectiveness in an open system. However, as 
critical realism ontology is not easy to apply (Ryan et al., 2012) this also posed some 
challenges for me. This is mainly because of the lack of critical realism based empirical 
studies in the literature in general and on the notion of RQ in particular to inform the 
research process. Therefore, it required considerable effort and innovativeness as a 
researcher in its deployment. However, my motivation to explore the ‘reality’ of the PSR-
physician relationship and its effect on prescription decision making persuaded me that I 
would not find explanations of this issue from another quantitative study that correlated 
variables. I determined that qualitative data would be necessary to investigate this social 
phenomenon thoroughly, and this meant I needed an ontological position from which to 
view the data I would generate. During my reading around research philosophy I compared 
approaches to what I was trying to achieve and determined that critical realism offered me 
the best chance of achieving my research aim. Indeed, on first reading about critical 
realism’s approach to reality, I felt that it explained how I was already thinking about the 
issues I had encountered in my work as a PSR, and offered a means to explore the conditions 
of PSR-physician interaction in particular and relationship quality in the pharmaceutical 
industry in an in-depth and useful manner. Therefore, this helped me as a researcher to 
explore critically not only PSR-physician RQ at deeper level in terms of its associated 
mechanisms, but also the other contextual mechanisms that either support or mitigate its 
influence. Therefore, this facilitated me to evaluate PSR-physician RQ, that is its possibilities, 
deficiencies, and limitations, and provide a fresh insight in different conditions or contexts. 
Although this fresh insight is context specific, nevertheless it has contributed to the existing 
RQ knowledge in terms of underlying causes or mechanisms, which was not possible by 
adopting the dominant research approach in studying RQ (Smith, 1998b; Wray et al., 1994).  
This research has also enhanced my abilities as a practitioner on how a PSR can practically 
achieve the return on their RQ with a physician by minimizing the effects of countervailing 
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mechanisms in terms of achieving objective or increased sales outcomes.  This is because, 
after generating the necessary knowledge on pharmaceutical selling structure’s objects, 
causal forces, and context mechanisms, I am now able to estimate the driving forces behind 
physician's actions regarding their prescription decision making. Practically, the research 
has convinced me that while RQ is valuable to a PSR-physician relationship, its effects are 
subsumed by other, more influential factors in certain circumstances. Therefore, this has 
increased my consultative abilities in terms of designing relationship marketing activities in 
order to develop PSR-physician's RQ, and its contribution to achieving a firm's core 
objectives of increased prescription share from physicians and thus increased product sales.       
Furthermore, this insight could also affect the planning of Pakistani pharmaceutical firms 
seeking to maximise the effectiveness of RQ between their sales force and physicians.  
177 
 
7 APPENDICES: 
Appendix-1 
 
 
Participant information on data generation and 
INFORMED CONSENT 
 
Copy for Mr.  
 
Dear Sir  
My name is Sohail Mahmood Khan. I am currently a doctoral student at University of 
Gloucestershire UK and conducting a research as a part of my doctoral thesis on the relationship 
marketing practices applied in Pakistani pharmaceutical Industry. This is because the Pakistani 
pharmaceutical market is a highly competitive in a sense that more than 600 license companies 
are operating and promoting almost same original and generic brands on varying prices. This 
means that physicians have more options to choose among the alternatives brands to prescribe 
their patients. Therefore pharmaceutical managers promote more relationship selling efforts to 
the pharmaceutical sales representative for competitive advantage and to achieve maximum sales 
outcomes. The recent research on relationship marketing in western countries identified 
'relationship quality' (RQ) as a central construct of relationship marketing that enables a selling 
firm to achieve customer's loyalty and increased sales. Particularly research on RQ in 
pharmaceutical setting has provide the evidence that RQ between representative and physician 
has a great impact on physician's prescription decision making. I am investigating the notion of 
relationship quality between pharmaceutical sales representatives and physician's; and I am 
interested to find the key qualities that a physician likes if a representative needed to build 
relationship quality with the physician in a Pakistani context as no work has done in this context. 
However, in practice along with physician's relationship with representative many patient related 
factors are there that also interplay in physician's prescription decision making. For instance the 
overall Pakistani patient's economic conditions are not sound and there is poor Governmental 
healthcare support for the patients. In such a context physicians not only consider their 
relationship with the representative but also product price and patient's affordability in their 
prescription decision making. Therefore, I am also investigating the representative-physician 
relationship quality's interplay or interaction with patient's economic conditions on the outcome 
as physician decision making. That is how far the brand price a representative promotes can 
influence the expected outcomes of a representative-physician relationship quality. The study's 
title is:  
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A Critical Evaluation of the Interplay between Relationship Quality and Pricing Mechanisms 
in Physicians' Prescription Decision Making. 
The conditions under which data are to be collected are as follows: 
1. Study participation is on a voluntary basis. 
2. No information will be collected in regard to who participated in the study and who did not. 
3. Data collection and analysis intends to answer the defined research questions and for 
achieving the defined objectives of the case study only. 
4. Should the combination of collected data allow for the identification of individual study 
participants, this information will be kept confidential and will not be taken into 
consideration when analyzing the data. 
5. All data will be collected and analyzed through Mr. Sohail Khan only.  
6. There will be no disclosure of data. 
7. All data collected will be kept only until the point the study results are submitted as a 
doctoral thesis to the University of Gloucestershire (UK) and the thesis is marked as “passed”. 
8. Study participation can be interrupted or cancelled at any time without statement of reasons. 
In this case, the collected data will not be used but deleted. 
 
Invitation to study participation 
I would like to invite you to take part in this research study and provide me the honour to take 
your valuable interview. As you have a field experience of many years and keep the relevant 
knowledge that will help me to better understands the issues I wanted to investigate. 
The study can only be successful when sufficiently supported by study participants. I would be 
happy if you could support my study by participating in the following measures of data collection: 
 
 Data collection by interview 
 
  
Confirmation of having been informed concerning the research study 
I hereby confirm that I was informed regarding the case study through the following measures:  
Information meeting 
 
Others (please specify) _____________________________ 
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I agree to participate in the research study. 
 
I confirm that I was sufficiently informed about the research through the 
above measures and that I was given the chance to ask and clarify questions. 
  
I am aware of the facts that my participation in this research study is voluntary 
and that participation can be interrupted and / or cancelled at any time 
without statement of reasons, and that withdrawing from the study will not 
result in any negative consequences for me. 
 
   
 
   
I understand that the data collected through this research study are recorded 
and stored safely in anonymous form and that the data is analyzed by Mr. 
Sohail Khan for the purpose of this research.   
 
 
   
 
 
 
 
 
 
 
         Participant name           Date                                    Signature 
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Appendix-2 
Interview Schedule for first phase data generation: 
RQ 
1) How would you describe the importance of your relationship with a PSR in your choice of 
pharmaceutical products? 
2) In your opinion when a PSR can achieve strong relationships with you?   
Prompts: - In your opinion, how important are your trust in, satisfaction and commitment with 
PSR? 
         a) What role does trust play in the relationship between you and PSR?  
         b) Can you talk me through how your satisfaction with a PSR affects your relationship with  
 the PSR? 
          c) Can you tell me what role does your trust in and satisfaction with a PSR can play in gaining 
 your commitment with PSR? 
RQ Determinants: 
4) What factors do you think are vital to helping a PSR develop a strong relationship with the 
you? 
Prompts:    
 a) In your opinion what is the role of a firm's image in a PSR building strong relationships  
 with you? 
 Prompt: - How would you describe the characteristics of a firm that has a good image? 
                                 - Why do you think that the image of a firm that a PSR represents affects his/or 
                      her relationship with you?  
 b) Can you talk me through the role that product quality can play in developing strong 
      relationships with you? 
 Prompt: - How would you describe the characteristics of a good product quality? 
                                - Why do you think that the product quality that a PSR promotes helps to achieve 
       strong relationship with you? 
               c) How important do you consider the PSR's visits to you in building a strong      
      relationship? 
               Prompt: - In your opinion what PSR visit frequency and visit timing is appropriate to 
                     facilitate developing strong relationship with physician and why? 
                                - What affect does visit frequency play in shaping strong relationship? 
 d) Can you talk me through what role investments like samples, gifts, dinners, educational 
      scholarships to the physician can play in shaping a PSR relationship with a physician? 
                Prompt: - Can you describe what investment is valued most? by you and why?  
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 e) In your opinion how important is the PSR's ethical selling behaviour (such as not   
      exaggerating his product characteristics or undermining the competitor's products)  
      during sales calls to you? 
    Prompt: - What affect does a PSR's ethical sales behaviour play in the development of 
                     strong relationship with the physician? 
 f) Can you talk me through what is the importance of a PSR's product knowledge in    
     develop strong relationships? 
   Prompt: - How does a PSR's product knowledge play a role in development of strong 
                    relationships with physicians? 
8)  Do you want to add any other factors that a PSR needs to develop strong relationship with  
physicians? 
RQ OUTCOMES: 
5) Does a PSR having strong quality relationship with you helps him to gain your more 
prescriptions as an outcome? 
5a) Why does a PSR having strong quality relationship with you helps him to gain your more 
prescriptions as an outcome? 
              Prompt: a) Think about a PSR with whom you have strong relationship. How frequently 
                      you prescribe the PSR's product? 
     b) Why does you behave in that way? 
6) In your opinion under what situations you do not prescribe the PSR's products (even though 
you have a strong  relationship with the PSR and can prescribe the product indication wise to 
treat the patient's ailment)? 
    Prompt: a) Does the price of the PSR's product in relation to the patient's affluence lessen 
                        the effect of your strong relationship with PSR? 
                         b) How and why does higher product price in relation to the patient's affluence 
                        cause a change in your prescription behaviour?   
                                 c) Do you hold more favourable attitude for the patient as compared to the PSR 
          with whom you have a strong relationship? 
                   d) Why you prefer your relationship with the patient over a PSR?  
7) Can you describe when a PSR's strong relationship with you works more given the patient's 
circumstances? 
8)  Do you want to add any other aspect with respect to PSR's strong relationship with physician 
and on its outcomes? 
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Appendix-3 
Interview schedule for second phase data generation: 
1). How important do you consider your strong relationships with PSR in your prescription 
decision making? 
2). Why do you consider your relationships with the PSR in your prescription decision making?  
     Prompts  
         2a). How important is yours justification and rationale that leads to your prescription of the   
   PSR's brand as it provides relief to your patient? 
         2b). What is the role of your feelings or sentiment engendered due to the PSR's efforts,   
    services and trust in his or her benevolence? 
3). How would you decide a medicine for the patient who cannot afford the one you want to  
prescribe on the basis of your strong relationship with the PSR and his or her product's efficacy? 
      Prompts 
         4). If you do not prescribe, why you do so? 
         4a). How would your beneficence approach plays a role that leads you to switch onto the  
   other medicine according to the patient's affluence?  
        4b). How would your sentiments of empathy for the patient's non-affluence function; Why  
   would you favour your sentiments towards patient as compare to the PSR? 
        4c). How would your preference of practice viability (i.e. patients retention) works in this  
 regard? 
 5). How would you deal with your concerns about the efficacy of the lower price brand as  
compare to the PSR's higher  price brand's efficacy on which you trust? 
 6). How would you manage your strong relationships with the PSR? or    
       Prompts: 
            6a). Why would you prefer to wait for the right patient to whom you can prescribe? 
            6b). Why would you behave in such a way; does it because of your positive sentiments 
      about the PSR's efforts?        
 7).  How would you favour the PSR's product if it is less expensive on the basis of your strong 
relationships? 
 8). How would you behave when PSR's product is less expensive and you do not hold the strong 
relationships? 
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Appendix-4 Interview dates and Length: 
a) Phase-one Interviews 
PSMs 
Interviewee Group-Number Interview Date Length of Interview 
PSM-1 02-04-2016 122 minutes 
PSM-2 03-04-2016 106 minutes 
PSM-3 09-04-2016 83 minutes 
PSM-4 15-04-2016 103 minutes 
PSM-5 18-04-2016                     81 minutes 
Average Interview Length 
99 minutes 
 
Physicians 
Interviewee Group-Number Interview Date Length of Interview 
GP-1 12-06-2016 43:56 minutes 
GP-2 16-06-2016 53:57 minutes 
GP-3 16-06-2016 30:39 minutes 
Average Interview Length 
43 minutes 
 
b) Phase-two Interviews 
Urban Area Physicians 
Interviewee Group-Number Interview Date Length of Interview 
UGP-1 17-06-2016 41 minutes 
UGP-2 21-06-2016 30 minutes 
UGP-3 27-06-2016 34 minutes 
UGP-4 28-06-2016 31 minutes 
UGP-5 05-07-2016 35 minutes 
UGP-6 07-07-2016 30 minutes 
UGP-7 08-07-2016 28 minutes 
Average Interview Length 
33 minutes 
Rural Area Physicians 
Interviewee Group-Number Interview Date Length of Interview 
RGP-1 18-06-2016 33 minutes 
RGP-2 24-06-2016 43 minutes 
RGP-3 24-06-2016 88 minutes 
RGP-4 03-07-2016 40 minutes 
RGP-5 04-07-2016 34 minutes 
RGP-6 07-07-2016 100 minutes 
RGP-7 08-07-2016  38 minutes 
   
Average Interview Length 
54 minutes 
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Appendix-5: Final Categories, sub-categories and codes for phase-one data analysis: 
Theme  Categories Sub-Categories Codes 
RQ 
Determinants 
Firm-Related 
RQ 
Determinants 
Firm Image (FI)  
FRD-FI 
FRD-FI-F-age 
FRD-FI-PSR-ExPK 
FRD-FI-due to Commit 
FRD-FI-due to PQ 
FRD-FI-due to Medu 
Product  
Product Quality 
(PQ) 
FRD-PQ 
FRD-PQ-Compliance 
FRD-PQ-Packaging 
FRD-PQ-Patient Welfare 
Context=competition 
Barr-RQOO-PQ 
Barr-RQOO-P-side-effects 
Barr-RQOO-out-dated-Prod 
 
 
Product Price 
(PPR) 
FRD-PPR 
 
PSR's Related 
RQ 
Determinants 
PSR's Visit 
Frequency (VF) 
 
PSR-VF 
PSR-VF-ASB 
PSR-VF-Less-Busy-Time 
PSR-VF-Phy-felt obliged 
PSR-VF-for Chamber Presence 
PSR-VF-for information-services 
PSR-VF-for recognition 
PSR-VF-for reminder 
Appearance 
(Appr) 
 
PSR-Appr-Enthuism 
PSR-Appr-Drs 
Flexible 
Responses to 
Varied Situations 
(ASB) 
 
PSR-ASB 
PSR-ASB-Detailing 
PSR-ASB-Postman Call 
PSR-ASB-VF and Time 
Context=competition 
Communication 
(Communication) 
 
PSR-Communication 
PSR-Communication-Eng 
PSR-Communication-ExPK 
PSR-Communication-Humor 
PSR-Communication-Non-verb 
PSR-Presentation 
Product 
Knowledge (ExPK) 
 
PSR-ExPK 
Ethical Selling 
Behaviour (ESB) 
 
PSR-ESB 
PSR-ESB-Avoid False Claims 
PSR-ESB-Inform Side Effects and Contra Indication 
PSR-ESB-Leave-negativity and discuss pat-benefit 
Relationship 
Investments (RI) 
Generalized 
Services 
PSR-RI-Services 
PSR-RI-Services for Phy-time for socialization 
 Personalized 
Services 
PSR-RI-Pservices 
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Appendix-5: Final Categories, sub-categories and codes for phase-one data analysis (Continued): 
Theme Sub-theme Categories Sub-Categories Codes 
RQ 
Dimensions 
 
Trust (Trust) 
Cognitive and 
Affective Trust 
Trust=Phy-trust-PSR 
Trust=Openness and uncertainty Removal  
Trust=PSR's Sincerity 
Trust=PSR's commitment fulfilment 
Trust=FRD-FI-Phy-trust-PSR-FI 
Trust=Phy-Aff-trust-PSR-VF-LBT 
Trust=Phy-trust-PSR-VF 
Trust=Phy-Aff-trust-PSR-ASB 
Trust=Phy-trust-PSR-ASB 
Trust=Phy-trust-PSR-App and dress 
Trust=Phy-trust-PSR-communication 
Trust=Phy-trust-PSR-ESB 
Trust=Phy-trust-PSR-ExPK 
Trust=Phy-trust-PSR-PQ 
Trust=Phy-trust-PSR-RI-Services 
Trust=Phy-trust-PSR-P-services 
  
 
 
 
 
 
Satisfaction 
(satisfaction) 
 
 
 
 
 
 
 Satisfaction=Phy-satis-PSR 
Satisfaction=Phy-commitment Fulfilment 
Satisfaction=Phy-satis-PSR-VF 
Satisfaction=Phy-satis-PSR-ASB 
Satisfaction=Phy-satis-PSR-Appr and Dress 
Satisfaction=Phy-satis-PSR-communication 
Satisfaction=Phy-satis-PSR-ESB 
Satisfaction=Phy-satis-PSR-ExPK 
Satisfaction=Phy-satis-PSR-FI 
Satisfaction=Phy-satis-PSR-PQ 
Satisfaction=Phy-satis-PSR-RI-Pservices 
Satisfaction=Phy-satis-PSR-RI-services 
Commitment 
(Commitment) 
Calculative and 
Affective 
Commitment 
Commitment=Phy-Commitment-PSR-trust 
Commitment=Phy-Commitment-PSR-satis 
Commitment=Phy-C-Commitment 
Commitment=Phy-C-commitment-PSR-Services 
Commitment=Phy-A-Commitment-PSR-Pserv 
Commitment=Phy-VerbCommit-Moral 
bounding 
Commitment=Phy-A-Commitment-PSR-VF 
Commitment=Phy-Commitment-PSR-VF 
Commitment=Phy-Commitment-PSR-PQ 
Commitment=RQOO-Sales 
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Appendix-5: Final Categories, sub-categories and codes for phase-one data analysis (continued): 
Theme Sub-themes Categories Sub-
Categories 
Codes 
RQ 
Outcomes 
Subjective 
Outcomes 
Recognition  
RQSO-Phy-intentions-Rx 
RQSO-PSR Recognition 
Time and Priority  
RQSO-Bar-for-compi 
RQSO-Phy-P-List 
RQSO-Phy-share-Pinf 
RQSO-Time 
RQSO-PSR Priority over the other 
PSRs 
RQSO-spec-treatment 
Objective or Actual 
Outcomes as 
Physician's PDM  
Expected increase in 
sales or prescription 
share 
 RQOO-Freq-RXs 
RQOO-Sales 
 
Expected Prescription 
DM When Product 
Price is High 
 
Barr-RQOO-HPPR 
Barr-RQOO-Phy-Reserv-HPPR 
RQOO-HPPR=affording PAT 
HPPR-CritC 
RQOO-HPPR=LowRxs 
RQOO-LPPR=HighRX 
Barr-RQOO-Pat-EconC and Aford 
Barr-Pat-eco=HPPR-switch-LPPR 
LPPR-EF-clinic-exp 
LPPR-no-RQ 
Pat-afford-RQOO 
Practice viability 
Pat-is-Priority 
Pat-Phy-customer 
Pat-satis 
Patient-Phy-earnings 
Phy-Empathy-PAT 
Phy-Semp-Pat 
 
Miscellaneous Codes on Context (Context) 
 
Context-Competition 
Context-Patient's EcoC 
Context-Why RQ is Required 
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 Appendix-6: Final Categories, sub-categories and codes for phase-two data analysis: 
Theme Sub-themes Categories Sub-Categories Codes 
RQ Objective 
Outcomes 
As 
Physicians' 
Prescription 
Decision 
Making 
 
(Prescription 
for PSR's 
Product or 
Switch for 
Alternative)  
PSR's-Physician 
RQ 
  
RQ developing determinants 
FI and PQ 
PSR's PQ 
PSR's VF 
PSR's RI 
PSR's P-services 
PSR's ASB 
PSR's appearance 
PSR's Communication 
PSR's ESB 
PSR's ExPK 
Phy-Recog-PSR's efforts 
Phy-technical-need-fulfilment 
Mech-Phy-sintrest-PSR 
Mech-efficacy 
Phy-Recog-PSR's-Mech Emo 
Phy-social-needs-fulfilment 
Mech-emotional-PSR 
Mech-emotional-PSR-VF 
Mech-Reciprocity-PSR 
RQSO 
Product-Price 
Price and RQ interaction 
RQOO=Rx when price is competitive 
RQ+HPPR+Critical Cond+PQ=RX 
RQ+HPPR+Pat-counciling+PQ=RX 
RQ+HPPR=No RX 
RQ+HPPR=RX for affording class 
RQ+HPPR=Switch  
Patients' 
Economic 
Conditions 
 
 
 
 
 Patient's economic cond 
Phys sensitivity of P-Econd 
Pat-eco-benefit  
Mech-Affordability 
Mech-Patient's Affordability  
Patient-
Physician 
Relationship 
Physicians' 
Professional Ethics 
 
Phy-Prof-ethics 
Mech Patient's wellbeing 
RX-DM=Quality and Economy 
RX-DM=Patient's w-being and ecno-benefit 
Physician's 
Humanity, empathy 
and sympathies 
 
Phy-Humanity 
Phy-Sympathies 
Phys-Empathy 
Humanity, empathy, symp-Mech-emotional  
Patients' 
Satisfaction & 
Practice Viability 
Competition within 
Physician's Practices 
Patient's Satisfaction 
Patient is Priority  
Practice Viability 
Patient's-Recovery-Practice-Viability  
Mech-Self-interest-P-retention 
Physician's awareness 
of pharmacies 
behaviour 
RQ+HPPR=RX dishonour 
Patients Adoption of 
other routes of 
treatment 
Patient's switch to Quack or Hakim 
Pat-switch-spiritual treatment 
P-viability due to economy  
P-viability with patient's satisfaction 
Physician's 
Interaction 
with other 
Firms' PSRs & 
Exposure of 
Alternatives 
  
Price exposure-MNC and Nat-firms 
LPPR-efficacy doubt 
Efficacy-doubt-clinical-exp 
Mech-clinical-exp 
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Appendix-7: Example Excerpts of Atlas ti Phase-1 interview: 
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 Appendix-7: Example Excerpt of Atlas ti Phase-2 interview: 
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Appendix-8: Further Representative Quotes: 
Q1. If your firm's image is better then you will save half of the time required to build your 
relationships with the doctor. And if your firm does not have a good standing in the market or it 
does not hold a good image then it will be hard for you to develop all these relations. [PSM-2]. 
Q2. Company is at the back. If a person represents a firm that holds a good image then the doctor 
offers him more respect and regard. This is because, the company has existed for many years and it 
takes many years to develop a good image. The company's PSRs have been visiting the doctors for 
these many years. And whatever they do, either fulfilling their commitment or doing mis-
commitments, the reflection of all this will link to any new PSR going from that firm. That is if the 
firm holds a good image it will help PSR in developing relationships and in achieving commercial 
benefits.  [PSM-4]. 
Q3. The first three conditions must be met in order to develop strong relationships. These are: the 
good company image, and its drug should be good in that it should not be an outdated drug. After 
this, the role of the PSR starts and that matters a lot [GP-2]. 
Q4. Product quality is above all in terms of its importance for the physician. So without this, nothing 
is possible. Because, a physician's prime concern is the patient. Physicians' earnings are linked with 
the patients. And also we are talking about the medicine as many patients come in life-threatening 
conditions; therefore, a physician cannot take the risk. No matter how much personal interest a 
physician has, the physician will never take the risk that might lead to a casualty. So, efficacy is a 
must. [PSM-1]. 
Q.5. From patient's feedback physician evaluates the impact of the medicine in that, are my patients 
recovering from disease? So patients' recovery is a measurement gauge and it helps to build 
physician's trust in the product and without trust, nothing is possible. [PSM-1]. 
Q.6. Doctor will develop his trust when there is a quality product For example, if a doctor 
prescribes a product to ten patients and he or she finds positive results in nine patients then this 
means his or her confidence or trust and satisfaction will be developed in the product. Therefore, 
you cannot ignore the importance of product quality in the formation of strong relationship 
between the doctor and PSR [PSM-3]. 
Q7. If the product quality is not appropriate then the PSR will not able to survive. It may be possible 
that the doctor prescribes once or twice but if patients do not recover then the doctor will not 
continue to prescribe. And it is also possible that the doctor tells the PSR...sorry I cannot prescribe 
your product because it is not giving me the desired results [PSM-4]. 
Q8. If the patient is satisfied then the physician will develop his trust and satisfaction because the 
physician is there to serve the patient. And if his patient is not recovering then what is the benefit 
for him to develop a relationship with the PSR. A physician will only prescribe the product when 
the patients recover from the disease. And if a patient's trust is shaken then how can a physician 
develop his or her trust in the product.[PSM-5]. 
Q9. If the product quality is absent then how can my relationship be developed with the PSR? It 
cannot be developed. Because my trust in and satisfaction with the product will not develop when 
my patient is not satisfied as he or she is not recovering [GP-1]. 
Q.10 When the quality of a product is good, a doctor will not feel hesitation and will not have any 
doubt that the patient will recover if he prescribes. So if the doctor is confident about the quality of 
a product then he or she will prescribe [PSM-4]. 
Q.11. I really dislike PSRs who came to visit at peak times. It gives me the feeling that the PSR is 
visiting me just for formality and to let their seniors know that he or she is on call by sending them 
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a text. There is no-doubt that the PSR is visiting; however, I really feel exhausted that the PSR visits 
me only to fulfil his or her job requirements. And I really dislike those who start over detailing 
when I am busy dealing with patients in an emergency. In such cases I tell them to come back later 
[GP-2]. 
Q.12. In my opinion the best PSR is one who moulds him or herself according to the physician in 
order to develop strong relationships [PSM-4]. 
Q.13a Physicians usually know all the family background of the patient; for example, how many 
kids a patient has or to which economic class he or she belongs. From such assessments physicians 
develop perceptions about a patient's affordability [PSM-3]. 
Q.13b. In fact, Pakistan is a developing country and the socio-economic conditions of the patients 
matters a lot here and therefore, the physician must keep pricing factor in his or her mind with 
regards to the patients' affordability [PSM-4].  
Q.13c. The product should be economical. If the product you are going to prescribe has no 
economic compliance then the patient will slip away to another physician. Or he or she will take the 
medicine for a couple of days and then switch physician. This is because; the patient cannot afford 
the cost of the product. So being a physician I have to see these aspects because I have to take care 
of my practice as well [GP-2]. 
Q13d. The relationship with the PSR has its own place, but patient's problem should be sorted out. 
You have to recover the patient from the disease, and you have to satisfy him or her. That is why a 
patient is the priority for you [GP-1]. 
Q13e. As a human you also developed sympathies with the patient because of the pains and the 
distress he or she is suffering. So whatsoever I can do, I will do, for instance: I do not take my fee, or 
arrange a free source of the medicine and/or at least convince the patient to take the medicine in 
order to avoid further serious consequences [GP-3].  
Q.14 Definitely, doubt about efficacy is there when you prescribe a low price product. However, I 
try to choose one from a firm that buys the raw material from where the brand leader buys, this 
gives me the satisfaction that the patient will recover and I find this works [GP-3].  
Q.15. The decision regarding the prescription should be based on merit. The PSR will come in my 
liking because of his or her hard work and on these basis I have good a good relationship with the 
PSR. Therefore I will definitely prefer that particular PSR [RGP-2]. 
Q.16. Buying power of patients living in non-urban areas is much less than compared to urban 
areas [RGP-5]. 
Q.17. Therefore being a physician you need to think that whether the patient can buy a product you 
are going to prescribe, so that you can save his or her life. So, patients' ability to afford has a first 
priority [RGP-3]. 
Q.18. Being a professional the most important thing for me is to consider my patients' welfare. It is 
my responsibility to take care of all their physical, mental and economic conditions [RGP-2]. 
Q.19. I myself am a son of a poor family and I know what sort of miseries one has to face. For me 
this is an appropriate way to prescribe a product that a patient can buy and not let the patient go 
empty handed [RGP-7]. 
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Q.20. For instance, if I myself earn fifty thousand rupees a month and a physician prescribes me 
fifteen thousand rupees worth medicine for a month, how will I be managed the rest of other 
household expenses, I cannot afford it [UGP-6]. 
Q.21. If you make a prescription while considering all aspects i.e. economy, efficacy, standard and 
the patient’s recovery then you do not need to think about the patient's retention. The patient will 
then automatically be retained [UGP-4]. 
Q.22. If the PSR's product price is reasonable then I will regularly prescribe it. Because I have a strong 
relationship with the PSR, as the PSR is knowledgeable, and represents a good quality product of a 
reputable firm [RGP-1]. 
Q.23. If you have RQ with the PSR and he or she offers a quality product at a reasonable price, it will be 
prescribed very frequently [RGP-4]? 
Q.24. If there are three or four products offering the same quality and price then definitely I will 
prescribe a product of a PSR with whom I have RQ. I even prefer his or her product if there is only a 
small price difference from its competitors [UGP-1]. 
25. If the PSR's product price is economical then his or her product will be prescribed. This is the 
PSR's right because his or her product is available in the market at a competitive price and I have 
friendship with the PSR. Therefore, I have no reason to leave my friend because his or her product 
meets all the quality and economy requirements [UGP-6]? 
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